fluorodeoxyglucose f18 has been researched along with Lung Neoplasms in 3507 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.03) | 18.7374 |
| 1990's | 168 (4.79) | 18.2507 |
| 2000's | 1110 (31.65) | 29.6817 |
| 2010's | 1699 (48.45) | 24.3611 |
| 2020's | 529 (15.08) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, T; Huang, Q; Shen, J; Wen, L; Yao, L; Zhang, N; Zuo, M | 1 |
| Chen-Yoshikawa, TF; Fukui, T; Goto, M; Iwano, S; Kadomatsu, Y; Nakamura, S; Nakanishi, K; Ozeki, N; Sugiyama, T; Ueno, H | 1 |
| Lin, J | 1 |
| Akl, P; Buvat, I; Duboucher, C; Lacroix, M; Soussan, M; Wallis, D | 1 |
| Cholewiński, W; Kunikowska, J; Marszałek, A; Medak, A; Pietrasz, K; Pietrzak, A; Piotrowski, T; Wojtowicz, J | 1 |
| Jiang, JY; Karikios, D; Lee, ME; Mansberg, R; Parry, NM | 1 |
| Aigner, C; Darwiche, K; Eberhardt, WEE; Gauler, T; Guberina, M; Guberina, N; Hautzel, H; Herrmann, K; Karpf-Wissel, R; Metzenmacher, M; Ploenes, T; Pöttgen, C; Schuler, M; Stuschke, M; Theegarten, D; Umutlu, L; Wiesweg, M | 1 |
| Inoue, H; Ito, R; Izumi, N; Komatsu, H; Matsuda, Y; Nishiyama, N; Tsukioka, T | 1 |
| Durgun, B; Guney, IB; Kucuker, KA; Kucuker, M | 1 |
| Abdollahi, H; Amini, M; Arabi, H; Deevband, MR; Hajianfar, G; Nazari, M; Rahmim, A; Shiri, I; Zaidi, H | 1 |
| Bai, T; Huang, Q; Yao, L; Zhang, N; Zuo, M | 1 |
| Chen, H; Feng, A; Huang, Y; Kong, Q; Shao, Y; Wang, H; Xu, Z | 1 |
| Dong, A; Wang, Y; Zhang, J | 3 |
| Cai, Q; Flores, R; Henschke, CI; Lee, DS; Taioli, E; Wang, Y; Yankelevitz, DF; Yip, R; You, N; Zhu, Y | 1 |
| Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Gao, C; Liu, H; Zou, Q | 1 |
| Iwata, H; Kuroda, H; Nakada, T; Ohtsuka, T; Sakakura, N; Takahashi, Y | 1 |
| Antonoff, MB; Blumenthaler, AN | 1 |
| Gundogdu, N | 1 |
| Bulloch, G; Chatterjee, R; Donnan, L; Guo, A; MacManus, M; Seth, I; Seth, N; Siu, AHY | 1 |
| Pak, K; Yoon, HJ | 1 |
| Ampollini, L; Arena, V; Bertoglio, P; Casadio, C; Filosso, PL; Guerrera, F; Lesca, A; Lococo, F; Lyberis, P; Marchese, V; Paci, M; Puma, F; Rena, O; Ruffini, E; Vannucci, J; Ventura, L; Viti, A | 1 |
| Faber, C; Frohwein, LJ; Hermann, S; Jacobs, AH; Schäfers, KP; Schelhaas, S; Wachsmuth, L | 1 |
| Feng, Y; Huang, K; Li, L; Liang, W | 1 |
| Bhatnagar, R; Bodtger, U; Fjaellegaard, K; Frost Clementsen, P; Gerke, O; Koefod Petersen, J; Laursen, CB; Malene Fischer, B; Porcel, JM; Reuter, S | 1 |
| Fu, P; Su, YX; Zhang, LH; Zhao, HY | 1 |
| Gartman, E; Jankowich, MD; Nici, L; Vayntrub, Y | 1 |
| Goksel, S; Ozcelik, N | 1 |
| Caruso, D; Daffina, J; Krokidis, ME; Laghi, A; Laurino, F; Orgera, G; Ronconi, E; Rossi, M; Tipaldi, MA; Zolovkins, A | 1 |
| Chan, SC; Chang, BS; Chen, YC; Chen, YH; Chu, SC; Li, MH; Lin, CB; Liu, SH; Lue, KH; Wang, LY | 1 |
| Dittmann, H; Schwenck, J; Solass, W; Tenev, A; Vogel, J | 1 |
| Calcagni, ML; Caldarella, C; Cocciolillo, F; Giacò, L; Giordano, A; Guido, D; Leccisotti, L; Lorusso, M; Palluzzi, F; Pizzuto, DA; Rufini, V; Scolozzi, V; Taralli, S | 1 |
| Buck, J; Dammak, S; Gee, H; Hanna, GG; Hau, E; Le, T; Lee, K; Lim, R; Ong, A; Palma, D; Vinod, S; Yeghiaian-Alvandi, R | 1 |
| Banerjee, A; Benedetto, V; Brindle, L; Callister, MEJ; Clegg, A; Cook, A; Cozens, K; Crosbie, PA; Dizdarevic, S; Eaton, R; Eichhorst, K; Frew, A; George, S; Gilbert, FJ; Gleeson, FV; Groves, AM; Han, S; Harris, S; Hill, J; Jones, J; Kankam, O; Karunasaagarar, K; Kurban, L; Little, L; Madden, J; McClement, C; Miles, KA; Moate, P; Peebles, C; Pike, L; Poon, FW; Qureshi, NR; Rintoul, RC; Shah, A; Sinclair, D; Tzelis, D; Vale, L; Weir-McCall, JR | 1 |
| Li, X; Piao, Y; Wen, W; Xu, D | 1 |
| Boellaard, R; Buvat, I; de Langen, AJ; Frings, V; García, DV; Kolinger, GD; Kramer, GM; Smit, EF; Zwezerijnen, GJC | 1 |
| Alhun, U; Bandyopadhyay, S; Marchbank, N; Modi, S; Patel, A; Pencharz, D; Wagner, T | 1 |
| Aksel, N; Anar, C; Erbaycu, AE; Gayaf, M; Koporal, H | 1 |
| Cao, Q; Fang, Y; Ge, D; Hou, Y; Jiang, D; Lin, D; Liu, G; Shen, Y; Shi, H; Tan, L; Wang, H; Wang, Q; Yin, J; Yu, Y; Zhang, S | 1 |
| Morishita, A; Naruse, K; Okano, Y; Takeuchi, E | 1 |
| Jacobson, FL; Van den Abbeele, AD | 1 |
| Bu, L; Feng, H; Han, X; Lin, H; Tu, N; Wang, K; Xie, X; Zhou, Y | 1 |
| Bennett, P | 1 |
| Burchett, PF; De Cecco, CN; Martin, SS; Muscogiuri, E; Schoepf, UJ; Tessarin, G; van Assen, M; Vogl, TJ | 1 |
| Hashimoto, K; Imai, H; Kagamu, H; Kaira, K; Kobayashi, K; Kuji, I; Matsusaka, Y; Miura, Y; Mouri, A; Shiono, A; Yamaguchi, O | 1 |
| Lei, Y; Li, X; Liao, Y; Liu, J; Peng, Y; Wan, Q; Wang, P; Xia, X; Xie, X; Zhou, J | 1 |
| Chen, H; Meng, T; Pang, Y; Shang, Q; Zhao, L | 1 |
| Adam, JA; de Geus-Oei, LF; Delgado Bolton, RC; Dubray, B; Herrmann, K; Hicks, RJ; Lievens, Y; Santos, A; Schöder, H; Troost, EGC; van Elmpt, W; Vaz, SC; Vera, P; Visvikis, D | 2 |
| Aokage, K; Ishii, G; Kojima, M; Miyazaki, S; Miyoshi, T; Nakai, T; Nishina, Y; Nomura, K; Sakamoto, N; Sakashita, S; Samejima, J; Suzuki, K; Taki, T; Tane, K; Tsuboi, M; Watanabe, R | 1 |
| Kang, F; Niu, J; Quan, Z; Wang, J; Zhao, X | 1 |
| Hino, H; Miyatake, K; Morizumi, S; Naruse, K; Shinohara, T | 1 |
| Asairinachan, A; Prasad, J; Soputro, NA | 1 |
| Chen, T; Fan, J; Li, J; Li, W; Wu, C | 1 |
| Decazes, P; Eude, F; Guisier, F; Pressat-Laffouilhere, T; Salaün, M; Thiberville, L; Vera, P | 1 |
| Andersen, FL; Barrington, SF; Dunn, JT; Fischer, BM; Kovacs, DG; Malaih, AA; Nygård, L | 1 |
| Fan, C; Guo, G; Liu, J; Shi, A; Wang, J; Wang, Y | 1 |
| Appelbaum, D; Ferguson, MK; Liu, L; Pu, Y; Zhang, J; Zhang, JX | 1 |
| Bom, HS; Cho, SG; Kang, SR; Kim, J; Kwon, SY; Lee, C; Min, JJ; Park, KS; Seon, HJ; Song, HC; Yoo, SW; Yun, JS | 1 |
| Chen, N; Chu, C; Guo, J; He, H; Hu, N; Li, Q; Liu, F; Liu, H; Peng, K; Qiu, B; Wang, D; Xie, CM; Yin, S | 1 |
| Amo-Salas, M; Bosque, JJ; García Vicente, AM; Honguero-Martinez, AF; Jiménez Londoño, GA; Pérez-Beteta, J; Pérez-García, VM; Soriano Castrejón, ÁM | 1 |
| Chatziioannou, SN; Dikaios, N; Doulamis, A; Doulamis, N; Kastis, GA; Katsamenis, I; Metaxas, M; Protonotarios, NE; Sykiotis, S | 1 |
| Ahn, SJ; Bom, HS; Cho, SG; Kim, J; Kim, YH; Park, H; Park, KS | 1 |
| Abd Elkareem, M; Abdelhafez, YG; Abdelsamie Kandeel, A; Mostafa, R; Nardo, L | 1 |
| Curioni, A; Deandreis, D; Grünig, H; Huellner, MW; Husmann, L; Kotasidis, F; Liberini, V; Mader, C; Maurer, A; Messerli, M; Opitz, I; Orita, E; Pizzuto, DA; Trinckauf, J; Winklhofer, S | 1 |
| Kim, SJ; Lee, SW | 1 |
| Diehn, M; Harris, JP; Hiniker, SM; Jiang, A; Lau, B; Loo, BW; Maxim, PG; Modlin, LA; Quon, A; Sodji, QH; Trakul, N | 1 |
| Hosoda, H; Koiso, H; Nakagawa, A; Nakashima, Y; Noguchi, C | 1 |
| Endoh, M; Nakahashi, K; Noguchi-Konaka, M; Ogata, S; Sasage, T; Shiono, S; Suzuki, H | 1 |
| Cheng, J; Feng, P; Fu, F; Gao, H; Li, Z; Liu, H; Meng, N; Wang, M; Wei, W; Wu, Y; Yang, Y; Yuan, J; Zhang, J | 1 |
| Cui, Y; Ji, Y; Shao, CC; Wang, Y; Zheng, JS | 1 |
| Antic, S; Chen, H; Cords, AJ; Eisenberg, R; Grogan, EL; Helton, JE; Manning, HC; Massion, PP; Muterspaugh, A; Paez, R; Shah, C; Walker, RC | 1 |
| Ay, MR; Bahadorzadeh, B; Ghafarian, P; Hajianfar, G; Hosseini, SA; Shiri, I; Zaidi, H | 1 |
| Hu, B; Li, L; Li, X; Liao, Y; Wang, X; Xiao, M; Yao, W; Zhang, F; Zhang, H | 1 |
| He, L; Jiang, L; Ren, J; Tan, X; Zeng, B | 1 |
| Du, R; Fang, H; Guo, F; Han, J; Kang, J; Lu, Z; Song, Q | 1 |
| Andraos, TY; Cheng, H; Halmos, B; Huntzinger, C; Ohri, N; Shirvani, SM | 1 |
| Bono, F; Cortinovis, D; Crivellaro, C; De Bernardi, E; Elisei, F; Guerra, L; L'Imperio, V; Landoni, C; Mathoux, G; Messa, C; Monaco, L; Musarra, M; Pagni, F; Turolla, EA | 1 |
| Castillo, E; Castillo, R; Chen, Y; Forghani-Arani, F; Guerrero, T; Miller, R; Rusthoven, C; Santangelo, T; Vinogradskiy, Y | 1 |
| Cui, Y; Ji, Y; Shao, C; Shao, G; Su, N; Wang, Y; Zheng, J | 1 |
| Guo, N; Li, H; Zhang, W; Zhao, M; Zhu, A | 1 |
| Amrane, K; Campedel, L; Kharroubi, D; Le Meur, C | 1 |
| Fukui, M; Hattori, A; Matsunaga, T; Nomura, K; Suzuki, K; Takamochi, K | 1 |
| Jang, SJ; Jo, IY; Lee, JH; Lee, JW; Lee, SM | 1 |
| Sang, S; Yu, Y; Zhang, X; Zhou, Y; Zhu, J; Zhu, Y | 1 |
| Hadzhiyska, V; Ilcheva, M; Mladenov, K; Nikolova, P | 1 |
| Hatakeyama, N; Hino, H; Sakiyama, S; Shinohara, T; Takeuch, E | 1 |
| Al-Hammadi, N; Chandramouli, SH; Divakar, SR; Gurusamy, VM; Hammoud, RW; Usman, M | 1 |
| Cassivi, SD; Giles, AE | 1 |
| Iguchi, K; Nakamura, M; Suzuki, E; Tanahashi, M; Tsuchida, H; Uchiyama, S; Watanabe, T; Yobita, S; Yoshii, N | 1 |
| Li, TC; Liu, KF; Liu, YN; Wang, GL; Zhao, K; Zhao, X | 1 |
| Bai, Y; El Fakhri, G; Gu, F; Hu, Z; Li, X; Liang, D; Liu, X; Shen, C; Sun, T; Wang, M; Wang, Z; Wu, Y; Yang, Y; Zheng, H; Zhou, Y | 1 |
| Choyke, PL | 1 |
| Chang, C; Chen, T; Lei, B; Liu, L; Ruan, M; Sun, X; Wang, L; Xie, C; Xie, W; Yan, H; Zhang, Q | 1 |
| Daimaru, Y; Kajitani, K; Kawamura, S; Koi, Y; Kondo, T; Ohara, M; Oride, Y; Sasada, T | 1 |
| Eren, G; Kupik, O | 1 |
| Hicks, RJ | 2 |
| Juneau, D; Léger, MA; Routy, B | 1 |
| Marcus, C; Rowe, SP; Sheikhbahaei, S; Solnes, LB; Tajmir, SH | 1 |
| Aras, F; Olmezoglu, A | 1 |
| Ikeda, H; Kanamori, T; Kometani, M; Nakano, Y; Nomura, C; Shima, KR; Takamura, T; Takeshita, Y; Tanaka, T; Yoneda, T | 1 |
| Chen, JY; Dai, ZH; Wang, ZT | 1 |
| Goksel, S; Karaman, E; Tuluce, K | 1 |
| Chen, M; Chen, WM; Lin, WC; Shia, BC; Wu, SY | 1 |
| Abdollahi, H; Ay, MR; Falahatpour, Z; Geramifar, P; Mahdavi, SR; Nikoofar, A; Salimi, Y | 1 |
| Basu, S; Parghane, RV | 1 |
| Laue, HOA; Persigehl, T | 1 |
| Kandathil, A; Subramaniam, RM | 1 |
| Borrelli, P; Edenbrandt, L; Enqvist, O; Góngora, JLL; Kaboteh, R | 1 |
| Atzinger, A; Förster, S; Hartmann, A; Hohenforst-Schmidt, W; Klink, T; Kuwert, T; Schmidkonz, C; Steppert, C; Sterlacci, W; Sziklavari, Z; Vieth, M; Zhang, R | 1 |
| Cao, M; Wang, Q; Wei, W; Zhang, X | 1 |
| Fujito, T; Ikeda, T; Ishida, J; Kondo, Y; Kuno, Y; Miyazaki, S; Mori, S; Nara, Y; Yamashita, R | 1 |
| Deng, S; Li, J; Sang, S; Xu, X; Yang, Y | 1 |
| Azzoli, C; Bai, HX; Cheng, G; Feng, X; Healey, T; Huang, B; Jiao, Z; Korogodsky, D; Li, J; Luo, YH; Mammarappallil, J; Reddy, A; Sollee, J; Wu, J; Yang, L; Zhang, P; Zhong, Z | 1 |
| Iguchi, M; Iwasa, H; Matsumoto, T; Miyatake, K; Nakaji, K; Nishimori, M; Nitta, N; Tamura, M; Yamagami, T; Yamanishi, T; Yoshimatsu, R | 1 |
| Akutsu, N; Hirano, T; Ishigami, K; Kawakami, Y; Nakase, H; Numata, Y; Sasaki, S; Wagatsuma, K | 1 |
| Bai, M; Gao, Z; Li, J; Liu, J; Meng, X; Wang, S; Wu, L; Wu, M; Yu, J | 1 |
| Bai, F; Chen, Q; Gao, K; Huang, Y; Ling, L; Sun, L; Wang, Y; Wen, Y; Xiong, J; Yang, L; Yang, W; Zhai, R; Zhang, X; Zhou, Z | 1 |
| Haga, N; Ito, K; Kasai, Y; Masuya, D | 1 |
| Andersen, MB; Drljevic-Nielsen, A; Hjorthaug, K; Kruis, MF; Nijkamp, JA; Rasmussen, F; Thygesen, J | 1 |
| Ecsedi, B; Grahovac, M; Hacker, M; Haug, A; Jiang, C; Kluge, K; Krajnc, D; Li, X; Papp, L; Spielvogel, CP; Wang, S; Yang, S; Zhang, W; Zhao, M | 1 |
| Endo, M; Nakahashi, K; Nakatsuka, M; Shiono, S | 1 |
| Chen, W; Cui, Y; Du, B; Li, X; Li, Y; Ma, Y | 1 |
| Chen, Y; Fan, K; Zhang, D | 1 |
| Adler, S; Cai, Q; Chan, H; Flores, R; Henschke, CI; Kaufman, A; Taioli, E; Triphuridet, N; Yankelevitz, DF; Yip, R; Zhu, Y | 1 |
| Ajdari, A; Bortfeld, T; Liao, Z; Mohan, R; Wei, X | 1 |
| Li, J; Ma, R; Wang, YY; Zhao, Q; Zhao, R | 1 |
| Baba, S; Haratake, N; Hashinokuchi, A; Ishigami, K; Kohno, M; Kosai, K; Matsudo, K; Nagano, T; Oku, Y; Ono, Y; Takamori, S; Takenaka, T; Watanabe, K; Yoshizumi, T | 1 |
| Du, X; Yu, C; Zhu, F | 1 |
| Agüloğlu, N; Can, C; Gündoğan, C; Güzel, Y; Kaplan, İ; Karaoğlan, H; Kepenek, F; Kömek, H; Taşdemir, B | 1 |
| Agüloğlu, N; Aksu, A; Akyol, M; Doksöz, TÇ; Katgı, N | 1 |
| Hashimoto, K; Imai, H; Kagamu, H; Kaira, K; Kobayashi, K; Kuji, I; Miura, Y; Mouri, A; Shiono, A; Yamaguchi, O | 1 |
| Han, Y; Huang, L; Liu, J; Tian, X | 1 |
| Erol, M; Karanis, MIE; Kucukosmanoglu, I; Unlu, Y | 1 |
| Li, S; Li, Y; Wang, P; Xin, J; Zhao, M | 1 |
| Fei, W; Kong, H; Li, N; Meng, X; Yan, S; Yao, Y; Zhang, A; Zhang, Y; Zhou, N; Zhou, X | 1 |
| Gouel, P; Mallet, R; Modzelewski, R; Thureau, S; Vera, P | 1 |
| Debruyn, E; Gilbert, FJ; Gleeson, FV; Harris, S; Qureshi, NR; Rintoul, RC; Weir-McCall, JR | 1 |
| Amthauer, H; Baur, ADJ; Becker, PH; Furth, C; Gorodetski, B; Hamm, B; Hartenstein, A; Makowski, M; Penzkofer, T; Rogasch, JMM | 1 |
| Gao, G; Huang, L; Quan, B; Zhang, P; Zheng, W | 1 |
| Cattaneo, M; Chirindel, A; Hojski, A; Kaumanns, A; König, D; Lardinois, D; Rothschild, SI; Tamm, M; Wiese, M | 1 |
| Fan, L; Jia, Y; Ma, W; Sun, B; Wang, Z; Xu, J; Xu, K; Yang, H; Yao, F | 1 |
| Annema, J; Crombag, L; Fielding, D; Hardcastle, N; Irving, LB; Jennings, BR; Kothari, G; Lee, P; Nguyen, P; Ost, DE; Rangamuwa, K; Siva, S; Steinfort, DP; Yasufuku, K; Yo, S | 1 |
| Endoh, M; Konaka, Y; Nakahashi, K; Ogata, S; Sasage, T; Shiono, S; Suzuki, H | 1 |
| Kita, H; Onda, T; Yoshida, T | 2 |
| Iijima, Y; Ishikawa, M; Iwai, S; Mizoguchi, T; Motono, N; Uramoto, H | 3 |
| Agackiran, Y; Aloglu, M; Atikcan, S; Cimen, F; Düzgün, S; Senturk, A | 1 |
| Araujo-Chumacero, MM; Barreto, L; Barreto-Acevedo, E; Quispe-Huamaní, EV; Rodríguez-Kadota, L; Saavedra-Rocha, C; Urrunaga-Pastor, D; Vences, MA | 1 |
| Cheng, G; Huang, Y; Jiang, X; Liu, LN; Shi, YH; Wu, HJ; Xia, YX; Xu, DK; Xu, H; Zhang, D | 1 |
| Cyran, C; Früh, M; Gatidis, S; Hepp, T; Küstner, T; La Fougère, C; Nikolaou, K; Pfannenberg, C; Rubin, D; Schölkopf, B | 1 |
| Liu, X; Lv, W; Ni, M; Shi, Q; Wang, S; Xie, Q; Zhang, Y; Zhu, X | 1 |
| Abbasguliyev, H; Karaman, A | 1 |
| Chen, J; Jiang, H; Wang, J; Xu, C; Zhang, H; Zhang, L; Zhang, X | 1 |
| Huang, Y; Jiang, L; Li, Q; Li, Y; Song, X; Yang, F; Yuan, H | 1 |
| Aloglu, M; Atikcan, Ş; Çimen, F; Düzgün, S; Özmen, Ö; Şentürk, A | 1 |
| Kesim, S; Oksuzoglu, K; Ozguven, S | 1 |
| Ganesan, P; Goyal, H; Halanaik, D; Kishore, S | 1 |
| Bülbül, HM; Bülbül, O; Çapa Kaya, G; Gezer, NS; Gürel, D; Tertemiz, KC; Ulukuş, EÇ | 1 |
| Gomi, T; Ito, K; Kajiyama, A; Kusumoto, M; Mizumura, S; Watanabe, H; Watanabe, SI; Yatabe, Y | 1 |
| Chen, BY; Clark, PM; Damoiseaux, R; Ghezzi, C; Perez, S; Ryan, K; Wong, A | 1 |
| Hsu, CX; Shiau, YC; Wang, SY | 1 |
| Inoue, F; Kamikawa, Y; Mori, M; Nishikawa, T; Okabayashi, T; Takahashi, M | 1 |
| Abenavoli, EM; Antonuzzo, L; Berti, V; Briganti, V; Danti, G; Grosso, AM; Lavacchi, D; Linguanti, F; Matteini, M; Miele, V; Mini, E; Mungai, F; Novelli, L; Sciagrà, R; Vaggelli, L | 1 |
| Bai, M; Jin, P; Liu, J; Meng, X; Yu, J | 1 |
| Gavane, S; Hasanovic, A; Trak, J | 1 |
| Agüloğlu, N; Aksu, A; Akyol, M; Unat, DS | 1 |
| Fukui, Y; Hamamoto, Y; Isogai, T; Takahashi, M | 1 |
| Iizasa, T; Iwata, T; Kawakami, E; Kuyama, J; Matsui, Y; Ogawa, K; Onozato, Y; Sakairi, Y; Shimizu, D; Uematsu, Y; Yamamoto, T; Yoshino, I | 1 |
| Chang, BS; Chen, YC; Chen, YH; Chu, SC; Li, MH; Lin, CB; Lue, KH; Wang, LY | 1 |
| Glaudemans, AWJM; Keijsers, RGM; Lam, MGEH; Lavalaye, J; van den Hoven, AF; Verburg, FA; Vogel, WV | 1 |
| Chang, BS; Chen, YH; Chu, SC; Lin, CB; Lue, KH | 1 |
| Guo, H; Tham, IWK; Wu, J; Xie, Z; Yan, J; Zhou, L | 1 |
| Pendleton, AC | 1 |
| Hwang, JH; Kim, KU; Lim, CH; Park, SB; Park, YW | 1 |
| Beyer, T; Hacker, M; Shiyam Sundar, LK | 1 |
| Azamat, S; Bulut, MT; Keskin, M; Kulle, CB; Omarov, N; Ozkan, ZG; Uymaz, DS | 1 |
| He, L; Jiang, L; Li, D; Sun, X; Tan, X; Yuan, H | 1 |
| Albano, D; Bellini, P; Bertagna, F; Cerudelli, E; Dondi, F; Treglia, G | 1 |
| Hama, Y; Tate, E | 1 |
| Kagimoto, A; Kambara, T; Kushitani, K; Mimae, T; Miyata, Y; Okada, M; Takeshima, Y; Tsutani, Y | 1 |
| Alpaydın, AÖ; Güler, N; Karaçam, V; Özdoğan, Ö; Tertemiz, KC; Ulukuş, Ç | 1 |
| Chen, Z; Jiang, L; Pan, X; Sun, X; Tan, X; Zeng, B | 1 |
| Dai, Q; Huang, G; Jin, M; Liu, L; Wang, M | 1 |
| Chen, Y; Gong, W; Liu, W; Xu, T; Yang, X | 1 |
| Erdil, TY; Kesim, S; Oksuzoglu, K; Ozguven, S | 1 |
| Ahn, MJ; Choi, JY; Han, J; Im, Y; Kim, J; Kwon, OJ; Park, YJ; Um, SW | 1 |
| Aigner, C; Darwiche, K; Hautzel, H; Hegedus, B; Hermann, K; Mardanzai, K; Nensa, F; Okumus, Ö; Plönes, T; Schuler, M; Stuschke, M; Theegarten, D | 1 |
| Liang, Z; Liu, W; Mo, Y; Zeng, X; Zhang, C | 1 |
| Baumgartner, M; Breit, HC; Bremerich, J; Jaeger, PF; Maier-Hein, KH; Sauter, AW; Sommer, G; Stieltjes, B; Thaiss, W; Weikert, T; Winkel, DJ; Yang, S | 1 |
| Keyhanian, K; Sekhon, HS | 1 |
| Doi, H; Hanaoka, K; Hosono, M; Inada, M; Ishii, K; Kaida, H; Komanishi, M; Nakamatsu, K; Nishimura, Y; Uehara, T | 1 |
| Belderbos, JSA; Cooke, SA; Damen, EMF; de Ruysscher, D; Dieleman, EMT; Faivre-Finn, C; Fredberg Persson, G; Lalezari, F; Lambrecht, M; Lewensohn, R; Reymen, B; Sikorska, K; Sonke, JJ; van Diessen, JNA; van Elmpt, W; Vogel, W | 1 |
| Bund, C; Mennecier, B; Namer, IJ; Ouvrard, E; Voulleminot, P | 1 |
| Hou, G; Peng, P; Zhao, Y; Zheng, R | 1 |
| Dong, A; Guo, J; Liao, Z | 1 |
| Franc, B; Khessib, T; Moradi, F; Yang, E | 1 |
| Abe, K; Aoki, K; Daimon, M; Iwahana, T; Kato, H; Kobayashi, Y; Ono, R | 1 |
| Nakahira, S; Oi, K; Saito, Y; Tamagawa, H; Taniguchi, E; Tsujimura, N | 1 |
| Bian, S; Lei, W; Meng, S; Yang, J; Ye, S; Zhao, C | 1 |
| Kang, SR; Kim, MS; Oh, IJ; Oh, S | 1 |
| Hayashi, N; Iwasa, H; Kato, M; Matsumoto, T; Miyatake, K; Nakaji, K; Nishimori, M; Nitta, N; Tamura, M; Toi, M; Yamagami, T; Yamanishi, T; Yoshimatsu, R | 1 |
| Agüloğlu, N; Aksu, A; Unat, DS | 1 |
| He, L; Jiang, L; Li, D; Sun, X; Tan, X; Yao, X; Yuan, H | 1 |
| Abuali, T; Amini, A; Du, D; Glaser, S; Ladbury, C; Liu, A; Liu, J; Massarelli, E; Salgia, R; Villaflor, V; Watkins, W; Williams, T | 1 |
| Huang, W; Li, L; Su, Y; Wang, J; Zhou, H | 1 |
| Byun, BH; Ju, HM; Kim, BC; Lim, I; Woo, SK | 1 |
| Bahce, I; Comans, EFI; Dahele, MR; Daniels, HJMA; Dickhoff, C; Heineman, DJ; Radonic, T; Rauh, SP; Smesseim, I; van Boerdonk, RA | 1 |
| Guo, H; Han, L; Lin, L; Liu, Z; Long, F; Zhang, T | 1 |
| Amthauer, H; Baumgärtner, GL; Frost, N; Furth, C; Gerhold, M; Michaels, L; Neudecker, J; Ochsenreither, S; Penzkofer, T; Rogasch, JMM; Rückert, JC; Schmidt, B; Schneider, P | 1 |
| Chan, SC; Chang, BS; Chen, KC; Chen, YC; Chen, YH; Chu, SC; Lin, CB; Lue, KH | 1 |
| Jiang, H; Li, Q; Li, X; Lu, Q; Ren, F; Shi, L; Zhang, L | 1 |
| Baste, JM; Bouyeure-Petit, AC; Cuvelier, A; Decazes, P; El Husseini, K; Lhuillier, E; Patout, M; Similowski, T; Vera, P | 1 |
| Chen, Y; Ding, H; Fu, S; Li, Y; Lin, S; Ren, P; Tang, S; Xu, Y; Ye, H; Zhang, Y | 1 |
| Erturk, K; Ozturk, A; Tas, F | 1 |
| Hongwei, S; Huiqin, X; Jianzhong, C; Li, L; Ruonan, W; Shuqin, X; Sijin, L; Xinzhong, H | 1 |
| Lei, Y; Li, X; Liu, J; Wan, Q; Xia, X; Xie, X; Zou, Q | 1 |
| Darwiche, K; Fendler, WP; Hautzel, H; Herrmann, K; Meetschen, M; Moter, A; Opitz, M; Sandach, P; Schaarschmidt, BM; Theegarten, D | 1 |
| Alcaide Ocaña, AB; Bastarrika Alemañ, G; Caballeros Lam, M; Campo Ezquibela, A; de-Torres, JP; Ezponda Casajús, A; García Del Barrio, L; García Velloso, MJ; Guillén Valderrama, F; Herrero Santos, I; Iñarrairaegui Bastarrica, M; Larrache Latasa, J; Lozano Escario, MD; Montuenga Badía, L; Pueyo Villoslada, J; Pujols, P; Seijo Maceiras, L; Wyss, A; Zulueta, J | 1 |
| Li, LJ; Xuan, JZ; Zheng, HN | 1 |
| Ahn, JH; Kim, HW; Kong, E; Shin, KC; Son, SH | 1 |
| Bartenstein, P; Belka, C; Eze, C; Holzgreve, A; Käsmann, L; Kunz, WG; Li, M; Manapov, F; Müller, P; Nieto, AE; Reinmuth, N; Ricke, J; Taugner, J; Tufman, A; Unterrainer, LM; Unterrainer, M; Winkelmann, M | 1 |
| Ikeda, H; Koyama, H; Nagata, H; Ohno, Y; Ozawa, Y; Takenaka, D; Toyama, H; Ueda, T; Yamamoto, K; Yoshikawa, T; Yui, M | 1 |
| Bai, Y; Dong, A; Lin, X; Xu, S; Yang, B | 1 |
| Fan, L; Liu, S; Lyu, D; Tu, W; Wang, Y; Zhou, T | 1 |
| Fan, Y; Guo, C; Huang, W; Li, S; Liao, X; Liu, J; Liu, M; Wang, R; Xiong, Y; Zhang, J | 1 |
| Fang, N; Jiang, YM; Lin, S; Wang, YL; Xu, AD; Zhang, J | 1 |
| Fu, AS; Ge, YL; Jiang, J; Ren, HQ; Yang, W; Zhao, Q | 1 |
| Boo, SH; Moon, SW; Park, HL; Park, SY; Yoo, IR | 1 |
| Bagnacci, G; Bellan, C; Bertelli, P; Di Martino, V; Di Meglio, N; Luzzi, L; Mazzei, MA; Perrella, A; Volterrani, L | 1 |
| Bakker, J; Borm, FJ; de Gruijl, TD; de Langen, AJ; Smit, EF; Smit, J; Wondergem, M | 1 |
| Barton, M; Carolan, M; Field, M; Harris, G; Holloway, L; Metcalfe, P; Nigam, R | 1 |
| Chen, X; Li, P; Wang, D; Wang, X; Zhang, M | 1 |
| Anselmo, P; Arcidiacono, F; Casale, M; Trippa, F | 1 |
| Hsia, JY; Kao, PF; Lu, XP; Sung, WW; Weng, JH | 1 |
| García Valiente, P; Sánchez Togneri, L | 1 |
| Ishimura, M; Kanaji, N; Manabe, Y; Mitamura, K; Murao, M; Murota, M; Nishiyama, Y; Norikane, T; Yamamoto, Y | 1 |
| Brose, A; Eschmann, SM; König, J; Michalski, K; Miederer, M; Nestle, U; Ruf, J; Schreckenberger, M; Tosch, M | 1 |
| Dong, A; Lu, W; Wang, Y; Xiao, Z | 1 |
| Bowen, SR; Gates, EDH; Hippe, DS; Vesselle, HJ; Zeng, J | 1 |
| Hayashi, T; Kita, H; Onda, T; Yoshida, T | 1 |
| Abe, K; Cardinale, J; Doki, Y; Eguchi, H; Giesel, FL; Inohara, H; Kamiya, T; Kato, H; Kimura, T; Kobayashi, S; Kurokawa, Y; Miyake, T; Mori, Y; Naka, S; Shimazu, K; Shintani, Y; Tatsumi, M; Watabe, T | 1 |
| Cui, Z; Feng, J; Huang, L; Li, J; Luo, Y; Ma, W; Tian, X; Xie, Y; Yuping, H; Zhang, K; Zhou, J | 1 |
| Wu, H; Zhou, W | 1 |
| Beheshti, M; Grambozov, B; Kalantari, F; Karner, J; Rinnerthaler, G; Ruznic, E; Sedlmayer, F; Stana, M; Zehentmayr, F; Zellinger, B | 1 |
| Guo, H; Han, L; Han, T; Lin, L; Liu, Z; Long, F; Zhang, T | 1 |
| Beiki, D; Eftekhari, M; Emami-Ardekani, A; Fallahi, B; Geramifar, P; Manafi-Farid, R; Mirshahvalad, SA; Seifi, S | 1 |
| Chen, Y; Wu, Y; Zeng, Q; Zhang, F; Zhang, X; Zhou, J | 1 |
| Shen, G; Su, H; Tian, R; Yang, L | 1 |
| Beppu, S; Hanai, N; Kodaira, T; Nishikawa, D; Nishio, M; Sasaki, E; Sawabe, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
| Li, J; Song, R; Sun, X; Tan, W; Wang, J; Xing, L; Zhang, Y; Zheng, Z | 1 |
| Aigner, C; Darwiche, K; Eberhard, W; Hautzel, H; Herrmann, K; Hockmann, J; Plönes, T; Stuschke, M | 1 |
| Dilber, I; Kelam, N; Kokeza, J; Ogorevc, M; Strikic, A; Vukoja, M; Zekic Tomas, S | 1 |
| Choi, K; Kim, HJ; Kim, HW; Kwon, YS; Noh, H; Park, JS; Park, SH; Song, BI; Won, KS | 1 |
| Chen, C; Dai, C; Deng, J; E, H; Hou, L; Huang, J; Li, C; Li, Q; Luo, Q; Ma, M; Ren, Y; Wu, J; Yang, M; Zhang, L; Zhao, D | 1 |
| Dai, J; Hou, W; Tian, R | 1 |
| Chae, Y; Kang, BT; Kim, H; Koo, Y; Lee, D; Lee, S; Yang, MP; Yun, T | 1 |
| Chen, Y; Dai, W; Feng, Y; Wang, P | 1 |
| Basu, A; Biswas, J; Chakraborty, A; Chakraborty, I; Ghosh, D; Mandal, B; Manna, A; Mondal, J | 1 |
| Chen, ZY; Cheng, Y; Huang, JJ; Shao, D | 1 |
| Beer, L | 1 |
| Brandner, C; Drexler, W; Hacker, M; Hillmich, S; Krajnc, D; Li, X; Moradi, S; Papp, L; Spielvogel, C; Traub-Weidinger, T; Wille, R | 1 |
| Gerbaudo, VH; Zukotynski, KA | 1 |
| Chang, C; Lei, B; Liu, L; Ruan, M; Sun, J; Wang, L; Wang, Y; Xie, W; Yan, H; Zhang, H | 1 |
| Chen, W; Li, T; Qiu, X; Song, Y; Sun, P; Wang, C; Zhang, P; Zhao, K; Zhu, X | 1 |
| Del Prado Talavera Rubio, M; García Zoghby, L; Padilla Bermejo, A; Pena Pardo, FJ; Poblete García, VM | 1 |
| Gao, Y; Liu, XS; Liu, ZY; Ming, X; Pei, ZJ; Yang, Y; Yuan, LL; Zhang, Y; Zhang, YH | 1 |
| Huang, W; Kang, L; Qiu, Y; Tao, Z; Wang, A | 1 |
| Abubakar, S; Akhter, SMJ; Al Busaidi, A; Al Riyami, K; Jain, A; Usmani, S | 1 |
| Alduraibi, A; Balaji, N; Bin Essa, N; Bomanji, J; Fraioli, F; Groves, AM; Kaplar, Z; Lilburn, DML; Navani, N | 1 |
| Chang, BS; Chen, YC; Chen, YH; Chu, SC; Lin, CB; Lin, HH; Liu, SH; Lue, KH | 1 |
| Hijikata, Y; Hosono, M; Kanagaki, M; Takahashi, M; Umehana, M | 1 |
| Bastidas Tamayo, JF; Bronte Viedma, A; García-Velloso, MJ; Lajusticia Andrés, H; Menendez-Sanchez, S | 1 |
| Byrne, SC; El Alam, R; Hammer, MM | 1 |
| Ajona, D; Calvo, A; Collantes, M; Ecay, M; Francisco-Cruz, A; Gil-Bazo, I; Iribarren, F; López, I; Peñuelas, I; Puyalto, A; Rodríguez-Remírez, M; Sandiego, S; Simón, JA; Solórzano, JL; Vilalta-Lacarra, A | 1 |
| Knol, RJJ; van der Zant, FM | 1 |
| Wang, T; Yang, M; Zhang, J; Zhou, L | 1 |
| Choi, JY; Lee, H; Lee, KH; Lee, SH; Moon, SH; Park, WY; Seo, S; Won, S | 1 |
| Chung, J; Hanneman, K; Metser, U; Murad, V; Ortega, C | 1 |
| Bando, Y; Ikushima, H; Kondo, K; Kuwahara, K; Miyoshi, H; Otani, T; Otsuka, H; Yamashita, M | 1 |
| Ahlström, H; Jönsson, H; Kullberg, J | 1 |
| Amthauer, H; Apostolova, I; Blüthgen, N; Cegla, P; Cholewiński, W; Hofheinz, F; Klinger, B; Kreissl, MC; Kukuk, E; Strobel, H; van den Hoff, J; Zips, D; Zschaeck, S | 1 |
| Cheng, J; Ren, C; Song, S; Sun, Y; Zhang, F; Zhang, J | 1 |
| Castello, A; Finocchiaro, G; Grizzi, F; Lopci, E; Mazziotti, E; Qehajaj, D; Rahal, D; Rossi, S; Toschi, L | 1 |
| Katsuki, NE; Tago, M; Tokushima, M; Yamashita, SI | 1 |
| Ahn, JS; Ahn, MJ; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Park, K; Sun, JM | 1 |
| Honma, K; Misawa, M; Nomori, H; O'uchi, T; Oyama, Y; Shiraishi, A; Shoji, K; Sugimura, H | 1 |
| Capoccetti, F; Castagnoli, H; Fattori, S; Manni, C; Marchesani, F; Rossi, G | 1 |
| Gao, Y; Guo, HY; Huang, HH; Lin, JT; Sun, M; Xu, WP; Yan, HH; Yan, MR; Yang, XN; Zhong, WZ | 1 |
| Clini, E; Facciolongo, N; Marchioni, A; Musci, G; Piro, R; Taddei, S; Tonelli, R | 1 |
| Court, LE; Fuller, CD; Gay, S; Ger, RB; Howell, RM; Layman, RR; Li, H; Mawlawi, O; Meier, JG; Mumme, R; Pahlka, RB; Stafford, RJ; Zhou, S | 1 |
| Benson, J; Davidzon, GA; Horng, G; Leung, ANC; Mattonen, SA; Nair, VS; Napel, S; Shrager, JB; Vasanawala, M | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Alloisio, M; Bottoni, E; Castello, A; Ceresoli, GL; Crepaldi, A; Ferraroli, GM; Lopci, E; Novellis, P; Perrino, M; Rahal, D; Testori, A; Veronesi, G; Voulaz, E; Zucali, PA | 1 |
| Auernhammer, CJ; Cyran, C; Ricke, J; Todica, A; Winter, KS | 1 |
| Albert, NL; Bartenstein, P; Brendel, M; Cyran, CC; Herms, J; Ruf, V; Schüller, U; Thon, N; Tonn, JC; Unterrainer, M | 1 |
| Abe, S; Ikeda, N; Masuno, R; Ohira, T; Shimada, Y; Yamamichi, T; Yoshimura, A | 1 |
| Li, L; Su, M; Wang, Y | 1 |
| Dubray, B; Ganem, J; Gouel, P; Salaun, M; Texte, E; Thureau, S; Vera, P | 1 |
| Damiano, V; De Placido, S; Del Vecchio, S; Fonti, R; Matano, E; Mazziotti, E; Mozzillo, E; Pellegrino, S; Piccin, L | 1 |
| Eura, R; Fujii, K; Higashi, Y; Hirohata, Y; Kanekura, T; Nakagawa, M; Okubo, A; Osako, Y; Tada, KI; Yoshino, H | 1 |
| Ono, K; Saito, H | 1 |
| Date, H | 1 |
| Inoue, H; Iwama, E; Nakanishi, Y; Okamoto, I; Ota, K; Otsubo, K; Tanaka, K; Tsutsumi, H; Yoneshima, Y | 1 |
| Davies, A; Dellaportas, D; Gossage, JA; Laliotis, A; Zylstra, J | 1 |
| Isoda, H; Koyasu, S; Nakamoto, Y; Nishio, M; Togashi, K | 1 |
| Gluskin, JS; Montane, G; Nanni, G; Perez, R | 1 |
| Mimae, T; Okada, M | 1 |
| He, Y; Li, C; Shen, Y; Tian, Y; Wen, B | 1 |
| Adriaensens, P; Derveaux, E; Mesotten, L; Owokotomo, OE; Shkedy, Z; Thomeer, M; Vanhove, K | 1 |
| Dai, M; Han, J; Wang, J; Wang, Y; Zhang, J; Zhang, Z; Zhao, X; Zhao, Y | 1 |
| Cai, Z; Chai, X; Jiang, B; Jiang, W; Li, J; Tang, Y; Wang, W; Xu, W; Yang, C; Yu, C; Zhang, R; Zhang, X; Zhu, L | 1 |
| Abraham, T; Brodin, NP; Ohri, N; Tomé, WA | 1 |
| Adam, J; Ammari, S; Berenbaum, A; Besse, B; Botticella, A; Caramella, C; Dercle, L; Deutsch, E; Grimaldi, S; Le Pechoux, C; Leboulleux, S; Mezquita, L; Planchard, D; Seban, RD | 1 |
| Higuchi, T; Hirasawa, H; Nakano, T; Ohno, T; Saitoh, JI; Shirai, K; Shrestha, S; Tokue, A; Tsushima, Y | 1 |
| Dubois, RL; Raisig, E; Stanifer, BP | 1 |
| Akiba, J; Azuma, K; Fujimoto, K; Ishibashi, M; Ishii, K; Kaida, H; Kawahara, A; Takamori, S | 1 |
| Choi, WH; Kang, JH; Kim, YS; Lee, HY; Park, JK; Sung, SW; Yoo, IR | 1 |
| Cecchin, D; Crimì, F; Frigo, AC; Lacognata, C; Orsatti, G; Pomerri, F; Stramare, R; Varotto, A; Zucchetta, P | 1 |
| Bauckneht, M; Biello, F; Bruzzi, P; Ceriani, V; Cittadini, G; Dal Bello, MG; Genova, C; Grossi, F; Lopci, E; Mennella, S; Morbelli, S; Piva, R; Rijavec, E; Rossi, G; Sambuceti, G | 1 |
| Gillies, RJ; Gray, JE; Mu, W; Qi, J; Schabath, MB; Tunali, I | 1 |
| Froelich, JW; Salavati, A | 1 |
| Cai, L; Deberardinis, RJ; Do, QN; Faubert, B; Hensley, CT; Kernstine, KH; Lenkinski, RE; Malloy, CR; Oliver, D; Rogers, TJ; Torrealba, J; Wachsmann, JW | 1 |
| Arimura, H; Ninomiya, K | 1 |
| Evangelista, L; Pasello, G; Sepulcri, M | 1 |
| Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
| Farsad, M | 1 |
| Hashimoto, J; Ichikawa, T; Ikoma, H; Kodama, E; Kodama, T | 1 |
| Choi, EK; Chung, YA; Im, JJ; Oh, JK; Park, M | 1 |
| Bao, YN; Cui, YT; Huang, CX; Lin, Y; Tian, Y; Wang, XC; Yu, ZL; Zhang, JH | 1 |
| Castello, A; Lopci, E; Rossi, S | 1 |
| Chang, C; Lei, B; Liu, L; Ruan, M; Shen, Y; Sun, X; Wang, L; Xie, W | 1 |
| Bejuy, O; Colin, DJ; Germain, S; Serre-Beinier, V; Triponez, F | 1 |
| Izutani, H; Mori, Y; Okazaki, M; Sakao, N; Sano, Y; Shigematsu, H; Yukumi, S | 1 |
| Becker, S; Bouyeure-Petit, AC; Chastan, M; Dubray, B; Edet-Sanson, A; Gouel, P; Hapdey, S; Thureau, S; Vera, P | 1 |
| Arshad, MA; Barwick, TD; Gandy, N; Khan, S; Ordidge, KL; Soneji, N; Wallitt, K | 1 |
| Kahn, J; Kocher, MR; Ravenel, JG; Waltz, J | 1 |
| Cao, Q; Cao, Y; Jin, H; Li, D; Lin, Z; Liu, Y; Lv, W; Xu, Z; Yang, M; Yang, S | 1 |
| Acevedo Báñez, I; Fernández-Rodríguez, P; Jiménez-Hoyuela García, JM; Martín-Marcuartu, JJ; Masero Carretero, JM | 1 |
| Dejust, S; El Farsaoui, K; Morland, D; Moubtakir, A; Prevost, A | 1 |
| Çizmecioğlu, HA; Kaya, B; Şahin, Ö; Şen, AE; Serdengeçti, M | 1 |
| He, L; He, R; Li, G; Li, X; Qiao, Y; Ren, YW; Song, YQ; Wang, CY; Wang, N; Wang, RZ; Wang, TL; Yang, QK; Zhang, XF | 1 |
| Wang, W; Xie, P; Yang, J | 1 |
| Aide, N; De Pontdeville, M; Lopci, E | 1 |
| Boldorini, R; Filice, A; Lococo, F; Paci, M; Rapicetta, C; Rena, O; Torricelli, F; Versari, A | 1 |
| Cheon, GJ; Chung, JH; Kang, KW; Kang, SY; Kim, DW; Kim, HJ; Seo, YS; Wu, HG | 1 |
| Castello, A; Lopci, E; Mazziotti, E; Rossi, S; Toschi, L | 1 |
| Baxter, G; Clegg, A; Dendl, LM; Gilbert, FJ; Joyce, S; MacKay, JW; Miles, K; Qureshi, NR; Rintoul, RC; Weir-McCall, JR | 1 |
| Chankowsky, J; Hirsh, V; Khokhar, RA; Kovacina, B; McDougall, CC; Nair, JKR; Probst, S; Raidu, BVS; Sabri, A; Saeed, UA; Taylor, J; Van Kempen, LC | 1 |
| Cheng, D; Fu, Z; Hu, B; Shi, H; Xiao, J; Xiu, Y | 1 |
| Ahn, MJ; Choi, JY; Han, J; Im, Y; Jeong, BH; Jhun, BW; Kim, H; Kim, J; Kwon, OJ; Lee, K; Lim, JH; Park, HY; Um, SW; Yoo, H | 1 |
| Bonardel, G; Dercle, L; Schwartz, LH; Seban, RD | 1 |
| Callahan, J; Everitt, S; Konert, T; La Fontaine, MD; MacManus, MP; Sonke, JJ; van de Kamer, JB; Vogel, WV | 1 |
| Al-Kandari, F; Ghanem, M; Marafi, F; Rasheed, R; Usmani, S | 1 |
| Chang, C; Chen, TX; Lei, B; Liu, L; Ruan, MM; Sun, XY; Teng, HH; Wang, LH; Xie, C; Xie, WH; Yang, YH | 1 |
| Altmayer, S; Basso Dias, A; de Souza Santos, F; Henz Concatto, N; Hochhegger, B; Hoefel Paes, J; Machado Medeiros, T; Mattiello, R; Mohammed, TL; Verma, N; Watte, G; Zanon, M | 1 |
| Bando, Y; Kawakami, Y; Kawakita, N; Kondo, K; Matsumoto, D; Otuska, H; Takashima, M; Takizawa, H; Tangoku, A; Toba, H; Tsuboi, M; Yoshida, M | 1 |
| Chen, W; Cheng, D; Hu, B; Shi, H; Xiu, Y; Zhang, Y | 1 |
| Dong, A; Dong, H; Zhou, W | 1 |
| Abdalah, MA; Aerts, HJWL; Andrearczyk, V; Apte, A; Ashrafinia, S; Bakas, S; Beukinga, RJ; Boellaard, R; Bogowicz, M; Boldrini, L; Buvat, I; Cook, GJR; Davatzikos, C; Depeursinge, A; Desseroit, MC; Dinapoli, N; Dinh, CV; Echegaray, S; El Naqa, I; Fedorov, AY; Gatta, R; Gillies, RJ; Goh, V; Götz, M; Guckenberger, M; Ha, SM; Hatt, M; Isensee, F; Lambin, P; Leger, S; Leijenaar, RTH; Lenkowicz, J; Lippert, F; Löck, S; Losnegård, A; Maier-Hein, KH; Morin, O; Müller, H; Napel, S; Nioche, C; Orlhac, F; Pati, S; Pfaehler, EAG; Rahmim, A; Rao, AUK; Richter, C; Scherer, J; Siddique, MM; Sijtsema, NM; Socarras Fernandez, J; Spezi, E; Steenbakkers, RJHM; Tanadini-Lang, S; Thorwarth, D; Troost, EGC; Upadhaya, T; Valentini, V; Vallières, M; van Dijk, LV; van Griethuysen, J; van Velden, FHP; Whybra, P; Zwanenburg, A | 1 |
| Kawajiri, H; Miyashita, M; Takada, K | 1 |
| Dai, D; Li, X; Liu, J; Song, X; Sun, Y; Wang, J; Xu, W; Yu, X; Zhang, Y; Zhu, L; Zhu, Y | 1 |
| Cheng, Y; Wang, Z; Yang, G; Yu, M | 1 |
| Castello, A; Lopci, E | 1 |
| Faivre-Finn, C | 1 |
| Adebahr, S; Bultel, YP; Dieckmann, K; Eschmann, SM; Fleckenstein, J; Gkika, E; Grosu, AL; Hass, P; Hehr, T; Holl, G; König, J; Kremp, S; Küsters, A; Miederer, M; Mix, M; Nestle, U; Rischke, HC; Schaefer-Schuler, A; Schimek-Jasch, T; Stockinger, M; Thieme, A; Tosch, M | 1 |
| Ito, K; Kusumoto, M; Morita, T; Motoi, N; Onishi, Y; Watanabe, SI | 1 |
| Evangelista, L; Fiordoro, S; Mansi, L; Porcaro, F; Sicignano, M; Spadafora, M | 1 |
| Casali, M; Ciammella, P; Filice, A; Fioroni, F; Galaverni, M; Iotti, C; Versari, A | 1 |
| Liu, B; Niu, R; Shao, XL; Shao, XN; Shi, YM; Wang, JF; Wang, XS; Wang, YT; Yu, WJ; Zhang, FF | 1 |
| Aoki, S; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Matsumoto, Y; Miyakawa, A; Miyawaki, D; Nishimura, Y; Nonaka, H; Onishi, H; Saito, M; Saito, R; Sano, N; Sasaki, R; Shibamoto, Y; Shioyama, Y; Suzuki, G; Tominaga, L; Yamada, S | 1 |
| Arena, V; Ceci, F; Ianniello, A; Pelosi, E; Penna, D; Poli, E; Polverari, G; Sandri, A | 1 |
| Amini, B; Behrens, C; Carter, BW; Cascone, T; Fujimoto, J; Gibbons, DL; Godoy, MCB; Heymach, JV; Hofstetter, WL; Hwu, P; Kadara, H; Lee, JJ; Mitchell, KG; Moran, CA; Parra, ER; Peng, W; Piwnica-Worms, D; Reuben, A; Sepesi, B; Swisher, SG; Vaporciyan, AA; Villalobos, P; Walsh, GL; Wang, J; Wang, Y; Weissferdt, A; William, WN; Wistuba, II | 1 |
| Kanda, T; Kubo, K; Kurimoto, T; Murakami, T; Nogami, M; Sofue, K; Ueno, YR; Zeng, F | 1 |
| Chaya, N; Chen, J; Chowdhary, V; Lowry, JW; Mehta, V | 1 |
| Al-Kadi, OS | 1 |
| Chen, H; Lin, Q; Zhao, L | 1 |
| Bengtsson, T; Carano, RAD; de Crespigny, A; Fredrickson, J; Jemaa, S; Nielsen, T | 1 |
| Blazak, JK; Lee, JC | 1 |
| Guo-Qiang, S; Jian, W; Jun, Z; Long-Bao, X; Ming-Ya, P | 1 |
| Abdulla, DSY; Backes, H; Behringer, D; Buettner, R; Eichstaedt, M; Fischer, RN; Franklin, J; Frechen, S; Fuhr, U; Gardizi, M; Junge, L; Kaminsky, B; Kinzig, M; Kobe, C; Limburg, M; Mattonet, C; Merkelbach-Bruse, S; Michels, S; Nogova, L; Ouyang, D; Persigehl, T; Rokitta, D; Scheffler, M; Schnell, R; Sörgel, F; Sos, ML; Stelzer, C; Suleiman, AA; Taubert, M; Tian, Y; Wolf, J | 1 |
| Li, L; Li, T; Liu, G; Zhu, L | 1 |
| Bohn, P; Damilleville-Martin, M; Decazes, P; Modzelewski, R; Thureau, S; Vera, P | 1 |
| Deng, J; Guo, S; Kong, W; Shi, Y; Zeng, W | 1 |
| Laffon, E; Marthan, R | 2 |
| Guo, Y; Qian, X; Zhai, X | 1 |
| Chen, J; Huang, J; Xia, J; Xu, R | 1 |
| Fenchel, M; Gratz, M; Hong, I; Quick, HH; Ruhlmann, V; Umutlu, L | 1 |
| Bernhardt, D; Combs, SE | 1 |
| Cho, SY; Jadvar, H; Kim, CK; Potvin, K; Winquist, E; Zukotynski, KA | 1 |
| Akatli, A; Akyol, H; Asik, M; Balci, TA; Comak, A; Elmali, F; Kekilli, E; Koroglu, R; Kuslu, D; Simsek, FS; Ulutas, H; Yalcin, NC | 1 |
| Gupta, S; Hammer, MM; Jacobson, FL; Kong, CY | 1 |
| Kobayashi Shimizu, S; Koyama, K; Nishida, N; Okamura, T; Seura, H | 1 |
| Flores, RM; Henschke, CI; Kaufman, A; Lee, DS; Wang, Y; Yankelevitz, DF; Yip, R; Zhu, Y | 1 |
| Baig, A; Hadi, Y; Hadique, S; Jain, P; Parker, JE | 1 |
| Bradley, KM; Ji-Xu, A; Yang, Y | 1 |
| Dai, M; Han, J; Hu, Y; Zhang, J; Zhao, X | 1 |
| Cao, J; Chen, Y; Hu, J; Xu, T; Zhang, X | 1 |
| Abgral, R; Bourhis, D; Calais, J; Leclère, JC; Lucia, F; Salaün, PY; Schick, U; Vera, P | 1 |
| Duan, J; Guo, Y; Liu, C; Ma, C; Qiu, Q; Yin, Y; Zhang, Z | 1 |
| Endoh, H; Ichikawa, A; Nishizawa, N; Oriuchi, N; Satoh, Y; Shiozawa, S; Yamamoto, R | 2 |
| Bian, J; Liu, N; Xu, X; Yan, K | 1 |
| Handa, Y; Ito, H; Mimae, T; Miyata, Y; Nakayama, H; Okada, M; Tsutani, Y | 1 |
| Iagaru, A; Ikeda, D; Kozlov, A; Pantel, A | 1 |
| Geol Lee, C; Kim, JS; Kim, N | 1 |
| Bosque, JJ; García Vicente, AM; Honguero-Martinez, AF; Jiménez Londoño, GA; Pérez-Beteta, J | 1 |
| Hojo, M; Hotta, M; Minamimoto, R; Naka, G; Takeda, Y | 1 |
| Brown, PJ; Callister, MEJ; Fatania, K; Gleeson, FV; Graham, R; McDermott, G; Scarsbrook, AF; Subesinghe, M; Xie, C | 1 |
| Andersen, TL; Dahlsgaard-Wallenius, SE; Gerke, O; Hildebrandt, MG; Høilund-Carlsen, PF; Johansen, A; Morsing, A; Petersen, H; Vilstrup, MH | 1 |
| Hales, RK; Rowe, SP; Sheikhbahaei, S; Solnes, LB; Verde, F | 1 |
| Ahac, V; Boc, N; Eickhoff, J; Jeraj, R; Simoncic, U; Skalic, K; Studen, A; Unk, M; Valentinuzzi, D; Vrankar, M; Zagar, I; Zupancic, Z | 1 |
| Abhay Elhence, P; Dutt, N; Jain, P; Pareek, P; Shadrach, BJ; Surekha, B; Vedant, D; Vishwajeet, V | 1 |
| Liu, J; Shi, J; Wang, H; Zhao, L | 2 |
| Koong, SS; Lee, KH; Yoo, JY; Yoo, MY | 1 |
| Arai, Y; Bando, Y; Harada, M; Kubo, M; Otomi, Y; Otsuka, H; Shinya, T; Toba, H; Yamanaka, M | 1 |
| Gill, S; Loh, N; Tan, D | 1 |
| Aragaki, M; Fujiwara-Kuroda, A; Hida, Y; Kaga, K; Kato, T; Wakasa, S | 1 |
| Almonte García, CE; Andrés Pretel, F; Callejas González, J; García Jiménez, MD; García Vicente, A; Genovés Crespo, M; Godoy Mayoral, R; Honguero Martínez, AF; Jiménez López, J; Lázaro Sahuquillo, M; León Atance, P; López Miguel, P; Morales Serrano, ML; Núñez Ares, AMDR; Peyró Sánchez, M; Rodríguez Ortega, CR; Sampedro Salinas, CA | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Alan, O; Arıkan, R; Babacan, NA; Bozkurtlar, E; Dane, F; Demircan, NC; Ercelep, O; Kaya, S; Lacin, T; Ones, T; Simsek, ET; Telli, TA; Tuylu, TB; Yumuk, PF | 1 |
| Kawakita, N; Matsumoto, D; Otsuka, H; Takashima, M; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Hashimoto, K; Kagamu, H; Kaira, K; Kobayashi, K; Kuji, I; Miura, Y; Mouri, A; Murayama, Y; Shiono, A; Yamaguchi, O | 1 |
| Cheon, GJ; Choi, H; Ha, S; Heo, DS; Kang, CH; Kang, KW; Keam, B; Kim, DW; Kim, M; Kim, TM; Kim, YT; Na, KJ; Ock, CY; Paeng, JC; Park, C; Park, IK; Park, S | 1 |
| Ceulemans, LJ; Deroose, CM; Gheysens, O; Neyrinck, AP; Van Raemdonck, DE; Van Rompaey, W; Vanaudenaerde, BM; Verleden, GM; Verleden, SE; Vos, R | 1 |
| Handa, Y; Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 2 |
| Kim, SJ; Kim, YS; Seol, HY | 2 |
| Bussink, J; de Geus-Oei, LF; Meijer, TWH; Noortman, WA; Slump, CH; van Velden, FHP; Vriens, D | 1 |
| Abe, S; Ikeda, N; Maehara, S; Ohira, T; Shimada, Y; Yamada, T; Yamamichi, T; Yoshimura, A | 1 |
| Eba, S; Noda, M; Notsuda, H; Oishi, H; Okada, Y; Saito, R; Sakurada, A; Takanami, K; Tanaka, R | 1 |
| Ait Sahel, O; Benameur, Y; Biyi, A; Doudouh, A; Oueriagli, SN | 1 |
| Cheng, Y; Jiang, BY; Shao, D; Wang, SX; Yuan, ZS | 1 |
| Eshghi, N; Garland, LL; Hamilton, RJ; Hsu, C; Kuo, PH; Sawyer, DM; Sawyer, TW | 1 |
| Bai, F; Bowen, SR; Chaovalitwongse, WA; Duan, C; Hippe, DS; Kinahan, PE; Liu, X; Miyaoka, RS; Pierce, LA; Rengan, R; Thammasorn, P; Vesselle, HJ; Wang, S; You, J; Zeng, J | 1 |
| Cheng, J; Qi, M; Ren, C; Song, S; Sun, Y; Zhang, J; Zhang, Y | 1 |
| Chang, C; Lei, B; Liu, L; Ruan, M; Sun, X; Wang, L; Xie, W; Yan, H | 1 |
| Kidane, B; Levin, DP | 1 |
| Yu, T | 1 |
| Assie, JB; Bonardel, G; Champion, L; Chouaid, C; Duchemann, B; Girard, N; Giroux-Leprieur, E; Goldfarb, L; Massiani, MA; Playe, M; Seban, RD; Soussan, M | 1 |
| Hashimoto, K; Kagamu, H; Kaira, K; Yamaguchi, O | 1 |
| Ball, D; Bressel, M; Bucknell, N; Campbell, BA; David, S; Haghighi, N; Hanna, GG; Kok, D; MacManus, M; Newman, S; Phillips, C; Plumridge, N; Shaw, M; Siva, S; Tran, P; Wheeler, G; Wirth, A | 1 |
| Cheow, HK; Dizdarevic, S; Gilbert, FJ; Harris, S; Miles, KA; Pike, L; Qureshi, NR; Rintoul, RC; Weir-McCall, JR | 1 |
| Bostanci, K; Bozkurtlar, E; Oksuzoglu, K; Ones, T; Tureli, D | 1 |
| Liao, Z; Lu, Y; Luo, D; Pan, T; Thomas, MA | 1 |
| Antonorsi, N; Cheze Le Rest, C; Filali Razzouki, A; Hatt, M; Mondon, R; Pinto-Leite, T; Tankyevych, O; Tixier, F; Visvikis, D | 1 |
| Cheon, M; Choi, JY; Hyun, SH; Kim, BT; Lee, KH; Park, YJ; Um, SW; Won, HH; Yoo, J; Zo, JI | 1 |
| Abbass, T; Buali, F; Colville, D; Dolan, RD; Horgan, PG; Maclay, JD; MacLeod, N; McMillan, DC; McSorley, ST | 1 |
| Kita, Y; Okamoto, T; Tokunaga, Y | 1 |
| Pöttgen, C; Stuschke, M | 1 |
| Adriaensens, P; Boellaard, R; Mesotten, L; Pfaehler, E; Pieplenbosch, S; Thomeer, M; Vanhove, K; Zhovannik, I | 1 |
| Chan, SC; Chen, YH; Chu, SC; Lin, CB; Liu, SH; Lue, KH; Wang, LY; Wang, TF | 1 |
| Bai, Y; El Fakhri, G; Fu, F; Gao, Y; Li, X; Shao, F; Wang, M; Wang, Z; Wei, W; Wu, Y; Xu, J; Zhang, W | 1 |
| Biondetti, P; Canamaque, LG; Catalano, OA; Digumarthy, SR; Furtado, FS; Groshar, D; Lahoud, RM; Mahmood, U; Rosen, BR; Shepard, JO; Umutlu, L; Vangel, MG; Zhang, EW | 1 |
| Henschke, CI; Siddique, M; Yankelevitz, DF; Yip, R | 1 |
| Cipriano, FEG; Correia, NSC; de Azevedo-Marques, PM; de Vita Graves, C; Fabro, AT; Ferreira Junior, JR; Koenigkam-Santos, M | 1 |
| Su, M; Wang, D; Xiao, J | 1 |
| Huang, Y; Li, M; Ma, L; Shi, F; Song, Y; Wang, C; Zhao, K | 1 |
| Kang, SY; Kim, BS; Kim, HO; Moon, BS; Yoon, HJ | 1 |
| Burger, IA; Ferraro, DA; Hüllner, M; Kaufmann, P; Kotasidis, F; Kudura, K; Messerli, M; Treyer, V; Trinckauf, J; Weyermann, C | 1 |
| Arpa, M; Eren, G; Kupik, O; Metin, Y; Orhan Metin, N | 1 |
| Caldeira, L; Große Hokamp, N; Lennartz, S; Mager, A; Maintz, D; Persigehl, T; Reinhardt, HC; Schäfer, S; Thomas, RK; Zopfs, D | 1 |
| Fischer, BM; Krarup, MMK; Krokos, G; Nair, A; Subesinghe, M | 1 |
| Chen, M; Liang, H; Qiu, X; Wang, M; Xu, Y; Zhao, J; Zhong, W; Zhu, Z | 1 |
| Chen, J; He, Y; Li, C; Tian, Y; Wen, B | 1 |
| Araujo-Filho, JAB; Chang, J; Ginsberg, MS; Lobaugh, S; Mayoral, M; Perez-Johnston, R; Plodkowski, AJ; Rekhtman, N; Rusch, VW; Zheng, J | 1 |
| Aigner, C; Darwiche, K; Eberhardt, WEE; Guberina, M; Guberina, N; Hautzel, H; Herrmann, K; Karpf-Wissel, R; Ploenes, T; Pöttgen, C; Schuler, M; Stuschke, M; Theegarten, D; Umutlu, L; Wetter, A | 1 |
| Agrawal, A; Jiwnani, S; Karimundackal, G; Kumar, R; Mathew, B; Prabhash, K; Prakash Agarwal, J; Pramesh, CS; Purandare, NC; Puranik, A; Rangarajan, V; Shah, S; Tandon, S | 1 |
| Cong, Y; Honma, K; Machida, Y; Nomori, H; Otsuki, A; Oyama, Y; Sugimura, H; Yamazaki, I | 1 |
| Anderton, J; Casey, R; Ghobrial, M; Kosmoliaptsis, V | 1 |
| Benedetti, L; Filippi, L; Massa, F; Morbelli, S; Nobili, F | 1 |
| Dang, H; Liu, H; Wang, R; Wu, Y; Xu, B; Yao, S | 1 |
| Arslan, E; Beyhan, E; Çermik, TF; Erol, Ö; Şahin, R | 1 |
| Aggarwal, C; Berman, AT; Cengel, KA; Dorsey, JF; Fan, Y; Feigenberg, SJ; Frick, MA; Jean-Baptiste, S; Kao, GD; Lee, SH; Levin, WP; Uche, CZ; Xiao, Y | 1 |
| Akagi, M; Hashimoto, K; Nishimura, S | 1 |
| Aldemir, OS; Beyan, E; Budak, A; Budak, E; Ileri, A; Inan, AH; Kanmaz, AG; Tosun, G | 1 |
| Djekidel, M; Kanbour, A; Syed, G | 1 |
| Alongi, P; Caobelli, F; Chiaravalloti, A; Cistaro, A; Evangelista, L; Laudicella, R; Quartuccio, N; Salem, A; Spataro, A | 1 |
| Bakhshi, S; Batra, A; Dhamija, E; Kumar, R; Pandey, AK; Patel, C; Sharma, A; Singh, TP | 1 |
| Bi, L; Dagan Feng, D; Fulham, M; Kim, J; Li, N; Liu, Q; Song, S | 1 |
| Belka, C; Dinkel, J; Eze, C; Käsmann, L; Kirchner, J; Kunz, WG; Manapov, F; Mittlmeier, LM; Ricke, J; Roengvoraphoj, O; Sawicki, LM; Schmidt-Hegemann, NS; Tufman, A; Unterrainer, M | 1 |
| Chang, H; Chen, YY; Chou, HP; Huang, HK; Huang, TW; Lee, SC; Lin, KH; Lin, LF; Wu, TH | 1 |
| Chen, H; Meng, T; Pang, Y; Sun, L; Yu, X | 1 |
| Aigner, C; Christoph, DC; Eberhardt, W; Faehling, M; Fendler, WP; Ferdinandus, J; Grünwald, V; Herrmann, K; Karl, KO; Kessler, L; Metzenmacher, M; Umutlu, L | 1 |
| Almahariq, MF; Bissonnette, JP; Everitt, S; Geiger, G; Grills, IS; Manus, MM; Sonke, JJ; Sun, A; Vogel, W | 1 |
| Huang, Z; Liu, Y; Tao, Y; Wang, F | 1 |
| Gage, KL; Gillies, RJ; Katsoulakis, E; Mu, W; Schabath, MB; Whelan, CJ | 1 |
| Ancın, B; Doğan, R; Köksal, D; Kumbasar, U; Tuncel, M; Uysal, S | 1 |
| Chen, CC; Cheng, MF; Chuang, PJ; Hsieh, MS; Ko, CL; Lin, YJ; Tien, YW; Wang, HP; Wu, YW; Yang, SH; Yen, RF | 1 |
| Bing-Qiang, H; Hongbin, S; Hongsheng, D; Huiling, L; Pengfei, Y; Tao, Z | 1 |
| Bruin, NM; Knegjens, JL; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; van Kranen, S; Vogel, WV | 1 |
| Khan, S; Kim, S; Pratx, G; Yang, YP | 1 |
| Cao, Y; Fan, X; Li, X; Wang, Y; Xu, W; Zheng, X | 1 |
| Aghayeva, G; Akhan, O; Akıncı, D; Arslan, S; Çiftçi, T; Önder, S; Sarıkaya, Y; Ünal, E | 1 |
| Choi, D; Choi, JY; Hyun, SH; Park, YJ | 1 |
| Ambrosini, V; Ardizzoni, A; Argalia, G; Calabrò, D; Conci, N; Dall'Olio, FG; Fabbri, F; Fanti, S; Fragomeno, B; Marchese, PV; Ricci, D | 1 |
| Flamini, MEDM; Flamini, RC; Mota, IA; Verçosa, AFA | 1 |
| Gungor, S; Yakar, Hİ | 1 |
| Kawaguchi, T; Ota, M; Taniguchi, S; Tojo, T; Yasukawa, M | 1 |
| Aoshima, H; Isaka, T; Kanzaki, M; Maeda, H; Matsumoto, T; Mitsuboshi, S; Shidei, H | 1 |
| Amthauer, H; Bluemel, S; Böhmer, D; Frost, N; Furth, C; Michaels, L; Neudecker, J; Ochsenreither, S; Penzkofer, T; Rogasch, JMM; Rückert, JC; Temmesfeld-Wollbrück, B; von Laffert, M | 1 |
| Doleschel, D; Gremse, F; Gross, J; Kiessling, F; Lederle, W; Mottaghy, FM; Palmowski, K; Palmowski, M; Rix, A; Verburg, F | 1 |
| Bruzzi, JF | 2 |
| Burchett, P; Costello, P; De Cecco, CN; Gordon, L; Martin, SS; Monti, CB; Ravenel, J; Rieter, WJ; Schoepf, UJ; van Assen, M; Vogl, TJ | 1 |
| Song, T; Sun, J; Wang, J; Zhao, B | 1 |
| Bonitta, G; Casagrande, S; Castellani, M; Cattoni, M; Cuzzocrea, M; De Palma, D; Dominioni, L; Franzi, S; Imperatori, A; Mendogni, P; Nosotti, M; Pieropan, S; Rotolo, N; Schiorlin, I; Tosi, D | 1 |
| Aprile, V; Bacchin, D; Bellafiore, S; Bertoglio, P; Carbognani, P; Cattoni, MA; Femia, F; Franzi, F; Gnetti, L; Guerrera, F; Imperatori, AS; Kestenholz, P; Lococo, F; Lucchi, M; Margaritora, S; Minervini, F; Nachira, D; Paci, M; Querzoli, G; Rindi, G; Rodriguez Perez, M; Ruffini, E; Terzi, AC; Ventura, L; Viti, A | 1 |
| Agrawal, S; Deshmukh, M; Dongre, A; Dongre, T; Kanchankar, N | 1 |
| Colandrea, M; Di Stasio, GD; Ferrari, ME; Galetta, D; Grana, CM; Maisonneuve, P; Sorbello, S; Spaggiari, L; Travaini, L; Travascio, L | 1 |
| Baek, JH; Chang, YH; Chen, WC; Chi, SY; Chiang, PL; Chou, CK; Huang, SC; Lin, WC; Luo, SD; Su, YY; Tung, YC | 1 |
| Bonnier, A; Chong, WH; Saha, B; Saha, S | 1 |
| Isaka, M; Konno, H; Mizuno, T; Nagata, T; Ohde, Y | 1 |
| Chieng, H; Chong, WH; Chopra, A; Saha, B | 1 |
| Bowen, SR; Horn, KP; Kinahan, PE; Miyaoka, RS; Rengan, R; Thomas, HMT; Vesselle, HJ; Zeng, J | 1 |
| Bedirhan, MA; Cansever, L; Seyrek, Y | 1 |
| Ichinose, J; Kawaguchi, Y; Kondo, Y; Matsuura, Y; Mun, M; Nakao, M; Okumura, S | 1 |
| Chen, W; Cheng, NC; Fang, G; Hu, CM; Huang, LL; Xie, WP | 1 |
| Johnson, A; Manners, D; Norman, R; Piccolo, F | 1 |
| Bizien, N; Corre, R; Fangous, MS; Goulon, D; Guerpillon, B; Khatchatourian, L; Le Gall, F; Lesecq, L; Martinet, P; Saidani, N; Talarmin, JP | 1 |
| Antonoff, MB; Blumenthaler, AN; Hofstetter, WL; Mehran, RJ; Rajaram, R; Rice, DC; Roth, JA; Sepesi, B; Strange, CD; Swisher, SG; Vaporciyan, AA; Walsh, GL | 1 |
| Dejanovic, D; Hansen, NL; Loft, A | 1 |
| Baldari, S; Laudicella, R; Minutoli, F; Parisi, S; Pergolizzi, S | 1 |
| Chen, X; Hua, J; Li, L; Liu, L; Liu, Q; Liu, Y | 1 |
| Ito, K; Motoi, N; Muraoka, Y; Nakagawa, K; Narita, T; Watanabe, H; Watanabe, SI; Yatabe, Y; Yoshida, Y; Yotsukura, M | 1 |
| Dong, A; Gao, J; Wang, Y; Zhang, J | 1 |
| Akpoviroro, O; Asokan, S; Burks, EJ; Litle, VR; Rebello, A; Steiling, K; Suzuki, K | 1 |
| Assié, JB; Bonardel, G; Champion, L; Chouaid, C; Deleval, N; Girard, N; Giroux-Leprieur, E; Massiani, MA; Mezquita, L; Richard, C; Seban, RD | 1 |
| Chen, H; Hao, B; Meng, T; Pang, Y; Shang, Q | 1 |
| Caruso, D; Daffina, J; Laghi, A; Lucertini, E; Polici, M; Polidori, T; Pucciarelli, F; Ronconi, E; Rossi, M; Tipaldi, MA; Zerunian, M | 1 |
| Besson, FL; Bulifon, S; Comtat, C; Durand, E; Fadel, E; Faure, S; Fernandez, B; Ghigna-Bellinzoni, MR; Jais, X; Lebon, V; Levy, A; Mercier, O; Mitilian, D; Montani, D; Mussot, S; Parent, F; Planchard, D; Seferian, A | 1 |
| Ajuria-Illarramendi, O; Gorospe, L; Lage-Alfranca, Y; Martín-Martín, M | 1 |
| Beeche, CA; Leader, JK; Pennathur, A; Pu, J; Sechrist, J; Villaruz, LC; Wilson, D; Zhang, D | 1 |
| Ghosh, I; Sharma, P | 1 |
| Gerbaudo, VH; Hasan, OK; Lubanovic, M; Zukotynski, KA | 1 |
| Brinkmann, JK; Digumarthy, SR; Fintelmann, FJ; Jeck, WR; Mino-Kenudson, M; Shepard, JO; Troschel, FM | 1 |
| Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 2 |
| Li, J; Ma, J; Wang, Y; Wang, Z; Wu, X | 1 |
| Chen, Y; Luo, X; Shao, F; Wang, Y; Zhang, L | 1 |
| Bayarri-Lara, CI; Cueto Ladrón de Guevara, A; de Miguel Pérez, D; Delgado-Rodríguez, M; Expósito Ruiz, M; Giraldo Ospina, CF; Lorente, JA; Moyano Rodriguez, MJ; Puche, JL; Rodriguez Fernández, A; Ruiz Zafra, J; Sánchez-Palencia Ramos, A; Serrano, MJ | 1 |
| Denoux, T; Li, H; Lian, C; Ruan, S; Vera, P | 1 |
| Han, YJ; Li, HS; Li, YC; Mohammed Shah Alam, MS; Ren, YY; Wang, QS; Wang, Z; Wu, HB; Zhou, WL | 1 |
| Prosch, H | 1 |
| Antunovic, L; Castiglioni, I; Chiti, A; Gallivanone, F; Kirienko, M; Leonardi, L; Sollini, M; Testanera, G; Veronesi, G; Voulaz, E | 1 |
| Baeza, JA; Barbeiro, AR; García-Gómez, FJ; Jiménez-Ortega, E; Leal, A; Ureba, A; Vargas, A; Wals-Zurita, A | 1 |
| Jin, G; Li, Y; Su, D | 1 |
| Han, A; Huang, Y; Jin, F; Li, M; Liu, A; Ma, L; Yang, Q; Yu, J; Zhu, H | 1 |
| Akeboshi, M; Fukui, M; Hayashizaki, Y; Imashimizu, K; Itoh, M; Kawaji, H; Ko, W; Mogushi, K; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Hu, Y; Li, Y; Liu, G; Shi, H; Tan, H; Xiao, J; Zhang, Y; Zhou, J | 1 |
| Hayashi, T; Kishima, G; Morita, T; Nakao, K; Tachibana, S; Tokitsu, K | 1 |
| Dasu, A; Even, A; Lambin, P; Lindblom, E; Toma-Dasu, I; Uhrdin, J; van Elmpt, W; Wersäll, P | 1 |
| Fujimoto, Y; Hanai, N; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Kodaira, T; Naganawa, S; Nishio, M; Sone, M; Suzuki, H; Tamaki, T | 1 |
| Kuang, A; Ma, H; Pang, F; Ren, P; Shen, G | 1 |
| Chang, YC; Chen, JL; Chen, YC; Hsu, FM; Huang, JY; Huang, YS; Jaw, FS; Ko, WC; Yen, RF | 1 |
| Cherian, SV; Estrada-Y-Martin, RM; Irani, AD; Weissferdt, A; Zhou, J | 1 |
| Dong, Y; Hu, G; Huang, P; Xiao, W; Zhao, X | 1 |
| Laffon, E; Marthan, R; Milpied, N | 1 |
| Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
| Grosu, HB; Kalhor, N; Miller, R; Mudambi, L; Vial, MR | 1 |
| Aktan, M; Kanyilmaz, G; Koc, M; Yavuz, BB | 1 |
| Azevedo Silva, F; Borges Faria, D; Pereira de Oliveira, J; Pimentel, F; Sampaio Vieira, T | 1 |
| Abe, H; Ahn, JM; Chen, M; Choe, JH; Choi, H; Endo, H; Goodwin, J; Helke, KL; Inoue, M; Jenkins, DMR; Jeong, JY; Kim, JW; Lee, SY; Minna, JD; Neugent, ML; Robinson, MW; Ruthenborg, RJ; Shackelford, DB; Singh, PK; Takeda, N; Wake, M; Xuan, Z; Yoo, H | 1 |
| Altorki, NK; Ghaly, G; Harrison, S; Kamel, MK; Lee, PC; Nasar, A; Nguyen, AB; Port, J; Rahouma, M; Stiles, BM | 1 |
| Bi, N; Cease, KB; Frey, KA; Gross, M; Hassan, KA; Hayman, J; Kalemkerian, GP; Kong, FM; Lawrence, TS; Matuszak, M; Orringer, M; Ramnath, N; Ritter, T; Schipper, M; Ten Haken, RK; Wang, W | 1 |
| Amouyal, G; Cholley, B; Déan, C; Pellerin, O; Pernot, S; Sapoval, M; Scotté, F | 1 |
| Cuocolo, A; Evangelista, L; Gridelli, C; Spadafora, M | 1 |
| El-Rabadi, K; Hirtl, A; Karanikas, G; Marik, W; Mayerhoefer, M; Pivec, C; Prosch, H; Rausch, I; Riegler, G; Weber, M | 1 |
| Hiroshima, K; Kamata, T; Kou, E; Masunaga, A; Oide, T; Sekine, Y | 1 |
| Barone, M; Crisci, R; Divisi, D; Zaccagna, G | 1 |
| Doi, H; Fujimoto, E; Kanemura, S; Kijima, T; Kitajima, K; Kuribayashi, K; Mikami, K; Nakano, T; Negi, Y | 1 |
| Bornschlegl, S; Delivanis, DA; Dietz, AB; Gustafson, MP; Kottschade, L; Merten, MM; Ryder, M; Withers, S | 1 |
| Boellaard, R; Hoekstra, OS; Kramer, GM | 1 |
| Gorospe, L; Muñoz-Molina, GM; Pacios-Blanco, RE; Rioja-Martín, ME; Santos-Carreño, AL | 1 |
| Little, N; Malkoski, SP; Mansoori, JN | 1 |
| Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 3 |
| Castanheira, JC; Costa, DC; Oliveira, C; Silva, ÂF; Vaz, SC | 1 |
| Bairey, O; Berger, T; Cohen, YC; Eshel, L; Raanani, P; Shpilberg, O; Stern, D | 1 |
| Li, ZG | 1 |
| Aktas, Z; Demirag, F; Ozturk, A; Tari, P; Yilmaz, A | 1 |
| Goldring, J; Lim, E; Mallorie, A; Patel, A; Wagner, T | 1 |
| Choe, YH; Jeong, JS; Kim, CH; Kim, SR; Lee, YC; Park, HS | 1 |
| Akhurst, T; Ashley Cox, R; Ball, D; Bressel, M; MacManus, M | 1 |
| Shao, C; Song, Y; Xu, S; Zhu, D | 1 |
| Higashi, K; Ishigaki, Y; Nakamura, Y; Oguchi, M; Shimasaki, M; Takegami, T; Ueda, Y; Watanabe, N | 1 |
| Ahn, SJ; Marcus, C; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Young, B | 1 |
| Baroni, G; Botta, F; Ciardo, D; Cremonesi, M; Ferrari, ME; Garibaldi, C; Gilardi, L; Grana, CM; Jereczek-Fossa, BA; Orecchia, R; Piperno, G; Ronchi, S; Timmerman, R; Travaini, LL | 1 |
| Ayyıldız, O; İçer, S; Karacavus, S; Kaya, E; Kayaaltı, Ö; Tasdemir, A; Yılmaz, B | 1 |
| Appelt, AL; Borissova, S; Brink, C; Drøgemüller Lund, M; Hansen, O; Hoffmann, L; Josipovic, M; Khalil, AA; Knap, MM; Lutz, CM; Møller, DS; Nielsen, TB; Nyhus, CH; Ottosson, W; Persson, G; Schytte, T; Sibolt, P | 1 |
| Alavi, A; Duan, F; Houshmand, S; Khiewvan, B; Machtay, M; Opanowski, A; Salavati, A; Siegel, BA; Simone, CB; Snyder, BS; Wei, B | 1 |
| Fu, Z; Han, A; Jin, F; Kong, L; Qu, B; Yu, J; Zhang, Y | 1 |
| Bhure, U; Del Sol Pèrez-Lago, M; Gautschi, O; Keller, FA; Roos, JE; Strobel, K; Tornquist, K; Werner, L | 1 |
| Colella, S; Frost Clementsen, P; Konge, L; Naur, TMH; Richter Larsen, K; Sivapalan, P | 1 |
| Koparal, H; Korkmaz, E; Ozbilek, E; Yalcın, B; Yasar, Z; Yılmaz, U | 1 |
| Hadžihasanović, B; Kristić, S; Vegar Zubović, S | 1 |
| Kan, Y; Wang, W; Yang, J; Yuan, L | 1 |
| Bol, A; Clermont, C; Delor, A; Geets, X; Ghaye, B; Goossens, S; Hanin, FX; Janssens, G; Lee, JA; Remouchamps, V; Van Maanen, A; Wanet, M | 1 |
| Carter, BW; Lichtenberger, JP; Shroff, GS; Truong, MT; Wu, CC | 1 |
| Baldassari, MP; Barbosa, EM; Connolly, C; Delikatny, EJ; Deshpande, C; Drebin, J; Dunbar, A; Keating, J; Kucharczuk, JC; Kularatne, SA; Low, P; Mizelle, J; Newton, AD; Okusanya, O; Predina, JD; Singhal, S; Xia, L | 1 |
| Chen, Y; Kong, Y; Wang, Z; Yu, M | 1 |
| Falcoz, PE; Filosso, PL; Guerrera, F; Massard, G; Nigra, V; Oliaro, A; Renaud, S; Ruffini, E; Santelmo, N; Schaeffer, M; Solidoro, P | 1 |
| Alves, FC; Costa, G; Costa, JMN; de Lima, JP; Isidoro, J; Lapa, P; Marques, M; Oliveiros, B | 1 |
| Kishida, Y; Koyama, H; Miyazaki, M; Ohno, Y; Seki, S; Yoshikawa, T; Yui, M | 1 |
| Dwary, AD; Khan, EM; Sharma, P | 1 |
| Bal, CS; Bhalla, AS; Kumar, R; Mohan, A; Pandey, AK; Sharma, A; Vishnubhatla, S | 1 |
| Chang-Halpenny, C; Diehn, M; Eclov, NCW; Gensheimer, MF; Graves, EE; Hara, WY; Hong, JC; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Neal, JW; Olson, MR; Quon, A; To, J; Wakelee, HA; Zhu, H | 1 |
| Chen, M; Chen, S; Harmon, S; Jeraj, R; Li, X; Li, Y; Perk, T | 1 |
| Belderbos, JSA; Das, M; De Ruysscher, D; Even, AJG; Jochems, A; La Fontaine, MD; Lambin, P; Mottaghy, FM; Reymen, B; van Elmpt, W | 1 |
| Abravan, A; Eide, HA; Helland, Å; Knudtsen, IS; Løndalen, AM; Malinen, E; van Luijk, P | 1 |
| Fukushima, T; Gomi, D; Katou, A; Kobayashi, T; Koizumi, T; Mamiya, K; Oguchi, K; Sekiguchi, N; Tateishi, K | 1 |
| Dong, X; Duan, Q; Jiang, R; Shen, Y; Xue, Y; Zhang, G; Zhu, W | 1 |
| Fujisawa, Y; Kishida, Y; Koyama, H; Ohno, Y; Seki, S; Sugihara, N; Yoshikawa, T | 2 |
| Bombardieri, E; Bonifacio, C; Bonomi, M; Ceresoli, GL; Chiti, A; Ciocia, G; De Vincenzo, F; Gianoncelli, L; Giordano, L; Lopci, E; Lorenzi, E; Perrino, M; Santoro, A; Setti, LR; Simonelli, M; Zucali, PA | 1 |
| Luo, W; Wu, Q; Xu, F; Zhao, Y; Zhou, Q | 1 |
| Cuocolo, A; Evangelista, L; Mansi, L; Pace, L; Spadafora, M | 1 |
| Aniskhin, M; Berezina, N; Cherkashin, M; Puchkov, D | 1 |
| Bailly, P; Bouzerar, R; Daouk, J; Meyer, ME; Shields, T | 1 |
| Ito, R; Ito, S; Iwano, S; Kato, K; Kawaguchi, K; Naganawa, S; Shimamoto, H; Umakoshi, H | 1 |
| Alifano, M; Charpentier, MC; Cusumano, G; Damotte, D; Fournel, L; Galia, A; Nicolosi, M; Regnard, JF; Strano, S; Terminella, A | 1 |
| Ito, K; Jingu, K; Shirata, Y; Takahashi, N; Takanami, K; Takase, K; Takeda, K; Yamamoto, T | 1 |
| Miyoshi, Y; Satoh, H; Takayashiki, N | 1 |
| Agarwal, KK; Bhalla, AS; Das, CJ; Kumar, R; Mohan, A; Pandey, AK; Patel, CD; Sekhar Bal, C; Sharma, A; Sharma, MC; Sharma, P; Vishnubhatla, S | 1 |
| Belka, C; Dantes, M; Eze, C; Huber, RM; Li, M; Manapov, F; Roengvoraphoj, O; Taugner, J; Tufman, A; Wijaya, C | 1 |
| Blume, JD; Deppen, SA; Grogan, EL; Isbell, JM; Lambright, ES; Maiga, AW; Mercaldo, SF; Montgomery, C; Nesbitt, JC; Pinkerman, R; Rickman, OB; Vaszar, LT; Williamson, C | 1 |
| Bettinardi, V; Coliva, A; Compierchio, A; Doglioni, C; Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Negri, G; Picchio, M; Rossetti, F; Savi, A | 1 |
| Belderbos, JSA; Das, M; De Ruysscher, D; Even, AJG; La Fontaine, MD; Lambin, P; Mottaghy, FM; Reymen, B; van Elmpt, W | 1 |
| Cho, S; Jheon, S; Kim, K; Son, BY; Yum, SW | 1 |
| An, YX; Liu, C; Ma, LJ; Zhang, XJ | 1 |
| Ding, CY; Guo, Z; Li, TR; Li, YY | 1 |
| Liu, Y | 3 |
| Bakari, KH; Lan, X; Niyonkuru, A | 1 |
| Everitt, S; MacManus, M | 1 |
| Cheng, G; Huang, H | 1 |
| Cheng, G | 2 |
| Bellò, M; Deandreis, D; Finessi, M; Giunta, FP; Veltri, A | 1 |
| Arimura, H; Honda, H; Ikushima, K; Jin, Z; Kawata, Y; Morita, K; Sasaki, M; Sasaki, T; Shioyama, Y; Tokunaga, C; Yabu-Uchi, H | 1 |
| Fayad, H; Hatt, M; Jaouen, V; Laurent, B; Le Rest, CC; Visvikis, D | 1 |
| Akamine, T; Haratake, N; Kozuma, Y; Maehara, Y; Matsubara, T; Nabeshima, K; Okamoto, T; Shoji, F; Takamori, S; Toyokawa, G; Yamada, Y | 1 |
| Bonomo, L; Calandriello, L; Congedo, MT; Del Ciello, A; Giordano, A; Infante, A; Larici, AR; Leccisotti, L; Poscia, A; Sica, G | 1 |
| Pan, Y; Zhang, Y | 1 |
| Carp, L; Dendooven, A; Desbuquoit, D; Lauwers, P; Parizel, PM; Snoeckx, A; Spinhoven, MJ; van Meerbeeck, JP; Van Schil, PE | 1 |
| Bowen, SR; Kinahan, PE; Samuel, JJE; Thomas, HM | 1 |
| Court, LE; Fried, DV; Gomez, DR; Jensen, GL; Mackin, DS; Yost, CM; Zhou, S | 1 |
| Jeong, JS; Kim, CH; Kim, SR; Lee, YC | 1 |
| Ayadi, M; Claude, L; Douillard, JY; Dupuy, C; Goulon, D; Isnardi, V; Jouglar, E; Mahé, MA; Ségura-Ferlay, C | 1 |
| Eshghi, N; Frankl, J; Kuo, PH; Lundeen, TF | 1 |
| Voigt, W | 1 |
| Byanju, S; Chen, J; Liao, M; Wang, L; Wang, Y; Zhang, H; Zhu, D | 1 |
| Gormsen, LC; Jochumsen, MR; Nielsen, GL | 1 |
| Eshghi, N; Kuo, PH; Lundeen, TF | 1 |
| González-Santoni, R; Gurrea-Rosas, C; Maldonado-Vargas, JA; McBurney-Henriquez, E; Montalvo-Fitzpatrick, J; Saadé-Yordán, C | 1 |
| Braybrooke, JP; Darby, M; Hall, DO; Harvey, JE; Hooper, CE; Lyburn, ID; Masani, V; Maskell, NA; Searle, J; White, P | 1 |
| Downey, RJ; Dunphy, M; Gandelman, S; Goncalves, MD; Halpenny, DF; Jackson, J; Jones, LW; Lukose, A; Plodkowski, AJ; Schwitzer, E; Tan, KS; Taylor, S | 1 |
| Ge, D; Gu, J; He, J; Huang, Y; Jin, X; Lu, C; Shi, S; Xu, F; Ye, L; Zeng, Z | 1 |
| Frood, R; McDermott, G; Scarsbrook, A | 1 |
| Bortfeld, T; Choi, N; Liao, Z; Liu, A; Mohan, R; Niemierko, A; Shusharina, N | 1 |
| Bekker, E; Marom, EM; Ofek, E; Onn, A | 1 |
| Hyun, SH; Koh, YW; Lee, SJ; Park, SY | 1 |
| Liu, Y; Wang, XY; Wu, N; Yang, YK; Zhao, YF; Zhu, Z | 1 |
| Ga, A; Kakkar, N; Kaushal, V; Mittal, BR; Parihar, AS; Seam, RK; Sood, A; Sood, K | 1 |
| Bajwa, SK; Berg-Hansen, P; Erichsen, EAS; Harbo, HF; Nilsen, KB | 1 |
| Hatanaka, K; Iwazaki, M; Miyaoka, M; Nakamura, N | 1 |
| Chan, J; Chew, C; Schultz, C; Verma, S | 1 |
| Hyun, IY; Lee, M; Ryu, JS; Suh, CH | 1 |
| Burgess, J; Hodgson, R; Pointon, O; So, A | 1 |
| Coolen, J; De Leyn, P; De Ruysscher, D; De Wever, W; Decaluwé, H; Depypere, L; Deroose, C; Dooms, C; Fieuws, S; Lambrecht, M; Moons, J; Nackaerts, K; Stanzi, A; Van Raemdonck, D; Vansteenkiste, J; Verbeken, E | 1 |
| Aguloglu, N; Altindag, S; Can, C; Karaoglan, H; Kepenek, F; Komek, H; Morcali, H | 1 |
| Cho, JS; Eom, JS; Kim, BS; Kim, IJ; Kim, K; Kim, MH; Kim, SJ; Kim, YS; Lee, MK; Pak, K | 1 |
| Fukuda, A; Kimura, T; Matsumura, T; Nagao, M; Seno, H | 1 |
| Bussink, J; Carvalho, S; de Geus-Oei, LF; Lambin, P; Leijenaar, RTH; Oberije, C; Troost, EGC; van Elmpt, W; van Timmeren, JE | 1 |
| Bradbury, P; Cho, J; de Perrot, M; Elliott, HS; Hussey, D; Metser, U; Noam, T; Veit-Haibach, P | 1 |
| Aigner, C | 1 |
| Cheng, J; Ou, X; Ye, Y | 1 |
| Carvalho, S; Dasu, A; Lambin, P; Lazzeroni, M; Toma-Dasu, I; Uhrdin, J; van Elmpt, W; Wersäll, P | 1 |
| Bires, P; Lederleitner, D; Masarykova, A; Pobijakova, M; Povinec, P; Scepanovic, D | 1 |
| Becker, A; Estes, T; Keshavamurthy, J; Pucar, D; Wilson, B | 1 |
| Choi, JS; Lee, JW; Lee, SM; Lyu, J | 1 |
| Hatabu, H; Kauczor, HU; Ohno, Y; Seo, JB; van Beek, EJR | 1 |
| Aggarwal, S; Arora, G; Arora, S; Bal, C; Behera, A; Damle, NA; Passah, A; Tripathi, M | 1 |
| Sidaway, P | 1 |
| Arnould, V; Besson, FL; Blanchet, E; Bulifon, S; Chaumet-Riffaud, P; Chekroun, M; Chevance, V; Durand, E; Grimon, G; Henry, T; Humbert, M; Lebon, V; Mabille, L; Meyer, C; Montani, D; Parent, F; Roblot, V; Seferian, A | 1 |
| Betancourt, SL; Carter, BW; Lichtenberger, JP; Shroff, GS | 1 |
| Attinà, G; Giordano, A; Lanni, V; Librizzi, A; Mastrangelo, S; Maurizi, P; Riccardi, R; Ruggiero, A | 1 |
| Antunovic, L; Chiti, A; Cozzi, L; Fogliata, A; Kirienko, M; Rossi, A; Sollini, M; Voulaz, E | 1 |
| Andreo, F; Centeno, C; López de Castro, P; Martínez-Barenys, C; Mendiluce, L; Ruiz-Manzano, J; Sanz-Santos, J; Serra, P; Torky, M | 1 |
| Doai, M; Funasaki, A; Matoba, M; Motono, N; Sekimura, A; Ueda, Y; Uramoto, H; Usuda, K; Yamada, S | 1 |
| Cho, S; Jheon, S; Kang, YK; Kim, K; Kim, SE; Lee, WW; Song, YS | 1 |
| Arisaka, Y; Asao, T; Bao, P; Erkhem-Ochir, B; Higuchi, T; Kaira, K; Kasahara, N; Kosaka, T; Kuwano, H; Mogi, A; Nishiyama, M; Ohtaki, Y; Oyama, T; Shimizu, K; Sunaga, N; Tsushima, Y; Yajima, T; Yokobori, T | 1 |
| Oldan, J; Patel, T | 1 |
| Itoh, T; Kishida, Y; Maniwa, Y; Nishimura, Y; Ohno, Y; Seki, S; Yoshikawa, T | 1 |
| Laila, H; Leila, A; Mohamed, R; Mustapha, E; Soumia, F | 1 |
| Deasy, JO; Gelb, E; Humm, JL; Hunt, MA; Lee, SH; Rimner, A; Tyagi, N | 1 |
| Belderbos, J; De Ruysscher, D; La Fontaine, M; Persson, G; Reymen, B; Sonke, JJ; van Diessen, J; van Elmpt, W; Vogel, W; Westman, G | 1 |
| Chung, JH; Kim, S; Lee, SH; Pahk, K | 1 |
| Chin, AL; Diehn, M; Gensheimer, MF; Guo, HH; Kumar, KA; Loo, BW; Maxim, PG; Neal, JW; Wakelee, H | 1 |
| Ayers, K; Bakr, S; Bouchard, G; Diehn, M; Gentles, AJ; Jamali, M; Nair, V; Napel, S; Plevritis, SK; Quon, A; Shafiq, M; Shrager, JB; van de Rijn, M; West, RB; Yu, A; Zhang, W | 1 |
| Donald, J; Sanders, V; Siegel, BA | 1 |
| Asioli, S; Dalpiaz, G; Fanti, S; Marchiori, E; Rea, G | 1 |
| Choi, JY; Franks, TJ; Han, J; Kim, HK; Kim, TJ; Lee, KS; Zo, J | 1 |
| Bains, M; Beets-Tan, RG; Erinjeri, J; Gonen, M; Gonzalez-Aguirre, A; Kemeny, NE; Kurilova, I; Petre, EN; Sofocleous, CT; Solomon, SB | 1 |
| Asanuma, K; Hagi, T; Matsubara, T; Nakamura, T; Sudo, A; Sugino, Y | 1 |
| Furumoto, H; Hagiwara, M; Ikeda, N; Imai, K; Kajiwara, N; Kakihana, M; Maeda, J; Maehara, S; Masuno, R; Ohira, T; Okano, T; Shimada, Y | 1 |
| Bartenstein, P; Belka, C; Dantes, M; Eze, C; Huber, RM; Manapov, F; Roengvoraphoj, O; Taugner, J; Tufman, A; Wijaya, C | 1 |
| Broggi, S; Calandrino, R; Cattaneo, M; Cuzzocrea, M; Dell'Oca, I; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Mapelli, P; Pasetti, M; Picchio, M; Samanes Gajate, AM | 1 |
| Koizumi, M; Koyama, M; Sato, Y; Tanaka, H; Terauchi, T | 1 |
| Appelbaum, D; Liu, H; Meng, J; Penney, BC; Pu, Y; Zhang, JX | 1 |
| Kato, K; Kondo, E; Umayahara, K; Usami, T; Yamamoto, A | 1 |
| Bezjak, A; Bissonnette, JP; Bratman, S; Le, L; Leighl, N; Palma, D; Raman, S; Schellenberg, D; Sun, A; Warner, A | 1 |
| Bennani, S; Chassagnon, G; Freche, G; Magdeleinat, P; Mansuet-Lupo, A; Revel, MP | 1 |
| Abravan, A; Eide, HA; Helland, Å; Løndalen, AM; Malinen, E | 1 |
| Kina, S; Miura, K; Nagano, N; Nagasaka, S; Sato, T; Sugiyama, H; Takeda, Y; Tsujimoto, Y | 1 |
| Cao, Y; Geng, H; Li, K; Shen, M; Zheng, L | 1 |
| Beer, DG; Brown, RKJ; Carrott, PW; Chang, AC; Chen, G; Heiden, BT; Hermann, M; Lin, J; Lynch, WR; Orringer, MB; Reddy, RM; Zhao, L | 1 |
| Barbacid, M; Cussó, L; Desco, M; Mulero, F; Musteanu, M | 1 |
| Baxa, J; Bejcek, J; Ferda, J; Flohr, T; Ludvik, J; Matouskova, T; Pesek, M; Schmidt, B; Sedlmair, M | 1 |
| Maki, Y; Nakata, K; Nishimura, R; Sugawara, Y; Sugimoto, R; Teramoto, N; Ueno, T; Yamashita, M | 1 |
| Chen, P; He, W; Li, J; Ouyang, R; Peng, H; Zong, D | 1 |
| Belderbos, J; Gilhuijs, K; Julyan, P; Mercieca, S; van Herk, M; van Loon, J | 1 |
| Meyer, HJ; Surov, A; Wienke, A | 1 |
| Chen, J; Huang, Y; Jia, X; Liu, N; Liu, W; Qi, Y; Sun, X; Yuan, S | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Wu, D | 1 |
| Cui, H; Feng, D; Fu, Z; Gong, G; Gu, J; Wang, X; Yin, Y; Zhou, J | 1 |
| Doroudinia, A; Dorudinia, A; Kaghazchi, F; Mehrian, P | 1 |
| Han, S; Kim, YJ; Lee, JJ; Oh, JS; Suh, CH; Woo, S | 1 |
| Huang, Y; Jiang, L; Wang, H; Wu, X; Zhang, C | 1 |
| Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D; Shalev, A | 1 |
| Chen, Y; He, C; Huang, X; Li, L; Li, T; Yang, L; Yuan, J | 1 |
| Inoue, S; Ito, K; Kasai, Y; Kume, S; Masuya, D; Monden, K; Okada, N; Suzuki, Y; Takata, N; Tanaka, Y; Yoshimatsu, H | 1 |
| Miura, K; Sakamoto, T | 1 |
| Futagawa, Y; Hirano, J; Inagaki, T; Matsudaira, H; Morikawa, T; Okamoto, T; Sato, S; Yabe, M | 1 |
| Dai, X; Fei, S; Hu, T; Liu, C; Ren, J; Wei, J; Wu, H; Xie, L; Xiong, J; Yin, Z; Zhao, Y | 1 |
| Cui, C; Feng, W; Guo, X; Huang, J; Li, X; Liang, Z; Liu, M; Ma, Y; Wu, Z; Zhang, F | 1 |
| Aluja Jaramillo, F; Bhalla, S; Gutierrez, F | 1 |
| Cha, SI; Hahm, MH; Jeong, JY; Kim, CH; Lee, H; Lee, HJ; Lee, J; Lim, JK; Park, TI; Shin, KM | 1 |
| Abu Saadeh, F; Cormack, CM; Gleeson, N; Riain, CO | 1 |
| Hou, S; Jia, Q; Lin, X; Meng, Z; Shen, Y; Tan, J; Wang, S | 1 |
| Asao, T; Atsumi, J; Higuchi, T; Kaira, K; Kitahara, S; Kosaka, T; Mogi, A; Ohtaki, Y; Oyama, T; Shimizu, K; Yajima, T | 1 |
| Abdelhady, G; Bailey, ST; Francis, KP; Jones, A; Lee, JT; Mansfield, J; Momcilovic, M; Shackelford, DB; Zamilpa, C | 1 |
| de Jong, EEC; De Ruysscher, DKM; Dingemans, AC; Gietema, HA; Hendriks, LEL; Hofman, PAM; van Elmpt, W | 1 |
| Blasberg, J; Carson, RE; Casey, M; Chen, MK; Detterbeck, F; Gallezot, JD; Liu, C; Liu, Y; Lu, Y; Ma, T; Naganawa, M; Tanoue, L; Wu, J; Ye, Q | 1 |
| Behzadi, B; Doroudinia, A; Karam, MB; Koma, AY; Mehrian, P | 1 |
| Egashira, H; Ichita, C; Kako, M; Kitagawa, I; Sasaki, A; Seki, K; Sugimoto, H; Takizawa, S; Teshima, S; Tokoro, S; Tsukiyama, T | 1 |
| Egashira, R; Hirakawa, H; Kai, K; Kimura, S; Komiya, K; Nakamura, T; Ogusu, S; Sueoka-Aragane, N; Takahashi, K; Takeda, Y; Tanaka, M | 1 |
| Li, TC; Lin, J; Ouyang, ML; Tang, K; Xu, MM; Zheng, XW | 1 |
| Buyuksimsek, M; Gokcay, S; Guney, IB; Kapukaya, TK; Karaalioglu, B; Mirili, C; Ogul, A; Paydas, S; Seydaoglu, G; Tohumcuoglu, M; Yetisir, AE | 1 |
| Kim, HJ; Kim, WC; Koom, WS; Lee, J; Lee, M | 1 |
| Ahn, JS; Ahn, MJ; Cha, H; Choi, JY; Joung, JG; Kim, BT; Kim, J; Lee, KH; Lee, SH; Moon, SH; Park, K; Park, WY | 1 |
| Hasegawa, G; Hoshi, T; Kanefuji, T; Kobayashi, M; Morita, S; Oda, C; Suda, T; Terai, S; Yagi, K | 1 |
| Chung, JH; Kim, S; Lee, SH; Pahk, K; Yi, E | 1 |
| Kan, Y; Liu, J; Wang, W; Yang, J; Yuan, L | 1 |
| Aboagye, EO; Arshad, MA; Barwick, TD; Chua, S; Cook, GJ; Dickson, J; Landau, D; Lu, H; McDermott, G; O'Connor, R; Power, DA; Rockall, A; Rodgers, N; Scarsbrook, A; Tam, H; Thornton, A; Wallitt, K | 1 |
| Hashimoto, H; Kameda, K; Ozeki, Y; Taguchi, S | 1 |
| Aktas, GE; Balta, C; Karamustafaoğlu, YA; Sarikaya, A; Sarikaya, İ; Süt, N | 1 |
| Cho, JY; Cho, YJ; Kim, ES; Kim, Y; Lee, CT; Lee, JH; Lee, SH; Lee, YJ; Leem, CS; Park, JS; Yoon, HI | 1 |
| Ding, M; Ebeling, R; Heard, D; Posey, R; Zollinger, W | 1 |
| Aide, N; Desmonts, C; Do, P; Guizard, AV; Houdu, B; Lasnon, C; Licaj, I; Thomas, G | 1 |
| Afshar-Oromieh, A; Ahmadzadehfar, H; Essler, M; Rahbar, K | 1 |
| Bignardi, S; Comelli, A; Ippolito, M; Petrucci, G; Russo, G; Sabini, MG; Stefano, A; Yezzi, A | 1 |
| Motosugi, U; Omiya, Y; Onishi, H; Saito, A; Satoh, Y | 1 |
| Lin, J; Tang, K; Yin, W; Zheng, X | 1 |
| Adli, M; Alan, O; Alkis, H; Babacan, NA; Dane, F; Ercelep, O; Kaya, S; Ones, T; Sahin, D; Salva, H; Telli, TA; Tuylu, TB; Yumuk, F | 1 |
| Alavi, A; Jahangiri, P; Pournazari, K; Simone, CB; Swisher-McClure, S; Torigian, DA; Werner, TJ | 1 |
| Chen, YN; Liu, SY; Nie, K; Nie, W; Xiao, YX; Yu, H; Zhang, YX; Zhu, L | 1 |
| Ni, J; Sun, S; Tian, J; Wei, K; Zhang, Y | 1 |
| Aydın, F; Boz, A; Bozkurt, S; Cengiz, A; Dertsiz, L; Erkılıç, M; Güngör, F; Özbilim, G; Sipahi, M | 1 |
| Broggi, S; Calandrino, R; Cattaneo, MG; Dell'Oca, I; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Pasetti, M; Passoni, P; Picchio, M; Samanes Gajate, AM | 1 |
| Aliyu, SA; Archibald, SJ; Avery, G; Cawthorne, C; Crooks, MG; Hart, SP; Kadir, T; Morice, AH; Willaime, JMY | 1 |
| Chang, JH; Keam, B; Kim, DW; Kim, E; Kim, HJ; Kim, TM; Paeng, JC; Wu, HG | 1 |
| Johnson, PB; Yang, F; Young, LA | 1 |
| Boerner, B; Bruehlmeier, M; Frey, LD; Gambazzi, F; Graber, SM; Heuberger, J; Irani, S; Janthur, WD; Springer, OS; Tini, GM; Zweifel, R | 1 |
| Altmayer, S; Balbinot, F; Barros, MC; Dalla Costa, R; Francisco, MZ; Hochhegger, B; Irion, K; Marchiori, E; Pacini, GS; Penha, D; Santos, MK; Watte, G; Zanon, M | 1 |
| Hayakawa, M; Oda, K | 1 |
| Belderbos, J; Bjorkestrand, H; Damen, E; De Ruysscher, D; Dieleman, E; Faivre-Finn, C; Fredberg Persson, G; Reymen, B; Sikorska, K; Sonke, JJ; van Diessen, J; van Elmpt, W; Westman, G | 1 |
| Fujino, H; Kajiura, K; Kondo, K; Miyoshi, H; Otani, T; Otsuka, H; Takizawa, H | 1 |
| Balink, H; Edel, JP | 1 |
| Bal, CS; Bhalla, AS; Gupta, P; Jain, D; Kumar, R; Mohan, A; Pandey, AK; Sharma, A; Sharma, MC; Thulkar, S; Vishnubhatla, S | 1 |
| Belderbos, JSA; Delorme, S; Mercieca, S; van Baardwijk, A; van Herk, M | 1 |
| Bashir, U; Bille, A; Cook, GJ; Foot, O; Goh, V; Mclean, E; Siddique, MM; Wise, O | 1 |
| Campbell, J; Cheng, M; Frey, KA; Gross, M; Huang, KC; Kong, FS; Lawrence, TS; Li, L; Owen, D; Piert, M; Stenmark, M; Ten Haken, RK; Waller, JL; Wang, W | 1 |
| Behr, SC; Flavell, RR; Hope, TA; Perez, PM; Small, EJ; van Zante, A | 1 |
| Ganem, J; Gardin, I; Hapdey, S; Modzelewski, R; Thureau, S; Vera, P | 1 |
| Chen, F; Chen, L; Chen, T; Huang, Y; Jing, M; Sun, H; Tang, X; Tian, Y; Wang, C; Xie, R; Yang, C; Yang, J; Zhou, Y | 1 |
| Beyzadeoglu, M; Demiral, S; Dincoglan, F; Dirican, B; Elcim, Y; Gamsiz, H; Gundem, E; Sager, O; Uysal, B | 1 |
| Fan, Y; Galperin-Aizenberg, M; Li, H; Pryma, D; Simone, CB | 1 |
| Castello, A; Grizzi, F; Lopci, E; Qehajaj, D; Russo, C | 1 |
| Altmayer, S; Basso Dias, A; Garcez, A; Henz Concatto, N; Hochhegger, B; Irion, K; Marchiori, E; Medeiros, T; Mohammed, TL; Sartori Pacini, G; Verma, N; Watte, G; Zanon, M | 1 |
| Arrieta, O; Izquierdo-Sánchez, V; Medina, LA; Muñiz-Hernández, S; Pacheco-Yepez, J; Romero-Piña, ME; Vázquez-Becerra, H | 1 |
| Antiga, L; Antunovic, L; Chiti, A; Kirienko, M; Mognetti, S; Rossi, A; Silvestri, G; Sollini, M; Voulaz, E | 1 |
| Aoyagi, K; Kishida, Y; Koyama, H; Ohno, Y; Seki, S; Yoshikawa, T; Yui, M | 1 |
| Ahn, JS; Ahn, MJ; Choi, JY; Moon, SH; Park, K; Sun, JM | 1 |
| Deng, S; Li, J; Sang, S; Zhang, B; Zhang, W | 1 |
| Eisenhuber, E; Mostbeck, G; Schaefer-Prokop, C | 1 |
| Wang, LJ; Wang, QS; Wu, HB; Zhang, Y; Zhou, WL | 1 |
| Chen, Y; Fu, S; Hu, C; Li, D; Liu, J; Wu, J; Wu, M; Wu, Z; Yang, J; Yang, L | 1 |
| Ho, KC; Lin, CY; Liu, CY; Su, TP; Wang, CW; Yang, CT; Yen, TC | 1 |
| Otto, G | 1 |
| Gawde, S; Kasat, A; Parekh, S; Ramaswamy, V; Singhal, A | 1 |
| Allen, AM; Aravot, D; Barac, YD; Flex, D; Kramer, MR; Krutzwald-Josefson, E; Peled, N; Peysakhovich, Y; Saute, M | 1 |
| Ackman, JB; Halpern, EF; Kilcoyne, A; McDermott, S; Scott, JA; Wang, Y | 2 |
| Bromińska, B; Bromiński, G; Czepczyński, R; Dyszkiewicz, W; Gabryel, P; Gut, P; Janicka-Jedyńska, M; Jarmołowska-Jurczyszyn, D; Ruchała, M; Sawicka-Gutaj, N | 1 |
| Bauman, JE; Behnia, F; Eaton, KD; Goulart, BHL; Kell, E; Martins, RG; Mulligan, MS; Patel, SA; Romine, PE; Vesselle, HJ; Wallace, SG; Wood, DE | 1 |
| Ishii, S; Ishii, Y; Kaburagi, T; Nakano, T | 1 |
| Calcagni, ML; Cardillo, G; Carleo, F; De Massimi, AR; Di Martino, M; Ricciardi, S; Scolozzi, V; Taralli, S; Triumbari, EK | 1 |
| Ajuria-Illarramendi, O; Benito-Berlinches, A; Cabañero-Sánchez, A; de la Puente-Bujidos, C; Gorospe, L; Moreno-Mata, N; Muñoz-Molina, GM | 1 |
| Kuang, A; Shen, G; Su, M | 1 |
| Can, C; Kepenek, F; Komek, H; Urakçi, Z | 1 |
| Aigner, C; Eberhardt, W; Gauler, T; Guberina, M; Herrmann, K; Jentzen, W; Pöttgen, C; Schuler, M; Stamatis, G; Stuschke, M; Theegarten, D | 1 |
| Andratschke, N; Bogowicz, M; Guckenberger, M; Huellner, MW; Kraft, J; Tanadini-Lang, S; Unkelbach, J; Veit-Haibach, P; Vuong, D | 1 |
| Cardo, AG; Chaparro, MÁS; Espíldora, J; Hidalgo, CM; Lillo, E; Palomo, L; Trigo, JM; Valdivielso, P; Villena García, AC | 1 |
| Egberts, JH; Grunow, R; Jacob, D; Krause, C; Röcken, C; Schawitzke, A | 1 |
| Coruzzi, C; Di Stefano, T; Filice, A; Lococo, F; Mengoli, MC; Paci, M; Rapicetta, C; Versari, A | 1 |
| Boo, SH; Moon, SW; Park, HL; Park, JK; Park, SY; Sung, SW; Yoo, IR | 1 |
| Chen, P; Chen, W; Jia, C; Jiang, W; Li, X; Lu, D; Xu, W; Yin, G; Yu, L; Yu, X; Zhang, Y; Zhu, L; Zhu, X | 1 |
| Hagiya, H | 1 |
| Colinas, D; Fra, J; García-Talavera, P; Montes, A; Tamayo, P | 1 |
| Adeni, AE; Alessandrino, F; Awad, MM; Nishino, M; Sahu, S; Shinagare, AB; Tirumani, SH | 1 |
| Cha, MJ; Chung, MJ; Kim, BT; Kim, HS; Kim, TJ; Kim, TS; Kim, YS; Lee, KS | 1 |
| Harada, K; Irisawa, R; Kanzaki, A; Kiriyama, N; Maeda, T; Tsuboi, R | 1 |
| Casal, RF; Chen, M; Eapen, GA; Grosu, HB; Jimenez, CA; Li, L; Ost, DE; Sagar, AS; Sepesi, B; Sunny, J; Tschirren, J; Williams, J | 1 |
| Amtoft, AG; Dejanovic, D; Pøhl, M; Sørensen, JB | 1 |
| Huang, Y; Jiang, L; Wang, H; Wu, J; Zhang, F | 1 |
| Asano, Y; Hirakawa, K; Kashiwagi, S; Ohira, M; Ohsawa, M; Takada, K; Takashima, T; Tokimasa, S | 1 |
| Wang, Y; Xu, P; Zeng, X | 1 |
| Bakr, S; Davidzon, GA; Echegaray, S; Horng, G; Leung, ANC; Mattonen, SA; Nair, VS; Napel, S; Vasanawala, M | 1 |
| Cheng, W; Hou, G; Jiang, Y | 1 |
| Han, JH; Koh, YW; Lee, SJ; Park, SY | 1 |
| Fujisawa, Y; Kishida, Y; Koyama, H; Ohno, Y; Ohyu, S; Seki, S; Sugihara, N; Yoshikawa, T; Yui, M | 1 |
| Lin, J; Tang, K; Wang, L; Wu, Y; Zheng, X | 1 |
| Koh, YW; Lee, D; Lee, SJ | 1 |
| Fukushima, T; Gomi, D; Kobayashi, T; Koizumi, T; Oguchi, K; Sekiguchi, N | 1 |
| Bao, X; Lu, S; Niu, X; Wang, M; Wang, Q; Wang, S; Wang, Y; Xu, L; Zhang, J | 1 |
| Handra-Luca, A | 1 |
| Ahn, HK; Hyun, SH; Kim, SG; Lee, H | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Moon, SH | 1 |
| Krombach, GA; Litzlbauer, D; Wörner, JM | 1 |
| Jiang, T; Li, W; Shi, HZ; Tong, ZH; Wang, W; Wang, XJ; Wang, Z; Wu, XZ; Xu, LL; Yang, MF; Zhang, YH; Zhang, YY | 1 |
| Grigsby, PW; Lin, AJ; Ma, S; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J | 1 |
| Wang, T; Wang, Z | 1 |
| Bando, Y; Harada, M; Kinoshita, M; Kubo, M; Otomi, Y; Otsuka, H; Shinya, T; Takechi, K; Terazawa, K; Toba, H; Uyama, N; Yamanaka, M | 1 |
| Ejima, M; Fujie, T; Fujii, S; Furusawa, H; Katayanagi, S; Kawahara, T; Majima, H; Masuo, M; Miyazak, Y; Nukui, Y; Sakashita, H; Shimada, S; Shirai, T; Suzuki, T; Taguchi, T; Tamaoka, M; Tasaka, Y; Tateishi, T; Tomii, S; Watanabe, Y | 1 |
| Arslan, M; Dag, Y; Simsek, FS | 1 |
| Ito, R; Ito, S; Iwano, S; Kamiya, S; Kato, K; Naganawa, S | 1 |
| Beer, L; Fabikan, H; Fazekas, A; Fuereder, T; Haug, AR; Herold, C; Hochmair, M; Kifjak, D; Mayerhoefer, ME; Prosch, H; Schwab, S; Schwabel, B; Wadsak, W | 1 |
| Diab, RH; Einstein, SA; Erasmus, LJ; Mawlawi, OR; Meier, JG; Xu, G | 1 |
| Bonanno, L; Cuppari, L; Evangelista, L; Frega, S; Menis, J; Pasello, G; Reccia, P | 1 |
| Fujisawa, Y; Koyama, H; Ohno, Y; Sugihara, N; Takenaka, D; Yoshikawa, T; Yui, M | 1 |
| Fujii, T; Hishizawa, M; Inagaki, N; Kawaguchi-Sakita, N; Kim, YH; Kitamura, M; Kitawaki, T; Matsumoto, S; Nomura, M; Otsuka, A; Saito, R; Sakamori, Y; Sone, M; Taura, D; Yamasaki, T; Yamauchi, I; Yasoda, A | 1 |
| Giraudet, AL; Kryza, D; Mognetti, T; Moreau, A | 1 |
| Alavi, A; Goodman, CR; Houshmand, S; Kalbasi, A; Rice, SR; Saboury, B; Salavati, A; Simone, CB; Vujaskovic, Z; Werner, TJ | 1 |
| Balkay, L; Berényi, E; Béresová, M; Beyer, T; DiFranco, MD; Forgács, A; Garai, I; Lassen, ML | 1 |
| Beets-Tan, RGH; Donswijk, ML; Jóźwiak, K; Kusters, M; Lahaye, MJ; Lambregts, DMJ; Maas, M; Min, LA; Roberti, S; Vegt, E; Vogel, WV; Zijlmans, HJ | 1 |
| Fangliang, L; Miao, H; Nan, L; Shanyuan, Z; Shaolei, L; Yue, Y; Yumei, L | 1 |
| Bootsma, G; de Booij, M; De Ruysscher, D; Dingemans, AM; Hendriks, LEL; Hofman, P; Houben, R; Schoenmaekers, J; Schreurs, W; Westenend, M | 1 |
| Carvalho, S; de Ruysscher, D; Denis, F; Jochems, A; Lambin, P; Leijenaar, RTH; Muratet, JP; Nestle, U; Oberije, C; Schimek-Jasch, T; Troost, EGC; van Elmpt, W; van Timmeren, JE; Woodruff, HC | 1 |
| Huang, Y; Jiang, L; Li, Y; Wang, H; Wang, Q; Wu, X | 1 |
| Pahk, K | 1 |
| Li, Y; Wen, G; Zhang, J; Zhong, K | 1 |
| Chen, S; Diao, Y; Du, B; Li, X; Li, Y; Sun, T | 1 |
| Lin, J; Ouyang, ML; Tang, K; Wang, LL; Xia, HW; Xu, MM; Zheng, XW | 1 |
| Akhurst, T; Ball, DL; Bressel, M; Callahan, JW; Everitt, SJ; Hicks, RJ; Hofman, MS; Iravani, A; Mac Manus, MP; Siva, S; Turgeon, GA | 1 |
| Liu, Y; Lyu, L; Tao, XL; Wang, XY; Wu, N; Yang, L; Zhang, ZK | 1 |
| Fukui, T; Goto, M; Hakiri, S; Hashimoto, K; Iwano, S; Kato, T; Kawaguchi, K; Mori, S; Nakamura, S; Ozeki, N; Yokoi, K | 1 |
| George, UR; Kow, KS; Liam, CK; Tan, TH; Wong, TH | 1 |
| Araz, M; Gönüllü, U; Kir, KM; Kucuk, ON; Nak, D; Özkan, E; Sen, E; Soydal, C | 1 |
| Ansari-Gilani, K; Ramaiya, NH; Yang, M | 1 |
| Cui, Y; Dong, A; Wang, Y; Zhang, J | 1 |
| Huang, WS; Xu, JH; Yang, M; Zhang, GX; Zheng, Y | 1 |
| Stirling, RG; Zalcberg, J | 1 |
| Charabi, B; Fischer, BM; Friborg, J; Gram, SB; Håkansson, K; Nøhr, A; Rasmussen, JH; Tvedskov, JF; von Buchwald, C; Wessel, I | 1 |
| Chen, D; Fu, L; Guo, D; Jiang, G; Jin, F; Jing, W; Kong, L; Li, M; Wu, J; Yu, J; Yue, J; Zhu, H; Zou, B | 1 |
| Lu, Y | 1 |
| Alves, L; Bassett, P; Bille, A; Breen, R; Chalampalakis, Z; Chicklore, S; Cook, GJ; Martins, N; Murphy, DJ; Nair, A; Royle, L; Subesinghe, M | 1 |
| Goo, JM; Kim, H; Kim, YT; Paeng, JC; Park, CM | 1 |
| Curull, V; Gimeno, E; Martín-Ontiyuelo, C; Sánchez-Font, A; Suárez-Piñera, M | 1 |
| Gong, J; Kang, F; Li, G; Mu, W; Qin, W; Tian, J; Wang, J; Wang, S | 1 |
| Aerts, J; Biesma, B; Dingemans, AC; Groen, HJM; Hoekstra, O; Klinkenberg, TJ; Kloosterziel, C; Pieterman, R; Schramel, FMNH; Smit, EF; Smit, HJM; van den Borne, B; van der Heijden, EHFM; van der Noort, V; van Tinteren, H; Verhagen, A | 1 |
| Choi, EK; Kim, SJ; Kim, YK; Park, HL; Yoo, IR | 1 |
| Li, R; Lin, J; Tang, K; Wang, L; Zheng, X | 1 |
| Haga, N; Inoue, S; Ito, K; Kasai, Y; Kume, S; Masuya, D; Miyoshi, K; Monden, K; Okada, N; Ootsuka, K; Suzuki, Y; Takata, N; Tanaka, Y | 1 |
| Kandathil, A; Sibley, RC; Subramaniam, RM | 1 |
| Abubaker, S; Al-Ibraheem, A; Altuhhova, D; Belderbos, JSA; Bieu, BQ; Canh, NX; Carvalho, H; Duarte, PS; Fidarova, E; Ha, LN; Hanna, GG; Kapoor, R; Karusoo, L; Khader, J; Konert, T; Kütük, T; Le, TA; MacManus, MP; Numair, Y; Paez, D; Polo, A; Santos, AO; Sood, A; Soydal, C; Thorwarth, D; Vogel, WV; Zuliani, AC | 1 |
| Adjei, A; Bogner, P; Cheney, R; Demmy, TL; Dexter, E; Hennon, M; Hutson, A; Kannisto, E; Morrison, C; Nwogu, CE; Picone, A; Reid, M; Tan, W; Yendamuri, S | 1 |
| Hayashi, A; Irie, K; Kaneko, K; Masunari, S; Omagari, J; Sadashima, E; Sadashima, S; Yoshida, T | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Billè, A; Girelli, L; Leo, F; Pastorino, U | 1 |
| Choi, JY; Hwang, HS; Kim, BT; Kim, H; Kim, S; Kwon, OJ; Lee, HY; Lee, KS; Shim, YM; Yi, CA | 1 |
| Cho, A; Choi, BW; Hong, YJ; Hur, J; Kim, HY; Kim, YJ; Lee, HJ; Lee, JW; Shim, HS | 1 |
| Suzawa, N; Taguchi, O; Takao, M; Takeda, K; Yamada, T; Yamakado, K | 1 |
| Fındıkcıoğlu, A; Hatipoglu, A; Karadayi, S; Kilic, D | 1 |
| Hao, C; Lu, SJ; Seet, JE; Sinha, A; Wong, AS | 1 |
| Grosu, HB; Gutterman, DD; Lazzaro, R; Naidich, DP; Naik, SK; Patel, VK; Raoof, S; Travis, WD; Weingarten, JA; Wentowski, C | 1 |
| Ceriani, L; Foppiani, L; Giovanella, L; Piccardo, A; Treglia, G; Trimboli, P; Verburg, FA | 1 |
| Miyata, Y; Okada, M; Tsutani, Y | 1 |
| El Badaoui, A; Hitzel, A; Melloni, B; Monteil, J; Wagner, T; Woillard, JB; Ziai, D | 1 |
| Adachi, S; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 4 |
| Baram, D; Bilfinger, TV; Bishawi, M; Freiberg, E; Halbreiner, MS; Matthews, R; Moore, W | 1 |
| Früh, M; Müller, J; Putora, PM | 1 |
| Hirami, Y; Maeda, A; Nakata, M; Okita, R; Saisho, S; Shimizu, K; Yasuda, K; Yukawa, T | 2 |
| Dong, A; Dong, H; Zuo, C | 1 |
| Bootsma, GP; Brans, BT; de Ruysscher, DK; Dingemans, AM; Hendriks, LE; Hofman, PA; Scheppers, NA | 1 |
| Isowa, N; Miura, H; Sakaguchi, Y; Tokuyasu, H | 1 |
| Bezrukov, I; Brendle, C; Claussen, CD; Hetzel, J; Martirosian, P; Müller, M; Pfannenberg, C; Sauter, A; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
| Ahn, JS; Ahn, MJ; Choi, JY; Chung, MP; Han, J; Jeon, K; Jhun, BW; Kim, H; Kwon, OJ; Lee, KJ; Lee, KS; Park, K; Suh, GY; Sun, JM; Um, SW | 1 |
| Lei, J; Tian, J; Wang, Y; Zhai, Y; Zhang, L | 1 |
| Bal, C; Jain, TK; Kumar, R; Sahoo, MK; Sharma, P; Suman, S | 1 |
| Calcagni, ML; Del Ciello, A; Fadda, G; Treglia, G | 1 |
| Ikeda, K; Mori, T; Ohba, Y; Shiraishi, K; Suzuki, M; Yamada, T; Yoshimoto, K | 1 |
| Dunne, RM; McDermott, R; O'Keeffe, SA; O'Mahony, D; Wilson, G | 1 |
| Hendel, HW; Jensen, BV; Nielsen, D; Skougaard, K | 1 |
| Castellucci, P; Ferretti, A; Fuccio, C; Marzola, MC; Rubello, D; Spinapolice, EG; Trifirò, G | 1 |
| Brocken, P; de Geus-Oei, LF; Dekhuijzen, PN; Peters-Bax, L; van der Heijden, HF | 1 |
| Ahn, JS; Ahn, MJ; Cho, SH; Choi, JY; Ji, JH; Moon, SH; Park, K; Park, LC; Sun, JM | 1 |
| Banzo, I; Carril, JM; Del Castillo-Matos, R; Ibáñez-Bravo, S; Jiménez-Bonilla, JF; Martínez-Amador, N; Martínez-Rodríguez, I; Ortega-Nava, F; Quirce, R; Rubio-Vassallo, AS | 1 |
| Aarons, Y; Binns, D; Callahan, J; Dunn, L; Hicks, RJ; Kron, T; Schneider-Kolsky, M; Siva, S; Thompson, M | 1 |
| Caldarella, C; Muoio, B; Parapatt, GK; Treglia, G | 1 |
| Berkowitz, F; Esposito, G; Nandu, H | 1 |
| Achong, DM | 1 |
| Agarwal, KK; Bal, C; Kumar, R; Sharma, P; Singla, S; Suman Kc, S | 1 |
| Gotoh, M; Hasegawa, T; Higuchi, M; Osugi, J; Suzuki, H | 1 |
| Alafate, A; Fujiwara, T; Gobara, H; Hiraki, T; Ishii, H; Kaji, M; Kanazawa, S; Kato, K; Miyoshi, S; Okumura, Y; Sato, S; Shinya, T | 1 |
| Apisarnthanarax, S; Christodouleas, JP; Corradetti, MN; Evans, TL; Fernandes, AT; Grover, S; Kim, M; Langer, CJ; Lee, TT; Lin, LL; Mitra, N; Pryma, DA; Rengan, R; Simone, CB; Stevenson, JP; Xanthopoulos, EP | 1 |
| Carozzi, FM; Carrozzi, L; Comin, C; Deliperi, A; Falaschi, F; Falchini, M; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maddau, C; Mascalchi, M; Paci, E; Picozzi, G; Pistelli, F; Vaggelli, L; Vella, A | 1 |
| Fujikawa, A; Kosuda, S; Kyoto, Y; Nakamori, T; Nakamori, Y; Naoi, Y | 1 |
| Bohle, RM; Bohnenberger, H; Fleckenstein, J; Grgic, A; Kim, YJ; Kirsch, CM; Kremp, S; Kuhnigk, JM; Mai, S; Rübe, C; Schaefer, A; Schäfers, HJ | 1 |
| Kodama, H; Suzawa, N; Takaki, H; Takeda, K; Yamada, T; Yamakado, K | 1 |
| Cardillo, G; Graziano, P; Treglia, G | 1 |
| Bertke, MH; Dunlap, NE; Harkenrider, MM | 1 |
| Kong, F; Li, J; Sun, X; Xu, W; Zuo, X | 1 |
| Boomsma, MF; Stigt, JA; van Bemmel, BC | 1 |
| Ahn, BC; Bom, HS; Hong, CM; Jeong, SY; Kim, YC; Lee, J; Lee, SW; Min, JJ; Oh, JR; Seo, JH; Song, HC | 1 |
| Corral, C; de Guevara, DL; Fariña, C; Fuentes, A; Pefaur, R | 1 |
| Alraiyes, AH; Bernal-Green, L; Daroca, P; Hirsh, S; Kheir, F; Salerno, D | 1 |
| Chen, HH; Chen, HY; Chiu, NT; Guo, HR; Lai, YH; Lee, BF; Su, WC; Yao, WJ | 1 |
| Zhao, Y; Zou, H | 1 |
| Constantinesco, A; Goetz, C; Hassler, S; Hubele, F | 1 |
| Chung, JH; Kim, SE; Kim, TJ; Lee, KW; Lee, Y | 1 |
| Bollineni, VR; de Groot, EH; Groen, HJ; Kerner, GS; Koole, MJ; Langendijk, JA; Luurtsema, G; Pruim, J; Steenbakkers, RJ; Widder, J; Wiegman, EM; Willemsen, AT | 1 |
| Boellaard, R; Huisman, MC; Kinahan, PE; Lammertsma, AA; Makris, NE | 1 |
| Hosokawa, K; Kajihara, M; Nishimura, R; Ohtani, H; Sakai, S; Sawada, S; Shimizu, T; Sugawara, Y; Takahashi, T; Tanabe, Y; Yamashita, M | 1 |
| Hara, M; Nishio, M; Omi, K; Ozawa, Y; Shibamoto, Y; Tamaki, T | 1 |
| Elnayal, A; Fox, PS; Marom, EM; Mawlawi, O; Moran, CA; Swisher, SG | 1 |
| Bongiovanni, M; Cafarotti, S; Ceriani, L; Dutly, A; Giovanella, L; Paone, G; Treglia, G | 1 |
| Bongaerts, AH; Coppes, MH; Glaudemans, AW; Links, TP; Wolffenbuttel, BH | 1 |
| Fu, L; Fu, Z; Han, DL; Kong, L; Li, J; Yu, JM; Yu, YH; Zhang, Y; Zhu, SH | 1 |
| Buchbender, C; Gauler, T; Hartung, V; Heusch, P; Heusner, TA; Köhler, J; Lanzman, RS; Nensa, F; Poeppel, TD; Wetter, A; Wittsack, HJ | 1 |
| Cho, SH; Kim, JY; Kim, MJ; Kim, SH; Kim, YH; Lee, HJ; Won, KS | 1 |
| Chen, L; Chen, M; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Zhang, H; Zhang, L | 1 |
| Allen, C; Anayama, T; Driscoll, B; Dunne, M; Jaffray, D; Keshavjee, S; Nakajima, T; Vines, D; Yasufuku, K; Zheng, J | 1 |
| Ball, DL; Callahan, J; Hicks, RJ; MacManus, MP; Martin, O; Siva, S | 1 |
| Antoch, G; Beiderwellen, K; Bockisch, A; Buchbender, C; Forsting, M; Gauler, T; Gomez, B; Heusch, P; Heusner, TA; Köhler, J; Kühl, H; Lanzman, RS; Nensa, F; Schuler, M; Wittsack, HJ | 1 |
| Bazhenova, L; Bethel, K; Gambhir, SS; Hoh, C; Iagaru, AH; Keu, KV; Kolatkar, A; Kuhn, P; Kuschner, W; Loo, BW; Luttgen, MS; Nair, VS; Nieva, J; Shrager, JB; Vasanawala, M | 1 |
| Bussink, J; de Geus-Oei, LF; Kaanders, JH; Oyen, WJ; Peters-Bax, L; Schuurbiers, OC; Troost, EG; Usmanij, EA; van der Heijden, EH | 1 |
| Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 2 |
| Behrendt, FF; Kuhl, CK; Mottaghy, FM; Palmowski, M; Pietsch, H; Verburg, FA | 1 |
| Huang, D; Li, B; Wang, H; Xu, H; Yao, Y; Yu, W; Zhao, X | 1 |
| Bashir, MR; Jaffe, TA; Neville, AM; Thacker, JM; Uronis, HE | 1 |
| Belderbos, JS; Houweling, AC; Kruis, MF; Sonke, JJ; van de Kamer, JB; van Herk, M | 1 |
| Domen, H; Hatanaka, KC; Hatanaka, Y; Hida, Y; Hirano, S; Kaga, K; Matsuno, Y; Okamoto, S; Tamaki, N | 1 |
| de Clermont, H; Laffon, E; Lamare, F; Marthan, R | 1 |
| Aide, N; Berriolo-Riedinger, A; Blagosklonov, O; Brenot-Rossi, I; Bridji, B; Cachin, F; Caignon, JM; Chaumet-Riffaud, P; Collombier, L; Courbon, F; Devillers, A; Doyeux, K; Dubray, B; Fernandez, P; Gremillet, E; Houzard, C; Kolesnikov-Gauthier, H; Modzelewski, R; Olivier, P; Roux, J; Tessonnier, L; Thureau, S; Vera, P; Vervueren, L | 1 |
| Bilfinger, TV; Franceschi, D; Kim, B; Matthews, R; Moore, WH; Vu, CC | 1 |
| Canales, BK; Stone, WZ; Wymer, DC | 1 |
| Akashi, K; Hayashi, M; Iwasaki, H; Kato, K; Kikushige, Y; Kuroiwa, M; Miyamoto, T; Nakaike, T; Ohshima, K; Oku, S; Takenaka, K; Teshima, T | 1 |
| Farjah, F; Lou, F; Rizk, NP; Rusch, VW; Sima, C | 1 |
| Bandiera, A; Gajate, AM; Gallivanone, F; Gianolli, L; Landoni, C; Melloni, G; Muriana, P; Sestini, S; Zannini, P | 1 |
| Ahn, HK; Ahn, MJ; Ahn, YC; Choi, JY; Hyun, SH; Kim, H; Kim, J; Park, K; Shim, YM | 1 |
| Adusumilli, PS; Bograd, AJ; Dunphy, MP; Morales, EA; Nitadori, J; Rizk, NP; Rusch, VW; Sima, CS | 1 |
| Feldmann, HJ; Nestle, U; Schanne, D | 1 |
| Ito, H; Karino, F; Kondo, T; Murakami, S; Nakayama, H; Oshita, F; Saito, H; Yamada, K; Yokose, T | 1 |
| Kozu, Y; Maniwa, T; Nakajima, T; Ohde, Y | 1 |
| Crocker, I; Curran, WJ; Fox, T; Schreibmann, E; Schuster, DM | 1 |
| Hakucho, T; Higashiyama, M; Hosoki, T; Jiang, B; Miyake, C; Morimoto, D; Nakanishi, K; Sakashita, N; Sato, Y; Takahashi, Y; Takashima, S; Tomita, Y | 1 |
| Endo, M; Isaka, M; Kondo, H; Maniwa, T; Nakagawa, K; Ohde, Y; Okumura, T | 1 |
| Faasse, T; Shreve, P | 1 |
| Dempsey, MF; Goh, YG; Han, S; Poon, FW; Sim, YT | 1 |
| Banchs, J; Chang, JY; Erasmus, JJ; Evans, JD; Gladish, GW; Gomez, DR; Komaki, R; Rebueno, N; Welsh, JW | 1 |
| Araki, T; Nambu, A; Onishi, H; Satoh, Y | 1 |
| Petrun'kin, AM; Tlostanova, MS | 1 |
| Friedman, K; Ko, JP; Rakheja, R | 1 |
| Bonichon, F; Cazeau, AL; de Baère, T; Descat, E; Devillers, A; Galy-Lacour, C; Godbert, Y; Lagoarde-Segot, L; Leboulleux, S; Meunier, C; Palussière, J; Pulido, M | 1 |
| Alavi, A; Bradley, JD; Cho, KH; DeNittis, A; Duan, F; Gorelick, JJ; Johnson, DW; Kim, SK; Komaki, R; Macapinlac, H; Machtay, M; Munden, R; Neumann, DR; Reddin, JS; Sherwin, N; Siegel, BA; Snyder, BS; Videtic, G; Wilf, LH | 1 |
| Bradley, JD; Lamb, JM; Low, DA; Robinson, CG | 1 |
| Das, M; De Ruysscher, D; Hüllner, M; Lambin, P; Reymen, B; Sharifi, H; Troost, EGC; van Elmpt, W; Veit-Haibach, P; Wildberger, JE; Zegers, K | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kim, CY; Kim, DH; Kim, HW; Lee, J; Lee, SW; Oh, JR; Son, SH; Song, BI | 1 |
| Csekeo, A; Csomor, J; Eszes, N; Kis, A; Losonczy, G; Muller, V; Tamasi, L | 1 |
| Aerts, HJ; Boellaard, R; Carvalho, S; Dekker, AL; Gillies, RJ; Hoekstra, CJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Parmar, C; van Elmpt, WJ; Velazquez, ER | 1 |
| Aerts, HJ; Carvalho, S; Dekker, A; Gillies, R; Lambin, P; Leijenaar, RT; Oberije, C; Oellers, M; Parmar, C; Reymen, B; Troost, EG; van Elmpt, W; Velazquez, ER | 1 |
| Toney, LK; Vesselle, HJ | 1 |
| Barrington, SF; Chicklore, S; Cook, GJ; Goh, V; Klabatsa, A; Lang-Lazdunski, L | 1 |
| Chen, GH; Fan, XW; Gao, HQ; Jiang, GL; Qian, W; Wu, KL; Yao, ZF; Zhang, YJ | 1 |
| Iuele, FI; Merenda, N; Niccoli-Asabella, A; Notaristefano, A; Pisani, AR; Rubini, G | 1 |
| d'Amico, A; Przeorek, C; Turska-d'Amico, M | 1 |
| Bhethanabhotla, S; Durgapal, P; Gajendra, S; Gogia, A; Gupta, R; Sahoo, MK; Tanwar, P | 1 |
| Dahlbom, M; Gaudio, S; Jani, SS; Lamb, JM; Low, DA; Robinson, CG; Thomas, DH; White, BM | 1 |
| Booth, K; Hanna, GG; Lynch, T; McAleese, J; McGonigle, N; McGuigan, J; McManus, KG; O'Sullivan, J | 1 |
| Jain, S; Karunanithi, S; Kumar, R; Mukherjee, A; Sharma, P | 1 |
| Awasthi, V; Sahoo, K; Yadav, VR | 1 |
| Arimura, H; Jin, Z; Magome, T; Nakamura, K; Sasaki, M; Shioyama, Y | 1 |
| Endo, M; Kaira, K; Kondo, H; Murakami, H; Naito, T; Nakajima, T; Ohde, Y; Takahashi, T; Yamamoto, N | 1 |
| Ishigatsubo, Y; Kaneko, T; Nagai, K; Shinkai, M; Watanabe, K; Yamaguchi, N | 1 |
| Ju, HZ; Wang, J; Yang, MF | 1 |
| Das, SK; Dewhirst, MW; Fels, DR; Hansen, KS; Vlahovic, G; Wong, TZ; Zhang, T | 1 |
| Cui, Y; Dong, A; Wang, Y; Zuo, C | 1 |
| Ouvrier, MJ; Thariat, J; Vignot, S | 1 |
| Azuma, K; Fujimoto, K; Fujita, H; Hattori, S; Hayabuchi, N; Hayakawa, M; Hiromatsu, Y; Hirose, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kurata, S; Nakashima, T; Takamori, S | 1 |
| Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Ohde, Y; Ono, A; Takahashi, T; Yamamoto, N | 1 |
| Hayashi, S; Hoshi, H; Tanaka, H | 1 |
| Chung, HW; Kim, HJ; Kim, WS; Lee, KY; So, Y | 1 |
| Feng, Y; Li, S; Ma, Y; Wang, Y; Yang, Y; Zhao, B; Zheng, Q | 1 |
| Fushiki, H; Jitsuoka, M; Matsunari, I; Mitsuoka, K; Miyoshi, S; Murakami, Y; Nishimura, S; Noda, A; Sasaki, H | 1 |
| Hida, Y; Hirano, S; Kaga, K; Matsui, Y; Muto, J; Nakada-Kubota, R; Ohtaka, K; Okamoto, S; Shiga, T; Tamaki, N | 1 |
| Feng, DD; Fulham, MJ | 1 |
| Duan, XY; Gao, JG; Guo, YM; Shang, J; Wang, JS; Wang, W | 1 |
| Geiger, GA; Grover, S; Kim, MB; Langer, CJ; Plastaras, JP; Pryma, DA; Rengan, R; Simone, CB; Xanthopoulos, EP | 1 |
| Alfieri, RR; Ardizzoni, A; Bartolotti, M; Bordonaro, R; Bortesi, B; Bruzzi, P; Caffarra, C; Cavazzoni, A; Cosentino, S; Fumarola, C; Ippolito, M; Latteri, F; Petronini, PG; Ruffini, L; Scarlattei, M; Soto Parra, HJ; Spadaro, P; Tiseo, M | 1 |
| Fukui, T; Ishiguro, F; Kawaguchi, K; Nakamura, S; Taniguchi, T; Usami, N; Yokoi, K | 1 |
| Kosaka, T; Kuwano, H; Mogi, A; Tanaka, S; Yamaki, E | 1 |
| Annunziata, S; Bertagna, F; Cafarotti, S; Ceriani, L; Giovanella, L; Lococo, F; Prior, JO; Sadeghi, R; Treglia, G | 1 |
| Cheng, AP; Dong, MJ; Fu, LP; Sun, WY; Wang, XG; Zhao, LJ | 1 |
| Dong, A; Wang, Y; Zhai, Z; Zhang, J; Zuo, C | 1 |
| Chander, A; Fielding, P; Huang, C; Kelly, M; Mehta, G | 1 |
| Gong, H; Han, SR; Tong, AN; Wang, YM; Yan, P; Yao, H; Zhao, H | 1 |
| Chen, CY; Chen, JH; Chien, CR; Kao, CH; Liang, JA; Lin, CC; Wang, HN; Wang, PH; Yeh, JJ | 1 |
| Bernardin, L; Desouza, NM; O'Flynn, EA | 1 |
| Choi, BH; Chung, SI; Go, SI; Hwang, IG; Jung, J; Kang, JH; Kang, MH; Kim, MJ; Kim, SH; Lee, GW; Ling, H; Song, HN | 1 |
| De Ruysscher, D | 2 |
| Aoki, Y; Fujii, H; Kunieda, E; Nishimura, S; Oku, Y; Ozawa, Y; Sanuki, N; Takeda, A; Yokosuka, N | 1 |
| Blanc, E; Calais, J; Cardot, V; Mabille, L | 1 |
| Fukui, M; Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K; Tsushima, Y | 1 |
| Davidzon, G; Gevaert, O; Nair, VS; Plevritis, SK; West, R | 1 |
| Aguiló, R; Arriola, E; Belda-Sanchis, J; Curull, V; Pijuan, L; Rodríguez de Dios, N; Rodríguez-Fuster, A; Sánchez-Font, A; Suárez-Piñera, M; Taus, Á; Vollmer, I; Zuccarino, F | 1 |
| Endo, M; Hanaoka, H; Kaira, K; Koh, Y; Nakajima, T; Ohde, Y; Oriuchi, N; Serizawa, M; Takahashi, T; Yamaguchi, A; Yamamoto, N | 1 |
| Choi, WH; Chun, SH; Hong, SH; Jeon, EK; Jung, CK; Kang, JH; Kim, JO; Kim, SJ; Kim, YK; Kim, YS; Lee, J; Yoo, IeR | 1 |
| Akers, SR; Alavi, A; Cheng, G; Del Bello, CV; Werner, TJ | 1 |
| Fukuda, M; Keino, D; Kinoshita, A; Kitagawa, H; Kondoh, K; Morimoto, M; Murata, S; Muto, S; Ohyama, R; Wakisaka, M | 1 |
| Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, H; Zhang, WJ; Zhao, SJ; Zheng, R | 1 |
| Feng, D; Fulham, M; Kim, J; Kumar, A; Wen, L | 1 |
| Eaton, A; Fazio, M; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; Lilienstein, J; Morris, PG; Patil, S; Ulaner, GA | 1 |
| Iinuma, T; Inoue, T; Jinnouchi, S; Minamimoto, R; Murano, T; Nakashima, R; Senda, M; Terauchi, T; Uno, K; Yoshida, T | 1 |
| MacRae, R; Nair, VJ; Pantarotto, JR; Sirisegaram, A | 1 |
| Bai, CX; Gu, YC; Hong, QY; Liu, FL; Shi, HC | 1 |
| Inubushi, M; Koizumi, M; Koyama, M; Miwa, K; Murata, T; Nagao, M; Sasaki, M; Wagatsuma, K | 1 |
| Karunanithi, S; Khilnani, GC; Kumar, A; Kumar, R; Venkitaraman, B | 1 |
| Lodge, MA; Tahari, AK; Wahl, RL | 1 |
| Bifulco, M; Bocchino, M; de Rosa, I; Rea, G; Somma, F; Valente, T | 1 |
| Bærentzen, S; Madsen, GA; Rasmussen, TR | 1 |
| Amler, L; Eaton, K; Fine, BM; Gitlitz, B; Hicks, R; Hughes, B; Loecke, D; Mileshkin, L; Mitchell, P; Pirzkall, A; Townley, P; Wood, K | 1 |
| Koizumi, M; Koyama, M | 1 |
| Avci, E; Cengiz, HH; Cengiz, M; Cetin, E; Demirci, NY; Eroglu, FN; Tatci, E; Tunc, M; Ulger, S; Yilmaz, U | 1 |
| Beriwal, S; Burton, SA; Christie, NA; Clump, DA; Heron, DE; Horne, ZD; Landreneau, RJ; Luketich, JD; Quinn, AE; Schuchert, MJ; Shah, S; Vargo, JA | 1 |
| Ambrosini, V; Colletti, PM; Fanti, S; Marzola, MC; Mascherini, D; Montesi, V; Nanni, C; Pettinato, C; Rossetti, V; Rubello, D; Zompatori, M | 1 |
| Bengel, F; Hinrichs, J; Vogel-Claussen, J; Wacker, F | 1 |
| Bodell, MA; Kraus, ES; Lipson, EJ; Sharfman, WH | 1 |
| Buchbender, C; Gauler, T; Gomez, B; Hartung, V; Heusch, P; Heusner, TA; Köhler, J; Kühl, H; Nensa, F; Reis, H; Stamatis, G | 1 |
| Bowen, SR; Chaovalitwongse, WA; Grabowski, TJ; Kinahan, PE; Sandison, GA; Wang, S | 1 |
| Couturier, O; Fosse, P; Hachemi, M; Hureaux, J; Lacœuille, F; Urban, T; Vervueren, L | 1 |
| Astoul, P; Coiffard, B; Dutau, H; Elharrar, X; Laroumagne, S; Vandemoortele, T | 1 |
| Hida, Y; Hirano, S; Kaga, K; Matsui, Y; Muto, J; Nakada-Kubota, R; Ohtaka, K; Okamoto, S; Tamaki, N | 1 |
| Ball, DL; Binns, DS; Brennan, S; Campeau, MP; Fisher, RJ; Hicks, RJ; Lin, MY; MacManus, M; Solomon, B; Wu, M | 1 |
| Ando, M; Asami, K; Atagi, S; Ishii, M; Kanazu, M; Kawaguchi, T; Kubo, A; Kusunoki, Y; Maruyama, K; Matsuda, Y; Minomo, S; Ogawa, Y; Takada, M; Uehira, K | 1 |
| Antoch, G; Flechsig, P; Giesel, FL; Haberkorn, U; Heussel, CP; Kauczor, HU; Kratochwil, C; Moltz, J; Rath, D; Rieser, M; Schwartz, LH; Warth, A; Zabeck, H | 1 |
| Ansaloni, L; Baiocchi, GL; Capponi, MG; Coniglio, A; D'Ugo, D; De Manzoni, G; Di Leo, A; Giacopuzzi, S; Giulini, SM; Marchet, A; Marrelli, D; Morgagni, P; Nitti, D; Pacelli, F; Rosa, F; Roviello, F; Saragoni, L; Tiberio, GA; Verlato, G | 1 |
| Cheng, MH; Duan, XB; Fan, W; Xie, LJ; Xu, ZQ | 1 |
| Caldarella, C; Taralli, S; Treglia, G | 1 |
| Evangelista, L; Panunzio, A; Polverosi, R; Pomerri, F; Rubello, D | 1 |
| Baqir, M; Lowe, V; Ryu, JH; Yi, ES | 1 |
| Bardet, S; Brenot-Rossi, I; Dubray, B; Edet-Sanson, A; Faure, G; Gomez, P; Houzard, C; Jalali, K; Lerouge, D; Mahé, MA; Ménard, JF; Meyer, ME; Mezzani-Saillard, S; Modzelewski, R; Mornex, F; Olivier, P; Rousseau, C; Salem, N; Thureau, S; Vera, P | 1 |
| Hirami, Y; Maeda, A; Nakata, M; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
| Carrasquillo, JA; Downey, RJ; Panicek, DM; Shia, J; Strong, VE; Untch, BR | 1 |
| Gao, X; Yang, CS; Ye, XD; Yuan, Z | 1 |
| Aldrich, MC; Andrade, GM; Ballman, KV; Cerfolio, RJ; Chen, CL; D'Amico, TA; Decker, PA; Deppen, SA; Grogan, EL; Harpole, DH; Jones, DR; Keenan, RJ; Meyers, BF; Putnam, JB; Shrager, JB; Verdial, FC | 1 |
| Gordon, LL; Greer, TJ; Koch, NC; Pastis, NJ; Sharma, AK; Silvestri, GA; Tanner, NT; Wahlquist, AE | 1 |
| Burke, L; Henry, MT; Hinchion, J; Kennedy, MP; Maher, MM; McCarthy, J; McCarthy, L; McSweeney, S; Moloney, F; O'Regan, K; Ryan, D | 1 |
| Lohrmann, C; Weber, WA | 1 |
| Bansal, P; Behera, D; Gupta, A; Gupta, N; Maturu, VN; Rai Mittal, B; Singh, N | 1 |
| Fujino, H; Kajiura, K; Kawakami, Y; Kondo, K; Kubo, H; Mokhtar, M; Nakagawa, Y; Ohtani, T; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Yoshida, M | 1 |
| Chakraborty, PS; Dhull, VS; Karunanithi, S; Kumar, R; Nadarajah, J; Salunkhe, NR | 1 |
| Bomanji, J; Sathekge, MM; Vorster, M | 1 |
| De Ruysscher, D; Doll, C; Duncker-Rohr, V; Eriksen, JG; Grosu, AL; MacManus, M; Mix, M; Nestle, U; Oyen, W; Rücker, G; Vogel, W; Weber, W | 1 |
| Ansari, S; Castillo, E; Castillo, R; Castillo, S; Guerrero, T; Hobbs, B; Li, M; Meshkov, D; Olanrewaju, A; Pham, N | 1 |
| Cruz, J; Ferreira, L; Pacheco, C | 1 |
| Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Ono, A; Takahashi, T; Yamamoto, N | 1 |
| Cui, X; Fang, N; Wang, Y; Zeng, L; Zhang, C; Zhang, H | 1 |
| Anzellotti, A; Awasthi, V; Bailey, J; Gali, H; Matlock, G; McFarland, A; Watson, J | 1 |
| Beer, AJ; Eiber, M; Fürst, S; Nekolla, SG; Rauscher, I; Rummeny, EJ; Schwaiger, M; Souvatzoglou, M; Ziegler, SI | 1 |
| Ando, T; Kimura, S; Kitamura, H; Kojima, K; Komiya, K; Sueoka-Aragane, N | 1 |
| Drescher, R; Freesmeyer, M; Winkens, T | 1 |
| Chen, JH; Chu, S; Kao, CH; Liang, JA; Lin, WY; Lu, YY | 1 |
| Miyoshi, S | 1 |
| Borms, M; Cocquyt, V; D'Asseler, Y; Kruse, V; Maes, A; Mees, G; Van De Wiele, C | 1 |
| Gyobu, T; Honda, O; Inoue, M; Johkoh, T; Kusumoto, M; Leung, AN; Morii, E; Okumura, M; Sumikawa, H; Tanaka, Y; Tomiyama, N; Ueda, K; Watanabe, H; Watanabe, S; Yanagawa, M | 1 |
| Chan, WW; Choy, TS; Ho, PP; Khong, PL; Kwong, DL; Lam, KO; Lee, EY; Lee, VH; Leung, DK; Leung, TW | 1 |
| Cho, J; Choi, NC; Sharp, GC; Shusharina, N | 1 |
| Domènech-Vilardell, A; Ichise, M; Rasiej, MJ; Taub, RN | 1 |
| Hyun, IY; Ryu, JS | 1 |
| Berlangieri, S; Eek, R; Murphy, C; Schwalb, H | 1 |
| Duan, F; Machtay, M; Siegel, BA; Snyder, BS | 1 |
| Berman, AT; Ellenberg, SS; Simone, CB | 1 |
| Badger, S; Jones, C; Lynch, T | 1 |
| Bie, P; Huan, H; Lau, WY; Li, G; Ma, K; Qian, C; Wu, L; Xia, F | 1 |
| Buvat, I; Chouahnia, K; Cyrta, J; Eder, V; Martinod, E; Morère, JF; Orlhac, F; Pouliquen, C; Soussan, M | 1 |
| Ameshima, S; Anzai, M; Araya, T; Demura, Y; Ishizaki, T; Ishizuka, T; Kasahara, K; Matsuoka, H; Morikawa, M; Nishi, K; Nishitsuji, M; Sumida, Y; Tsuchida, T; Umeda, Y | 1 |
| Aboagye, EO; Faber, C; Griffiths, J; Heinzmann, K; Hermann, S; Honess, DJ; Jacobs, AH; Kopka, K; Kuhlmann, MT; Müller-Tidow, C; Schäfers, M; Schelhaas, S; Schneider, R; Schober, O; Smith, DM; Viel, T; Wachsmuth, L; Wagner, S | 1 |
| Antoniou, AJ; Marcus, C; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Asa, S; Halaç, M; Sager, S; Uslu, L | 1 |
| Chen, CY; Hsiao, YC; Hsieh, BT; Huang, WS; Ooi, H | 1 |
| Ahn, SJ; Ban, HJ; Bom, HS; Chung, WK; Jeong, JU; Kim, KS; Kim, YC; Kwon, SY; Nam, TK; Oh, IJ; Song, JY; Yoon, MS | 1 |
| Cortot, A; Hossein-Foucher, C; Olivier, A; Petyt, G; Scherpereel, A | 1 |
| Li, F; Li, L; Li, Y; Su, M; Tian, R | 1 |
| Deng, L; Li, C; Lu, Y; Na, F; Wang, J; Xue, J | 1 |
| Haro, A; Nagashima, A; Saitoh, G; Yasuda, M | 1 |
| Lu, P; Sun, Y; Yu, L | 1 |
| Ampel, NM; Knox, KS; Luraschi-Monjagatta, Mdel C; Onadeko, OO; Rennels, MA; Reyes, N; Walsh, TK | 1 |
| Aukema, TS; Burgers, SA; Klomp, HM; Rijna, H; Schaake, EE; Valdés Olmos, RA; van Gool, MH; van Pel, R; van Tinteren, H | 1 |
| Berstad, AE; Bugge, AS; Johnsrud, K; Kongerud, J; Lund, MB; Naalsund, A | 1 |
| Le, BB; Nguyen, BD | 1 |
| Ball, DL; Binns, D; Callahan, J; Collins, M; Everitt, SJ; Herschtal, A; Hicks, RJ; Kron, T; MacManus, M; Plumridge, N; Schneider, M | 1 |
| Chiou, YR; Huang, TC; Kao, CH; Wang, YC | 1 |
| Coolen, J; De Wever, W; Verschakelen, J | 1 |
| Aukema, TS; Burgers, SA; Codrington, HE; Klomp, HM; Rijna, H; Schaake, EE; Teertstra, HJ; Valdés Olmos, RA; van Gool, MH; van Pel, R; van Tinteren, H | 1 |
| Alifano, M; Cavazza, A; Cesario, A; Filice, A; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Sgarbi, G; Treglia, G; Versari, A | 1 |
| Xi, K; Xi, S; Xie, X | 1 |
| Chang, H; Chang, TH; Chang, WC; Chu, CM; Gao, HW; Ho, CL; Hsu, HH; Hsu, YC; Huang, TW; Ko, KH; Shen, DH | 1 |
| Bagni, O; Ciorra, A; Filippi, L; Sardella, B; Scopinaro, F | 1 |
| Agrawal, K; Mohan, HK; Weaver, J | 1 |
| Bahce, I; Boellaard, R; Dahele, M; Dickhoff, C; Hartemink, KJ; Hoekstra, OS; Smit, EF; Thunnissen, E; Vos, CG | 1 |
| Fujii, H; Fujita, A; Kanazawa, H; Kijima, S; Kimura, Y; Sasaki, T; Shinozaki, T; Sugimoto, H; Utano, K; Utano, Y | 1 |
| Ball, DL; Chabrot, M; Everitt, SJ; Hicks, RJ; Leimgruber, A; MacManus, M; Möller, A; Solomon, B | 1 |
| Iwata, T; Mizobuchi, T; Nakajima, T; Nakatani, Y; Sakairi, Y; Suzuki, H; Tagawa, T; Yamamoto, T; Yoshida, S; Yoshino, I | 1 |
| Graumann, O; Laursen, CB; Pareek, A | 1 |
| Li, S; Lv, C; Wang, X; Yan, S; Yang, Y; Yu, J; Zhao, B | 1 |
| Burger, IA; de Clermont, H; Laffon, E; Lamare, F; Marthan, R | 2 |
| Ezzouhri, S; Fleury, V; Hatt, M; Ingrand, P; Lamour, C; Le Rest, CC; Perdrisot, R; Tixier, F; Valla, C; Visvikis, D | 1 |
| Deng, H; Hu, S; Jia, Z; Shen, G | 1 |
| Kang, HC; Kim, HK; Kim, SJ; Kim, SS; Oak, CY; Yoon, JH | 1 |
| Babacan, NA; Erselcan, T; Hasbek, Z; Kacan, T; Salk, I; Turgut, B; Yucel, B | 1 |
| Bucchi, L; Burgio, MA; Crociani, L; Gavelli, G; Genestreti, G; Gurioli, C; Matteucci, F; Monti, M; Parisi, E; Piciucchi, S; Poletti, V; Scarpi, E | 1 |
| Balink, H; Hoogendoorn, M | 1 |
| Gotoh, M; Higuchi, M; Honjo, H; Shigihara, T; Shishido, F; Suzuki, H | 1 |
| Abgral, R; Clodic, C; Gobel, Y; Marianowski, R; Mornet, E; Potard, G; Salaun, PY; Valette, G | 1 |
| Abele, J; Allegretto, M; Bedard, E; Hunt, I; Maquire, C; Patel, A; Perry, T | 1 |
| Mimae, T; Miyata, Y; Okada, M; Sasada, S; Tsubokawa, N; Yoshiya, T | 1 |
| Abel, F; Haalck, T; Klutmann, S; Schumacher, U; Yanar, M | 1 |
| Cheng, CY; Huang, WS; Lee, CH; Lee, KW; Oliver Wong, CY; Tyan, YS; Wang, JJ; Yang, CW | 1 |
| Freesmeyer, M; Reissig, A; Tauhardt, E; Winkens, T | 1 |
| Caicedo, C; Garcia-Velloso, MJ; Gurpide, A; Labiano, T; Lopez-Picazo, JM; Lozano, MD; Perez Gracia, JL; Richter Echevarria, JA; Vigil Diaz, C; Zulueta, J; Zulueta, JJ | 1 |
| Akgun, M; Araz, O; Calik, M; Daloglu, F; Demirci, E; Durur-Subasi, I; Karaman, A; Orsal, E; Subasi, M; Ucar, EY | 1 |
| Alavi, A; Chauhan, MS; Hess, S; Jacob, MJ; Ravina, M | 1 |
| Bal, C; Jain, TK; Karunanithi, S; Kumar, R; Singh, A | 1 |
| Amini, B; Jorgensen, JL; Kumar, R; Salem, U; Zhang, L | 1 |
| Bueno, F; Cross, G; Pitoia, F | 1 |
| Basu, S; Borde, C; Kand, P | 1 |
| Akers, SR; Alavi, A; Cheng, G; Lee, NJ | 1 |
| Guo, R; Jin, Y; Li, B; Xu, H | 1 |
| Gotoh, M; Higuchi, M; Muto, S; Ohsugi, J; Okabe, N; Sakuma, H; Suzuki, H; Teranishi, Y; Yonechi, A | 1 |
| Kagohashi, K; Kurishima, K; Satoh, H; Taguchi, S | 1 |
| Alavi, A; Boon-Keng, TK; Borofsky, S; Codreanu, I; Houshmand, S; Khiewvan, B; Saboury, B; Salavati, A; Torigian, DA; Zaidi, H | 1 |
| Force, S | 1 |
| Aldrich, MC; Davis, WT; Deppen, SA; Fletcher, S; Green, EA; Grogan, EL; Putnam, JB; Rickman, O | 1 |
| Garcheva, M; Gocheva, L; Zlatareva, D | 1 |
| Kato, K; Kawachi, T; Kohara, S; Naganawa, S; Sobajima, A; Sone, Y | 1 |
| Barnes, A; Bomanji, JB; Fraioli, F; Groves, AM; Janes, SM; Kayani, I; Menezes, L; O'Meara, C; Punwani, S; Screaton, NJ; Syed, R; Win, T; Zaccagna, F | 1 |
| Duan, YL; Guo, YL; Li, FX; Li, JB; Shang, DP; Sun, XR; Wang, W; Zhang, YJ | 1 |
| Fukui, M; Inoue, D; Ishitoko, M; Itotani, R; Matsumoto, M; Nakayama, T; Sakuramoto, M; Suzuki, S; Takamatsu, K; Takemura, M; Yoshie, O; Yuba, Y | 1 |
| Ariyaratnam, P; Beddow, E; Darr, A; Dusmet, M; Granato, F; Greenwood, A; Iyer, S; Kirk, A; Leung, M; Lim, E; Loubani, M; Marchbank, A; Mohamed, S; Naidu, B; Nicholson, AG; Pattenden, HA; Shackcloth, M; West, D | 1 |
| De Raedt, N; De Ruysscher, D; Deroose, CM; Dooms, C; Gheysens, O; Nackaerts, K | 1 |
| Cho, YS; Choi, JY; Chung, DR; Kim, BT; Lee, KH | 1 |
| Bazhenova, L; Bethel, K; Carlsson, A; Gambhir, SS; Hoh, CK; Horng, G; Iagaru, AH; Jamali, M; Keu, KV; Kolatkar, A; Kuhn, P; Kuschner, W; Loo, BW; Luttgen, MS; Nair, VS; Nieva, J; Shrager, JB; Vasanawala, M | 1 |
| Allgäuer, M; Andratschke, N; Appold, S; Dieckmann, U; Ernst, I; Ganswindt, U; Grosu, AL; Guckenberger, M; Holy, R; Molls, M; Nestle, U; Nevinny-Stickel, M; Schanne, DH; Semrau, S; Sterzing, F; Wittig, A | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motomo, N; Sagawa, M; Sakuma, T; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K | 1 |
| Bussink, J; de Geus-Oei, LF; Kaanders, JH; Looijen-Salamon, MG; Meijer, TW; Oyen, WJ; Schuurbiers, OC; Span, PN; van der Drift, MA; van der Heijden, EH; Visser, EP | 1 |
| Al-faham, Z; Jolepalem, P; Thie, J; Wong, CY; Wong, WW | 1 |
| Hiraoka, M; Iizuka, Y; Matsuo, Y; Mizowaki, T; Nakamoto, Y; Togashi, K; Ueki, N; Umeoka, S | 1 |
| Di Perri, D; Geets, X; Lee, J; Sterpin, E; Wanet, M | 1 |
| Cheon, GJ; Chung, JK; Im, HJ; Kang, KW; Kim, EE; Kim, IJ; Kim, SJ; Lee, DS; Pak, K | 1 |
| Créhange, G; Feutray, S; Humbert, O; Maingon, P; Martin, E; Peignaux-Casasnovas, K; Truc, G; Vulquin, N | 1 |
| Das, M; Fontanarosa, D; Spijkerman, J; Van Elmpt, W | 1 |
| Fan, M; Fu, Z; Gong, H; Huang, W; Li, B; Liu, B; Zhang, Z; Zhou, T | 1 |
| Frechen, S; Fuhr, U; Kahraman, D; Kobe, C; Nogova, L; Scheffler, M; Suleiman, AA; Wolf, J; Zander, T | 1 |
| Choi, WH; Chung, SK; Kim, YK; Lee, KY; Park, HL; Wang, YP; Yoo, IeR | 1 |
| Li, D; Qiao, H; Wang, D; Wang, L; Wang, Y | 1 |
| Choi, JY; Choi, YL; Han, J; Jeong, CJ; Jeong, JY; Lee, HY; Lee, KS | 1 |
| Ginsberg, MS; Hayes, SA; Plodkowski, AJ | 1 |
| Kim, H; Kim, SJ; Pak, K; Shin, S | 1 |
| Aldrich, MC; Blume, JD; Deppen, SA; Grogan, EL; Kensinger, CD; Massion, PP; McPheeters, ML; Morgan, AM; Putnam, JB; Walker, RC | 1 |
| García Vicente, AM; Honguero Martínez, AF; Jiménez Londoño, GA; León Atance, P; Soriano Castrejón, AM; Udias, JM; van Gómez López, O | 2 |
| Burger, IA; Dinkelborg, L; Friebe, M; Graham, K; Haerle, SK; Hany, TF; Horn-Tutic, M; Kowal, K; Luurtsema, G; Maas, B; Pruim, J; Schaefer, NG; Schibli, R; Stephens, A; von Schulthess, GK; Wiegers, J; Zitzmann-Kolbe, S | 1 |
| Bellomi, M; Bertolotti, R; Maisonneuve, P; Paganelli, G; Rampinelli, C; Spaggiari, L; Travaini, LL; Veronesi, G | 1 |
| Bai, X; Chen, L; Gao, J; Hu, H; Nie, Y; Niu, X; Xu, H; Zhao, W | 1 |
| Bashirzadeh, F; Bhatt, M; Fielding, D; Hundloe, J; Nguyen, P; Ravi Kumar, AS; Ware, R | 1 |
| Ito, R; Ito, S; Iwano, S; Kato, K; Kishimoto, M; Naganawa, S | 2 |
| Bal, C; Gupta, RK; Kumar, K; Kumar, R; Singh, H | 1 |
| Asao, T; Fujii, T; Kuwano, H; Morita, H; Tsutsumi, S; Yajima, R; Yamaguchi, S | 1 |
| de Vries, AC; Poley, JW | 1 |
| De Ruysscher, D; Eriksson, J; Even, AJ; Hoebers, FJ; Houben, RM; Lambin, P; Mottaghy, FM; Ollers, MC; Reymen, B; Troost, EG; van Elmpt, W; Windhorst, AD; Zegers, CM | 1 |
| Fujiwara, H; Konishi, E; Kubo, T; Mizoshiri, N; Shimada, J; Shirai, T; Terauchi, R; Tomita, Y; Tsuchida, S | 1 |
| Acksteiner, C; Steinke, K | 1 |
| Czyżewski, D; Gabryś, J; Kuś, E | 1 |
| de Geus-Oei, LF; Grootjans, W; Meeuwis, AP; Oyen, WJ; Slump, CH; van der Vos, CS; Visser, EP | 1 |
| Chen, R; Huang, G; Liu, J; Ni, Y; Xie, W; Zhou, X | 1 |
| Wang, Y; Yao, Y; Zheng, K | 1 |
| Biederer, J; Kim, HS; Lee, KS; Ohno, Y; van Beek, EJ | 1 |
| Collins, GP; Corcoran, JP; Davies, SJ; Ho, LP; Moore, AJ | 1 |
| Calais, J; Castier, Y; De Kerviler, E; Lussato, D; Menard, J; Merlet, P; Mongiat-Artus, P | 1 |
| Kimura, H; Kosaka, N; Shimizu, K; Tsuchida, T; Tsuji, K | 1 |
| Miwa, K | 1 |
| Kessler, A; Son, H | 1 |
| Carney, JA; Chen, CC; Papadakis, GZ; Patronas, NJ; Stratakis, CA | 1 |
| Knudtsen, IS; Malinen, E; Ollers, M; van Elmpt, W | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Buchert, R; Furth, C; Hofheinz, F; Lougovski, A; Riedel, S; Rogasch, J; Schramm, G; Schreiber, J; Steffen, IG; Wertzel, H | 1 |
| Bussink, J; de Geus-Oei, LF; Usmanij, EA | 1 |
| Buvat, I; Doyeux, K; Edet-Sanson, A; Gardin, I; Hapdey, S; Michel, C; Vauclin, S; Vera, P | 1 |
| Fang, Y; Han, Y; Wu, H; Xiao, H; Yuan, M; Zeng, Y; Zhou, Z | 1 |
| Bodner, WR; Garg, MK; Gucalp, R; Guha, C; Keller, SM; Ohri, N; Perez-Soler, R; Piperdi, B | 1 |
| Chen, X; Han, Y; Hu, X; Jiang, C; Tang, T; Yang, B; Zhao, H | 1 |
| Calcagni, ML; Di Franco, D; Galli, G; Giordano, A; Indovina, L; Leccisotti, L; Rufini, V | 1 |
| Koizumi, H; Kurimoto, N; Nakamura, H; Saji, H; Shinmyo, T; Tagaya, R; Takagi, M | 1 |
| Chu, C; Gao, X; Li, Y; Liu, W; Lu, P; Wang, W; Yu, L | 1 |
| Correa, AM; Erasmus, JJ; Hofstetter, W; Kim, MP; Mehran, R; Rice, DC; Roth, JA; Swisher, SG; Vaporciyan, AA; Walsh, GL | 1 |
| Fan, L; Kohan, A; Rajiah, P; Sher, A; Vercher-Conejero, J | 1 |
| Aerts, HJ; Aristophanous, M; Berbeco, R; Chen, AB; McCall, K; Yip, S | 1 |
| Cho, A; Chung, KY; Kim, DJ; Lee, CY; Lee, JG; Park, SY; Yu, WS | 1 |
| Fan, M; Fu, Z; Huang, W; Li, B; Li, H; Liu, B; Zhang, Z; Zhou, T | 1 |
| Antoine, M; de Figueiredo, BH; Fernandez, P; Hatt, M; Lagarde, P; Lamare, F; Petit, A; Trouette, R | 1 |
| Campion, L; Denis, F; Krhili, S; Muratet, JP; Septans, AL; Yossi, S | 1 |
| Chen, Y; Guo, L; Hu, X; Huang, J; Ji, C; Ling, C; Xu, H; Zhang, B; Zhu, W | 1 |
| Aliyev, A; Asa, S; Atahan, E; Halaç, M; Özhan, M; Sağer, MS; Sönmezoğlu, K; Vatankulu, B; Yilmaz Aksoy, S | 1 |
| Machida, Y; Motono, N; Sagawa, M; Sakuma, T; Tanaka, M; Ueno, M; Usuda, K | 1 |
| Kawakami, W; Koshida, K; Nakajima, K; Takemura, A; Yokoyama, K; Yokoyama, S | 1 |
| Bailly, P; Daouk, J; Jounieaux, V; Kamimura, M; Meyer, ME; Sacksick, D | 1 |
| Calais, J; Dubray, B; Gardin, I; Modzelewski, R; Thiberville, L; Thureau, S; Vera, P | 1 |
| Buchbender, C; Gomez, B; Grueneien, J; Grueneisen, J; Heusch, P; Köhler, J; Nensa, F; Reis, H; Ruhlmann, V; Schaarschmidt, BM; Umutlu, L | 1 |
| Aoyagi, K; Koyama, H; Matsumoto, S; Ohno, Y; Seki, S; Sugimura, K; Takenaka, D; Yamagata, H; Yoshikawa, T; Yui, M | 1 |
| Appelbaum, DE; Liao, C; Penney, BC; Pu, Y; Simon, CA; Zhang, C | 1 |
| Hugo, G; Saraiya, S; Weiss, E | 1 |
| Choi, NC; Sharp, GC; Shusharina, N | 1 |
| Ditt, H; Homann, G; Horger, M; Kopp, HG; Mustafa, DF; Nikolaou, K; Spengler, W | 1 |
| Alokla, K; Kheir, F; Palomino, J | 1 |
| Cardillo, G; De Waure, C; Filice, A; Giordano, A; Granone, P; Graziano, P; Lococo, F; Perotti, G; Rindi, G; Rossi, G; Rufini, V; Sgarbi, G; Stefanelli, A; Versari, A | 1 |
| Khong, PL; Lee, EY; Lee, VH; Qian, W; Wong, MP; Yu, X | 1 |
| Chen, J; Geng, D; Sun, D; Yu, R; Zhang, L | 1 |
| Arveschoug, AK; Hager, H; Harders, SW; Hjorthaug, K; Hoejbjerg, JA; Madsen, HH; Meldgaard, P; Pilegaard, HK; Rasmussen, F; Rasmussen, TR; Rehling, M | 1 |
| Ahn, MJ; Ahn, YC; Choi, JY; Kim, BT; Kim, H; Moon, SH; Park, K; Park, SB; Yoo, J | 1 |
| Arkies, H; de Boer, J; Jager, PL; Koopman, D; Lagerweij, MC; Oostdijk, AH; Slump, CH; van Dalen, JA | 1 |
| Li, XD; Liu, WK; Ouyang, X; Quan, JT; Zheng, H | 1 |
| Davis, G; Hardy, TG; Kurniawan, ED; McKelvie, P | 1 |
| Chang, WC; Chen, JH; Cheng, CY; Chu, CM; Gao, HW; Hsu, HH; Hsu, YC; Huang, TW; Ko, KH; Lee, SC | 1 |
| Jansen, JP; Kanters, S; Mills, EJ | 1 |
| Blume, JD; Deppen, SA; Grogan, EL | 1 |
| Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 1 |
| Groen, HJM; Klinkenberg, TJ; van den Berg, LL; Widder, J | 1 |
| Hong, SA; Jang, SJ; Kim, MY; Kim, SS; Lee, HJ; Oh, SY; Shin, SY | 1 |
| Fu, C; Gao, YJ; Li, WL; Shi, DP; Xu, JL; Xuan, A; Zhang, J | 1 |
| Carvalho, S; Dasu, A; Lambin, P; Lazzeroni, M; Toma-Dasu, I; Uhrdin, J; van Elmpt, W | 1 |
| Akosman, C; Altunok, EC; Eren, OO; Ordu, C; Oyan, B; Selcuk, NA; Toklu, T | 1 |
| Kung, AL; Wang, Y | 1 |
| Colletti, PM; Fellner, F; Gabriel, M; Hatzl, M; Hodolic, M; Huber, H; Lamprecht, B; Rubello, D; Stelzmüller, I; Wunn, R | 1 |
| Duan, XY; Guo, YM; Li, M; Li, Y; Wang, W | 1 |
| Fernandez, P; Lamare, F; Merlin, T; Visvikis, D | 1 |
| Bartholmai, BJ; Hartman, TE; Johnson, GB; Koo, CW; Lindell, RM; Moynagh, MR; Raghunath, SM; Rajagopalan, S; White, DB | 1 |
| Barizzi, J; Giovanella, L; Treglia, G | 1 |
| A Korkmaz, N; Acat, M; Cetinkaya, E; H Dincer, E; Onaran, H; Ozgül, A; Yasar, Z | 1 |
| Auffermann, WF; Bechara, R; Behera, M; Chen, Z; Deng, X; Force, SD; Fu, H; Fu, RW; Gal, AA; Harvey, RD; Khuri, FR; Kim, S; Mendel, J; Miller, DL; Owonikoko, TK; Pickens, A; Ramalingam, SS; Rogatko, A; Rossi, MR; Saba, NF; Sica, GL; Sun, SY; Tighiouart, M; Torres, WE | 1 |
| Fulham, MJ; Gnaneswaran, S; Tandy, B | 1 |
| Abe, M; Cong, Y; Kato, Y; Nomori, H; Sugimura, H | 1 |
| Alavi, A; Bradley, JD; DeNittis, A; Duan, F; Gorelick, JJ; Johnson, DW; Machtay, M; Ohri, N; Siegel, BA; Snyder, BS; Werner-Wasik, M | 1 |
| Akdemir, UO; Baha, A; Demircan, S; Kokturk, N; Turktas, H; Yildirim, F | 1 |
| Ball, D; Caine, H; Eade, T; Foroudi, F; Kirby, K; Kron, T; MacManus, M; Pham, D; Siva, S; Stevens, MJ; Te Marvelde, L; Whalley, D | 1 |
| Abgral, R; Carai, S; Le Roux, PY; Palard, X; Salaün, PY | 1 |
| Dong, X; Li, W; Sun, X; Wan, H; Wu, P; Xing, L; Yu, J | 1 |
| Apte, AP; Burger, IA; Carlin, SA; Deasy, JO; Dogan, S; Durack, JC; Erinjeri, JP; Fanchon, LM; Humm, JL; Kirov, AS; Maybody, M; Moreira, AL; Schmidtlein, CR; Schöder, H; Siegelbaum, RH; Sofocleous, CT; Solomon, SB; Yorke, E | 1 |
| Duan, X; Li, J; Li, XF; Ma, Y; Postel, GC; Wang, F; Wang, X; Yin, X; Zhang, G; Zheng, H | 1 |
| Acevedo-Báñez, I; García-Gómez, FJ; Mangas-Cruz, MA; Muñiz-Grijalvo, O; Tirado-Hospital, JL | 1 |
| Ding, G; Fu, Z; Huang, W; Kong, L; Li, M; Yang, G; Yu, J; Zhang, Y; Zhao, F | 1 |
| Abiko, M; Sato, T; Shiono, S; Yanagawa, N | 1 |
| Aygün, MS; Bakdik, S; Bekci, TT; Burnik, C; Çayci, M; Düzgün, N; Esme, H; Kurtipek, E; Terzi, Y; Unlü, Y | 1 |
| Duan, Y; Fan, T; Guo, Y; Li, J; Shang, D; Shao, Q; Sun, X; Wang, W; Xu, M; Zhang, Y | 1 |
| De Luca, G; Martucci, N; Rocco, G; Setola, S | 1 |
| Benveniste, AP; Benveniste, MF; Godoy, MC; Truong, MT; Viswanathan, C | 1 |
| Everitt, S; Hicks, RJ; MacManus, M | 1 |
| Chou, PC; Ho, TY; Tsang, NM; Yang, CT; Yen, TC | 1 |
| Boland Froemming, JM; Brinjikji, W; Holland, WP; Johnson, GB; Peikert, T | 1 |
| Alifano, M; Caillat-Vigneron, N; Farid, K; Petras, S; Poullias, X; Regnard, JF; Servois, V | 1 |
| Chen, M; Li, Y; Shao, T; Yu, L | 1 |
| Herndon, JE; Howard, BA; Kwon, W; Patz, EF | 2 |
| Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H | 1 |
| Chen, T; Deng, Z; Jia, L; Li, G; Liu, C; Xiang, X | 1 |
| Wang, HQ; Wang, Q; Zhao, J; Zhao, L | 1 |
| Akhurst, T; Hicks, RJ; MacManus, M | 1 |
| Ball, DL; Barnett, SA; Callahan, JW; Chesson, B; Hicks, RJ; Kron, T; Macmanus, MP; Siva, S | 1 |
| Antoch, G; Buchbender, C; Gomez, B; Grueneisen, J; Heusch, P; Hild, F; Köhler, J; Quick, HH; Reis, H; Rubbert, C; Ruhlmann, V; Schaarschmidt, B; Wetter, A | 1 |
| Han, X; Ji, G; Pei, B; Qiang, Y; Shi, Z; Zhao, J | 1 |
| Clavero R, JM; Furnaro L, F; Ladrón de Guevara H, D; Lazo P, D; Pardo B, C; Pefaur D, R; Piottante B, A; Rodríguez D, P; Yévenes A, S | 1 |
| Dang, Y; Jiang, J; Qiao, Z; Shi, R; Song, W; Sui, X; Wang, Y; Wang, Z; Zhang, B; Zhang, W; Zhang, Y | 1 |
| Dong, M; Liu, K; Ma, S; Wang, Y; Yao, Y; Zhou, J | 1 |
| Chazan, R; Dabrowska, M; Korczynski, P; Krenke, R; Kunikowska, J; Maskey-Warzechowska, M; Orłowski, T; Zukowska, M | 1 |
| Barber, PV; Booton, R; Califano, R; Crosbie, PA; Evison, M; Martin, J; Summers, Y | 1 |
| Fachinger, P; Fankhauser, H; Gambazzi, F; Grobholz, R; Irani, S; Tini, GM | 1 |
| Gao, K; Li, XY; Liang, Y; Wu, N; Zhang, LF; Zhou, LN | 1 |
| Bassett, P; Chicklore, S; Chua, S; Cook, GJ; Goh, V; Loi, HY; O'Brien, ME; Punwani, R; Sharma, B; Siddique, M | 1 |
| Andratschke, N; Bundschuh, RA; Essler, M; Mayer, B; Papp, L; Pyka, T; Specht, HM; Zsótér, N | 1 |
| Hoshikawa, M; Kimura, H; Kurimoto, N; Marushima, H; Nakamura, H; Saji, H; Tagaya, R; Takagi, M | 1 |
| Aberle, DR; Gatsonis, CA; Govindan, R; Halvorsen, RA; Hanna, LG; Karp, JS; Mozley, PD; Shields, AF; Siegel, BA; Subramaniam, RM; Torigian, DA; Weber, WA; Yu, JQ | 1 |
| Cui, LB; Fang, Y; Li, J; Liu, LP; Qi, S; Tang, X; Yang, HN; Yang, JL; Yin, H; Zhang, J; Zhang, XX; Zhang, Y; Zhou, Y | 1 |
| Kishida, M; Kondo, K; Miyoshi, H; Nagata, M; Otani, T; Otsuka, H; Takizawa, H | 1 |
| Biersack, HJ; Buermann, J; Essler, M; Gärtner, FC; Skowasch, D | 1 |
| Fu, Z; Hu, M; Li, C; Liu, J; Lu, J; Meng, X; Shi, X; Sun, X; Xing, L; Yu, J | 1 |
| Bernstine, H; Domachevsky, L; Galili, R; Groshar, D; Saute, M | 1 |
| Alavi, A; Bashyam, A; Blomberg, BA; Gholami, S; Houshmand, S; Ramachandran, A; Salavati, A; Werner, T; Zaidi, H | 1 |
| Astoul, P; Dutau, H; Laroumagne, S; Loundou, A; Lucchini, S; Maldonado, F; Pinelli, V; Roca, E | 1 |
| Bilfinger, T; Franceschi, D; LoGiurato, B; Matthews, R; Moore, W; Relan, N; Safaie, E | 1 |
| Bussink, J; de Geus-Oei, LF; Oyen, WJ; Usmanij, EA | 1 |
| Belcher, E; Black, E; Bradley, KM; Gleeson, FV; McGowan, DR; Teoh, EJ | 1 |
| Balata, H; Evison, M; O'Donnell, P | 1 |
| Calais, J; Lussato, D; Merlet, P | 1 |
| Olivencia-Yurvati, AH; Rodriguez, AE | 1 |
| Ishino, S; Miyake, H; Mori, I; Vincent, P | 1 |
| Imataki, O; Kida, J; Shiroshita, K; Uchida, S; Uemura, M | 1 |
| Araki, T; Koizumi, K; Nambu, A; Satoh, Y | 1 |
| An, DZ; Han, D; Li, BS; Sun, JL; Wang, ZT; Zhang, DK; Zhao, Q | 1 |
| Besenyi, Z; Csenki, M; Cserháti, A; Dobi, Á; Együd, Z; Gaál, S; Hideghéty, K; Lengyel, Z; Maráz, A; Mózes, P; Pávics, L; Rusz, O; Szántó, E; Varga, Z; Zag, L | 1 |
| Abe, K; Ishikawa, Y; Jingu, K; Kadoya, N; Kaneta, T; Koto, M; Kubozono, M; Matsushita, H; Shirata, Y; Sugawara, T; Takeda, K; Umezawa, R; Yamamoto, T | 1 |
| Steinke, K; Thomas, PA; Whitley, JM; Zaheer, SN | 1 |
| Torigian, DA; Vilstrup, MH | 1 |
| Ito, H; Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
| Ahn, SY; Cho, JY; Goo, JM; Lee, JM; Lee, KH; Lee, SM; Paeng, JC; Park, CM | 1 |
| Din, SU; Downey, R; Foster, A; Kohutek, ZA; Rimner, A; Rosenzweig, KE; Weber, WA; Wu, AJ; Yorke, ED; Zhang, Z | 1 |
| Anić, B; Barešić, M; Brčić, L; Hećimović, A; Janevski, Z; Sreter, KB | 1 |
| Alama, A; Barletta, G; Biello, F; Boccardo, S; Bottoni, G; Coco, S; Dal Bello, MG; Genova, C; Grossi, F; Rijavec, E; Sambuceti, G; Truini, A; Vanni, I | 1 |
| Kinahan, PE; Linden, HM; Mankoff, DA | 1 |
| Chen, S; Fu, YL; Hu, B; Li, H; Yang, MF; Zhang, WQ | 1 |
| Cho, DG; Jeong, S; Kim, HK; Kim, SH; Kwak, YK; Lee, GJ; Lee, JH; Park, YH; Yoon, SC; Yu, M | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Oh, JR; Son, SH | 1 |
| Hofheinz, F; van den Hoff, J | 1 |
| El Naqa, I; Freeman, CR; Skamene, SR; Vallières, M | 1 |
| Guckenberger, M | 1 |
| Collen, C; De Ridder, M; Engels, B; Fabien, JM; Gevaert, T; Kunos, CA; Poels, K; Shanahan, JP; Van den Begin, R | 1 |
| Ichimura, K; Kaji, M; Kanazawa, S; Mitsuhashi, T; Miyoshi, S; Sato, S; Shinya, T; Soh, J; Tanaka, T; Toyooka, S | 1 |
| Ahsanuddin, S; Ashamalla, H; Foster, A; Mattes, MD; Moshchinsky, AB; Rimner, A; Rizk, NP; Weber, WA; Wu, AJ | 1 |
| Court, LE; Fave, X; Fried, DV; Ibbott, G; Liao, Z; Mawlawi, O; Zhang, L; Zhou, S | 2 |
| Beer, AJ; Ganter, C; Herrmann, K; Holzapfel, K; Lorenzen, S; Metz, S; Nekolla, SG; Rummeny, EJ; Schwaiger, M; van Marwick, S; Wester, HJ | 1 |
| Cho, H; Choi, JY; Kim, HK; Kim, J; Lee, HY; Lee, KS; Um, SW | 1 |
| Chandarana, H; Friedman, KP; Heacock, L; Melsaether, A; Ponzo, F; Raad, RA | 1 |
| Chung, DH; Chung, JK; Heo, DS; Jeon, YK; Kang, KW; Keam, B; Kim, DW; Kim, TM; Lee, SH; Lee, SJ; Paeng, JC | 1 |
| Baek, JH; Choe, J; Choi, CM; Kim, HJ; Kim, MY | 1 |
| Ampel, NM; Pasha, AK; Walsh, TK | 1 |
| Marquez-Medina, D; Martin-Marco, A; Popat, S | 1 |
| Cimen, F; Demirag, F; Gokcek, A; Ozmen, O; Tatci, E; Unsal, E; Yazici, S | 1 |
| Dwivedi, R; Jones, TM; Kinshuck, AJ; Wieshmann, H; Williams, C; Williams, SP | 1 |
| Arnesen, MR; Bruheim, K; Dale, E; Eilertsen, K; Helland, Å; Hellebust, TP; Knudtsen, IS; Løndalen, AM; Malinen, E; Rekstad, BL | 1 |
| Kassai, Y; Koyama, H; Matsumoto, S; Ohno, Y; Sugimura, K; Takenaka, D; Yoshikawa, T; Yui, M | 1 |
| Bengtsson, T; Binns, DS; de Crespigny, AJ; Hicks, RJ; McCarthy, TJ; Sanabria-Bohorquez, SM | 1 |
| Aerts, HJ; Boellaard, R; Carvalho, S; Gillies, RJ; Lambin, P; Leijenaar, RT; Nalbantov, G; Troost, EG; van Elmpt, WJ | 1 |
| Gatsonis, C; Siegel, B; Weber, WA | 1 |
| Cho, J; Choe, JG; Eo, JS; In, KH; Kim, CH | 1 |
| Cui, XJ; Fang, N; Wang, YL; Wu, ZJ; Zeng, L | 1 |
| Maeda, A; Nakata, M; Nojima, Y; Okita, R; Saisho, S; Shimizu, K; Yukawa, T | 1 |
| Francis, RJ; Lee, YC; Millward, MJ; Morandeau, L; Nowak, AK; Segal, A; Segard, T | 1 |
| Hong, SH; Jang, HS; Kang, JH; Kim, SJ; Kim, YK; Kim, YS; Lee, DS; Lee, KY; Na, SJ; Park, KR; Yoo, IR | 1 |
| Bosari, S; Castellani, M; Del Gobbo, A; Ferrero, S; Franco, R; Gaudioso, G; Nosotti, M; Palleschi, A; Pellegrinelli, A; Vaira, V; Zito Marino, F | 1 |
| Duncker-Rohr, V; Eschmann, SM; Essler, M; Grosu, AL; Holl, G; König, J; Leifert, A; Miederer, M; Mix, M; Nestle, U; Plotkin, M; Puskas, C; Rischke, HC; Rühl, F; Schimek-Jasch, T; Tosch, M; Vach, W | 1 |
| Ibuki, Y; Mimae, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M; Yoshiya, T | 1 |
| Alamgeer, M; David, S; Ganju, V; Ng, SP | 1 |
| Goo, JM; Jin, KN; Lee, KW; Lee, Y; Oh, SW | 1 |
| Dieckmann, W; Kebebew, E; Nilubol, N; Patel, D; Satoh, K | 1 |
| Ahn, BC; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
| Horiike, A; Inubushi, M; Koizumi, M; Nishio, M; Ohyanagi, F; Saga, T; Tanimoto, K; Yanagitani, N; Yoshikawa, K; Zhang, MR | 1 |
| Ahn, HK; Ahn, MJ; Ahn, YC; Choi, JY; Hyun, SH; Kim, J; Shim, YM | 1 |
| Borghammer, P; Haraldsen, A; Hjorthaug, K; Højbjerg, JA; Knap, MM; Kramer, SM; Tietze, A; Zacho, HD | 1 |
| Charest, M; Danilenko, A; Leblond, A | 1 |
| Choi, CM; Kim, GH; Kim, MY; Koo, HJ; Song, JS | 1 |
| Dunphy, M; Foster, A; Gelblum, DY; Ong, LT; Perez, CA; Pietanza, CM; Rimner, A; Rosenzweig, KE; Woo, KM; Wu, AJ; Zhang, Z | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Bae, KT; Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Noda, Y; Ono, H; Watanabe, H | 1 |
| Das, M; Dingemans, AC; Even, AJG; Lambin, P; Mottaghy, FM; Oellers, M; Reymen, B; Troost, EGC; van Elmpt, W; Wildberger, JE; Zegers, CML | 1 |
| Bao, M; Chen, Q; Han, Y; Li, J; Li, Z; Lin, Q; Lin, Z; Liu, S; Peng, M; Xiong, L; Xu, B; Ye, B; Zhu, W | 1 |
| Ardito, A; Arena, V; Basile, V; Brambilla, R; Duregon, E; Massaglia, C; Pelosi, E; Penna, D; Perotti, P; Terzolo, M; Vigna-Taglianti, F; Zaggia, B | 1 |
| Da, J; Di, J; Guo, Y; Liang, C; Liu, D; Liu, J; Qiang, G; Shi, B; Xu, R; Xu, Y; Yan, J | 1 |
| Bae, SK; Jung, SJ; Kim, CK; Lee, SM | 1 |
| Chang, B; Jin, H; Tian, R; Wei, Z; Yu, H; Yuan, L; Zhao, M | 1 |
| Choi, WH; Han, EJ; Kim, SH; Park, JC; Park, SY; Yang, YJ | 1 |
| Acuff, S; de Geus-Oei, LF; Grootjans, W; Hamill, JJ; Meeuwis, AP; Osborne, DR; van der Vos, CS; Visser, EP | 1 |
| Furukawa, T; Kushitani, K; Mimae, T; Miyata, Y; Okada, M; Takeshima, Y; Tsutani, Y | 1 |
| Girard, P | 1 |
| Altorki, NK; Ameye, L; Berghmans, T; Borst, GR; de Jong, WK; Eschmann, S; Flamen, P; Garcia, C; Govindan, R; Higashi, K; Komaki, R; Lafitte, JJ; Meert, AP; Paesmans, M; Patz, EF; Rami-Porta, R; Sculier, JP; Van Baardwijk, A; Vansteenkiste, J; Wong, CY | 1 |
| Azoulay, É; Lemiale, V; Pineton De Chambrun, M | 1 |
| Anouan, KJ; Edet-Sanson, A; Gardin, I; Hapdey, S; Lelandais, B; Ruan, S; Vera, P | 1 |
| Choi, WH; Kim, TJ; Kim, YK; Lee, KY; O, JH; Yoo, IeR | 1 |
| de Geus-Oei, LF; Grootjans, W; Hermsen, R; Oyen, WJ; Schuurbiers-Siebers, OC; van der Heijden, EH; Visser, EP | 1 |
| Brambilla, D; Fazio, N; Galetta, D; Gasparri, R; Maisonneuve, P; Paganelli, G; Petrella, F; Rezende, GC; Spaggiari, L; Travaini, LL | 1 |
| Chen, K; Hai, W; Huang, Q; Peng, J; Xu, Y; Yang, Z; Zan, Y; Zheng, X | 1 |
| Chen, P; Hou, P; Jiang, Y; Liu, H; Pu, Y; Wroblewski, K; Zhang, CP | 1 |
| Akdemir, ÜÖ; Özkaya, S; Öztürk, C; Yıldırım, F; Yurdakul, AS | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motono, N; Sagawa, M; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K; Watanabe, N | 1 |
| Fleckenstein, J; Kremp, K; Kremp, S; Palm, J; Rübe, C | 1 |
| Bussink, J; de Geus-Oei, LF; Grootjans, W; Troost, EG; van der Heijden, EH; Visser, EP; Wijsman, R | 1 |
| Guo, Y; Wang, T; Yang, M | 1 |
| Ahn, JH; Choi, JY; Choi, YS; Han, J; Kang, J; Kim, EY; Kim, HK; Kim, J; Kwon, OJ; Lee, G; Lee, HY; Lee, KS; Shim, YM; Song, SH | 1 |
| Bradley, JD; Duan, F; Machtay, M; Markovina, S; Siegel, BA; Snyder, BS | 1 |
| Bach, AM; Carollo, G; Mannelli, L; Nougaret, S; Ragucci, M | 1 |
| Fan, W; Zhang, L; Zhang, R; Zhang, X | 1 |
| Freesmeyer, M; Kapfhammer, A; Lesser, T; Reissig, A; Steinert, M; Winkens, T | 1 |
| Kondo, K; Nagata, M; Nakaya, K; Otani, T; Otsuka, H | 1 |
| Cho, JH; Choi, YL; Kim, H; Kim, J; Kim, JH; Lee, G; Lee, HY; Lee, KS; Sohn, I; Yoon, HJ | 1 |
| Chan, JKI; Tai, WM; Wen, JM | 1 |
| Bibault, JE; Durand-Labrunie, J; Kolesnikov-Gauthier, H; Lartigau, É; Mirabel, X; Oudoux, A | 1 |
| Ashizawa, K; Hayashi, H; Machino, R; Matsumoto, K; Miyazaki, T; Nagayasu, T; Tanaka, T; Tsuchiya, T; Yamasaki, N | 1 |
| Fuccio, L; Giaccherini, L; Guido, A; Morganti, AG | 1 |
| Corbusier, F; Gevenois, PA; Goldman, S; Keyzer, C; Kyratzi, E; Sokolow, Y | 1 |
| Brink, C; Hansen, O; Pan, Y; Petersen, H; Schytte, T; Wu, YL | 1 |
| Antoch, G; Buchbender, C; Gomez, B; Grueneisen, J; Heusch, P; Ruhlmann, V; Sawicki, LM; Schaarschmidt, BM; Umutlu, L | 1 |
| Dostbil, Z; Goya, C; Simsek, FS; Tasdemir, B; Teke, F; Unal, K; Urakci, Z | 1 |
| Behera, D; Garg, K; Jaiswal, A; Kumar, R; Mathur, S; Mohan, A; Mohanti, BK; Pathy, S; Raina, V; Roy, S; Taywade, S; Thulkar, S | 1 |
| Bae, JM; Choi, JY; Lee, HY | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Furth, C; Kalinski, T; Riedel, S; Rogasch, JM; Schreiber, J; Schultz, M; Steffen, IG; Steinkrüger, FL; Wertzel, H | 1 |
| Canpolat, T; Erhamamci, S; Nursal, GN; Reyhan, M; Yapar, AF | 1 |
| Baillet, C; Dewalle-Vignion, AS; Fechter, T; Gardin, I; Gibon, D; Massoptier, L; Modzelewski, R; Nemer, U; Nestle, U; Parcq, C; Schaefer, A; Vera, P; Vermandel, M | 1 |
| Higashi, M; Jinguji, M; Nakabeppu, Y; Nakajo, M; Nakamura, Y; Nakayama, H; Sato, M; Yoshiura, T | 1 |
| Álvarez, A; Calzado, MA; Caro, T; Lara-Chica, M; Medina, M; Moreno, P; Muñoz, E; Salvatierra, Á; Soler-Torronteras, R | 1 |
| Gotoh, M; Higuchi, M; Suzuki, H | 1 |
| Alavi, A; Grupe, P; Houshmand, S; Høilund-Carlsen, PF; Salavati, A; Segtnan, EA | 1 |
| Çelik, G; Ceyhan, K; Çiftci, F; Çiledağ, A; Gürün Kaya, A; Karaçay, E; Kaya, A | 1 |
| Chang, S; Kim, SJ | 1 |
| Abid, Q; Srinivasan, L; Taylor, M | 1 |
| Bar-Shalom, R; Dan, LF; Guralnik, L; Kagna, O; Kremer, R; Nir, RR; Peysakhovich, Y | 1 |
| Brandi, L; Carbonelli, C; Cavazza, A; Cesario, A; Di Paolo, ML; Gasparini, E; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Serra, S; Sgarbi, G; Sverzellati, N | 1 |
| Boissiere, L; Bouche, O; Brasseur, M; Deslee, G; Dury, S; Launois, C; Lebargy, F; Lestra, T; Papathanassiou, D; Perotin, JM; Prevost, A; Vallerand, H; Vella-Boucaud, J | 1 |
| Belmondo, B; Bourhis, J; Lovis, A; Ozsahin, M; Pappon, M; Péguret, N; Pomoni, A; Prior, JO; Vienne, M; Zeverino, M | 1 |
| Chotipanich, C; Iamsa-art, C; Kunawudhi, A; Phadungrerk, R; Promteangtrong, C | 1 |
| Chen, J; Dong, M; Li, X; Li, Z; Liu, J; Ren, D; Shi, T; Song, Z; Xu, S | 1 |
| Buvat, I; Chouahnia, K; Martinod, E; Orlhac, F; Soussan, M | 1 |
| Fledelius, J; Frøkiaer, J; Hjorthaug, K; Khalil, AA | 1 |
| Baillet, C; Béron, A; Frimat, M; Gnemmi, V; Huglo, D; Jaillard, A; Noël, C; Perbet, R; Scherpereel, A; Tabibzadeh, N | 1 |
| Ahn, HK; Choi, JY; Hyun, SH; Kim, BT; Kim, H; Kim, J; Kwon, OJ; Lee, KH; Zo, JI | 1 |
| Allen, AM; Bernstine, H; Domachevsky, L; Flex, D; Groshar, D; Nidam, M; Rapson, Y; Stemmer, SM; Zer, A | 1 |
| Lee, SJ; Park, KJ; Park, SY; Yoon, JK | 1 |
| Asamura, H; Fujii, H; Hayashi, Y; Kamiyama, I; Kinoshita, T; Ohtsuka, T | 1 |
| Becker, N; Bezjak, A; Bissonnette, JP; Clarke, K; Ford, V; Higgins, J; Le, LW; Marshall, A; McCloskey, P; Mehmood, Q; Sun, A; Vines, DC; Yap, M | 1 |
| Kang, F; Li, G; Li, X; Liu, C; Tian, F; Wang, J; Wang, S; Wang, Z; Yang, W; Zhang, M; Zhao, M | 1 |
| Bai, C; Dong, A; Zuo, C | 1 |
| Azzoli, CG; Chaft, JE; Downey, R; Dunphy, M; Ginsberg, MS; Hellmann, M; Kris, MG; Naidoo, J; Rusch, V; Travis, WD; Woo, K | 1 |
| Dong, M; Li, W; Liu, J; Sun, X; Xing, L; Yu, J | 1 |
| Antoch, G; Buchbender, C; Gomez, B; Grueneisen, J; Heusch, P; Ruhlmann, V; Sawicki, LM; Schaarschmidt, BM; Umutlu, L; Wetter, A | 1 |
| Ahmad, R; Demaerel, P; Deroose, CM; Gheysens, O; Goffin, KE; Ooms, D; Van Laere, K; Van Paesschen, W; Vansteenkiste, J | 1 |
| Bauersachs, J; Bengel, FM; Derlin, T; Jonigk, D | 1 |
| Ahmad, S; Algan, O; Algan, S; Ali, I; Confer, M; Herman, T; Matthiesen, C | 1 |
| Ishimori, T; Kim, YH; Koyasu, S; Kubo, T; Nakamoto, Y; Nobashi, T; Togashi, K; Yoshizawa, A | 1 |
| Ciunci, CA; Epstein, AJ; Paulson, EC; Vachani, A; Veenstra, CM; Zafar, HM | 1 |
| Alaerts, H; Beels, L; D'hulst, L; Gheysens, O; Maes, A; Nicolaij, D; Van de Wiele, C | 1 |
| Igai, H; Kaira, K; Kakegawa, S; Kamiyoshihara, M; Nagashima, T; Nakazawa, S; Nishiyama, M; Obayashi, K; Ohtaki, Y; Shimizu, K; Takeyoshi, I | 1 |
| Kanda, Y; Kanzaki, A; Kariya, T; Kato, Y; Ohara, T; Tsuboi, R | 1 |
| Bentzen, SM; Fischer, BM; Klausen, TL; Langer, SW; Lonsdale, MN; Nygård, L; Persson, GF; Vogelius, IR | 1 |
| Calcagni, ML; Caldarella, C; Cardillo, G; Carleo, F; Di Franco, D; Giordano, A; Graziano, P; Ialongo, P; Indovina, L; Mattoli, MV; Taralli, S | 1 |
| Burger, IA; Casanova, R; Curioni, A; Hillinger, S; Huellner, MW; Husmann, L; Schmidtlein, CR; Soltermann, A; Steiger, S; Stolzmann, P | 1 |
| Axelsson, R; Dobra, K; Grundberg, O; Jacobsson, H; Kölbeck, KG; Sánchez-Crespo, A; Sundin, A; Uhlén, N | 1 |
| Bernard, C; Coucke, P; Duysinx, B; Hatt, M; Hustinx, R; Jansen, N; Janvary, ZL; Jodogne, S; Lovinfosse, P; Visvikis, D | 1 |
| Marcus, C; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R | 1 |
| Buck, AK; Herrmann, K; Kropf, S; Lapa, C; Lückerath, K; Pelzer, T; Rudelius, M; Samnick, S; Schirbel, A; Schmid, JS; Schoene, A; Wester, HJ | 1 |
| Datz, L; Pirich, C; Rendl, G; Rettenbacher, L; Rodrigues, M; Stark, H; Studnicka, M | 1 |
| An, YS; Choi, JH; Hyun, SH; Kwon, SH; Lee, SJ; Oh, YT; Park, KJ; Yoon, JK | 1 |
| Chao, IM; Chen, ML; Hsieh, PJ; Hsieh, TS; Su, HY | 1 |
| Choi, JY; Han, J; Heo, JH; Jang, SJ; Kim, BT; Kim, J; Kim, K; Lee, JY; Shim, YM | 1 |
| Cheon, GJ; Goo, JM; Kim, YT; Lee, SM; Paeng, JC; Park, CM; Park, YS; Yoon, SH | 1 |
| Gariani, J; Martin, SP; Tabouret Viaud, C | 1 |
| Bauer, TT; Förster, GJ; Kaiser, D; Kollmeier, J; Pfannschmidt, J; Tönnies, M; Tönnies, S; Wernecke, KD | 1 |
| Belderbos, JS; Chen, C; Sonke, JJ; van den Heuvel, MM; van Diessen, JN | 1 |
| Healy, MA; Reddy, RM; Wong, SL; Yin, H | 1 |
| Chan, I; Etemad-Rezai, R; Johnson, C; Landis, M; Louie, AV; Mattonen, SA; Palma, DA; Rodrigues, G; Senan, S; Ward, AD; Yeung, TP | 1 |
| Alavi, A; Bradley, JD; DeNittis, A; Duan, F; El Naqa, I; Johnson, DW; Machtay, M; Ohri, N; Siegel, BA; Snyder, BS; Wei, B; Werner-Wasik, M | 1 |
| Hole, EO; Knudtsen, IS; Malinen, E; Öllers, M; Rekstad, BL; Rødal, J; Skaug Sande, EP; Svestad, JG; van Elmpt, W | 1 |
| Shi, B; Wang, Z; Wu, F; Xing, X; Yu, M | 1 |
| Belcher, E; Black, E; Bradley, KM; Gleeson, FV; McGowan, DR; Moore, A; Sykes, A; Teoh, EJ | 1 |
| Abid, A; Biyi, A; Elouazzani, H; Oukabli, M; Raoufi, M; Rhorfi, IA | 1 |
| Boellaard, R; de Langen, AJ; Frings, V; Hoekstra, OS; Kramer, GM; Mulder, ER; Nissen, IA; Smit, EF; van Velden, FH | 1 |
| Aukema, TS; Bard, MP; Klomp, HM; Konings, R; Rijna, H; Sikorska, K; Titulaer, BM; Valdés Olmos, RA; van Gool, MH; Zwijnenburg, A | 1 |
| Cheze-Le Rest, C; de Geus-Oei, LF; Disselhorst, JA; Hatt, M; Oyen, WJ; Tixier, F; Visser, EP; Visvikis, D; Vriens, D | 1 |
| Cook, GJ; Goh, V; Szlosarek, P; Szyszko, TA; Yip, C | 1 |
| Fledelius, J; Meldgaard, P; Sorensen, BS; Winther-Larsen, A | 1 |
| Binkley, MS; Chaudhuri, A; Diehn, M; Loo, BW; Maxim, PG; Popat, R; Shrager, JB; Shultz, DB | 1 |
| Biner Uslu, I; Dikmen, A; Erdoğan, Y; Yilmaz Demirci, N; Yılmaz, A; Yilmaz, Ü | 1 |
| Hotta, K; Kaji, M; Kiura, K; Kubo, T; Minami, D; Ninomiya, T; Oda, N; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanimoto, M | 1 |
| Cuplov, V; Groves, AM; Holman, BF; Hutton, BF; Thielemans, K | 1 |
| Matsunaga, N; Shigemoto, Y; Suga, K | 1 |
| Aldelaijan, S; De Blois, F; Devic, S; Faria, S; Lehnert, S; Mohammed, H; Seuntjens, J; Tomic, N | 1 |
| Dong, A; Xiao, Z; Yang, J; Zuo, C | 1 |
| Burckhardt, D; Chung, JH; Kesner, AL; Koo, PJ; Kwak, JJ; Lind, KE; Lynch, D | 1 |
| Barbolosi, D; Bardia, F; Baret, A; Barlesi, F; Ciccolini, J; Muracciole, X; Padovani, L; Taieb, D; Teissonnier, L | 1 |
| Aguilera, T; Diehn, M; Gudur, M; Li, R; Loo, BW; Rubin, DL; Shultz, D; Wu, J | 1 |
| Aras, G; Bahadır, A; Çermik, TF; Gündoğan, C; Kanmaz, ZD; Kocatürk, C; Öz, B; Özkurt, CÜ; Tuncay, E; Yaşar, ZA | 1 |
| Koyama, H; Lee, HY; Ohno, Y; Sugimura, K; Yoshikawa, T | 1 |
| Burnette, BL; Du, L; Huang, D; Jamshidi, N; Korn, RL; Kuo, MD; Yamamoto, S | 1 |
| Bi, GC; Fang, Y; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, DS; Zhang, WJ; Zheng, R | 1 |
| Chen, Z; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X; Zong, Z | 1 |
| Boellaard, R; de Langen, AJ; Frings, V; Hoekstra, OS; Hoetjes, N; Kramer, GM; Smit, EF | 1 |
| Huang, H; Ren, H; Ren, X; Song, X; Xu, W; You, J; Zhang, X; Zhao, N | 1 |
| Doi, H; Kaida, H; Kanda, T; Kitajima, K; Kuribayashi, K; Tamaki, Y; Tsujikawa, T; Yamane, T | 1 |
| Chen, H; Li, J; Li, M; Wang, S; Zeng, Q | 1 |
| Baldari, S; Iatì, G; Minutoli, F; Pergolizzi, S; Pontoriero, A; Sindoni, A | 1 |
| Cavedon, C; Ferdeghini, M; Giri, MG; Mazzarotto, R | 1 |
| Baselli, G; Castellani, M; De Bernardi, E; Soffientini, CD; Zito, F | 1 |
| Gorgoni, G; Gori, S; Inno, A; Lunardi, G; Pasetto, S; Salgarello, M; Severi, F | 1 |
| Christensen, JB; Holdgaard, PC; Høilund-Carlsen, PF; Madsen, PH | 1 |
| Cheng, X; Li, H; Wu, X | 1 |
| Bussink, J; de Geus-Oei, LF; Grootjans, W; Hatt, M; Oyen, WJ; Usmanij, EA; van der Heijden, EH; Visser, EP; Visvikis, D | 1 |
| Desai, M; Gould, MK; Nair, VS; Sundaram, V | 1 |
| Chen, Q; Fang, W; Gao, W; Han, B; Liu, Y; Sun, Y; Xiang, Y; Ye, X; Zhu, L | 1 |
| Chin, BB; Oldan, JD | 1 |
| Albano, D; Bertagna, F; Bosio, G; Dib, B; Giubbini, R; Piccardo, A | 1 |
| Diehn, M; Dong, X; Gensheimer, MF; Li, R; Loo, BW; Napel, S; Rubin, DL; Wu, J | 1 |
| Ben-Haim, S; Ben-Nun, A; Chikman, B; Davidson, T; Goshen, E; Komissar, O; Shalmon, B | 1 |
| Asakura, K; Masai, K; Nakagawa, K; Sakurai, H; Suzuki, S; Watanabe, S | 1 |
| Doi, H; Kitajima, K; Kuribayashi, K | 1 |
| Marwaha, G; Oh, SC; Pham, YD; Stephans, KL; Videtic, GM; Ward, MC; Woody, NM | 1 |
| Cheng, Y; Gong, J; Guo, B; Huang, L; Ling, X; Shang, J; Tang, Y; Xiao, Z; Xu, H; Zhang, L | 1 |
| Alcaide, AB; Bastarrika, G; Campo, A; de-Torres, JP; Garcia-Velloso, MJ; Lozano, MD; Nuñez-Cordoba, JM; Richter, JA; Sanchez-Salcedo, P; Sancho, L; Torre, W; Zulueta, JJ | 1 |
| Mattonen, SA; Palma, DA; Ward, AD | 1 |
| Bellendorf, A; Bockisch, A; Cordes, S; Darwiche, K; Eberhardt, W; Friedel, G; Gauler, T; Guberina, M; Heinzelmann, F; Jöckel, KH; Pöttgen, C; Schuler, MH; Schwenzer, N; Stamatis, G; Stuschke, M; Welter, S | 1 |
| Allavena, P; Alloisio, M; Castino, GF; Chiti, A; Cortese, N; Grizzi, F; Lopci, E; Marchesi, F; Marchetti, S; Olivari, L; Pistillo, D; Qehajaj, D; Rahal, D; Roncalli, M; Santoro, A; Toschi, L | 1 |
| Arai, Y; Gobara, H; Inaba, Y; Kanazawa, S; Kobayashi, T; Kodama, Y; Kurihara, H; Okumura, Y; Shinya, T; Sone, M; Watanabe, H; Yamagami, T; Yamakado, K | 1 |
| Chang, JW; Cheng, NM; Chung, HW; Fang, YD; Ho, KC; Hou, MM; Liu, YC; Su, TP; Yang, CT; Yen, TC | 1 |
| Aggarwal, S; Binkley, MS; Bush, K; Carter, JN; Chaudhuri, AA; Diehn, M; Dudley, SA; Gensheimer, M; Guo, HH; Hara, WY; Kumar, KA; Le, QT; Loo, BW; Maxim, PG; Nair, VS; Qian, Y; Rigdon, J; Shultz, DB; Trakul, N | 1 |
| Buchpiguel, CA; Coutinho, AM; de Menezes, MR; do Vale, RH; Queiroz, MA | 1 |
| Hou, J; Li, B; Shi, H; Yu, H; Zhang, Y | 1 |
| Behr, SC; Flavell, RR; Hernandez-Pampaloni, M; Mabray, MC; Naeger, DM | 1 |
| Bussink, J; de Geus-Oei, LF; Grootjans, W; Le Rest, CC; Oyen, WJ; Tixier, F; van der Vos, CS; Visser, EP; Visvikis, D; Vriens, D | 1 |
| De Leyn, P; De Ruysscher, D; De Wever, W; Decaluwé, H; Deroose, CM; Dingemans, AM; Dooms, C; Martinussen, H; Nackaerts, K; Peeters, ST; Van Baardwijk, A; Vansteenkiste, J; Yserbyt, J | 1 |
| Filice, A; Franceschetto, A; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Rossi, G; Stefani, A; Treglia, G | 1 |
| Chang, S; Kim, SJ; Koo, PJ; Pak, K | 1 |
| Dong, X; Huang, Y; Li, W; Maxim, PG; Sun, L; Sun, X; Wan, H; Xing, L; Yu, J; Zhao, X | 1 |
| Cease, K; Chen, G; Chopra, V; Gross, M; Raghunathan, R; Ramnath, N; Troeschel, S; Zhao, L | 1 |
| Aide, N; Do, P; Hatt, M; Lasnon, C; Lavigne, B; Madelaine, J; Majdoub, M; Visvikis, D | 1 |
| Gao, X; Wang, D; Yu, L; Zhang, M | 1 |
| BaBa, S; Honda, H; Isoda, T; Kitamura, Y; Maruoka, Y; Sasaki, M; Tahara, K | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Furth, C; Genseke, P; Kalinski, T; Riedel, S; Rogasch, JM; Schreiber, J; Schultz, M; Steffen, IG; Steinkrüger, FL; Wertzel, H | 1 |
| Eaton, RJ; Gilbert, FJ; Miles, K; Qureshi, NR; Shah, A | 1 |
| Akin, O; Arslan, A; Deniz, E; Ozcakir-Tomruk, C | 1 |
| Benisvy, D; Dufour, M; Gastaud, L; Iannessi, A; Kogay, M; Saada, E; Thariat, J; Thyss, A | 1 |
| Bai, X; Niu, R; Wang, X; Zheng, N | 1 |
| Asakura, K; Kaseda, K; Kazama, A; Ozawa, Y | 1 |
| Basher, R; Bhattacharya, A; Malik, D; Mittal, B; Vadi, S | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Buchert, R; Derlin, T; Ego, K; Furth, C; Hofheinz, F; Kalinski, T; Riedel, S; Schreiber, J; Schultz, M; Steffen, IG; Wertzel, H | 1 |
| Chen, LH; Chen, M; Dai, YM; Guan, J; Li, L; Li, QY; Li, XZ; Liu, LY; Wang, S; Wu, HB; Xiao, NJ; Yang, M; Zhang, Y; Zhang, YW; Zhou, WL | 1 |
| Harada, M; Hayashi, T; Hirata, K; Ichimura, W; Kitao, T; Kondo, K; Sekizawa, M; Shima, K; Takei, T; Tamaki, N | 1 |
| Kang, DY; Lee, JW; Lee, SM; Lee, SY; Na, JO | 1 |
| Djuran, B; Erak, MDj; Mitrić, M; Tesanović, D; Vasiljev, S | 1 |
| Buck, A; Bundschuh, R; Dandekar, G; Fecher, D; Hofmann, E; Lückerath, K; Nietzer, S; Steinke, M; Walles, H; Walles, T | 1 |
| Cho, YS; Choe, YS; Im, YH; Kim, BT; Lee, KH; Lim, CH; Moon, SH | 1 |
| Bai, L; Guo, Y; Li, X; Ning, N; Niu, G; Yang, J; Zhang, W | 1 |
| Antoch, G; Flechsig, P; Frank, P; Giesel, FL; Haberkorn, U; Kauczor, HU; Kratochwil, C; Moltz, J; Rath, D; Rieser, M; Schwartz, LH; Warth, A | 1 |
| Descallar, J; Ho Shon, I; Koh, ES; Pramana, A; Vinod, SK; Wang, D | 1 |
| Bui, C; Do, V; Hadjashrafi, A; Loh, H; Mansberg, R; Shetty, D | 1 |
| Chen, YR; Hsieh, TC; Hsu, CN; Kao, CH; Kuo, YC | 1 |
| Arens, AI; Hendrickx, BW; Lafeber, A; Oyen, WJ; Postema, JW; Schreurs, WM; Vogel, WV | 1 |
| Kollàr, A; Langer, R; Sachpekidis, C; Wartenberg, J | 1 |
| Blanc, E; de Margerie-Mellon, C; Groheux, D; Lemarignier, C; Merlet, P; Quere, G; Querellou, S; Vercellino, L | 1 |
| Elboğa, U; Kara, A; Şahin, E | 1 |
| Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A | 1 |
| Kim, ES; Lee, JW; Lee, SM; Seo, KH | 1 |
| Fukuhara, M; Hasegawa, T; Higuchi, M; Inoue, T; Owada, Y; Suzuki, H; Watanabe, Y; Yamaura, T | 1 |
| Boellaard, R; de Jong, EE; Dingemans, AC; Groen, HJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Smit, EF; Troost, EG; van der Noort, V; van Elmpt, W | 1 |
| Dejust, S; Fabre, G; Morland, D; Papathanassiou, D; Prevost, A | 1 |
| Boyum, RD; Dalane, SS; Kelly, W; Peterson, PG; Warren, BD; Warren, WA | 1 |
| Hapdey, S; Thureau, S; Vera, P | 1 |
| Hustinx, R | 1 |
| Bernhart, M; Del Ciello, A; Larici, AR; Mancino, L; Montemezzi, S; Motton, M; Perandini, S; Rizzardi, G; Signorini, M; Soardi, GA; Solazzo, A; Zeraj, F | 1 |
| Becker, N; Bezjak, A; Bissonnette, JP; Clarke, K; Higgins, J; Le, LW; Marshall, A; Sun, A; Vines, DC; Yap, ML | 1 |
| Bazan, JG; Duan, F; Graves, EE; Horng, D; Loo, BW; Machtay, M; Siegel, BA; Snyder, BS | 1 |
| Dolak, W; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Simonitsch-Klupp, I; Weber, M | 1 |
| Chillura, I; Migliore, M; Milazzotto, R; Militello, C; Pagana, A; Pergolizzi, S; Privitera, G; Raffaele, L; Salamone, V; Spatola, C; Tocco, A | 1 |
| Higashi, K; Ishigaki, Y; Nakamura, Y; Oguchi, M; Sagawa, M; Shimasaki, M; Takegami, T; Tonami, H; Ueda, Y; Yamagishi, T | 1 |
| Chen, M; Chen, S; Li, N; Li, X; Li, Y; Yin, Y | 1 |
| Briere, TM; Court, LE; Gomez, DR; Liao, Z; Martel, MK; Mohan, R; Niedzielski, JS; Stingo, F; Yang, J | 1 |
| Conti, M; Schaefferkoetter, JD; Sjöholm, T; Soo, RA; Tam, JK; Tham, I; Townsend, DW; Yan, J | 1 |
| Mansi, L; Pace, L; Spadafora, M | 1 |
| Hara, T; Ishii, S; Ito, H; Kubo, H; Kuroiwa, D; Miyajima, M; Nanbu, T; Oriuchi, N; Sekino, H; Suenaga, H; Sugawara, S | 1 |
| Mena, E; Reddy, S; Sheikhbahaei, S; Solnes, LB; Subramaniam, RM; Wachsmann, J; Yanamadala, A | 1 |
| Botticella, A; Coolen, J; De Ruysscher, D; Defraene, G; Deroose, CM; Nackaerts, K; Nafteux, P; Peeters, S; Ricardi, U | 1 |
| Balkay, L; Czernin, J; D DiFranco, M; Dahlbom, M; Daver, F; Forgacs, A; Garai, I; K Krizsan, A; Opposits, G; Pall Jonsson, H; Tron, L; Varga, J | 1 |
| Chunjie, W; Daohai, X; Lei, T; Li, G; Ruilong, Z; Xiaohong, W | 1 |
| Bertolini, G; Moresco, RM; Moro, M; Pastorino, U; Prisinzano, G; Raccagni, I; Roz, L; Sozzi, G; Tortoreto, M; Valtorta, S | 1 |
| Ishizaki, U; Itagaki, H; Itoh, R; Matsuo, Y; Onuki, T; Sakai, S; Tamaoki, J; Yamada, T | 1 |
| Geramifar, P; Kamali-Asl, A; Rahmim, A; Soufi, M | 1 |
| Hsu, J; Jia, L; Keshavamurthy, J; Pucar, D; Williams, H | 1 |
| Alstrup, AK; Bender, D; Borghammer, P; Breining, P; Dagnæs-Hansen, F; Gormsen, LC; Jakobsen, S; Jørgensen, NP; Knudsen, K; Madsen, LB; Mortensen, FV; Petersen, MS; Schleimann, MH | 1 |
| Choi, JY; Choi, YS; Han, J; Jeong, JY; Jung, SH; Kim, HK; Kim, J; Kim, W; Lee, HY; Lee, KS; Shim, YM; Woo, MA; Zo, JI | 1 |
| Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
| Chen, D; Guan, W; Han, Y; Shi, Z; Zang, Z; Zhou, J | 1 |
| Baroli, A; Crivelli, F; Gilardi, L; Lomuscio, G; Vadrucci, M | 1 |
| Ding, LY; Jiang, ZL; Liu, KJ; Wu, HY; Wu, SX | 1 |
| Anile, G; Banna, GL; Calcara, G; Castaing, M; Fraggetta, F; Gieri, S; Ippolito, M; Marletta, F; Nicolosi, M; Patanè, D; Russo, G; Spina, R; Stefano, A; Strano, S; Vigneri, P | 1 |
| Abbassi-Senger, N; Adebahr, S; Andratschke, N; Blanck, O; Duma, M; Eble, MJ; Ernst, I; Flentje, M; Gerum, S; Guckenberger, M; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, ND; Krempien, R; Lohaus, F; Lohr, F; Petersen, C; Rieber, J; Schrade, E; Sterzing, F; Streblow, J; Uhlmann, L; Wittig, A | 1 |
| Bae, JM; Choi, JY; Jeong, JY; Kim, HS; Kwon, OJ; Lee, HY; Lee, KS; Shim, YM; Sohn, I; Son, JY | 1 |
| Hare, S; Musaddaq, B; Wagner, T; Yeung, CS | 1 |
| Matsuoka, K; Matsuoka, T; Miyamoto, Y; Nagai, S; Ueda, M; Yamada, T | 1 |
| Bailly, P; Bouzerar, R; Daouk, J; Meyer, MÉ | 1 |
| Ferguson, MK; Li, F; Liao, C; Liu, H; Penney, BC; Pu, Y; Simon, CA; Wu, T; Zhu, X | 1 |
| Dudek, W; Grützmann, R; Schreiner, W; Sirbu, H; Stapel, P; Vassos, N | 1 |
| Berna, L; Botana, MI; Cases, E; Cordovilla, R; Fernández-Villar, A; Gallego, M; García-Luján, R; Masdeu, MJ; Monsó, E; Montón, C; Serra Fortuny, M; Vigil, L | 1 |
| Becker, S; Bouyeure-Petit, AC; Chastan, M; Edet-Sanson, A; Hapdey, S; Houivet, E; Thureau, S; Vera, P | 1 |
| Gu, XM; Huo, TL; Li, TR; Liu, G; Lu, GM; Tan, YY; Wang, FL | 1 |
| Dai, D; Li, X; Men, X; Song, X; Wang, J; Xu, W; Yu, X; Zhu, L; Zhu, Y | 1 |
| Caplin, ME; Karpathakis, A; Lumgair, H; Marelli, L; Pericleous, M; Reiner, J; Thirlwell, C; Toumpanakis, C | 1 |
| Doi, H; Fukushima, K; Hasegawa, S; Hashimoto, M; Hirota, S; Kitajima, K; Kuribayashi, K; Nakano, T; Tanooka, M; Tsuchitani, T | 1 |
| Doi, H; Funaguchi, N; Hasegawa, S; Kanemura, S; Kitajima, K; Kuribayashi, K; Mikami, K; Nakano, T; Shibata, E | 1 |
| Annunziata, T; Bellafiore, S; Cesario, A; Filice, A; Fioroni, F; Formisano, D; Galeone, C; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T | 1 |
| Galeone, C; Lococo, F; Patricelli, G; Rapicetta, C | 1 |
| Calcagni, ML; Castelluccia, A; Mantini, G; Massaccesi, M; Mattoli, MV; Scolozzi, V | 1 |
| Bodner, WR; Cheng, H; Garg, M; Halmos, B; Kalnicki, S; Keller, SM; Ohri, N; Perez-Soler, R | 1 |
| Haneishi, H; Kanai, M; Sakohira, A; Suga, K; Tamai, Y | 1 |
| Bailey, ST; Braas, D; Christofk, HR; Czernin, J; Demo, S; Dubinett, SM; Emberley, E; Fishbein, MC; Garon, E; Graeber, T; Gross, M; Jackson, NJ; Janes, J; Krysan, K; Lee, JT; Mackinnon, A; Magyar, C; Momcilovic, M; Pan, A; Parlati, F; Rodriguez, M; Sadeghi, S; Shackelford, DB; Walser, TC; Works, M; Zhang, W | 1 |
| Kurian, EM | 1 |
| Thie, JA | 2 |
| Cho, YS; Hyun, SH; Jeong, E; Kim, BT; Lee, KH; Moon, SH | 1 |
| Matsuoka, K; Miyamoto, Y; Ueda, M | 1 |
| Aye, RW; Brown, LM; Cattoni, M; Costas, K; Farivar, AS; Farjah, F; Hubka, M; Imperatori, A; Kaplan, S; Louie, BE; Mann, C; Margaritora, S; Rotolo, N; Sarkeshik, AA; Siciliani, A; Vallières, E; Wandell, G | 1 |
| Koh, YW; Lee, SJ; Park, SY | 1 |
| Ma, Y; Wang, Y; Yang, B; Zhao, M | 1 |
| Fu, Z; Li, Q; Li, Z; Liu, M; Zhang, J | 1 |
| Cheon, GJ; Chung, JK; Goo, JM; Kang, KW; Lee, DS; Lee, JM; Lee, SJ; Paeng, JC | 1 |
| Jia, Z; Lan, Y; Ren, P; Shen, G; Zhang, K | 1 |
| Ferguson, CD; Luis, CR; Steinke, K | 1 |
| Deuschl, C; Forsting, M; Gramsch, C; Grueneisen, J; Heusch, P; Mönninghoff, C; Nensa, F; Poeppel, TD; Quick, HH; Sawicki, LM; Schlamann, M; Umutlu, L | 1 |
| Al-Kadhimi, Z; Alshekhlee, A; Grommes, C; Preston, DC | 1 |
| Bipat, S; IJzermans, JN; Oyen, WJ; Planting, AS; Stoker, J; van Leeuwen, MS | 1 |
| Agarwal, A; Avril, N; Becker, C; Bencherif, B; Degirmenci, B; Landreneau, R; Laymon, CM; Luketich, J; Mason, NS; Wilson, D | 1 |
| Ishikawa, S; Kimura, N; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Yamamoto, Y | 1 |
| Chung, JK; Jeong, JM; Jung, HW; Kim, DG; Lee, DS; Lee, HY; Lee, MC | 1 |
| Kotani, Y; Koyama, H; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Choi, JY; Chung, MJ; Kim, BT; Kim, H; Kwon, OJ; Lee, KS; Shin, KM; Yi, CA | 1 |
| Gao, ZR; Jia, Q; Lan, XL; Wei, H; Wu, ZJ; Zhang, YX | 1 |
| Cheng, HF; He, GQ; Liu, HB; Ye, XJ; Zhan, HW; Zhang, H; Zhao, CL | 1 |
| Durnick, DK; Peller, PJ; Subramaniam, RM | 1 |
| Law, I; Louring-Andersen, J | 1 |
| Bossuyt, A; Deryk, S; Geers, C; Goethals, L; Hove, KV; Lahoutte, T; Vandenbroucke, F; Vanhove, C | 1 |
| Conrad, GR; Jackson, RT; Sinha, P | 1 |
| Mahmood, S; Martinez de Llano, SR | 1 |
| Abad, MJ; Arsenak, M; Caridad, V; Colmenter, LF; Guillén, N; Martín, R; Taylor, P | 1 |
| Godwin, JD; Lewis, DH; Manchanda, V; Martins, RG; Pipavath, SN; Schmidt, RA | 1 |
| Bae, YA; Lee, KS | 1 |
| Fletcher, JW; Jennings, SG; Sandrasegaran, K; Tann, M; Welling, ME; Winer-Muram, HT | 1 |
| Grgic, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Schaefer-Schuler, A | 1 |
| Inoue, T; Kawano, T; Ohtake, E | 1 |
| Fu, Z; Hu, M; Li, M; Liu, N; Shi, F; Yang, G; Yu, J; Yuan, S; Zhang, P | 1 |
| Hou, M; Li, XN; Liu, J; Liu, YF; Yu, HM; Yu, JM | 1 |
| Akiduki, S; Ishizaka, A; Kuwabara, K; Sawafuji, M; Takahashi, S | 1 |
| Chen, CJ; Cheng, L; Chiu, NT; Chu, CL; Lee, BF; Wu, PS; Yao, WJ | 1 |
| Ahn, SH; Jeon, SY; Kim, CH; Koh, JS; Lee, JC; Lim, SM | 1 |
| Boscolo, E; Bussoli, L; Gelain, F; Lubin, E; Pizzolato, R; Quaia, E; Tona, G | 1 |
| Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer, A | 1 |
| Aida, S; Kita, T; Kosuda, S; Ozeki, Y; Sakata, I; Shinmoto, H; Soga, S; Watanabe, S; Yano, F | 1 |
| Chang, CP; Hsieh, HJ; Lee, CY; Lin, KH; Lin, SH; Wang, SJ | 1 |
| Liang, CY; Liu, HF; Liu, X; Zhang, JM; Zhang, T; Zhou, NK | 1 |
| Almeida, SA; Fonseca, LM; Franco, CA; Landesmann, MC; Martins, Rde C; Siciliano, AA; Silva, FB | 1 |
| Kitamura, H; Nakamura, H; Nishikawa, J; Taguchi, M | 1 |
| Fujii, T; Kishi, K; Miyamoto, A; Sugino, K; Takaya, H; Yoshimura, K | 1 |
| Chong, CF | 1 |
| Carrozzi, L; Comin, C; Falaschi, F; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maria Carozzi, F; Mascalchi, M; Paci, E; Picozzi, G; Ronchi, C; Spinelli, C | 1 |
| Goya, T; Kim, EE; Takeuchi, M; Tateishi, U; Terauchi, T; Tsushima, Y; Uno, H | 1 |
| Alavi, A; Basu, S; Cermik, TF; Dhuriraj, T; Kumar, R; Mavi, A; Torigian, D; Urhan, M; Wasik, M | 1 |
| Akashi, T; Chiba, T; Ito, H; Ito, K; Kubota, K; Mochizuki, M; Morita, T; Morooka, M; Murata, Y; Nomura, T; Shibuya, H | 1 |
| Jordan, CD; Salskov, A; Schmidt, R; Turcotte, E; Vallières, E; Vesselle, H; Wiens, L; Wood, DE | 1 |
| Chang, J; Feustel, P; Karam, M; Roberts-Klein, S; Shet, N | 1 |
| Guo, HB; Hu, M; Liu, LP; Liu, NB; Xu, XQ; Yang, GR; Yu, JM; Zhang, PL | 1 |
| Weder, W | 1 |
| Ameshima, S; Demura, Y; Fujibayashi, Y; Ishizaki, T; Miyamori, I; Okazawa, H; Sasaki, M; Uesaka, D | 1 |
| Bar-Shalom, R; Gorenberg, M; Israel, O | 1 |
| Chen, MY; Fan, W; Liang, PY; Lin, XP; Zhang, X; Zhao, C; Zhi, SF | 1 |
| Berthelsen, AK; Brenøe, J; Loft, A; Ravn, J; Sørensen, JB | 1 |
| Csiki, Z; Garai, I; Sóvágó, J; Szabados, L; Tóth, C; Tóth, L | 1 |
| Demos, JM; Engel, JM; Mukesh, B; Onitilo, AA | 1 |
| Hall, NC; Johnson, MA; Martin, EW; Moffatt-Bruce, SD; Povoski, SP; Ross, P; Sharif, S | 1 |
| Bellomi, M; Guarize, J; Leo, F; Maisonneuve, P; Masullo, M; Pelosi, G; Preda, L; Rampinelli, C; Scanagatta, P; Solli, P; Spaggiari, L; Veronesi, G | 1 |
| Abdel-Nabi, H; Baker, J; Gona, J; Khalaf, M; Lamonica, D; Shao, Y | 1 |
| Fukumoto, T; Imataki, O; Kitanaka, A; Kubota, Y; Kurokohchi, K; Ohnishi, H; Tanaka, T | 1 |
| Goo, JM; Jeon, YK; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Park, CM; Park, EA | 1 |
| Bepler, G; Boulware, D; Eikman, EA; Robinson, L; Sommers, E; Tanvetyanon, T | 1 |
| Choong, NW; Hellman, RS | 1 |
| Behr, TM; Gratz, S; Höffken, H; Kaiser, W; Kempke, B; Pfestroff, A | 1 |
| Bury, T; Corhay, JL; Duysinx, B; Hustinx, R; Larock, MP; Louis, R; Nguyen, D | 1 |
| Fu, Z; Han, A; Li, K; Sun, X; Xu, X; Yang, G; Yu, J; Zheng, J | 1 |
| Allen, MS; Cassivi, SD; Deschamps, C; Fortes, DL; Lowe, VJ; Nichols, FC; Shen, KR; Wigle, DA | 1 |
| Bar-Shalom, R; Guralnik, L; Israel, O; Kagna, O | 1 |
| De Marinis, F; Miele, E; Pasciuti, G; Rossi, L; Spinelli, GP; Tomao, F; Tomao, S; Zoratto, F; Zullo, A | 1 |
| Higashi, K; Ito, K; Kato, T; Kobayashi, T; Niho, S; Sakuma, T; Sekiguchi, R; Takahashi, T; Tonami, H; Ueda, Y | 1 |
| Obando, JA; Samii, JM; Yasrebi, M | 1 |
| Baarslag, HJ; de Haas, MJ; de Jong, JA; de Klerk, JM; Oud, K; Quarles van Ufford, HM | 1 |
| Fakhry, N; Giovanni, A; Mundler, O; Taïeb, D; Tessonnier, L | 1 |
| Akduman, EI; Nguyen, NC; Oliver, D; Osman, MM; Sayed, MH | 1 |
| Arnold, JF; Flentje, M; Jakob, PM; Kotas, M; Pracht, ED; Pyzalski, RW | 1 |
| Hicks, RJ; Mac Manus, M | 1 |
| Hong, TS; Killoran, JH; Mamede, M; Mamon, HJ | 1 |
| Cheon, GJ; Kim, CH; Kim, MS; Lee, JC; Lim, SM | 1 |
| Dua, SG; Pramesh, CS; Purandare, NC; Rajnish, A; Rangarajan, V; Shah, S | 1 |
| Boersma, L; Bootsma, G; De Ruysscher, D; Dingemans, AM; Fatah, SA; Geraedts, W; Grutters, J; Hochstenbag, M; Lambin, P; Oellers, M; Pitz, C; Simons, J; Snoep, G; van Loon, J; Wanders, R | 1 |
| Cheng, NM; Ho, KC; Liu, YC; Wang, CW; Wu, YC; Yen, TC; Yu, CT | 1 |
| Goya, T; Honda, Y; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Uno, K | 1 |
| Nakazawa, K; Ohtsuka, M; Satoh, H; Sekizawa, K | 1 |
| Chiba, H; Fujii, M; Inomata, S; Nakamura, N; Sawazumi, T; Takahashi, H; Takahashi, M; Tanaka, H | 1 |
| Ameshima, S; Demura, Y; Fujibayashi, Y; Ishizaki, T; Kimura, H; Miyamori, I; Morikawa, M; Okazawa, H; Sasaki, M; Tsuchida, T | 1 |
| Henderson, R; Ho, L; Seto, J; Youngworth, H | 1 |
| De Neve, W; De Ruysscher, D; Dehing-Oberije, C; Lambin, P; Lievens, Y; Meersschout, S; Rao, B; Van Beek, K; van der Weide, H; Van Meerbeeck, J; Yu, S | 1 |
| Deroose, CM; Himpe, U; Leyn, PD; Vansteenkiste, J; Verbeken, E | 1 |
| Delaloye, AB; Letovanec, I; Martins Favre, M; Orcurto, MV; Prior, JO | 1 |
| Bailly, P; Daouk, J; Fin, L; Meyer, ME | 1 |
| Dusmet, M; Griffin, N; Mansfield, L; Mullen, M; Redmond, KC | 1 |
| Kraemer, K; Passlick, B; Schlaudraff, E; Troester, F; Weske, G | 1 |
| Cheng, MF; Hsu, YC; Huang, CT; Shih, JY; Tsai, MF; Tsai, YJ; Wei, PF; Yang, CH; Yang, PC; Yen, RF | 1 |
| Endo, K; Endou, H; Higuchi, T; Hisada, T; Imai, H; Ishikita, T; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Nakajima, T; Oriuchi, N; Shimizu, K; Sunaga, N; Yanagitani, N | 1 |
| Choi, CM; Kim, WS; Oh, YM; Ryu, JS; Shim, TS; Song, JW | 1 |
| Jeong, YJ; Kim, IJ; Kim, SJ; Kim, YS; Lee, TH | 1 |
| Brix, WK; Jones, DR; Kozower, BD; Lau, CL; Smith, PW; Swenson, BR; Taylor, MD; Theodosakis, N; Wick, MR | 1 |
| Chun, EJ; Goo, JM; Kang, WJ; Kim, KG; Lee, CH; Lee, HJ; Park, CM | 1 |
| Bandiera, A; Carretta, A; Casiraghi, M; Ciriaco, P; Libretti, L; Melloni, G; Zannini, P | 1 |
| Larson, SM; Schwartz, LH; Zhao, B | 1 |
| Fisher, RE | 1 |
| Abolmaali, N; Abramyuk, A; Gillham, C; Herrmann, T; Koch, A; Szluha Lazanyi, K; Tokalov, S; Zöphel, K | 1 |
| Duan, Y; Lu, PO; Wang, WZ; Yu, LJ | 1 |
| Hu, M; Kong, L; Li, MH; Liu, NB; Yang, GR; Yu, JM | 1 |
| Cheng, Z; He, J; Lin, L; Liu, L; Mao, YS; Zheng, R | 1 |
| Brady, MJ; Franklin, KM; Ho, LM; Paulson, EK; Thomas, J; Wong, TZ | 1 |
| Bar-Shalom, R; Fruchter, O; Guralnik, L; Israel, O; Kagna, O; Keidar, Z; Solomonov, A; Yigla, M | 1 |
| Aerts, HJ; Boersma, L; Borger, J; De Ruysscher, D; Dehing, C; Dekker, A; Dingemans, AM; Hochstenbag, M; Houben, A; Lambin, P; Ollers, M; Wanders, R | 1 |
| Hwang, SC; Lee, KB; Park, KJ; Sheen, SS; Sun, JS; Yoon, JK; Yoon, SN | 1 |
| Ghesani, N; Maldjian, PD | 1 |
| Amemiya, R; Asato, Y; Hashimoto, I; Iijima, H; Kaburagi, T; Kaito, K; Kiyoshima, M; Okumura, T; Sato, M; Uchiumi, K | 1 |
| Adachi, S; Hara, H; Ishii, K; Kida, T; Sakai, H; Suzuki, K; Ueda, O; Yamaguchi, T | 1 |
| Jheon, S; Kim, DJ; Kim, HR; Lee, WW; Sung, SW | 1 |
| Aikawa, H; Higashi, K; Machida, Y; Sagawa, M; Sakuma, T; Tanaka, M; Ueno, M; Usuda, K | 1 |
| Chakraborty, PK; Chugani, DC; Jahania, MS; Juhász, C; Khalaf, M; Lu, X; Mangner, TJ; Muzik, O; Peng, F; Soubani, AO | 1 |
| Basu, S | 1 |
| Lupi, A; Malfatti, V; Salgarello, M; Zanco, P; Zaroccolo, M | 1 |
| Aoyagi, M; Inaji, M; Kawano, Y; Maehara, T; Nakagawa, K; Nariai, T; Ohno, K; Tamaki, M; Toriyama, H | 1 |
| Grunkemeier, GL; Kernstine, KH | 1 |
| Kobayashi, H; Mori, T; Nakashima, R; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, S | 1 |
| di Scioscio, V; Fabbri, M; Fasano, L; Feraco, P; Malvi, D; Miglio, L; Pacilli, AM; Toni, F; Zompatori, M | 1 |
| Caldwell, C; Mah, K; Mozeg, D; Yu, H | 1 |
| Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Motosugi, U; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A | 1 |
| Eslamy, HK; Krupitskaya, Y; Kumar, A; Nguyen, DD; Wakelee, HA | 1 |
| Feng, M; Fernando, S; Gross, M; Hayman, JA; Kong, FM; Ten Haken, RK | 1 |
| Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K; Yamashita, K | 1 |
| Baik, SH; Beak, SK; Choi, DS; Kim, NH; Kim, SG | 1 |
| Abdulkader, I; Gude, F; León, L; Ruibal, A | 1 |
| Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nishii, R; Tamura, S; Wakamatsu, H | 1 |
| Fu, Z; Hu, M; Li, M; Liu, N; Ma, L; Pang, Q; Shi, F; Yang, G; Yu, J; Zhou, W | 1 |
| Fujiwara, K; Kanazawa, S; Kawai, H; Matsuo, K; Okumura, Y; Rai, K; Sato, S; Sato, T; Shinya, T; Watanabe, K; Yonei, T | 1 |
| Fan, C; Fan, Q; Li, F; Su, M; Tian, Y; Yang, X; Zhuang, H | 1 |
| Chen, X; Song, J; Xing, Y; Zhao, J | 1 |
| Chou, YH; Kao, PF; Kuo, KT; Lim, KR; Tsao, TC; Yue, CT | 1 |
| Borbély, K; Fekésházy, A; Lengyel, Z; Magyar, M; Markóczy, Z; Zsiray, M | 1 |
| Chang, J; Cho, A; Cho, BC; Choi, HJ; Kim, JH; Kim, SK; Lee, YJ; Moon, JW; Park, IK; Yun, M | 1 |
| Aerts, HJ; De Ruysscher, D; Dekker, AL; Houben, R; Lambin, P; Offermann, C; Ollers, MC; Petit, SF; van Loon, JG; Winkens, B | 1 |
| Aerts, HJ; Boersma, L; Bootsma, G; Borger, J; Bosmans, G; De Ruysscher, D; Dekker, AL; Dingemans, AM; Geraedts, W; Houben, R; Lambin, P; Loon, Jv; Oellers, M; Offermann, C; Petit, SF; Pitz, C; Simons, J; van Baardwijk, AA; Wanders, R; Wouters, BG | 1 |
| Kleinig, TJ; Kneebone, CS; Thompson, PD | 1 |
| Carson, KJ; Cosgrove, VP; Hounsell, AR; Jarritt, PH; Young, VA | 1 |
| Baum, RP; Hellwig, D; Kirsch, C | 1 |
| Clifton, IJ; Muers, MF; Scarsbrook, AF | 1 |
| Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A; Sato, Y | 1 |
| Fujii, A; Hayashi, A; Hidaka, D; Hiyama, J; Ikeda, K; Koshizuka, H; Misumi, Y; Miyagawa, Y; Nakatsubo, S; Sawamoto, R | 1 |
| Erasmus, JJ; Rohren, E; Swisher, SG | 1 |
| Absher, K; Conrad, GR; Lee, J; Sinha, P | 1 |
| Choe, W; Hwang, KH; Jeon, IS; Kim, JE; Kwon, CG; Lee, MK; Tchah, H | 1 |
| Abe, K; Baba, S; Honda, H; Isoda, T; Kaneko, K; Matsuo, Y; Sasaki, M; Tashima, Y; Yabuuchi, H | 1 |
| Minoshima, S; Yeatman, CF | 1 |
| Allen-Auerbach, M; Weber, WA | 1 |
| Harada, T; Isowa, N; Kawasaki, Y; Maeda, R; Miura, H; Onuma, H; Tokuyasu, H; Touge, H | 2 |
| Mori, T; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, K; Yoshimoto, K | 1 |
| Bral, S; De Ridder, M; Duchateau, M; Everaert, H; Schallier, D; Storme, G; Tournel, K; Verellen, D | 1 |
| Baek, H; Byun, BH; Cheon, GJ; Choe, du H; Kim, CH; Kim, KM; Koh, JS; Lee, DY; Lee, JC; Lim, SM; Na, II; Ryoo, BY; Yang, SH | 1 |
| Begueret, H; de Clermont, H; Ducassou, D; Laffon, E; Marthan, R; Thumerel, M; Vernejoux, JM | 1 |
| Ball, D; Binns, D; Everitt, S; Hicks, RJ; Kron, T; Mac Manus, M; Schneider-Kolsky, M; Walter, T | 1 |
| Fox, JJ; Pandit-Taskar, N; Rohan, S | 1 |
| Abiko, T; Koizumi, S; Takanami, I | 1 |
| Bensadoun, ES; Reichert, M | 1 |
| Koyama, H; Matsumoto, K; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Han, SK; Kim, YW; Min, JW; Shim, YS; Um, SW; Yim, JJ; Yoo, CG | 1 |
| Chua, SC; O'Connor, SR; Rozalli, FI | 1 |
| D'Hoore, I; De Leyn, P; Dooms, C; Nackaerts, K; Stroobants, S; Vansteenkiste, J; Wauters, I | 1 |
| de Geus-Oei, LF; Krabbe, PF; Oyen, WJ; Timmer-Bonte, JN; van Laarhoven, HW; Visser, EP; Vriens, D | 1 |
| Chung, JK; Kang, WJ; Kim, BS; Kim, S; Lee, DS; Lee, JW; Lee, MC | 1 |
| Feins, R; Funkhouser, WK; Khandani, AH; Socinski, MA | 1 |
| Hiyama, A; Kawakami, Y; Matsumoto, T; Matsunaga, N; Okabe, K; Suga, K; Sugi, K; Tanaka, N; Ueda, K | 2 |
| Horikoshi, T; Ito, H; Kasai, T; Kuniyasu, Y; Motoori, K; Takahashi, F; Takiguchi, Y; Uchiyama, K; Yasufuku, K | 1 |
| Bom, HS; Chong, A; Ha, JM; Jeong, SY; Kwon, SY; Min, JJ; Oh, JR; Seo, YS; Song, HC | 1 |
| Hata, Y; Homma, S; Isobe, K; Shibuya, K; Sugino, K; Takai, Y | 1 |
| Fu, Z; Li, X; Ling, CC; Mu, D; Sun, X; Xing, L; Yang, G; Yu, J; Zhang, B | 1 |
| Ardissone, F; Arena, V; Billé, A; Borasio, P; Errico, L; Mancini, M; Pelosi, E; Skanjeti, A | 1 |
| Lee, SK; Rho, BH | 1 |
| Ichiguchi, O; Yoshioka, M | 1 |
| Fakiris, AJ; Fletcher, JW; Henderson, MA; Hoopes, DJ; Lin, PF; McGarry, RC; Tann, M; Timmerman, RD; Williams, MD; Yiannoutsos, CT | 1 |
| Djemil, T; Gajdos, SM; Kolar, M; Machuzak, M; Mazzone, P; Reddy, CA; Stephans, KL; Videtic, GM | 1 |
| Han, JY; Kang, KW; Kim, HT; Kim, HY; Kim, SK; Lee, DH; Lee, HY; Lee, JS; Lee, SY; Park, SH | 1 |
| De Ruysscher, D; Dooms, C; Stroobants, S; van Baardwijk, A; van Suylen, RJ; Vansteenkiste, J; Verbeken, E | 1 |
| Hara, M; Mizuno, A; Nakagawa, M; Nishio, M; Ozawa, Y; Sakurai, K; Shibamoto, Y; Tamaki, T | 1 |
| Carrère, MO; Giammarile, F; Morelle, M; Pommier, P; Remonnay, R | 2 |
| Behzadi, A; Deschamps, C; Lowe, V; Ung, Y | 1 |
| Buck, AK; Hasenkamp, E; Hombach, V; Krüger, S; Merk, T; Mottaghy, FM; Pauls, S; Reske, SN; Schumann, C; Wibmer, T | 1 |
| Chetty, M; Currie, GP; Denison, AR | 1 |
| Diederich, S; Engeser, P; Junker, K; Passlick, B; Pfluger, T; Pottgen, C; Reck, M | 1 |
| Komori, E; Kurita, A; Maeda, A; Mimae, T; Sawada, S; Suehisa, H; Takashima, S; Toyosaki, R; Yamashita, M | 1 |
| Feintuch, A; Frenkel, A; Gidron, Y; Golan, H; Kennedy, JA; Levi, O; Parmet, Y | 1 |
| Che, WJ; Qiao, WL; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Cai, L; Chen, QS; Gao, S; Li, DC; Li, YS; Xing, XL | 1 |
| Foster, CC; Hagge, RJ; Lin, FI; Shelton, DK | 1 |
| Coquia, S; Tulchinsky, M; Wagner, H | 1 |
| Biron, P; Cimarelli, S; Deshayes, E; Desuzinges, C; Giammarile, F; Mognetti, T; Rivoire, M | 1 |
| Barron, BJ; Caram, P; Joseph, UA; Nguyen, AP; Wan, DQ | 1 |
| Chang, CY; Cheng, CY; Huang, WS; Ku, CH; Lee, JK; Lee, SC; Liu, CH; Oliver Wong, CY; Tzao, C | 1 |
| Bootsma, GP; de Bruin, PC; Keijsers, RG; Schramel, FM; van den Heuvel, DA; van Es, HW; van Heesewijk, JP | 1 |
| Banks, KP; Bradley, YC; Cloran, FJ; Kim, Y; Song, WS | 1 |
| Goya, T; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Tomiyoshi, K; Uno, K | 1 |
| Baillet, G; Groheux, D; Hindie, E; Martineau, A; Moretti, JL; Vrigneaud, JM | 1 |
| Bolacchi, F; Bruni, C; Calabria, F; Cicciò, C; Guazzaroni, M; Orlacchio, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
| Cline, KJ; Darling, GE; Driedger, AA; Evans, WK; Gu, CS; Gulenchyn, KY; Inculet, RI; Levine, MN; Maziak, DE; Miller, JD; Ung, YC | 1 |
| Guo, WH; Jia, P; Zhang, Y | 1 |
| Li, M; Liang, Y; Liu, Y; Wu, N; Zhang, WJ; Zhao, P; Zheng, R | 1 |
| Barwick, T; Breen, R; Cane, P; Gnanasegaran, G; Rankin, S; Szyszko, T | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Zhang, WG; Zhang, X | 1 |
| Ikeda, K; Katahira, K; Kobayashi, H; Mori, T; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, S | 1 |
| Aoyama, N; Koyama, H; Matsumoto, K; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Baron, O; Bridji, B; Despins, P; Duveau, D; Mugniot, A; Perigaud, C; Roussel, JC; Sagan, C | 1 |
| Inoue, T; Jinnouchi, S; Kawamoto, M; Minamimoto, R; Nakashima, R; Nishizawa, S; Senda, M; Terauchi, T; Yoshida, T | 1 |
| Dooms, C; Stroobants, S; Vansteenkiste, J; Verbeken, E | 1 |
| Aurengo, A; Leenhardt, L; Lloret Linares, C; Sellier, P; Troisvallets, D | 1 |
| Cheng, HF; Hsu, PK; Hsu, WH; Wu, YC; Yeh, YC | 1 |
| Carson, KJ; Cosgrove, VP; Eakin, RL; Hanna, GG; Hounsell, AR; Jarritt, PH; Lynch, T; McAleese, J; O'Sullivan, JM; Stewart, DP; Young, VA; Zatari, A | 1 |
| Okagawa, T; Suyama, M; Uchida, T | 1 |
| Divgi, CR | 1 |
| Aukema, TS; Baas, P; Belderbos, JS; Burgers, SA; Klomp, HM; Teertstra, HJ; Valdés Olmos, RA; van den Heuvel, MM; Vogel, WV | 1 |
| Chung, SY; Kim, HJ; Kim, SJ; Kim, TH; Kim, TS; Lee, JD; Lee, JH; Pai, M; Ryu, YH; Yun, M | 1 |
| Abikhzer, G; Makis, W; Rush, C | 1 |
| Chamberlain, MC; Eaton, KD; Fink, JR; Tredway, T | 1 |
| Feng, R; Ma, L; Meng, X; Yu, JM; Yue, JB; Zhang, HQ | 2 |
| DeCamp, MM; Gangadharan, SP; Kent, MS; Nicotera, SP; Okereke, IC; Shen, C | 1 |
| Choi, JY; Chung, MP; Han, J; Kim, H; Kim, J; Koh, WJ; Kwon, OJ; Lee, KS; Suh, GY; Um, SW | 1 |
| Abe, K; Honda, H; Ito, K; Kawano, D; Maehara, Y; Miura, N; Morodomi, Y; Shoji, F; Takenaka, T; Yano, T | 1 |
| Han, B; Lin, S; Wang, RZ; Wang, YY; Yu, LJ | 1 |
| Futatsubashi, M; Kanno, T; Okada, H; Ouchi, Y; Tanizaki, Y; Torizuka, T; Yoshikawa, E | 1 |
| Kawai, H; Muguruma, M; Ohara, T; Watanabe, K | 1 |
| Bol, A; Castadot, P; Geets, X; Grégoire, V; Lee, JA | 1 |
| Bourland, W; Garrington, T; Grunzke, M; Hayes, K | 1 |
| Cao, YX; Dong, JC; Duan, XH; Guan, YH; Le, JJ; Liu, BJ; Wu, JF; Xu, CQ; Zhao, J; Zuo, CT | 1 |
| Boersma, L; Bootsma, G; De Ruysscher, D; Dehing-Oberije, C; Dingemans, AM; Geraedts, W; Hochstenbag, M; Lambin, P; Oellers, M; Pitz, C; Rhami, A; Simons, J; Snoep, G; Teule, J; Thimister, W; van Loon, J; Wanders, R | 1 |
| Chang, H; Chen, JC; Cheng, YL; Huang, TW; Huang, WS; Lee, SC; Tzao, C | 1 |
| Amdur, RJ; Liu, C; Lu, B; Newlin, HE; Olivier, KR; Shi, W; Yeung, A | 1 |
| Adachi, K; Fujimoto, H; Ibata, H; Kaneda, M; Omoto, Y; Sakai, T; Watanabe, F | 1 |
| Belderbos, J; Sonke, JJ | 1 |
| Bangard, C; Boellaard, R; Dietlein, M; Dimitrijevic, S; Eschner, W; Giaccone, G; Gross, SH; Hayes, W; Hoekstra, OS; Hoetjes, N; Kobe, C; Lammertsma, AA; Nogová, L; Pellas, T; Schmidt, K; Thomas, RK; Wolf, J; Zander, T | 1 |
| Endo, K; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Oriuchi, N; Shimizu, K; Sunaga, N; Tominaga, H; Yanagitani, N | 1 |
| Alavi, A; Gambhir, SS; Jadvar, H | 1 |
| Alavi, A; Cengel, KA; Dubroff, JG; Friedberg, JS | 1 |
| Pietrzykowski, J; Wardyn, KA; Zielonka, TM | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, M; Heusner, T; Peng, Z; Zhan, Y; Zhou, X | 1 |
| Erasmus, JJ | 1 |
| Calabrò, E; Fazio, F; Landoni, C; Marchianò, A; Mariani, L; Messa, C; Miceli, R; Pastorino, U; Picchio, M; Sozzi, G | 1 |
| Gauthier, H | 1 |
| Christodoulou, M; Letovanec, I; Prior, JO; Stupp, R | 1 |
| Akiyama, T; Kaneta, T; Kudou, K; Saito, A; Takahashi, R; Takahashi, Y | 1 |
| Kaira, K | 1 |
| Gould, MK; Krupitskaya, Y; Nair, VS | 1 |
| Hirata, T; Kitamura, H; Nakamura, H; Nishikawa, J | 1 |
| Ballek, E; Fleckenstein, J; Grgic, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer-Schuler, A | 1 |
| Bomanji, JB; Caplin, M; Conry, BG; Dickson, J; Groves, AM; Kayani, I; Win, T | 1 |
| Demura, Y; Fujibayashi, Y; Kiyono, Y; Kudo, T; Lohith, TG; Okazawa, H; Umeda, Y | 1 |
| Agarwal, M; Bajaj, SK; Brahmanday, G; Ravikrishnan, KP; Wong, CY | 1 |
| Azad, A; Berlangieri, SU; Chionh, F; Lee, ST; Mitchell, PL; Scott, AM; White, S | 1 |
| Chung, SY; Kim, HJ; Kim, SJ; Kim, TH; Lee, JH; Ryu, YH | 1 |
| Bagni, B; Barbieri, F; Casali, C; Cucca, M; Iacuzio, L; Rossi, G; Uliano, M | 1 |
| Boersma, L; Bootsma, G; Brans, B; De Ruysscher, D; Dingemans, AM; Geraedts, W; Grutters, JP; Hochstenbag, M; Lambin, P; Pitz, C; Simons, J; Snoep, G; van Loon, J; Wanders, R | 1 |
| Antoch, G; Bockisch, A; Eberhardt, W; Esser, S; Forsting, M; Gölitz, P; Hamami, M; Heusner, T | 1 |
| Baum, RP; Prasad, V; Świętaszczyk, C | 1 |
| Hata, Y; Homma, S; Isobe, K; Shibuya, K; Takagi, K; Takai, Y | 1 |
| Bruna-Muraille, C; Cuif-Job, A; Domange-Testard, A; Jovenin, N; Liehn, JC; Menéroux, B; Papathanassiou, D; Prévost, A | 1 |
| Ishikawa, Y; Ito, H; Kameda, Y; Kondou, T; Mizutani, Y; Murakami, S; Nakayama, H; Noda, K; Oshita, F; Saito, H; Sakuma, Y; Suga, Y; Tsuboi, M; Yamada, K; Yokose, T | 1 |
| Ito, K; Kawano, D; Maehara, Y; Miura, N; Morodomi, Y; Shoji, F; Yano, T | 1 |
| Ak, I; Entok, E; Sivrikoz, MC; Vardareli, E | 1 |
| Cong, CS; Fu, Z; Guo, SF; He, W; Liu, XJ; Yu, JM; Yu, YH; Zhang, Y | 1 |
| Ahn, BC; Lee, J; Lee, SW; Seo, JH | 1 |
| Gnanasegaran, G; Nunan, T; Szyszko, T; Trautner, M | 1 |
| Farghaly, HR; Mekkawy, MA; Mostafa, MS; Nguyen, NC; Osman, MM; Sayed, MH | 1 |
| Cui, R; Li, F; Zhuang, H | 1 |
| Canpolat, ET; Reyhan, M; Yapar, AF | 1 |
| Digumarthy, SR; Kalra, MK; Prakash, P; Sharma, A; Shepard, JA | 1 |
| Ananth, L; Barnett, PG; Gould, MK; Nair, VS | 1 |
| Hata, Y; Homma, S; Isobe, K; Kaburaki, K; Sakaguchi, S; Takai, Y | 1 |
| Baurain, JF; Beguin, C; Crott, R; Krug, B; Lonneux, M; Pirson, AS; Roch, I; Vander Borght, T | 1 |
| Fang, HY; Huang, HJ; Lin, YM; Wu, CY | 1 |
| Buvat, I; Doyeux, K; Gardin, I; Grotus, N; Hapdey, S; Stute, S; Tylski, P; Vanderlinden, B | 1 |
| Beyer, F; Buerke, B; Gerss, J; Heindel, W; Puesken, M; Scheffe, K; Schober, O; Weckesser, M; Wessling, J | 1 |
| Hara, M; Nakagawa, M; Nishio, M; Ozawa, Y; Sakurai, K; Shibamoto, Y; Tamaki, T | 1 |
| Gong, H; Huang, W; Lu, Y; Xie, D; Yu, J | 1 |
| Arguis, P; Garcia, S; Gimferrer, JM; Gómez-Caro, A; Lomeña, F; Marrades, R; Reguart, N; Sanchez, M | 1 |
| Carrel, TP; Fischer Biner, R; Gugger, M; Krause, TM; Minder, S; Nicod, LP; Schmid, RA; Stoupis, C; Tueller, C; Vock, P | 1 |
| Abedalthagafi, M; Anderson, ED; Banovac, F; Chang, T; Collins, BT; Collins, SP; Debrito, P; Esposito, G; Gutierrez, CJ; Oermann, EK; Suy, S; Vahdat, S; Yousefi, S; Yu, X | 1 |
| Algara, M; Foro, P; Lacruz, M; Lozano, J; Membrive, I; Quera, J; Reig, A; Rodríguez, N; Sanz, X; Trampal, C | 1 |
| Banzo, I; Barragán, J; Carril, JM; Jimenez-Bonilla, J; Martinez-Rodriguez, I; Medina-Quiroz, P; Portilla-Quattocciochi, H; Quirce, R; Sainz-Esteban, A | 1 |
| Antoine, M; Balogova, S; Cadranel, J; Gutman, F; Huchet, V; Kerrou, K; Lavolée, A; Mayaud, C; Montravers, F; Nataf, V; Prignon, A; Ruppert, AM; Talbot, JN | 1 |
| Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Salles, Y; Staub, E; Vaylet, F | 1 |
| Choi, BW; Kim, HW; Kwon, KY; Won, KS; Zeon, SK | 1 |
| García Vicente, AM; León Martín, AA; Palomar Muñoz, AM; Pilkington Woll, JP; Poblete García, VM; Soriano Castrejón, AM; Talavera Rubio, MP | 1 |
| Marchiori, E; Mauro Mano, C; Zanetti, G | 1 |
| Fu, Z; Tan, GZ; Yang, WF; Yu, JM | 1 |
| Chung, DH; Goo, JM; Jang, BG; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Lee, HY; Park, CM | 1 |
| Hasegawa, Y; Higashiyama, M; Hosoki, T; Kanzaki, R; Kodama, K; Maeda, J; Okami, J; Takami, M | 1 |
| Cook, GJ; Llamas Elvira, JM; Ramos-Font, C; Rebollo-Aguirre, AC; Romero Tabares, A; Villegas Portero, R | 1 |
| Berger, F; Issels, R; Reiser, MF; Rist, C; Schlemmer, M; Schramm, N | 1 |
| Nwogu, C | 1 |
| Evans, PM; Partridge, M; Perrin, R; Webb, S | 1 |
| Berghmans, T; Dusart, M; Garcia, C; Hossein-Foucher, C; Lafitte, JJ; Mascaux, C; Meert, AP; Paesmans, M; Roelandts, M; Scherpereel, A; Sculier, JP; Terrones Munoz, V | 1 |
| Alavi, A; Chamroonrat, W; Gopal, R; Houseni, M; Zhuang, H; Zhuang, J | 1 |
| Bertolini, F; Cavazza, A; Guicciardi, N; Marchioni, A; Rossi, G; Valli, R | 1 |
| Hirokawa, Y; Itano, H; Takauchi, K | 1 |
| Csiki, I; Delbeke, D; Diaz, R; Duggan, D; Lu, B; McElmurray, J; Spratt, DE | 1 |
| Apostolova, I; Brenner, W; Buchert, R; Dreilich, T; Kabus, S; Klutmann, S; Mester, J; Paulus, T; Plotkin, M; van den Hoff, J; Wiemker, R | 1 |
| Han, J; Shim, SS | 1 |
| Fu, Z; Han, A; Mu, D; Sun, X; Yang, W; Yu, J; Zhang, Y | 1 |
| Carson, KJ; Cosgrove, VP; Eakin, RL; Hanna, GG; Hounsell, AR; Lynch, T; McAleese, J; O'Sullivan, JM; Stewart, DP; Zatari, A | 1 |
| Chou, SH; Huang, MS; Lien, CT; Yang, CJ; Yang, SF | 1 |
| Jo, WS; Kim, IJ; Kim, SJ; Kim, YK; Kim, YS; Lee, MK; Park, SK | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Herrmann, T; Lazanyi, KS; Tokalov, S; Wolf, G; Zöphel, K | 1 |
| Chang, HY; Chiu, NT; Lee, BF; Tseng, YL; Yan, JJ | 1 |
| Aristei, C; Falcinelli, L; Palumbo, B; Tarducci, R | 1 |
| Liang, CY; Liu, X; Tian, XD; Zhang, JM; Zhang, T; Zhou, NK | 1 |
| Chen, L; Chen, W; Dai, YM; Huang, XQ; Jian, W; Li, C; Li, HT; Lin, Y; Lu, M; Xie, B; Xu, CX; Zhang, YK; Zhou, DQ | 1 |
| De Ruysscher, D; den Holder, L; Lambin, P; Ollers, M; van Elmpt, W; van Herwijnen, H; Vercoulen, L; Wouters, M | 1 |
| Dooms, C; Vansteenkiste, J | 1 |
| Dierckx, R; Mees, G; Pauwels, P; Van de Wiele, C; Van Meerbeeck, J; Vangestel, C | 1 |
| Higashi, T; Hiraoka, M; Matsuo, Y; Mizowaki, T; Nagata, Y; Nakamoto, Y; Narabayashi, M; Norihisa, Y; Saga, T; Shibuya, K; Takayama, K; Togashi, K | 1 |
| Aizawa, H; Azuma, K; Hattori, S; Imamura, Y; Ishibashi, M; Kaida, H; Kawayama, T; Kinoshita, T; Kurata, S; Okamoto, M; Sasada, T | 1 |
| Fan, W; Hu, Y; Lang, P; Lin, X; Sun, X; Zhang, X | 1 |
| Ahmad, M; Bucci, MK; Chandler, AG; Johnson, V; Luo, D; Mawlawi, OR; Pan, T; Riegel, AC; Sun, X | 1 |
| Burke, C; Howlett, DC; Maxwell, D; Sharma, N; Thomas, R | 1 |
| Hanaoka, K; Hosono, M; Kanamori, S; Nakamatsu, K; Nishimura, Y; Okubo, M; Okumura, M; Shibata, T | 1 |
| Burdick, MJ; Djemil, T; Reddy, CA; Srinivas, SM; Stephans, KL; Videtic, GM | 1 |
| Allen, P; Dong, L; Erasmus, J; Ikushima, H; Komaki, R; McAleer, MF; Sasaki, R; Zhuang, Y | 1 |
| Carrasquillo, JA; Larson, SM; Nehmeh, SA; Schoellnast, H; Solomon, SB; Thornton, RH | 1 |
| Li, J; Liu, Y; Wang, JW; Xu, LM; Zhao, S | 1 |
| Araki, T; Ishihara, H; Kato, S; Miyata, K; Miyazawa, M; Motosugi, U; Nambu, A; Nishikawa, K; Okuwaki, H; Ozawa, K; Saito, A; Sato, Y; Sawada, E | 1 |
| Castelnovo, G; Collombier, L; Debrigode, C; Fourcade, G; Labauge, P; Renard, D | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Ball, DL; Brennan, SM; Gregory, DL; Herschtal, A; Hicks, RJ; MacManus, MP; Stillie, A | 1 |
| Holloway, LC; Kumar, S; Shafiq, J; Vinod, SK | 1 |
| Bussink, J; de Geus-Oei, LF; Dijkman, BG; Looijen-Salamon, M; Oyen, WJ; Schuurbiers, OC; Snoeren, MM; Timmer-Bonte, JN; van der Heijden, HF; Vriens, D | 1 |
| Christensen, JD; Colby, TV; Patz, EF | 1 |
| Hwang, SH; Kim, IJ; Kim, SJ; Lee, CH; Lee, EY; Lee, MK; Lee, SY | 1 |
| Koyama, H; Maniwa, Y; Matsumoto, K; Matsumoto, S; Nishimura, Y; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Mineura, K; Miyamoto, J; Owada, K; Sasajima, H | 1 |
| Adachi, S; Daisaki, H; Kato, Y; Nakayama, H; Okada, M; Okumura, S; Uehara, H; Yoshimura, M | 1 |
| Chung, MP; Han, J; Jeon, K; Kim, H; Koh, WJ; Kwon, OJ; Lee, KS; Park, HK; Shim, YM; Suh, GY; Um, SW | 1 |
| Han, SK; Heo, EY; Kim, YW; Shim, YS; Yang, SC; Yoo, CG | 1 |
| Barnett, S; Baste, JM; Berlangieri, S; Knight, S; Murugappan, K; Scott, A; Seevanayagam, S; Tog, C | 1 |
| Kley, K; Oehr, P | 1 |
| Fowler, A; Gabriel, G; Holloway, LC; Lin, M; Shon, IA; Vinod, SK; Yap, ML | 1 |
| Abaleke, S; Chatwin, CR; Ganeshan, B; Miles, KA; Young, RC | 1 |
| Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
| Ball, D; Bayne, M; Everitt, S; Fimmell, N; Hicks, RJ; Lau, E; MacManus, M; Pitman, A; Reynolds, J; Ware, R | 1 |
| Ball, D; Binns, D; Callahan, J; Everitt, S; Herschtal, A; Hicks, RJ; Kron, T; MacManus, M; Plumridge, N; Schneider-Kolsky, M | 1 |
| Hong, HS; Jeong, HT; Kim, KW; Lee, JD; Yun, M | 1 |
| Derbekyan, V; Makis, W; Novales-Diaz, JA | 1 |
| Abe, M; Endo, M; Hayashi, I; Kaira, K; Kondo, H; Murakami, H; Naito, T; Nakagawa, K; Nakajima, T; Nakamura, Y; Ohde, Y; Okumura, T; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Devic, S; Faria, S; Lehnert, S; Lisbona, R; Menard, S; Tomic, N | 1 |
| Carrie, C; Chabaud, S; Dussart, S; Giammarile, F; Le Pechoux, C; Pommier, P; Touboul, E | 1 |
| Giesel, FL; Haberkorn, U; Kratochwil, C | 1 |
| Bujko, K; Dziuk, M; Gizewska, A; Kepka, L; Kolodziejczyk, M; Szalus, N; Zawadzka, A | 1 |
| Han, B; Pan, H; Wang, R; Yu, L | 1 |
| Ball, DL; Binns, D; Ding, Z; Herschtal, A; Hicks, RJ; Hogg, A; Mac Manus, MP | 1 |
| Dua, SG; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR; Suryawanshi, PV | 1 |
| Jung, SA; Kim, CG; Kim, DW; Park, SA; Yang, SH | 1 |
| Hata, Y; Homma, S; Isobe, K; Sakaguchi, S; Shibuya, K; Takagi, K; Takai, Y | 1 |
| Alvfors, C; Bergman, A; Bergqvist, M; Bergström, S; Dahg, P; Ekman, S; Frödin, JE; Harmenberg, J; Hedlund, A; Ståhl, B | 1 |
| Aikawa, H; Higashi, K; Machida, Y; Sagawa, M; Sakuma, T; Tanaka, M; Ueda, Y; Ueno, M; Usuda, K; Zhao, XT | 1 |
| Araki, O; Chida, M; Fukushima, Y; Honma, K; Inoue, T; Tamura, M; Tatewaki, M; Umezu, H | 1 |
| Ishii, S; Kawai, N; Kishi, K; Minamiguchi, H; Nakai, M; Noda, Y; Sanda, H; Sato, M; Sonomura, T; Takasaka, I; Takeuchi, T | 1 |
| Hiyama, J; Kaneko, K; Omagari, J; Ono, K; Yoshida, T | 1 |
| Buechel, RR; Husmann, L; Kaufmann, PA; Pazhenkottil, AP; Tatsugami, F | 1 |
| Appelbaum, DE; Chen, CF; Huang, YE; Huang, YJ; Konda, SD; Pu, Y | 1 |
| Fujimori, H; Matsumoto, I; Oda, M; Shimizu, Y; Tamura, M; Watanabe, G | 1 |
| Hasumi, T; Hoshi, F; Kawamura, M; Oishi, H; Saito, Y | 1 |
| Aukema, TS; Codrington, HE; Kappers, I; Klomp, HM; Olmos, RA; van Pel, R; van Tinteren, H | 1 |
| Appelbaum, DE; Chen, CF; Huang, YE; Huang, YJ; Konda, SD; Pu, QH; Pu, YL | 1 |
| Baumert, BG; Borger, J; De Ruysscher, D; Lambin, P; Lammering, G; Lutgens, L; Ollers, M; van Baardwijk, A; van den Ende, P | 1 |
| Fukushi, M; Ishii, K; Ishiwata, K; Kimura, Y; Kosaka, T; Mashima, Y; Oda, K; Toyama, H | 1 |
| Maes, A; Pottel, H; Sathekge, MM; Stoltz, A; van de Wiele, C | 1 |
| Asakura, K; Endo, M; Kaira, K; Murakami, H; Naito, T; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Aerts, HJ; De Ruysscher, D; Lambin, P; Oberije, C; Velazquez, ER | 1 |
| DeCamp, MM; Gangadharan, SP; Kent, MS; Nicotera, SP; Okereke, IC | 1 |
| Hu, M; Li, L; Yang, G; Yu, J; Zhao, W; Zhu, H | 1 |
| Devenney-Cakir, B; Dunfee, B; Mehra, P; Sakai, O; Spiegel, J; Subramaniam, R; Sundararajan, D | 1 |
| Darling, G; Hwang, D; Mah, K; Maziak, DE; Tirona, R; Tsao, MS; Ung, YC; Wong, CS; Wu, K | 1 |
| Kenzaki, K; Kondo, K; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Conron, M; Hutchinson, AF; Irving, LB; Liew, D; Steinfort, DP | 1 |
| Doyle, D; Leong, S; Maher, MM; Murphy, DM; O'Connor, OJ | 1 |
| Busiello, L; Fiorelli, A; Laperuta, P; Mansi, L; Rambaldi, PF; Rotondo, A; Santini, M; Vicidomini, G | 1 |
| Ito, M; Murashima, S; Qiao, S; Suzawa, N; Takao, M; Takeda, K; Uchida, K; Yamada, T | 1 |
| De Ruysscher, D; Dekker, AL; Dingemans, AM; Lambin, P; Oberije, CJ; Petit, SF; van Elmpt, WJ; Vegt, E | 1 |
| Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L | 1 |
| Brianzoni, E; Crisci, R; De Vico, A; Di Leonardo, G; Di Tommaso, S; Divisi, D | 1 |
| Badran, K; Bykowski, J; Hayeri, MR; Hoh, CK; Obrzut, S | 1 |
| Hyun Yoon, J; Jung Moon, H; Kim, EK; Min Jeon, H; Young Kwak, J | 1 |
| Brambs, HJ; Feuerlein, S; Juchems, MS; Klass, O; Luster, M; Pauls, S; Reske, SN; Schmidt, SA | 1 |
| Bonardel, G; Foehrenbach, H; Gontier, E; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Ngampolo, I; Rivière, F; Vaylet, F | 1 |
| Jin, GH; Kweon, DC; Lee, JD; Lee, SB; Oh, KB; Park, DS; Park, HH | 1 |
| Guo, J; Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
| Bertin, F; Bonnaud, F; Dalmay, F; Gaillard, S; Melloni, B; Monteil, J; Vergnenègre, A | 1 |
| Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Yap, JT | 1 |
| Endo, K; Ishizuka, T; Kaira, K; Mori, M; Oriuchi, N; Sunaga, N; Yanagitani, N | 1 |
| Blauwgeers, H; Boersma, L; Burgers, S; Gilhuijs, K; Klomp, H; Knegjens, J; Rossi, M; Siedschlag, C; Stroom, J; van Baardwijk, A; van Loon, J; van Suylen, RJ; Vogel, W | 1 |
| Auperin, A; Coulot, J; de Baère, T; Deandreis, D; Deschamps, F; Dromain, C; Leboulleux, S; Lumbroso, J; Rao, P; Schlumberger, M | 1 |
| Schönberg, S | 1 |
| Carr, HM; Cuthbertson, DJ; Gardner, CJ; Gosney, J; Macfarlane, IA; Wieshmann, H | 1 |
| Bohn, P; Dubray, B; Edet-Sanson, A; Gardin, I; Hapdey, S; Ménard, JF; Modzelewski, R; Salles, A; Thiberville, L; Vera, P | 1 |
| Iwatani, K; Iyama, K; Mori, T; Ohba, Y; Shiraishi, K; Yoshimoto, K | 1 |
| Miyashita, T | 1 |
| Bruce, I; Ghosal, N; Hastings, D; Homer, J; Julyan, P; Mais, K; Ryder, WD; Shenjere, P; Slevin, NJ; Ward, T | 1 |
| Coche, E; De Bast, M; Geets, X; Grégoire, V; Lacroix, V; Lee, JA; Poncelet, A; Wanet, M; Weynand, B | 1 |
| Araki, K; Kadowaki, T; Morioka, N; Tokushima, T; Yano, S | 1 |
| Gönen, M; Larson, SM; Schöder, H; Singnurkar, A; Solomon, SB | 1 |
| Boellaard, R; de Langen, AJ; Frings, V; Hoekstra, OS; Smit, EF; van Tinteren, H; van Velden, FH | 1 |
| Abiko, M; Sato, T; Shiono, S | 1 |
| Bonardel, G; Carette, MF; de Labriolle-Vaylet, C; Grahek, D; Housset, B; Lebeau, B; Mangiapan, G; Margery, J; Meignan, M; Milleron, B; Talbot, JN; Vaylet, F | 1 |
| Brennan, C; Dineen, J; Hinchion, J; Keohane, C; Maher, MM; O'Connor, OJ; O'Regan, KN; Sweeney, B | 1 |
| Hatt, M; Visvikis, D | 1 |
| Abuodeh, Y; Khader, J; Salem, A | 1 |
| De Ruysscher, D; Lambin, P; Öllers, M; van Elmpt, W | 1 |
| Bai, YR; Liu, T; Xu, JY; Xu, W; Yan, WL; Yang, HL | 1 |
| Chida, M; Honma, K; Inoue, T; Murakami, K | 1 |
| Kim, SK; Lee, HS; Lee, JW; Park, JW | 1 |
| Hamakawa, H; Katakami, N; Kokubo, M; Neri, S; Takahashi, Y; Terashi, T; Tomii, K | 1 |
| Cho, A; Cho, HJ; Hur, J; Kang, WJ; Lee, JD; Lee, JH; Yun, M | 1 |
| Akamatsu, H; Endo, M; Kaira, K; Murakami, H; Naito, T; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Backes, WH; Brans, B; de Langen, AJ; Dingemans, AM; Groen, HJ; Hoekstra, OS; Leffers, P; Lubberink, M; Marcus, JT; Pruim, J; Smit, EF; van den Boogaart, V; van Tinteren, H | 1 |
| Kim, IJ; Kim, SJ; Kim, YD; Kim, YK; Lee, MK | 2 |
| Buck, AK; Frechen, D; Kley, H; Krüger, S; Maschke, S; Mottaghy, FM; Pauls, S; Reske, SN; Wibmer, T | 1 |
| Antinolfi, F; Antinolfi, G; Barra, E; Brunese, L; Cappabianca, S; Caputi, M; Catalano, M; De Rimini, ML; De Rosa, I; De Rosa, N; Di Matteo, A; Grassi, R; Greco, B; Muto, P; Muto, R; Petrillo, M; Piccolo, S; Porto, A; Reginelli, A; Ronza, F; Rossi, G; Rotondo, A; Setola, F | 1 |
| Bhattacharjee, S; Longano, A; Powell, A; Yap, K | 1 |
| Furonaka, O; Miyata, Y; Noriyuki, T; Osaki, N; Shimoda, K; Shioya, S; Takahashi, G; Yonehara, S | 1 |
| Higashi, Y; Ibusuki, A; Kanekura, T | 1 |
| Kim, J; Visioni, A | 1 |
| Abiko, T; Koizumi, S; Takanami, I; Tanaka, F | 1 |
| Minami, M | 1 |
| Bezjak, A; Bissonnette, JP; Brade, A; Cho, BC; Dahele, M; Franks, K; Freeman, M; Hope, A; Jaffray, DA; Pearson, S; Purdie, T; Sun, A | 1 |
| Binns, DS; Callahan, J; Conti, P; Fine, BM; Hicks, RJ; Macfarlane, D; Mileshkin, L; Pirzkall, A; Scott, AM; Yu, W | 1 |
| Groen, HJ; Langendijk, JA; Pruim, J; Ubbels, JF; Widder, J; Wiegman, EM | 1 |
| Chung, DH; Goo, JM; Han, SK; Kang, CH; Kim, YT; Kim, YW; Lee, CH; Lee, SH; Min, JW; Park, CM; Shim, YS; Yim, JJ | 1 |
| Huang, P; Liu, L; Pan, D; Wang, L; Xu, Y; Yang, M | 1 |
| Alauddin, MM; Balatoni, J; Flores, L; Gelovani, JG; Gonzalez-Lepera, C; Krasnykh, V; Mukhapadhyay, U; Najjar, AM; Ogawa, K; Pal, A; Shavrin, A; Soghomonyan, S; Tong, W; Volgin, AY; Yeh, HH; Young, D | 1 |
| Baum, RP; Daffner, W; Hommann, M; Kaemmerer, D; Katenkamp, K; Kaufmann, R; Petrovitch, A; Prasad, V; Sauerbrey, A; Settmacher, U | 1 |
| De Ruysscher, D; Hamill, J; Jones, J; Lambin, P; Ollers, M; van Elmpt, W | 1 |
| Carson, KJ; Hanna, GG; Hounsell, AR; O'Sullivan, JM; Senan, S; Van Sörnsen De Koste, JR | 1 |
| Fujii, H; Fukushi, M; Inoue, K; Kitamura, H; Moriya, E; Moriyama, N; Ohnuki, Y; Sasaki, T; Sato, T; Suzuki, T | 1 |
| Gnanasegaran, G; Navalkissoor, S; Rankin, S; Szyszko, T | 1 |
| Agoglia, BG; Brambilla, D; Casiraghi, M; Guarize, J; Maisonneuve, P; Spaggiari, L; Tessitore, A; Travaini, LL | 1 |
| Kaushik, A; Nguyen, NC; Osman, MM; Wolverson, MK | 1 |
| Baek, HJ; Cheon, GJ; Choe, DH; Kim, KM; Koh, JS; Lee, JC; Na, II; Park, JY | 1 |
| Bugaj, JE; Gokhale, PC; Guleryuz, S; Manning, HC; Mantis, C; McKinley, ET; Wild, R; Zhao, P | 1 |
| Ballek, E; Fleckenstein, J; Grgic, A; Hellwig, D; Kirsch, CM; Kremp, S; Kuhnigk, JM; Moca, N; Rübe, C; Schaefer, A | 1 |
| Hamamoto, Y; Inoue, T; Kataoka, M; Ochi, T; Sakai, S; Sugawara, Y; Takahashi, T | 1 |
| Avila, EK; Gutin, PH; Lassman, AB; Morris, PG; Rosenblum, MK | 1 |
| Kaji, M; Mori, T; Nomori, H; Ohba, Y; Oya, N; Sasaki, J; Shibata, H; Shiraishi, K | 1 |
| Ladrón De Guevara H, D; Pefaur D, R | 1 |
| Celen, Z; Elboga, U; Isik, F; Tutar, E; Yilmaz, M | 1 |
| Han, A; Ma, T; Niu, Z; Yu, J; Zhao, S; Zheng, J; Zhu, D | 1 |
| Lyburn, I; Macdonald, K; Searle, J | 1 |
| Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
| Cavallaro, A; Kuwert, T; Manger, B; Schett, G; Schmidt, D; Wacker, J | 1 |
| Aoe, M; Misao, T; Yoshikawa, T | 1 |
| Boersma, L; De Ruysscher, D; Lambin, P; Ollers, M; van Baardwijk, A; van Loon, J | 1 |
| Baba, M; Fukumura, T; Inubushi, M; Koizumi, M; Miyamoto, T; Nakajima, M; Saga, T; Tanimoto, K; Yamamoto, N; Yoshikawa, K | 1 |
| Steinert, HC | 2 |
| Choi, NC; Digumarthy, SR; Engelman, JA; Mak, RH; Muzikansky, A; Sequist, LV; Shepard, JA | 1 |
| Morrison, PR; Sainani, NI; Shyn, PB; Silverman, SG; Tatli, S; Tuncali, K | 1 |
| Dai, K; Huang, X; Qu, X; Wu, L; Yan, W | 1 |
| Amler, LC; Charu, V; Fine, BM; Gitlitz, BJ; Hicks, RJ; Hughes, BG; Macfarlane, D; Mileshkin, L; Mitchell, PL; Pirzkall, A; Solomon, B; Yu, W | 1 |
| Chachoua, A; Friedman, K; Probst, S; Seltzer, A; Spieler, B | 1 |
| Allen, AM; Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Larson, E; Sher, DJ; Yap, JT | 1 |
| Bezjak, A; Bissonnette, JP; Brade, A; Cho, J; Dahele, M; Fung, S; Hope, A; Pearson, S; Purdie, T; Sun, A; Taremi, M | 1 |
| Gokce, M; Kilicgun, A; Saydam, O; Tanriverdi, O | 1 |
| Kim, IJ; Kim, SJ; Kim, YD; Kim, YK; Kim, YS; Lee, MK | 1 |
| Alagoz, E; Arslan, N; Budakoglu, B; Kuzhan, O; Ozet, A; Ozguven, MA; Tuncel, M | 1 |
| Hatt, M; Le Rest, CC; Visvikis, D | 1 |
| Boellaard, R; Buettner, R; Dietlein, M; Draube, A; Engel-Riedel, W; Hallek, M; Hellmich, M; Heukamp, L; Jacobs, AH; Ko, YD; Kobe, C; Lammertsma, AA; Neumaier, B; Nogova, L; Papachristou, I; Querings, S; Scheffler, M; Schlesinger, A; Schulte, K; Smit, E; Stoelben, E; Thomas, RK; Toepelt, K; Ullrich, RT; Wolf, J; Zander, T | 1 |
| Berthelsen, AK; Christensen, CB; Damgaard Pedersen, K; Daugaard, G; Graff, J; Loft, A; Moller, AK; Perell, K; Petersen, BL | 1 |
| Burton, WB; Godelman, A; Haramati, LB; Jain, VR; Levsky, JM; Little, BP; Mahadevia, PS; May, BJ | 1 |
| Adachi, S; Daisaki, H; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
| Kong, FM; Ma, L; Meng, X; Mu, D; Sun, X; Xing, L; Yang, G; Yu, J; Zhang, B; Zhao, S | 1 |
| Atasalihi, A; Iskender, I; Kadioglu, SZ; Kir, A; Kosar, A | 1 |
| Cui, L; Liang, W; Liu, W; Xu, S | 1 |
| Liang, W; Meng, J; Xu, S; Zhang, G | 2 |
| Baiden-Amissah, K; Baxter, CG; Bishop, P; Denning, DW; Low, SE | 1 |
| Bilici, A; Cinaral, F; Dogusoy, I; Kefeli, U; Oven Ustaalioglu, BB; Seker, M; Ustaalioglu, R | 1 |
| Chiu, JS; Hung, GU; Kao, CH; Pei, YL; Yang, SK | 1 |
| Bilici, A; Canpolat, N; Gumus, M; Salepci, T; Seker, M; Ustaalioglu, BB | 1 |
| Fleckenstein, J; Grgic, A; Gröschel, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C | 1 |
| Katahira, K; Mori, T; Namimoto, T; Nomori, H; Ohba, Y; Shiraishi, K | 1 |
| Liang, W; Liu, W | 1 |
| Brower, V | 1 |
| Hirose, Y; Iwata, H; Mizuno, Y; Shirahashi, K; Takemura, H | 1 |
| Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Saint-Blancard, P; Salles, Y; Staub, E; Vaylet, F | 1 |
| Abi-Hatem, N; Benard, F; Daube-Witherspoon, ME; El Fakhri, G; Karp, JS; Lim, R; Mankoff, D; Moussallem, E; Scheuermann, J; Surti, S | 1 |
| Endo, M; Kaira, K; Kondo, H; Murakami, H; Nakajima, T; Ohde, Y; Okumura, T; Oriuchi, N; Takahashi, T; Yamamoto, N | 1 |
| Feng, R; Jiang, S; Wang, R; Yan, H; Zhao, F; Zhao, W; Zhu, K | 1 |
| Erasmus, JJ; Truong, MT; Viswanathan, C | 1 |
| Li, M; Liang, Y; Liu, Y; Wu, N; Zhang, W; Zhao, P; Zheng, R | 1 |
| Bailly, P; Daouk, J; El Esper, I; Fin, L; François, G; Jounieaux, V; Leloire, M; Meyer, ME; Morvan, J; Moullart, V; Saidi, L | 1 |
| Faivre-Finn, C; Hulse, P; Lorigan, P; Thomson, D | 1 |
| Gobara, H; Hiraki, T; Kanazawa, S; Matsui, Y; Mimura, H; Toyooka, S | 1 |
| El-Deiry, WS; Ferrara, TA; Katz, SI; Mayes, PA; Smith, CD; Wang, W; Zhou, L | 1 |
| Hasegawa, C; Ito, H; Kameda, Y; Kondo, T; Murakami, S; Nakayama, H; Oshita, F; Saito, H; Sakuma, Y; Tsuboi, M; Yamada, K; Yokose, T | 1 |
| Kurita, A; Okazaki, M; Sawada, S; Shien, K; Suehisa, H; Yamashita, M | 1 |
| Alkhawaldeh, K; Biersack, HJ; Ezziddin, S; Henke, A | 1 |
| Fu, Z; Han, A; Hu, M; Huang, C; Kong, L; Xing, L; Yang, W; Yu, J; Zhang, P | 1 |
| Gonzalez, M; Krueger, T; Prior, JO; Ris, HB; Rotman, S | 1 |
| Bücker, A; Grgic, A; Hellwig, D; Khreish, F; Kirsch, CM; Mathews, J | 1 |
| Castrejón, AS; García Vicente, AM; García, BG; León Martín, AA; Muñoz, AP; Pilkington Woll, JP | 1 |
| De Ruysscher, D; Dingemans, AM; Lambin, P; Offermann, C; Ollers, M; Rahmy, A; van Elmpt, W; van Loon, J; Vegt, E | 1 |
| Au, DH; Ghaus, SJ; Gould, MK; Provenzale, D; Schultz, EM; Wagner, TH; Wallace, RB; Xu, X | 1 |
| Cline, KJ; Darling, GE; Driedger, AA; Evans, WK; Gu, CS; Gulenchyn, KY; Inculet, RI; Julian, JA; Kuruvilla, MS; Levine, MN; Maziak, DE; Ung, YC | 1 |
| Boers, JE; Groen, HJ; Oostdijk, AH; Stigt, JA; van den Berg, JW | 1 |
| Albert, M; Allen, AM; Caglar, HB; Killoran, J; Soto, R; Sun, Y; Zygmanski, P | 1 |
| Chiba, W; Fuseya, Y; Kanemitsu, Y; Katayama, Y; Kita, H; Nishihara, Y; Suga, M; Tanimura, K | 1 |
| Andrade, G; Deppen, S; Grogan, EL; Lambright, ES; Massion, PP; Nesbitt, JC; Putnam, JB; Speroff, T; Walker, R | 1 |
| Hihara, J; Ikeda, T; Mimura, T; Misumi, K; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Boellaard, R; Cheebsumon, P; Hoekstra, OS; Lammertsma, AA; Smit, EF; van Velden, FH; Yaqub, M | 1 |
| Gong, H; Huang, W; Li, B; Ma, L; Sun, H; Wang, J; Yu, J; Zhou, T | 1 |
| Dahele, M; Lagerwaard, F; Palma, D; Senan, S; Slotman, B | 1 |
| Kim, BS; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
| Matsumoto, I; Oda, M; Shimizu, Y; Tamura, M; Waseda, R; Watanabe, G | 1 |
| Borri, A; Brambilla, D; Casiraghi, M; Ciprandi, B; De Pas, T; Donghi, SM; Galetta, D; Gasparri, R; Guarize, J; Maisonneuve, P; Petrella, F; Solli, P; Spaggiari, L; Tessitore, A; Veronesi, G | 1 |
| Lv, YL; Miao, XH; Qian, Q; Song, Y; Wang, K; Wei, SZ; Yuan, DM; Zhu, XX | 1 |
| Ishibashi, T; Ishikawa, K; Kadoya, M; Kaji, M; Kato, T; Tamaki, N | 1 |
| Berghmans, T; Flamen, P; Garcia, C; Meert, AP; Paesmans, M; Sculier, JP; van Ruychevelt, V | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H; Leblond, P; Rocourt, N | 1 |
| Avril, A; Brouste, V; Cannella, M; Descat, E; Ferron, S; Fonck, M; Gómez, F; Palussière, J | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Schmid, DT; Stoeckli, SJ | 1 |
| Bertolaccini, L; Bianchi, A; Rizzardi, G; Terzi, A | 1 |
| Durand, M | 1 |
| Mouroux, J; Padovani, B; Pop, D; Rigo, P; Vénissac, N | 1 |
| Baek, S; Choi, CM; Kim, SW; Lee, DH; Lee, JS; Moon, DH; Ryu, JS; Suh, C; Yoon, DH | 1 |
| Cantos, B; Gasent, JM; Ibeas, P; Provencio, M; Rodríguez, B | 1 |
| Lammertsma, AA; Lubberink, M; Smit, EF; van der Veldt, AA | 1 |
| Ak, I; Döner, E; Dündar, E; Simsek, FS; Sivrikoz, CM | 1 |
| Dutta, R; Jindal, T; Kumar, A; Kumar, R; Malhotra, A; Meena, M; Venkitaraman, B | 1 |
| Heussel, CP; Hochhegger, B; Irion, K; Kauczor, HU; Ley, S; Ley-Zaporozhan, J; Marchiori, E; Sedlaczek, O; Soares Souza, A | 1 |
| Bazan, JG; Graves, EE; Lavori, PW; Le, QT; Lee, P; Loo, BW; Quon, A; Wakelee, HA; Weerasuriya, DK | 1 |
| Abe, T; Hayashi, Y; Ito, Y; Koyama, K; Sato, M | 1 |
| Iwano, S; Kato, K; Koike, W; Naganawa, S; Ueda, Y; Usami, N; Yokoi, K | 1 |
| Neuman, A; Ouvrier, MJ; Pop, G; Soussan, M; Weinmann, P | 1 |
| Kao, PF; Lee, JK; Shen, CY; Weng, JH; Wu, MF | 1 |
| Citak, N; Gurses, A; Kök, A; Melek, H; Metin, M; Pekcolaklar, A; Sayar, A | 1 |
| Delappe, E; Dunphy, M | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Vliegen, RF | 1 |
| Barth, T; Muehling, B; Oberhuber, A; Orend, KH; Schelzig, H; Wehrmann, C | 1 |
| Brockenbrough, JS; Feng, Q; Grierson, J; Hawes, SE; Leblond, A; Morihara, JK; Rasey, JS; Souquet, T; Stern, JE; Vesselle, H; Wiens, LW | 1 |
| Brustugun, OT; Helland, Å; Knudtsen, IS; Malinen, E; Rødal, J; Skretting, A | 1 |
| Bazan, J; Diehn, M; Donington, JS; Graves, EE; Hara, WY; Hoang, CD; Kozak, MM; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Schipper, ML; Shrager, JB; Wakelee, HA; Whyte, RI; Zhou, L | 1 |
| Ho-Shon, I; Koh, ES; Lin, M; Lin, P; Som, S; Vinod, SK; Yap, J | 1 |
| Aerts, HJ; Bussink, J; De Ruysscher, D; Emans, D; Folgering, AM; Lambin, P; Oyen, WJ; van Elmpt, W; Velders, M | 1 |
| Dupuy, DE; Fernando, HC; Hillman, SL; Rilling, WS; Shepard, JA; Siegel, BA; Yoo, DC | 1 |
| Matsumoto, I; Oda, M; Tamura, M; Waseda, R; Watanabe, G | 1 |
| Bandiera, A; Bolognesi, A; Carretta, A; Ciriaco, P; Franzin, A; Gregorc, V; Melloni, G; Picozzi, P; Viganò, M; Zannini, P | 1 |
| Goo, JM; Jeon, YK; Kim, H; Lee, HJ; Park, CM; Song, SW; Yoo, IeR | 1 |
| de Clermont, H; Laffon, E; Marthan, R | 2 |
| Bernardi, S; Bertolotto, M; De Marchi, S; Fabris, B; Finato, N; Grimaldi, F; Proclemer, A; Sabato, N | 1 |
| Allen, TL; Kendi, AT; Maddaus, MA; Mitiek, MO | 1 |
| Chen, RC; Chiu, WK; Fried, DV; Higginson, DS; Jagtap, MR; Khandani, AH; Lawrence, MV; Marks, LB; Qaqish, BF; Saynak, M; Veeramachaneni, NK; Xie, L | 1 |
| Apfaltrer, P; Chu, TQ; Dinter, DJ; Fink, C; Henzler, T; Krissak, R; Manegold, C; Meyer, M; Nance, JW; Schmid-Bindert, G; Schoenberg, SO; Schoepf, UJ | 1 |
| Du, WN; Hu, C; Peng, NJ; Su, HM; Tsay, DG; Wu, CS | 1 |
| Boellaard, R; Cheebsumon, P; de Langen, AJ; Frings, V; Hoekstra, OS; Lammertsma, AA; van Velden, FH; Yaqub, M | 1 |
| Leitzin, L; Peer, A; Shai, A; Shalom, RB; Srour, S; Steiner, M | 1 |
| Brichon, PY; Chaffanjon, P; Guigard, S; Righini, C | 1 |
| Colomer, R; Quintela-Fandino, M | 1 |
| Briggs, RH; Chowdhury, FU; Lodge, JP; Scarsbrook, AF | 1 |
| Chiu, CH; Chou, TY; Lee, YC; Lin, KH; Tsai, CM; Wu, YC; Yeh, YC | 1 |
| Mornex, F; Roelandts, M; Van Houtte, P | 1 |
| de Koning, HJ; Groen, HJ; Lammers, JW; Mali, W; Nackaerts, K; Oudkerk, M; Thunnissen, FB; van Klaveren, RJ; van't Westeinde, SC; Vernhout, R; Weenink, C | 1 |
| Kuang, A; Li, F; Li, Y; Su, M; Tian, R | 1 |
| Dubray, B; Edet-Sanson, A; Mezzani-Saillard, S; Modzelewski, R; Thureau, S; Vera, P | 1 |
| Fukuda, I; Hatanaka, R; Kimura, D; Sakai, T; Tsushima, T; Yamada, Y | 1 |
| Furukawa, M; Kiura, K; Miyoshi, S; Oto, T; Toyooka, S; Yamane, M | 1 |
| Back, A; Bohn, P; Doyeux, K; Dubray, B; Edet-Sanson, A; Gardin, I; Hapdey, S; Modzelewski, R; Vera, P | 1 |
| Guo, F; Li, J; Pan, T; Pan, Y; Wei, H; Wu, S; Zheng, Z | 1 |
| Grant, FD; Treves, ST | 1 |
| Aoki, Y; Fujii, H; Koike, N; Kunieda, E; Ohashi, T; Ozawa, Y; Sanuki, N; Takeda, A; Yokosuka, N | 1 |
| Bertagna, F; Bosio, G; Giubbini, R; Lucchini, S; Terzi, A | 1 |
| Basoglu, T; Canbaz, F; Kefeli, M; Sahin, Z | 1 |
| Francis, R; Morandeau, L; Segard, T | 1 |
| Hatazawa, J; Inoue, T; Itoh, H; Kubota, K; Murakami, K; Saga, T; Shiomi, S | 1 |
| Inoue, T; Kubota, K; Murakami, K; Saga, T; Shiomi, S | 1 |
| Antoch, G; Forsting, M; Geiger, B; Hartung, V; Herbrik, M; Heusner, TA; Riegger, C; Rosenbaum-Krumme, SJ; Treffert, J | 1 |
| De Ruysscher, D; Jeraj, R; Macmanus, M; Nestle, U | 1 |
| Aoyama, N; Itoh, T; Koyama, H; Maniwa, Y; Matsumoto, S; Nishimura, Y; Nishio, M; Nishio, W; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Wang, SX; Wu, YL; Xu, CR; Yan, HH; Yang, JJ; Zhong, WZ | 1 |
| Brocken, P; de Geus-Oei, LF; Dekhuijzen, PN; Kiers, BA; Looijen-Salamon, MG; Peters-Bax, L; Smits-van der Graaf, C; van der Heijden, HF | 1 |
| Appelbaum, DE; Chen, CT; Chen, S; Kampalath, R; Liao, S; Penney, BC; Pu, Y; Salgia, R; Shih, MC; Shimada, N; Simon, CA; Suzuki, K; Wroblewski, K; Zhang, H | 1 |
| Bal, M; De Jaeger, K; Meijer, G; Schuring, D; Steenhuijsen, J; Theuws, J | 1 |
| Hu, SL; Shi, W; Xu, JY; Yang, ZY; Zhang, YJ; Zhu, BL | 1 |
| Endo, M; Kaira, K; Kondo, H; Murakami, H; Naito, T; Nakagawa, K; Nakajima, T; Ohde, Y; Okumura, T; Takahashi, T; Yamamoto, N | 1 |
| Li, H; Li, Y; Liang, S; Liu, J; Zhang, Y; Zhu, G | 1 |
| de Marco, L; Mamede, M | 1 |
| Belli, G; Diciotti, S; Falaschi, F; Falchini, M; Lopes Pegna, A; Mascalchi, M; Mazzoni, LN; Merlini, V; Paci, E; Picozzi, G; Vella, A | 1 |
| Cheze-le Rest, C; Hatt, M; Lambin, P; Pradier, O; van Baardwijk, A; Visvikis, D | 1 |
| Aerts, JG; Baas, J; Hoogsteden, HC; Smit, EF; van der Leest, C; van Walree, N; Versteijlen, RJ | 1 |
| Eshuis, SA; Gemmel, F; Gemmel, P; van Vollenhoven, F | 1 |
| Cornelissen, C; Frechen, D; Krüger, S; Kweider, S; Temur, Y | 1 |
| Goya, S; Hatazawa, J; Hirata, H; Inoue, A; Kawase, I; Kida, H; Kijima, T; Kumagai, T; Kumanogoh, A; Nagatomo, I; Okumura, M; Shimosegawa, E; Tachibana, I; Takahashi, R; Takeda, Y; Yoshida, M | 1 |
| Akiyama, K; Ishihara, K; Iwano, M; Kobayashi, Y; Kumita, S; Satoh, H; Shiiba, M; Yoshihara, H | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Figlin, R; Garon, EB; Herrmann, K; Phelps, ME; Reckamp, KL; Walter, F; Weber, WA | 1 |
| Chang, CF; Gould, MK; Rashtian, A | 1 |
| Kong, FM; Wang, J; Wang, L; Welch, K | 1 |
| Haasbeek, CJ; Lagerwaard, FJ; Senan, S; Slotman, BJ; Verstegen, NE | 1 |
| Giaj Levra, M; Novello, S; Vavalà, T | 1 |
| Boellaard, R; Dietlein, M; Holstein, A; Kahraman, D; Kobe, C; Lammertsma, AA; Neumaier, B; Nogova, L; Scheffler, M; Ullrich, RT; Wolf, J; Zander, T | 2 |
| Feng, J; Jia, HL; Li, HM; Li, XD; Zhang, JY | 1 |
| Chen, L; Chen, M; Hu, X; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Yue, J; Zhang, H; Zhang, L | 1 |
| Bootsma, G; Borger, J; Bosmans, G; Botterweck, A; De Ruysscher, D; Dekker, A; Dingemans, AM; Geraedts, W; Lambin, P; Lunde, R; Oellers, M; Pitz, C; Reymen, B; Steevens, J; van Baardwijk, A; Wanders, R | 1 |
| Cui, L; Gao, J; Guan, Z; Shen, Z; Tian, J; Wang, H; Xu, B; Yao, S | 1 |
| Barger, RL; Nandalur, KR | 1 |
| Evans, T; Fernandes, AT; Kucharczuk, JC; Langer, C; Lin, L; Mitra, N; Rengan, R; Stevenson, J; Xanthopoulos, E | 1 |
| Ashley, S; Chua, S; Cook, G; Coward, JI; Gunapala, R; Myerson, JS; O'Brien, ME; Popat, S; Puglisi, M; Sharma, B; Trani, L; Wotherspoon, A | 1 |
| Fukushima, Y; Kawai, K; Mukasa, A; Ota, T; Saito, N; Uozaki, H | 1 |
| Balasubramanian Harisankar, CN; Bhattacharya, A; Kashyap, R; Malhotra, P; Manohar, K; Rai Mittal, B; Singh, B; Varma, S | 1 |
| Bellyei, S; Farkas, R; Hideghéty, K; Kovács, P; Lõcsei, Z; Mangel, L; Sárosi, V; Sebestyén, K; Sebestyén, Z | 1 |
| Gurel, D; Kargi, A; Onen, A; Ozdogan, O; Sevinc, C; Turan, O | 1 |
| Choi, DJ; Chung, JH; Jheon, S; Lee, CT; Lee, JH; Lee, SW; Park, JS; Yoon, HI | 1 |
| Datseris, IE; Oikonomopoulos, G; Platis, I; Skoura, E; Syrigos, KN | 1 |
| Liao, S; Penney, BC; Pu, Y; Suzuki, K; Zhang, H | 1 |
| Gohil, H; Muthukrishnan, A | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Lin, CC; Yang, KT; Yeh, JJ | 1 |
| Aoki, S; Araki, T; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Nambu, A; Oguri, M; Onishi, H; Saito, R; Satoh, Y; Sawada, E; Tominaga, L | 1 |
| Fujiwara, T; Gobara, H; Harada, S; Hiraki, T; Kaji, M; Kanazawa, S; Mimura, H; Okumura, Y; Sato, S; Suzuki, E | 1 |
| Goo, JM; Kim, TJ; Lee, KW; Park, CM | 1 |
| Aoyama, N; Koyama, H; Matsumoto, K; Ohno, Y; Onishi, Y; Sugimura, K; Yoshikawa, T | 1 |
| Cui, ML; He, ZY; Zhao, L; Zhong, XN | 1 |
| Adam, G; Buhk, JH; Derlin, T; Groth, M; Henes, FO; Kooijman, H; Laqmani, A; Regier, M; Schwarz, D | 1 |
| Ambati, C; Lin, M | 1 |
| Hirami, Y; Maeda, A; Nakata, M; Saisho, S; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
| Ascui, R; Caro, R; Díaz, RE; Utreras, C; Véliz, J; Wohllk, N | 1 |
| Atsumi, J; Hirato, J; Kakegawa, S; Kamiyoshihara, M; Nakano, T; Nakazawa, S; Shimizu, K; Takeyoshi, I | 1 |
| Collaud, S; Lardinois, D; Stahel, R; Steinert, HC; Tischler, V; Weder, W | 1 |
| Chang, H; Cheng, YL; Hsieh, CM; Huang, TW; Huang, WS; Lee, SC; Tzao, C | 1 |
| Di Domenico, M; Fiorelli, A; Izzo, A; Messina, G; Pannone, G; Rizzo, A; Santini, M; Vicidomini, G | 1 |
| Hayashi, K; Kita, T; Kosuda, S; Tomita, H | 1 |
| Abikhzer, G; Alabed, YZ; Lisbona, R; Nahal, A; Rakheja, R | 1 |
| Chen, K; Li, N; Ma, S; Shen, L; Wang, F; Yang, Z | 1 |
| Gladish, G; Gomez, D; Komaki, R; Liao, Z; Lopez Guerra, JL; Zhuang, Y | 1 |
| Huang, P; Liu, L; Pan, Dh; Shao, G; Wang, Lz; Xu, Yp; Yang, M | 1 |
| Jacobsson, H; Sanchez-Crespo, A; Staaf, J | 1 |
| Bomanji, JB; Lu, SJ; Read, S; Rodriguez-Justo, M | 1 |
| Huang, YT; Ravi Kumar, AS | 1 |
| Allen, AM; Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Yap, JT; Yong, Y | 1 |
| Ahn, MJ; Ahn, YC; Han, J; Kim, BT; Kim, J; Kwon, OJ; Lee, HY; Lee, KS; Park, J; Park, K; Shim, YM | 1 |
| Donington, JS | 1 |
| Bom, HS; Chong, A; Kim, YC; Min, JJ; Oh, JR; Seo, JH; Song, HC | 1 |
| Fig, LM; Komissarova, M; Wong, KK | 1 |
| Abele, JT; Bédard, EL; Gill, RS; Perry, T; Schiller, D | 1 |
| Inoue, M; Kadota, Y; Minami, M; Okumura, M; Ose, N; Sawabata, N; Shintani, Y | 1 |
| Arguis, P; Boada, M; Cabañas, M; Gómez-Caro, A; Lomeña, F; Molins, L; Ramirez, J; Sanchez, M | 1 |
| Bading, JR | 1 |
| Baldwin, D; Benamore, R; Bradley, K; Breen, D; Carter, R; Craig, J; Gleeson, F; Macpherson, R; Panakis, N; Sayeed, R | 1 |
| de Bruin, WI; Siepel, FJ; Slump, CH; Steenvoorde, P; van Dalen, JA; van Duyn, EB; Wagenaar, NR | 1 |
| Endo, S; Endo, T; Hasegawa, T; Ishikawa, S; Kanai, Y; Mitsuda, S; Nakano, T; Otani, S; Saito, N; Tetsuka, K; Tezuka, Y; Yamamoto, S | 1 |
| Ni, B; Pan, LD; Wang, ZX; Wu, YW; Zhang, B | 1 |
| Albert, DH; Day, M; Fox, GB; Hickson, JA; Luo, Y; Mudd, SR; Refici-Buhr, M; Reuter, DR; Tapang, P; Voorbach, MJ | 1 |
| de Geus-Oei, LF; Disselhorst, JA; Oyen, WJ; Visser, EP; Vriens, D | 1 |
| Jiang, F; Mi, B; Wan, W; You, Q; You, X; Yu, C | 1 |
| Cicone, F; Comito, F; Del Forno, M; Festa, A; Papa, A; Scopinaro, F; Uccini, S | 1 |
| Bom, HS; Choi, S; Chong, A; Jung, MY; Kim, JW; Kim, YH; Seon, HJ; Shin, SS | 1 |
| Goo, JM; Im, HJ; Kang, CH; Kim, JI; Kim, YW; Lee, HJ; Lee, SM; Paeng, JC; Park, CM | 1 |
| Ghimire, P; Sah, AK | 1 |
| Ciarallo, A; Lisbona, R; Makis, W; Novales-Diaz, JA | 1 |
| Barlesi, F; Bonardel, G; Cammilleri, S; Colavolpe, C; Guedj, E; Mundler, O | 1 |
| Kim, H; Kim, IJ; Kim, K; Kim, SJ; Kim, YS; Pak, K | 1 |
| Bengtsson, T; Hicks, RJ; Peterson, A; Port, RE | 1 |
| Claussen, CD; Hann von Weyhern, C; Hetzel, J; Horger, MS; Klotz, E; Mueller, M; Pfannenberg, C; Sauter, AW; Schulze, M; Spira, D; Winterstein, S | 1 |
| Bollineni, VR; Langendijk, JA; Pruim, J; Widder, J; Wiegman, EM | 1 |
| Iwasaki, T; Kawahara, K; Ohta, M; Okimura, A | 1 |
| Harris, J; Hu, J; Kurien, G; Seikaly, H | 1 |
| D'Asseler, Y; Maes, A; Sathekge, M; Van de Wiele, C; Vorster, M | 1 |
| Callahan, K; Garff, M; Stoddard, GJ; Yung, RC; Zeng, MY | 1 |
| Altabef, A; Bardeesy, N; Butaney, M; Cameron, MD; Cantley, LC; Castrillon, DH; Chen, Z; Cheng, K; Chirieac, LR; Costa, DB; Demetri, GD; Ebi, H; Engelman, JA; Franchetti, Y; Gao, P; Hayes, DN; Jackman, D; Jänne, PA; Kung, AL; Lee, C; Lee, CB; Li, J; Liu, Y; Nakada, Y; Nishino, M; Ouyang, J; Pandolfi, PP; Peña, CG; Roberts, PJ; Saur, A; Sharpless, NE; Shimamura, T; Sun, Y; Tupper, T; Walton, Z; Wang, S; Wang, Y; Wilkerson, MD; Wong, KK; Woo, MS; Xu, C; Yanagita, M; Yao, C | 1 |
| Ceresoli, GL | 1 |
| Chen, JH; Kao, CH; Liang, JA; Liao, CY; Yeh, JJ | 1 |
| Carson, KJ; Dahele, MR; Haasbeek, CJ; Hanna, GG; Hounsell, AR; Migchielsen, R; Senan, S; van Sörnsen de Koste, JR | 1 |
| Ishida, T; Kunimasa, K; Masuda, G; Watanabe, N | 1 |
| Chang, CJ; Chiu, PH; Ho, KC; Kuo, WH; Lin, C; Wang, CW; Wu, CY; Wu, YC; Yen, TC; Yu, CT | 1 |
| Edenbrandt, L; Garpered, S; Höglund, P; Jönsson, E; Ly, J; Valind, S; Wollmer, P | 1 |
| Chang, CC; Chen, YW; Hou, MF; Hou, PN; Lai, YC; Yin, SL | 1 |
| Bauer, TT; Bittner, RC; Blum, T; Boch, C; Förster, GJ; Kollmeier, J; Misch, D; Tönnies, S | 1 |
| Ding, XP; Li, BS; Li, HS; Sun, HF; Wang, DQ; Wang, ZT; Yi, Y; Zhang, J | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Eaton, A; Evangelista, L; Fazio, M; Howard, J; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; McArthur, HL; Morris, PG; Park, JY; Patil, S; Serna-Tamayo, C; Ulaner, GA | 1 |
| Nakamura, H | 1 |
| Bolton, WD; Geraldson, CT; Greene, RA; Lagrew, JP; Schammel, CM; Schammel, DP; Stephenson, JE | 1 |
| Abolmaali, N; Bornstein, SR; Därr, R; Eisenhofer, G; Gastmeier, J; Hofbauer, LC; Jelinek, V; Kamvissi, V; Wieczorek, K; Zöphel, K | 1 |
| Bonomo, L; Calcagni, ML; Giordano, A; Leccisotti, L; Maggi, F; Rufini, V; Taralli, S; Treglia, G | 1 |
| Chen, J; Gu, HY; Haacke, EM; Hu, J; Hua, J; Wu, LM; Xu, JR; Zhang, W | 1 |
| Gill, BS; Hoh, CK; Jensen, LG; Nobiensky, PD; Rivandi, AH; Sandhu, AP; Sandhu, SP | 1 |
| Annema, JT; Keller, SM; Tournoy, KG | 1 |
| Allen, PK; Balter, P; Chang, JY; Chuang, HH; Komaki, R; Liu, H; Pan, T; Zhang, X | 1 |
| Al Hallack, MN; Castillo, R; Guerrero, T; Lichter, J; Martinez, J; McCurdy, MR; Zouain, N | 1 |
| Lin, M; Lin, P; Sam, S; Shon, IH; Vinod, SK | 1 |
| Aras, O; Bagci, U; Bernardo, M; Capala, J; Choyke, P; Kiesewetter, DO; Kramer-Marek, G; Kuban, M; Omer, A; Seidel, J; Zielinski, R | 1 |
| Kejariwal, D; Mansour, D | 1 |
| Alavi, A; Codreanu, I; Torigian, DA; Zhuang, H | 1 |
| Mason, DP | 1 |
| Appelbaum, D; Pu, Y; Wroblewski, K; Zhang, H | 1 |
| Adusumilli, PS; Colovos, C; Dunphy, MP; Kadota, K; Rizk, NP; Rusch, VW; Sima, CS; Suzuki, K; Travis, WD; Yoshizawa, A; Zabor, EC | 1 |
| Brendle, C; Claussen, CD; Müller, M; Pfannenberg, AC; Sauter, A; Schmidt, H; Schraml, C; Schwenzer, NF; Spengler, W | 1 |
| Herold, CJ; Karanikas, G; Mayerhoefer, ME; Prosch, H; Weber, M | 1 |
| Pu, Y; Wroblewski, K; Zhang, H | 1 |
| Anghinolfi, M; Casalini, A; Gnetti, L; Majori, M; Pavarani, A; Scarascia, A | 1 |
| Nakajima, J | 1 |
| Ball, DL; Binns, DS; Gregory, DL; Hicks, RJ; Hogg, A; Link, E; Mac Manus, MP; Milner, A; Shum, PL | 1 |
| Erasmus, JJ; Macapinlac, HA | 1 |
| Schillaci, O | 1 |
| Ardissone, F; Arena, V; Billè, A; Errico, L; Okiror, L; Pelosi, E; Penna, D; Skanjeti, A | 1 |
| Bezjak, A; Brade, A; Cho, J; Clarke, K; Dahele, M; Franks, K; Freeman, M; Fung, S; Hope, A; Sun, A; Taremi, M | 1 |
| Chen, CY; Cheng, CY; Cheng, YL; Gao, HW; Lin, LF; Shen, DH | 1 |
| Bom, HS; Byun, BH; Chong, A; Hong, SP; Kang, SR; Kim, J; Min, JJ; Oh, JR; Song, HC; Yoo, SW | 1 |
| Chen, HH; Chiu, NT; Guo, HR; Lee, BF; Su, WC | 1 |
| Huang, G; Wang, YT | 1 |
| Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Herbrik, M; Heusner, TA; Treffert, J | 1 |
| Sawant, AC; Srivatsa, SS | 1 |
| Davidzon, G; Gevaert, O; Graves, EE; Hoang, CD; Nair, VS; Napel, S; Plevritis, SK; Quon, A; Rubin, DL; Shrager, JB | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Aide, N; Bardet, S; Crouzeix, G; Michels, JJ; Sevin, E; Vaur, D | 1 |
| Gevaert, O; Hoang, CD; Leung, AN; Napel, S; Plevritis, SK; Quon, A; Rubin, DL; Xu, J; Xu, Y | 1 |
| Haasbeek, CJ; Lagerwaard, FJ; Senan, S; Senthi, S; Slotman, BJ | 1 |
| Bae, WK; Kim, YH; Lee, HS; Lee, JW; Lee, SM | 1 |
| Cha, SW; Cho, YD; Choi, DL; Jang, JY; Jeong, SW; Jin, SY; Kim, BS; Kim, HS; Kim, SG; Kim, YS; Lee, JE; Lee, SH | 1 |
| Brach Del Prever, A; Cistaro, A; Fagioli, F; Fania, P; Gastaldo, L; Lopci, E | 1 |
| Chopra, A; De Noronha, R; Ford, A; Matthews, S | 1 |
| Illés, A; Jóna, A; Lieber, A; Miltényi, Z; Páyer, E; Simon, Z; Szilasi, M | 1 |
| Bremerich, J; Forrer, F; Klarhöfer, M; Lardinois, D; Lenz, C; Sommer, G; Wiese, M; Winter, L | 1 |
| Bonomo, L; Calcagni, ML; Cocciolillo, F; Giordano, A; Massaccesi, M; Pelligrò, F; Spitilli, MG; Valentini, V | 1 |
| Kato, K; Okada, M; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB; Wakizaka, H; Yoshida, C; Zhang, MR | 1 |
| Clarke, R; Convery, R; Harney, J; Masih, I; McCarthy, A; Porter, G; Porter, S; Sidhu, P | 1 |
| Adalet, I; Kuyumcu, S; Ozkan, ZG; Sanli, Y; Turkmen, C; Yilmazbayhan, D | 1 |
| Scappaticci, AA; Yoo, DC | 1 |
| Kuang, AR; Li, FL; Su, MG; Tian, R; Tian, Y | 1 |
| Fujii, K; Ichiyasu, H; Kohrogi, H; Saeki, S; Saita, N; Sakata, S; Sasaki, J; Sato, R | 1 |
| Jujo, T; Oide, T; Sakao, S; Tatsumi, K | 1 |
| Chen, JH; Ding, HJ; Kao, CH; Liang, JA; Lin, YY; Yeh, JJ | 1 |
| Hamamoto, Y; Kataoka, M; Kozuki, T; Nakajima, N; Nogami, N; Sawada, S; Shinkai, T; Shinohara, S; Suehisa, H; Sugawara, Y; Yamashita, M | 1 |
| Kong, FM; Mahasittiwat, P; Quint, LE; Wang, J; Wong, KK | 1 |
| Kim, EK; Kim, HO; Kim, SW; Lee, DH; Ryu, JS; Sohn, BS; Suh, C; Yoon, DH | 1 |
| Abe, K; Baba, S; Honda, H; Ito, K; Kawano, D; Maehara, Y; Miura, N; Morodomi, Y; Shoji, F; Takenaka, T; Yano, T | 1 |
| De Ruysscher, D; Dingemans, AM; Lambin, P; Ollers, M; van Elmpt, W | 1 |
| Azuma, K; Hattori, S; Hoshino, T; Imamura, Y; Ishibashi, M; Kaida, H; Kawahara, A; Kinoshita, T; Kurata, S; Sadashima, E; Sasada, T; Zaizen, Y | 1 |
| Akers, SR; Alavi, A; Cheng, G; Lim, E | 1 |
| Lewis, DH; Reeve, IP; Zhang, Y | 1 |
| Li, C; Li, P; Qian, Y; Shi, Y; Wu, H; Wu, Y; Yang, J; Zhang, H; Zhang, J | 1 |
| Abe, K; Baba, S; Honda, H; Isoda, T; Kubo, Y; Maruoka, Y; Matsuo, Y; Ogawa, S; Sasaki, M; Yano, T | 1 |
| Ayabe, T; Onitsuka, T; Shimizu, T; Tomita, M | 1 |
| Clauditz, TS; Derlin, T; Habermann, CR; Quaas, A | 1 |
| Aide, N; Bardet, S; Beauregard, JM; Gervais, R; Guizard, AV; Hicks, RJ; Lasnon, C; Lemoel, G; Milner, A; Paciencia, M; Zalcman, G | 1 |
| Kawakami, Y; Kenzaki, K; Kondo, K; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Carli, P; Cournac, JM; de Jaureguiberry, JP; Fauchais, AL; Landais, C; Paris, JF; Poisnel, E | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Hietschold, V; Zöphel, K | 1 |
| Chang, JY; Cox, JD; Erasmus, J; Komaki, R; Xiang, ZL | 1 |
| Cook, GJ | 1 |
| Giammarile, F; Houzard, C; Jegou, C; Moussallem, M; Traverse-Glehen, A; Valette, PJ | 1 |
| Choi, JY; Hyun, SH; Kim, BT; Kim, H; Kim, J; Kim, K; Lee, KH; Shim, YM; Um, SW | 1 |
| James, J; McWilliam, L; Prescott, M; Shawgi, M | 1 |
| Liu, T; Peng, F; Zhang, JJ | 1 |
| Akazawa, K; Hibino, M; Hikino, K; Oe, M | 1 |
| Dickson, J; Ghosh-Ray, S; Sanghera, B; Sonoda, LI; Wong, WL | 1 |
| Chen, CY; Cheng, CY; Hou, CH; Lin, LF; Shen, DH; Tsai, WC | 1 |
| Kampalath, R; Liao, S; Penney, BC; Pu, Y; Wroblewski, K; Zhang, H; Zhang, Y | 1 |
| Cioc, AM; Dvorak, LA; Hart, MK; Jessurun, J; Pambuccian, SE; Schmechel, SC | 1 |
| Abelson, JA; Bazan, JG; Diehn, M; Graves, EE; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Trakul, N | 1 |
| Chang, SM; Chuang, TL; Lai, CL; Wang, YF | 1 |
| Boellaard, R; Dietlein, M; Holstein, A; Kahraman, D; Kobe, C; Lammertsma, AA; Neumaier, B; Nogova, L; Scheffler, M; Wolf, J; Zander, T | 1 |
| Abakay, A; Erdem, V; Kaya, H; Kömek, H; Selimoğlu Şen, H; Senyiğit, A; Sezgi, C; Tanrikulu, AC | 1 |
| Öztürk, C; Varol, A; Yeni Akten, S; Yurdakul, AS | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Allende-Riera, A; Cabello-García, D; Cárdenas-Negro, JC; De Sequera-Rahola, M; Martínez-Gimeno, E; Muñoz-Iglesias, J; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
| Kara Gedik, G; Kaya, B; Ozcan Kara, P; Sari, O; Varoglu, E | 1 |
| Alkadhi, H; Boss, A; Chuck, N; Frauenfelder, T; Rossi, C; Stolzmann, P; Veit-Haibach, P; von Schulthess, G | 1 |
| Huang, G; Liu, J; Song, S; Sun, X; Tong, J; Zhang, C | 1 |
| Andersen, JB; Arveschoug, AK; Hager, H; Harders, SW; Hjorthaug, K; Madsen, HH; Meldgaard, P; Pilegaard, HK; Rasmussen, F; Rasmussen, TR; Rehling, M | 1 |
| Manych, M | 1 |
| Allen, PK; Cox, JD; Erasmus, JJ; Fossella, FV; Gladish, GW; Gomez, DR; Komaki, R; Kotamarti, KR; O'Reilly, MS; Wei, X | 1 |
| Kucharczuk, J; Pryma, DA; Rengan, R; Sterman, D; Trister, AD; Xanthopoulos, E | 1 |
| Basaran, G; Dane, F; Demir, G; Korkmaz, T; Madenci, OC; Okutur, K; Ones, T; Polat, O; Seber, S; Turhal, NS; Yumuk, F | 1 |
| Li, M; Liu, Q; Peng, Z; Sun, J; Yao, S | 1 |
| Fukuoka, K; Hasegawa, S; Miyata, Y; Nakano, T; Okada, M; Takuwa, T; Tsutani, Y | 1 |
| Hakucho, T; Higashiyama, M; Hosoki, T; Miyake, C; Morimoto, D; Nakanishi, K; Takahashi, Y; Takashima, S; Tomita, Y; Watanabe, S | 1 |
| Capraro, C; De Ponti, E; Guerra, L; Ippolito, D; Messa, C; Sironi, S | 1 |
| Ballangan, C; Eberl, S; Feng, DD; Fulham, M; Wang, X | 1 |
| Kruse, V; Maes, A; Sathekge, M; Smeets, P; Van de Wiele, C | 1 |
| Chen, ZF; Luo, BQ; Rao, LJ; Shi, XC; Wang, XY; Yi, C; Zhang, XS | 1 |
| Dong, S; Liao, R; Nie, Q; Wang, S; Wu, Y; Yang, X; Zhong, W; Zhou, Q | 1 |
| Betancourt, SL; Gutierrez, FR; Martinez-Jimenez, S; Restrepo, CS | 1 |
| Harders, SW | 1 |
| Ito, S; Iwano, S; Kato, K; Naganawa, S; Tsuchiya, K | 1 |
| de Jong, WK; Groen, HM; Kluin, PM | 1 |
| Ahmad, S; Chicklore, S; Cook, GJ; Goh, V; Landau, D; Marsden, P; Roy, A; Siddique, M; Yip, C | 1 |
| Belderbos, J; Kwint, M; Lebesque, J; Nijkamp, J; Rossi, M; Sonke, JJ; Uyterlinde, W; van den Heuvel, M; Vogel, W | 1 |
| Matsunaga, T; Miyasaka, Y; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Demura, Y; Kimura, H; Morikawa, M; Okazawa, H; Tsuchida, T; Umeda, Y | 1 |
| Abrar, ML; Bhattacharya, A; Dey, P; Mandal, AK; Manohar, K; Mittal, BR; Vyas, S | 1 |
| Ozgul, MA; Sanli, Y; Somay, A; Tamam, M; Yildirim, D | 1 |
| Cueto, A; Rodríguez-Fernández, A; Ruiz-Zafra, J; Sánchez-Palencia, A | 1 |
| Al-Harbi, AS; Al-Jahdali, H; Khan, AN; Loutfi, S | 1 |
| Aoki, Y; Fujii, H; Kunieda, E; Mizuno, T; Ohashi, T; Oku, Y; Oooka, Y; Ozawa, Y; Sanuki, N; Takeda, A; Yokosuka, N | 1 |
| Armenise, F; Canniello, E; D'Aluisio, L; Fazio, V; Gadaleta, CD; Gadaleta-Caldarola, G; Gaudiano, A; Goffredo, V; Goldberg, SN; Mattioli, V; Ranieri, G; Rubini, G; Solbiati, L; Vinciarelli, G | 1 |
| Li, L; Su, M | 1 |
| Alavi, A; Kwee, TC; Torigian, DA | 1 |
| Choi, H; Chung, JK; Kang, KW; Kim, DW; Lee, DS; Lee, JK; Paeng, JC; Park, CM | 1 |
| Goto, H; Hata, Y; Isobe, K; Mitsuda, A; Otsuka, H; Sato, F; Shibuya, K; Takagi, K; Wakayama, M; Watanabe, Y; Yuasa, R | 1 |
| Levra, MG; Novello, S; Pelosi, E; Scagliotti, GV; Solitro, F; Vavalà, T; Veltri, A | 1 |
| Archie, DS; Freire, AX; Kadaria, D; SultanAli, I; Weiman, DS; Zaman, MK | 1 |
| Gardin, I; Lelandais, B; Mouchard, L; Ruan, S; Vera, P | 1 |
| Ding, X; Huang, W; Li, B; Li, H; Sun, H; Wang, Z; Yi, Y; Zang, R | 1 |
| Hamamoto, Y; Kajihara, M; Kataoka, M; Mochizuki, T; Nakajima, N; Ochi, T; Sakai, S; Sugawara, Y; Takahashi, T; Teramoto, N; Yamashita, M | 1 |
| Hwang, SH; Jeon, TJ; Kim, SJ; Kim, TH; Park, CH; Yoo, MR | 1 |
| Claussen, CD; Hetzel, J; Horger, MS; Klotz, E; Pfannenberg, C; Reimold, M; Sauter, AW; Schulze, M; Spira, D | 1 |
| Boubaya, M; Buvat, I; Chouahnia, K; Eder, V; Maisonobe, JA; Morère, JF; Soussan, M | 1 |
| Boellaard, R; Büttner, R; Dietlein, M; Engel-Riedel, W; Heukamp, L; Kahraman, D; Kobe, C; Lammertsma, AA; Neumaier, B; Nogova, L; Papachristou, I; Querings, S; Scheffler, M; Stoelben, E; Wolf, J; Zander, T | 1 |
| Liu, Y; Wang, CL; Zhang, LM; Zhang, TM; Zhang, ZF | 1 |
| Baldwin, J; Blaydorn, L; Downhour, M; Hoff, DD; Korn, RL; Thacker, CA; Tibes, R; Weiss, GJ; White, E | 1 |
| Lee, P; Singhvi, M | 1 |
| Bonardel, G; Chargari, C; Foehrenbach, H; Le Moulec, S; Védrine, L | 1 |
| Baschnagel, AM; Grills, IS; Kestin, LL; Mangona, VS; Robertson, JM; Welsh, RJ | 1 |
| Li, X; Liu, W; Ouyang, X; Quan, J; Zheng, H | 1 |
| Pai, M; Yoon, SN | 1 |
| Al-Nabhani, K; Almukhailed, O; Bomanji, J; Haroon, A; Syed, R | 1 |
| Bal, C; Bandopadhyaya, GP; Damle, NA; Kumar, L; Kumar, P; Lata, S; Malhotra, A | 1 |
| Bianco, A; Brunese, L; De Rimini, M; De Rosa, N; Grassi, R; Greco, B; Guarracino, MR; Lassandro, F; Muto, P; Muto, R; Piccolo, S; Rotondo, A; Setola, FR | 1 |
| Li, M; Li, N; Liang, Y; Liu, Y; Wu, N; Zhang, W; Zhao, P; Zheng, R | 1 |
| Ancukiewicz, M; Choi, NC; Chun, TT; Fidias, PM; Fischman, AJ; Kradin, RL; Lynch, TJ; Mathisen, DJ; Niemierko, A | 1 |
| Detry, R; Gigot, JF; Kartheuser, A; Lonneux, M; Pauwels, S; Reffad, AM | 1 |
| Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA; Smit, EF; Stroobants, SG; Vansteenkiste, JF | 1 |
| Ichihara, K; Kobayashi, H; Kosuda, S; Kusano, S; Watanabe, M | 3 |
| Coleman, RE; Hagge, RJ | 1 |
| Peschina, W | 1 |
| Jörg, L; Langsteger, W | 1 |
| Sun, Y; Wang, R; Wang, T; Yao, S; Yin, D; Zhou, N | 1 |
| Kawana, A; Kobayashi, N; Kudo, K; Morita, T; Nomura, T; Takeda, Y; Tsuduki, E | 1 |
| Lin, EC | 1 |
| Aldighieri, F; Alonso, G; Duarte, PS; Machado, C; Martins, LR; Zhuang, H | 1 |
| Griffiths, MR; Hicks, RJ; Keith, CJ; Miles, KA; Pitman, AG; Wong, D | 1 |
| Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Yap, CS | 1 |
| Chung, JK; Han, SK; Jeong, HJ; Jeong, JM; Kim, BT; Lee, DS; Lee, MC; Min, JJ; Park, JM; Shim, YS | 1 |
| Pugsley, JM; Vallières, E; Vesselle, H; Wood, DE | 1 |
| Borrego Dorado, I; Vázquez Albertino, R | 1 |
| Bartsch, P; Belhocine, T; Green, A; Hustinx, R; Jerusalem, G; Rigo, P; Seidel, L; Steinmetz, N | 1 |
| Decamp, MM | 1 |
| Gorenberg, M; Hallett, WA; O'Doherty, MJ | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Gratz, FW; Knapp, WH; Otto, D | 1 |
| Beggs, AD; Hain, SF | 1 |
| Ahn, SH; Noto, RB; Scheiner, JD | 1 |
| Boers, M; Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA; Nuyts, J; Smit, EF; Stroobants, SG; Twisk, JW; Vansteenkiste, J | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L | 1 |
| Scott, WJ | 1 |
| Changlai, SP; Hsia, TC; Kao, CH; Shen, YY; Yen, RF | 1 |
| Grijseels, EW; Herder, GJ; Hoekstra, OS; Smit, EF; van den Bergh, JH; van Velthoven, PC; Verboom, P | 1 |
| Alavi, A; Chacko, TK; Hickeson, M; Zhuang, H | 1 |
| Buck, A; Goerres, GW; Hany, TF; Steinert, HC; von Schulthess, GK | 1 |
| Kirsch, CM; Licht, N; Nestle, U; Schmidt, S; Schnabel, K; Ukena, D; Walter, K | 1 |
| Choi, NC; Fidias, P; Fischman, AJ; Lynch, T; Mathisen, D; Niemierko, A; Ryu, JS; Wain, J; Wright, C | 1 |
| Atkins, M; Graeber, GM; Gregory, JL; Gupta, NC; Mullet, D; Rogers, JS; Waheed, U | 1 |
| Gonen, M; Krug, L; Larson, SM; Pandit, N | 1 |
| Comans, EF; De Winter, GV; Hoekstra, OS; M Herder, GJ; Welling, A | 1 |
| Stroobants, S; Vansteenkiste, J; Verschakelen, J | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Bares, R; Eschmann, SM; Friedel, G | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Gallkowski, U; Guhlke, S; Reichmann, K; Sartor, J; Willkomm, P | 1 |
| Comans, EF; Herder, GJ; Hoekstra, OS; Joshi, U; Postmus, PE; Smit, EF; Teule, GJ; Van Tinteren, H | 1 |
| Steinert, HC; von Schulthess, GK | 1 |
| Bingham, JB | 1 |
| Berthezène, Y; Blineau, N; Cinotti, L; Guérin, JC; Hominal, S; Marchand, B; Tahon, F | 1 |
| Maisey, MN; O'doherty, MJ; Shon, IH | 1 |
| Blaufox, MD; Li, Y; Valdivia, AY; Zhao, DS | 1 |
| Graeter, TP; Hellwig, D; Hoffmann, K; Kirsch, CM; Schäfers, HJ; Ukena, D | 1 |
| Constable, CJ; Fulham, M; McCaughan, BC; Szeto, E; Wilkinson, MD | 1 |
| Alavi, A; Ponzo, F; Woodfield, C; Zhuang, H | 1 |
| Azhdarinia, A; Bryant, JL; Kim, CG; Kim, EE; Oh, CS; Podoloff, DA; Schechter, NR; Won, JJ; Yang, DJ; Yu, DF | 1 |
| Ho, CL; Yeung, DW; Yu, SC | 1 |
| Delbeke, D; Pinson, CW | 1 |
| Goldsmith, SJ; Kostakoglu, L | 3 |
| Matsumoto, K; Mori, H | 1 |
| Biesma, B; Hoekstra, CJ; Hoekstra, OS; Schramel, FJ; Smit, EF; Stroobants, SG; van Tinteren, H; van Zandwijk, N; Vansteenkiste, J | 1 |
| Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
| Fukuchi, K; Hayashida, K; Ishida, Y; Yamaguchi, M | 1 |
| Constable, CJ; Fulham, MJ; McCaughan, BC; Wilkinson, MD | 2 |
| Adachi, S; Hamanaka, A; Kadoh, T; Kono, M; Kotani, Y; Monzawa, S; Ohbayashi, K; Sakamoto, S; Senda, M; Sugimura, K; Takada, Y; Uotani, K | 1 |
| Cohade, C; Marshall, LN; Osman, M; Wahl, RN | 1 |
| Bakker, PF; de Klerk, JM; Schlösser, NJ; Stevens, H; van Rijk, PP | 1 |
| Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
| Bomanji, J; Costa, DC; Croasdale, I; Ell, PJ; Gacinovic, S; Lonn, AH; Visvikis, D | 1 |
| Graham, MM; Reddy, MP | 1 |
| Alavi, A; Bhargava, P; Zhuang, H | 1 |
| Hsu, NY; Hsu, WH; Kao, CH; Shen, YY; Yen, RF | 1 |
| Kaim, AH; von Schulthess, GK | 1 |
| Ball, DL; Hicks, RJ; Mac Manus, MP; Matthews, JP; McKenzie, A; Rischin, D; Salminen, EK | 1 |
| Buell, U; Cremerius, U; Hochstenbag, M; Lamers, R; Reinartz, P; ten Velde, G; Zimny, M | 1 |
| Ball, DL; Fisher, R; Hicks, R; MacManus, MR; Michael, M; Rischin, D; Wirth, A | 1 |
| Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H | 1 |
| Aerts, J; Cataldo, D; Duysinx, B; Fassotte, MF; Foidart, J; Hustinx, R; Jerusalem, G; Lemaire, C; Luxen, A; Moreau, P | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Miyamori, I; Mizuno, S; Sasaki, M; Totani, Y; Tsuchida, T; Yonekura, Y | 1 |
| Guo, J; Higashi, K; Ikeda, R; Matsunari, I; Oguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Bass, CS; Cerfolio, RJ; Katholi, CR; Mukherjee, S; Ojha, B; Pask, AH | 1 |
| Eubank, W; Haynor, DR; Lewellen, TK; Mattes, D; Vesselle, H | 1 |
| Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
| Dimitrakopoulou-Strauss, A; Rudi, J; Strauss, LG | 1 |
| Bourguet, P | 1 |
| Liu, JJ; Miao, JS; Pan, HZ; Shen, Y; Wang, HQ; Wu, JY | 1 |
| Ahn, SD; Choi, EK; Kim, JH; Kim, KJ; Kim, YS; Lee, SW; Park, HJ; Yi, BY; Yoon, SM | 1 |
| Cook, GJ; Husband, JE; Koh, DM | 1 |
| Hany, TF; Kamel, EM; Korom, S; Lardinois, D; Seifert, B; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Carlisle, MR; Franc, B; Segall, G | 1 |
| Lowe, VJ | 1 |
| Chen, T; Hayashi, K; Honda, H; Kaneko, K; Koga, H; Kuwabara, Y; Nakagawa, M; Sakai, S; Sasaki, M; Shioyama, Y; Sugio, K | 1 |
| Hatazawa, J; Higuchi, I; Nakamura, H | 1 |
| Baumert, B; Trotman-Dickenson, B | 1 |
| Aide, N; Balogova, S; Colombet, C; De Beco, V; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N | 1 |
| Link, T; Peschel, C; Petersen, V; Schmidt, B; Schwaiger, M; Tyndale-Hines, L; Weber, WA | 1 |
| Dalhoff, K; Reincke, B; Rupp, J; Schaaf, B | 1 |
| Boan, JF; Castellano, JM; Cortes, J; Garcia-Velloso, MJ; Rodriguez, J; Rodriguez-Espiteri, N; Torre, W | 1 |
| Alavi, A; Ghesani, NV; Sam, JW; Sun, X; Zhuang, H | 1 |
| Alavi, A; Duarte, PS; Feng, Q; Rebenstock, A; Zhuang, H | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Zhang, H | 1 |
| Dietlein, M; Hellwig, D; Kirsch, CM; Schicha, H; Schwaiger, M; Weber, WA | 1 |
| Cheng, WY; Cui, RX; Li, LY; Li, YF; Zhou, Q; Zhu, ZH | 1 |
| Buchmann, I; Gfrörer, W; Glatting, G; Kotzerke, J; Leithäuser, F; Möller, P; Reske, SN; Schulte, M; Schultheiss, S; Vogg, AT | 1 |
| Bartalucci, AA; Bass, CS; Bryant, AS; Cerfolio, RJ; Mountz, JM; Ojha, B | 1 |
| Eyrich, GK; Grätz, K; Hugenin, P; Sigg, MB; Steinert, H; Stoeckli, S | 1 |
| Hara, T; Kosaka, N; Kudo, K; Niino, H; Suzuki, T | 1 |
| Nguyen, BD | 2 |
| Hsu, CH; Lee, CM; Lin, YH; Wang, FC | 1 |
| Alavi, A; Bhargava, P; Reich, P; Zhuang, H | 1 |
| Hicks, RJ; Mac Manus, MP | 2 |
| Amols, H; Ling, CC; Rosenzweig, KE | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Kuehl, H; Marnitz, S; Nemat, AT; Stattaus, J | 1 |
| Chang, CH; Kao, A; Lee, CC; Lin, CC; Shen, YY; Shiau, YC | 1 |
| del Maschio, A; Fazio, F; Garavaglia, E; Mangili, G; Messa, C; Picchio, M; Sironi, S; Taccagni, GL; Voci, C; Zangheri, B | 1 |
| Conrad, GR; Sinha, P | 1 |
| Higashi, K; Higuchi, T; Ikeda, R; Kodama, Y; Matsunari, I; Miura, K; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Araki, T; Higashi, K; Higuchi, T; Ikeda, M; Kinuya, S; Nakajima, K; Namura, M; Tagawa, S; Taki, J; Tonami, N; Tsuchiya, T; Yoshida, N | 1 |
| Boers, M; Comans, EF; Diepenhorst, FW; Grijseels, EW; Hoekstra, OS; Postmus, PE; Schreurs, AJ; Smit, EF; Stallaert, RA; Teule, GJ; Uyl-de Groot, CA; van den Bergh, JH; van Mourik, JC; van Tinteren, H; van Velthoven, PC; Verboom, P | 1 |
| Delahaye, N; Gardin, I; Gutman, F; Hitzel, A; Le Guludec, D; Manrique, A; Rakotonirina, H; Véra, P | 1 |
| Kransdorf, MJ; O'Connor, MI; Peterson, JJ | 1 |
| Fukunaga, H; Hosokawa, K; Ikeda, M; Ikenaga, M; Monden, M; Nakai, K; Ohue, M; Sekimoto, M; Yamamoto, H; Yano, K | 1 |
| Garcia, JR; Lomeña, F; Lopez, S; Perez, G; Setoain, X; Simo, M; Soler, M | 1 |
| Aubier, M; Charpentier, E; Crestani, B; Delahaye, N; Fery-Lemonnier, E; Girard, P; Le Guludec, D; Lebtahi, R; Rakotonirina, H; Sarda, L; Syrota, A | 1 |
| Chan, JK; Demas, AN; Gould, MK; Kuschner, WG; Maclean, CC; Owens, DK; Rydzak, CE; Shigemitsu, H | 1 |
| Bandoh, S; Fujita, J; Ishida, T; Ishii, T; Kubo, A; Nishiyama, Y; Tojo, Y; Ueda, Y; Yamamoto, Y | 1 |
| Kamel, EM; Steinert, HC; Stumpe, KD; von Schulthess, GK; Wyss, MT; Zwahlen, D | 1 |
| Haynor, D; Turcotte, E; Vesselle, H; Wiens, L | 1 |
| Bohdiewicz, PJ; Dworkin, HJ; Gaskill, M; Kondas, D; Wong, CY | 1 |
| Alavi, A; Duarte, PS; Kung, J; Yu, JQ; Zhuang, H | 1 |
| Argiris, A; Mellott, A; Spies, S | 1 |
| Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS | 1 |
| Bĕlohlávek, O; Kosatová, K; Pafko, P; Schützner, J; Skácel, Z; Stolz, A | 1 |
| Kernstine, KH | 1 |
| Coleman, RE; D'Amico, TA; Gonzalez-Stawinski, GV; Harpole, DH; Lemaire, A; Merchant, F; O'Halloran, E | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, M; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Spaggiari, L; Veronesi, G | 1 |
| Downey, RJ; Harpole, DH; Heelan, RT; Jung, SH; MacApinlac, HA; Meyers, BF; Posther, KE; Reed, CE; Rusch, VW; Siegel, BA; Silvestri, GA; Woolson, SL | 1 |
| Line, BR; White, CS | 1 |
| Liu, XB; Sun, YE; Tian, JH; Wang, K; Wang, T; Yao, SL | 2 |
| Black, AS; Donnelly, EF; Fleischer, AC; Grippo, RJ; Hallahan, DE | 1 |
| Berbaum, K; Bushnell, D; Kahn, D; Kernstine, K; McLaughlin, K; Menda, Y; Miller, S | 1 |
| Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
| Abe, K; Kosuda, S; Kusano, S | 1 |
| Dong, JC; Guan, YH; He, SL | 1 |
| Graham, M; Kubo, A; Nishitani, H; Otsuka, H | 1 |
| Ichinari, H; Iiboshi, H; Kisanuki, A; Mine, K; Shibata, K; Tomita, M; Tomita, Y | 1 |
| Stroobants, SG; Vansteenkiste, JF | 2 |
| Annema, JT; Hoekstra, OS; Rabe, KF; Smit, EF; Versteegh, MI; Veseliç, M | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 3 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Neumaier, B; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L; Wurziger, I | 1 |
| Ball, D; Blum, R; Hicks, RJ; MacManus, MP; Michael, M; Rischin, D | 1 |
| Sun, YE; Tian, JH; Wang, T; Yao, SL; Yin, DY; Yu, CH | 2 |
| Dirksen, A; Eigtved, A; Fischer, BM; Højgaard, L; Mortensen, J | 1 |
| Chung, JK; Jeong, JM; Kim, SK; Lee, DS; Lee, MC; Lee, YJ | 1 |
| Guo, J; Higashi, K; Ikeda, R; Katsuda, S; Kodama, Y; Matsunari, I; Oguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Alavi, A; Bhargava, P; Kumar, R; Yu, JQ; Zhuang, H | 1 |
| Eimoto, T; Hara, M; Iida, A; Murase, T; Ogino, H; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Fukuda, H; Hosono, MN; Inoue, Y; Ishii, K; Kondo, S; Matsumura, A; Okamura, T; Takada, Y; Tashiro, M; Wada, Y; Watanabe, Y; Yamada, R | 1 |
| Kawahara, M | 1 |
| Coit, DG; Wong, SL | 1 |
| Holmstrom, A; Kelly, RF; Murar, J; Segurola, RJ; Tran, T | 1 |
| Bootsma, GP; Brouwer, MH; Corstens, FH; Cox, AL; Oyen, WJ; Tjan-Heijnen, VC; van der Wilt, GJ; Verhagen, AF | 1 |
| Johnstone, PA; Paulino, AC | 1 |
| Bertrand, RJ; Bosch, W; Bradley, J; Dehdashti, F; Miller, TR; Mutic, S; Siegel, BA; Thorstad, WL | 1 |
| Ollenberger, GP; Poon, AM | 1 |
| Chen, YK; Kao, CH; Shen, YY | 1 |
| Ho Shon, IA; Maisey, MN | 1 |
| Cheran, SK; Nielsen, ND; Patz, EF | 1 |
| Aksoy, E; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Mühling, B; Neumaier, B; Nüssle-Kügele, K; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L | 1 |
| Aigner, RM; Fasching, G; Groell, R; Maier, A; Nicoletti, R; Schaffler, GJ; Schoellnast, H; Smolle-Jüttner, FM; Wolf, G; Woltsche, M | 1 |
| Chao, D; Gregson, NA; Leff, A; Mak, I; McCabe, DJ; Perkin, GD; Schapira, AH; Turner, NC; Womersley, HJ | 1 |
| Endo, K; Tsushima, Y | 1 |
| Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K | 1 |
| Cheran, SK; Herndon, JE; Patz, EF | 1 |
| Constable, CJ; Fulham, MJ; Gradinscak, DJ; Mohamed, A | 1 |
| Jain, M; Katz, DS; Trow, T; Yung, E | 1 |
| Comans, EF; Golding, RP; Herder, GJ; Hoekstra, OS; Postmus, PE; Smit, EF; Teule, GJ | 1 |
| Avril, N | 1 |
| Baek, HJ; Cheon, GJ; Cho, KJ; Choi, CW; Chung, JH; Lee, SS; Lim, SM; Park, JH | 1 |
| Epstein, M; London, D; Mayerhoff, R; Shah, R; Stanek, A; Talwar, A | 1 |
| Alavi, A; Bhargava, P; Charron, M; Kumar, R; Zhuang, H | 1 |
| Carreras, JL; de Juan, R; Lapeña, L; Montz, R; Peñas, JM; Ruiz-Hernández, G; Samanes, A; Verea, H; Veres, A | 1 |
| Vansteenkiste, JF | 3 |
| Berlangieri, SU; Foo, SS; Ramdave, S; Scott, AM | 1 |
| Baum, RP; Hellwig, D; Mezzetti, M | 1 |
| Coulden, R; Sala, E | 1 |
| Brink, I; Digel, W; Ghanem, N; Henke, M; Mix, M; Moser, E; Nitzsche, EU; Ruhland, S; Schumacher, T; Stoelben, E | 1 |
| Baydush, AH; Bell, M; Craciunescu, O; Das, SK; Dewhirst, MW; Marks, LB; Miften, MM; Munley, MT; Rosenman, JG; Whiddon, CS; Wong, T; Zhou, S | 1 |
| Vaylet, F | 1 |
| Lalani, T; Schmidt, R; Takasugi, JE; Turcotte, E; Vallières, E; Vesselle, H; Wiens, L; Wood, DE | 1 |
| Bootsma, GP; Bussink, J; Corstens, FH; Oyen, WJ; Verhagen, AF | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Buck, AK; Glatting, G; Reske, SN | 1 |
| Alavi, A; Chiang, S; Fuster, D; Johnson, G; Schuchter, LM; Zhuang, H | 1 |
| Guo, J; Higashi, K; Kodama, Y; Nagao, Y; Oguchi, M; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Backer, V; Eigtved, A; Enevoldsen, H; Friberg, L; Hansen, H; Mortensen, J; Nielsen, HW; Olesen, KP; Oturai, PS; Stentoft, P | 1 |
| Bradley, JD; Dehdashti, F; Govindan, R; Mintun, MA; Siegel, BA; Trinkaus, K | 1 |
| Akhurst, T; Bains, MS; Downey, RJ; Gonen, M; Larson, S; Rusch, V; Vincent, A | 1 |
| Graves, A; Hutchins, EB; Shelton, B | 1 |
| Bares, R; Besenfelder, H; Bitzer, M; Dittmann, H; Eschmann, SM; Friedel, G; Horger, M; Paulsen, F; Pfannenberg, AC; Reimold, M | 1 |
| Dooms, C; Fischer, BM; Mortensen, J; Vansteenkiste, J | 1 |
| Blackstone, EH; Lauer, MS | 1 |
| Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Itoh, H; Nishizawa, S; Sugimoto, K; Tsuchida, T; Yonekura, Y | 1 |
| Antoine, JC; Cinotti, L; Cottin, V; Honnorat, J; Janier, MF; Ternamian, PJ; Tronc, F; Trouillas, P; Younes-Mhenni, S | 1 |
| Aquino, SL; Fischman, AJ | 1 |
| Bossuyt, A; De Mey, J; Everaert, H; Franken, PR; Lahoutte, T; Muylle, K | 1 |
| Katz, DS; Shin, L; Yung, E | 1 |
| Knight, S; Ollenberger, GP; Tauro, AJ | 1 |
| Ball, DL; Binns, D; Hicks, RJ; Hogg, A; Mac Manus, MP; Matthews, JP; Peters, LJ; Rischin, D | 1 |
| Ball, D; Bayne, M; Hicks, R; Leong, T; MacManus, M; Peters, L | 2 |
| Bar-Shalom, R; Ben-Nun, A; Guralnik, L; Haim, N; Israel, O; Keidar, Z; Wollner, M | 1 |
| Broussolle, C; Grange, JD; Kodjikian, L; Sève, P; Vautrin, C | 1 |
| Alberini, JL; Corone, C; Dartevelle, P; De Montpreville, V; Leroy-Ladurie, F; Nguyen, C; Pecking, AP; Wartski, M | 1 |
| Cole, RL; Fagen, K; Silverman, ED | 1 |
| Marks, LB; Wong, TZ; Zhou, SM | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Uno, K; Watanabe, K | 1 |
| Liu, FY; Shang, JB; Wang, QS; Zhang, XL | 1 |
| Hara, M; Iida, A; Itoh, M; Nishio, M; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Bertin, F; Bonnaud, F; Ducloux, T; Gaillard, S; Maubon, A; Melloni, B; Monteil, J; Vandroux, JC; Verbeke, S; Vincent, F | 1 |
| Brinkmann, M; Könemann, S; Schober, O; Weckesser, M; Willich, N | 1 |
| Black, QC; Grills, IS; Kestin, LL; Martinez, AA; Wong, CY; Wong, JW; Yan, D | 1 |
| Foehrenbach, H; Vaylet, F | 1 |
| Cohade, C; Jacene, HA; Wahl, RL | 1 |
| Binns, D; Hicks, R; Jong, I; Lau, E; Ramdave, S | 1 |
| Greenspan, B; Singh, A; Thomas, A | 2 |
| Fulham, MJ; Modi, D; Mohamed, A | 1 |
| Franzius, C | 1 |
| Hellwig, D; Ukena, D | 2 |
| Passlick, B | 1 |
| Mornex, F | 1 |
| Chapet, O; Lagerwaard, FJ; Senan, S; Ten Haken, RK | 1 |
| Fox, JL; Giraud, P; Rosenzweig, KE | 1 |
| Bartolucci, AA; Bryant, AS; Cerfolio, RJ; Ohja, B; Winokur, TS | 1 |
| Dai, JZ; Dong, MJ; Guan, YH; Lin, XT; Yu, DF; Zhao, J; Zuo, CT | 1 |
| Georg, T; Graeter, TP; Hellwig, D; Kirsch, CM; Schäfers, HJ; Ukena, D | 1 |
| Bouhnik, JP; Even-Sapir, E; Lerman, H; Levin, C; Lievshitz, G; Miller, E; Yuzefovich, B; Zak, O | 1 |
| Berkhof, J; Franssen, EJ; Hoekstra, OS; Sturkenboom, MG | 1 |
| Alavi, A; El-Haddad, G; Kumar, R; Kung, J; Potenta, S; Takalkar, A; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Kratochwil, C; Mattfeldt, T; Möller, P; Mottaghy, FM; Neumaier, B; Reske, SN; Schirrmeister, H; Wahl, A | 1 |
| Ball, DL; Hicks, RJ; Manus, MP; Rischin, D; Roberts, KB; Wirth, A; Wright, GM | 1 |
| Lowe, JE; Lyburn, ID; Wong, WL | 1 |
| Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
| Birim, O; Bogers, AJ; Kappetein, AP; Stijnen, T | 1 |
| Liu, SW; Xing, LG; Yu, JM | 1 |
| Ishii, G; Murakami, K; Nagai, K; Niho, S; Nishimura, M; Nishiwaki, Y; Suzuki, K; Takamochi, K; Yoshida, J | 1 |
| Fahy, RJ; King, M | 1 |
| Ding, YG; Kim, CK; Kim, S; Krynyckyi, BR; MacHac, J | 1 |
| Amir, R; Bourgeot, B; Liehn, JC; Marcus, C; Papathanassiou, D | 1 |
| Endo, K; Higuchi, T; Inoue, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Bossuyt, A; Everaert, H; Lahoutte, T; Poppe, K; Velkeniers, B | 1 |
| Deniaud-Alexandre, E; Lerouge, D; Moureau-Zabotto, L; Touboul, E | 1 |
| Aoki, T; Higashi, T; Hiraoka, M; Ishimori, T; Konishi, J; Mamede, M; Mukai, T; Nagata, Y; Nakamoto, Y; Negoro, Y; Saga, T | 1 |
| Hayashi, T; Higashiyama, S; Kawabe, J; Kawamura, E; Kotani, J; Oe, A; Osugi, H; Shiomi, S; Torii, K | 1 |
| Alavi, A; Gupta, NC; Lakhani, P; Mavi, A; Zhuang, H | 1 |
| Higashi, K; Higuchi, T; Hiramatsu, Y; Ishikawa, T; Ito, K; Kuga, G; Matsunari, I; Miura, K; Sakuma, T; Tonami, H; Yamamoto, I | 1 |
| Bentzen, SM; Boersma, L; De Ruysscher, D; Hochstenbag, M; Lambin, P; Lamers, R; Lutgens, L; Nijsten, S; van Der Wel, A; Wanders, R; Wouters, B; Zimny, M | 1 |
| Han, J; Kim, BT; Lee, EJ; Lee, KS; Sung, YM | 1 |
| Allen, P; Cox, JD; Erasmus, J; Forster, K; Herbst, RS; Komaki, R; Macapinlac, H; Moran, CA; Podoloff, DA; Putnam, JB; Roth, JA; Sasaki, R | 1 |
| Fulham, MJ; McCaughan, BC; Modi, D; Mohamed, A | 1 |
| An, YS; Joh, CW; Lee, MH; Yoon, JK; Yoon, SN | 1 |
| Calcagni, ML; Castaldo, S; Delaloye, AB; Kamel, EM; Markl, S; McKee, TA; Schmidt, S | 1 |
| Higuchi, T; Ito, K; Kuga, G; Matsunari, I; Sagawa, M; Takegami, T; Toga, H; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Hoekstra, OS; Smit, EF; van Tinteren, H | 1 |
| Bomanji, J; Ell, PJ; George, PJ; Groves, AM; Kayani, I | 1 |
| Ramaswamy, MR; Reddy, MP | 1 |
| Huang, B; Puri, S | 1 |
| Sönmezoğlu, K | 1 |
| Cook, G; Fogelman, I; Israel, O; Van der Wall, H | 1 |
| Gong, M; Li, CL; Lü, KJ; Wang, TY; Wei, B; Zou, LF | 1 |
| Khuri, F; Saba, N | 1 |
| Dang, YP; Li, M; Liu, G; Wang, H | 1 |
| Alcaide, AB; Bastarrika, G; Campo, A; Cano, D; Cosín, O; Domínguez, P; García-Velloso, MJ; Lozano, MD; Montes, U; Montuenga, L; Pueyo, J; Richter, JA; Seijo, L; Serra, P; Spiteri, N; Torre, W; Vivas, I; Zulueta, JJ | 1 |
| Boellaard, R; Hoekstra, CJ; Hoekstra, OS; Krak, NC; Lammertsma, AA; Twisk, JW | 1 |
| Bading, JR; Bart, R; Bremner, R; Chen, X; Conti, PS; Hou, Y; Park, R; Sievers, E; Tohme, M | 1 |
| Baum, RP; Bonnet, R; Junker, K; Müller, KM; Schmücking, M | 1 |
| Lee, M; Lilien, DL; Nathan, CO; Ramaswamy, MR | 1 |
| Hensing, TA | 1 |
| Al Zahouri, K; Arveux, P; Bernard, A; Binquet, C; Guillemin, F; Lejeune, C; Woronoff-Lemsi, MC | 1 |
| Bilfinger, TV; Franceschi, D; Komaroff, E; Sachs, S | 1 |
| Erdi, Y; Fox, JL; Leibel, SA; Nehmeh, S; O'Meara, W; Rengan, R; Rosenzweig, KE; Yorke, E | 1 |
| Deguchi, E; Furukawa, T; Iwai, N; Kinoshita, H; Shimotake, T | 1 |
| Liu, Y; Xu, HF; Yuan, MH; Zhang, JH; Zhou, FH; Zhou, RS | 1 |
| Cao, Y; Chen, ZG; Meng, QL; Wang, F; Wang, ZZ; Xie, H; Xu, CY; Yao, WX | 1 |
| Li, LY; Song, ZF; Wang, MZ; Zhu, ZH | 1 |
| Hirabayashi, H; Maeda, J; Matsuda, H; Ohta, M | 1 |
| Agostini, D; Bouvard, G; Halley, A; Hugentobler, A; Icard, P; Lerochais, JP; Porret, E; Sobrio, F; Zalcman, G | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Orikasa, H; Suemasu, K; Uno, K; Watanabe, K; Yamazaki, K | 1 |
| Emerson, LL; Karwande, SV; Schreiber, G; Tanaka, R | 1 |
| Aquino, SL; Gilman, MD | 1 |
| Coppage, L; Hazelton, TR | 1 |
| Hualde-Enguita, AM; Morales-Rull, JL; Ruiz-Ruiz, FJ; Saenz-Abad, D | 1 |
| Acker, MR; Burrell, SC | 1 |
| Ball, DL; Hicks, RJ; Mac Manus, MP; Matthews, JP; Rischin, D; Wirth, A | 1 |
| Belderbos, JS; Boellaard, R; Borst, GR; Comans, EF; De Jaeger, K; Lammertsma, AA; Lebesque, JV | 1 |
| Hirashima, T; Iwasaki, T; Kawahara, K; Kawase, I; Kobayashi, M; Matsui, K; Sasada, S; Takimoto, T; Yamadori, T | 1 |
| Higashi, T; Ishimori, T; Ishizu, K; Kitaichi, M; Li, M; Mamede, M; Manabe, T; Nakamoto, Y; Saga, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Canessa, J; Galaz, R; González, P; Humeres, P; Jofré, MJ; Massardo, T; Sierralta, P; Valdebenito, R | 1 |
| Abdel-Dayem, H; Ashamalla, H; Evola, A; Goswami, G; Guirguis, A; Kambam, S; Mokhtar, B; Parikh, K; Rafla, S; Ross, P | 1 |
| Gladish, GW; Macapinlac, HA; Marom, EM; Munden, RF; Podoloff, DA; Sabloff, BS; Truong, MT; Yi, JG | 1 |
| Bentzen, SM; Boersma, L; Buell, U; De Ruysscher, D; Dohmen, J; Geeraedts, W; Hochstenbag, M; Lambin, P; Minken, A; Rhami, A; Simons, J; Snoep, G; Thimister, P; Utama, I; van Baardwijk, A; van Haren, E; Verschueren, T; Wanders, S | 1 |
| De Ruysscher, D; Senan, S | 1 |
| Finger, PT; Kurli, M; Pavlick, AC; Reddy, S; Tena, LB | 1 |
| Watanabe, H | 1 |
| Baehre, M; Gerl, J; Horstmann, O; Meller, B; Meller, J; Sahlmann, C | 1 |
| Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H | 1 |
| Choi, JY; Chung, MJ; Han, J; Kim, BT; Kim, S; Kwon, OJ; Lee, EJ; Lee, KS; Shim, SS; Shim, YM | 1 |
| Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
| Huber, M; Mirzaei, S; Mostbeck, G; Oschatz, E; Prosch, H; Strasser, G | 1 |
| Chang, TC; Ma, SY; Ng, KK; Shaw, SW; Wang, CW | 1 |
| Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer-Schuler, A; Sebastian-Welsch, C | 1 |
| Ell, PJ | 1 |
| Erdi, YE; Humm, JL; Larson, SM; Nehmeh, SA | 1 |
| Deniaud-Alexandre, E; El Balaa, H; Foulquier, JN; Grahek, D; Grès, B; Keraudy, K; Kerrou, K; Lebeau, B; Lerouge, D; Milleron, B; Montravers, F; Petegnief, Y; Talbot, JN; Touboul, E | 2 |
| Fazio, F; Galli, L; Gianolli, L; Grimaldi, A; Landoni, C; Messa, C; Mezzetti, M; Pastorino, U; Pepe, G; Rossetti, C; Sironi, S; Zannini, P | 1 |
| Buatti, JM; Chang, K; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Smith, RB; Tan, H; Yao, M | 1 |
| Mackie, GC; Pohlen, JM | 1 |
| Brokx, HA; Comans, EF; Herder, GJ; Hoekstra, OS; Pasic, A; Postmus, PE; Risse, EK; Sutedja, TG | 1 |
| Bubeck, B; Klaeser, B | 1 |
| Graeter, TP; Gröschel, A; Hellwig, AP; Hellwig, D; Kirsch, CM; Nestle, U; Schäfers, HJ; Sybrecht, GW | 1 |
| Ali, A; Bonomi, P; Cohen, ES; Hassaballa, HA; Khan, AJ; Rubin, DB | 1 |
| Abe, K; Hayashi, K; Iwasaki, Y; Kosuda, S; Watanabe, S; Yano, F | 1 |
| Atkins, CD | 1 |
| Artioli, D; Castellone, P; Cattaneo, M; Ceresoli, GL; Fazio, F; Gregorc, V; Landoni, C; Messa, C; Picchio, M; Rizzo, G | 1 |
| Bar-Shalom, R; Ben-Nun, A; Bentur, L; Brik, A; Brook, OR; Guralnik, L; Vladavsky, E | 1 |
| Griffiths, MR; Keith, CJ; Miles, KA | 1 |
| Lardinois, D; Moch, H; Roudas, M; Stahel, RA; Steinert, HC; Tutic, M; von Schulthess, GK; Weder, W | 1 |
| Biersack, HJ; Jaeger, U; Joe, AY; Matthies, A; Reinhardt, MJ; Strunk, H; Wiethoelter, N | 1 |
| Belderbos, JS; Bussink, J; Comans, EF; De Jaeger, K; Deurloo, KE; Duppen, JC; Fitton, I; Kramer, GW; Nowak, PJ; Rasch, CR; Rodrigus, PT; Steenbakkers, RJ; Uitterhoeve, AL; van Herk, M; Zijp, LJ | 1 |
| Sun, Y; Tian, J; Wang, K | 1 |
| Campa, MJ; Furumai, R; Howard, BA; Patz, EF; Rabbani, ZN; Vujaskovic, Z; Wang, XF | 1 |
| Bonardel, G; Foehrenbach, H; Gontier, E; Guigay, J; L'Her, P; Mantzarides, M; Salles, Y; Vaylet, F | 1 |
| Arenas de Pablo, A; Calero-García, R; García de Barajas, S; García-Lujan, R; Lopez-Encuentra, A; Maldonado, A; Martín de Nicolás, JL; Martín-Escribano, P; Martín-García, I; Pozo, MA; Pozo-Rodríguez, F; Sánchez-Nistal, MA | 1 |
| Gotoh, M; Haba, R; Kameyama, K; Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Yamamoto, Y | 1 |
| Brada, M; Cook, G; Lavrenkov, K; Partridge, M | 1 |
| Costa, DB; Parker, JA; Schumer, ST | 1 |
| Chott, A; Hoffmann, M; Raderer, M; Streubel, B; Woehrer, S | 1 |
| Comans, EF; Golding, RP; Herder, GJ; Hoekstra, OS; Kostense, PJ; Smit, EF; van Tinteren, H | 1 |
| Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Tsutsui, K; Yamamoto, Y; Yokoe, K | 1 |
| Bares, R; Budach, W; Dittmann, H; Eschmann, SM; Friedel, G; Hehr, T; Machulla, HJ; Paulsen, F; Reimold, M; Scheiderbauer, J; Vonthein, R | 1 |
| Pan, MH; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Handa, M; Hirai, S; Ihaya, A; Imamura, Y; Kawabe, M; Morioka, K; Sasaki, K; Shinoda, T; Tanabe, S; Tanaka, K; Uesaka, T; Yamada, N | 1 |
| Biesma, B; Golding, RP; Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA; Postmus, PE; Schramel, FJ; Smit, EF; Stroobants, SG; van Tinteren, H; van Zandwijk, N; Vansteenkiste, J | 1 |
| Alifano, M; Bellenot, F; Grahek, D; Lemeunier, P; Magdeleinat, P; Molina, T; Perrotin, C; Petino, A; Regnard, JF; Talbot, JN | 1 |
| Kobayashi, T; Kosaka, N; Naruke, T; Nomori, H; Ohtsuka, T; Uno, K; Watanabe, K | 1 |
| Hu, M; Liu, BD; Su, L; Wang, HR; Xu, QS; Zhang, Y; Zhi, XY | 1 |
| Bachaud, JM; Bègue, M; Caselles, O; Courbon, F; Dygai, I; Gancel, M; Hamelin, D; Laprie, A; Marre, D; Zerdoud, S | 1 |
| Poon, A; Saunder, TH; Yap, KK | 1 |
| de Langen, AJ; Hoekstra, OS; Paul, MA; Raijmakers, P; Riphagen, I | 1 |
| Chen, DL; Dehdashti, F | 1 |
| Avram, AM; Brown, RK; Francis, IR | 1 |
| Knoepp, UW; Ravenel, JG | 1 |
| Antoch, G; Bockisch, A; Eberhardt, W; Gauler, T; Grehl, S; Levegrün, S; Marnitz, S; Pink, R; Pöttgen, C; Stamatis, G; Stuschke, M; Theegarten, D | 1 |
| Chasen, M; Erasmus, JJ; Knight, AE; Macapinlac, HA; Mawlawi, O; Munden, RF; Pan, T; Podoloff, DA | 1 |
| Aronsky, A; Gates, GF; Ozgur, H | 1 |
| Gong, HY; Yu, JM | 1 |
| Freixinet, J; Hussein, M; Rodríguez de Castro, F; Rodríguez, P; Romero, T | 1 |
| Feng, YL; Liu, DJ; Pan, YJ; Wei, GY; Yu, FW; Zhang, N | 1 |
| Maeda, S; Sagawa, M; Sakuma, T; Sugita, M | 1 |
| Beetz, M; Franzius, C; Heindel, W; Juergens, KU; Schober, O; Stegger, L; Weckesser, M; Wormanns, D | 1 |
| Dusart, M; Eisendrath, P; Faber, J; Haller, A; Hutsebaut, J; Ninane, V; Pierard, P; Plat, G; Sculier, JP | 1 |
| Allen-Auerbach, M; Czernin, J; Park, J; Phelps, M; Yeom, K | 1 |
| Azhari, H; Bar-Shalom, R; Frenkel, A; Israel, O; Kennedy, JA | 1 |
| Cheng, V; Gaskill, M; Kestin, L; Nagle, C; Thie, J; Wong, CY; Yan, D | 1 |
| Rankin, SC | 1 |
| Cameron, RB; Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Weber, WA; Yap, CS | 1 |
| Huang, CL; Ishikawa, S; Liu, D; Masuya, D; Yamamoto, Y; Yokomise, H | 1 |
| Higashi, K; Maeda, S; Sagawa, M; Sakuma, T; Sugita, M; Toga, H; Ueda, Y | 1 |
| Chan, V; Chaudhry, AA; Clark, CT; Daw, HA; Kundranda, MN | 1 |
| Guo, J; Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Takegami, T; Toga, H; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Hashimoto, Y; Kondo, C; Kusakabe, K; Maki, M; Momose, M; Nagai, A; Nishikawa, T; Ohnuki, T; Tsujikawa, T | 1 |
| Bunyaviroch, T; Coleman, RE | 1 |
| Aquino, SL; Fischman, AJ; Halpern, EF; Kuester, LB; Muse, VV | 1 |
| Asadpour, B; Buell, U; Coenen, HH; Demirel, C; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Pinkawa, M; Piroth, M; Reinartz, P; Stanzel, S; Zimny, M | 1 |
| Adebonojo, SA; Katz, N; Little, AG; Moezzi, J; Paull, DE | 1 |
| Lardinois, D | 1 |
| Boers, M; Comans, EF; Groen, HJ; Herder, GJ; Hoekstra, OS; Kramer, H; Paul, MA; Postmus, PE; Pruim, J; Smit, EF; Teule, GJ; Uyl-de Groot, CA; van Tinteren, H; Verboom, P; Welling, A | 1 |
| Dimitrakopoulou-Strauss, A; Eisenhut, M; Georgoulias, V; Haberkorn, U; Herth, F; Koukouraki, S; Mäcke, HR; Strauss, LG | 1 |
| Bénard, F; Boileau, R; Boucher, L; Larivée, P; Prévost, S | 1 |
| Kawana, A; Kobayashi, N; Kubota, K; Kudo, K; Naka, G; Shukuya, T; Sugiyama, H; Tamegai, Y; Yago, Y | 1 |
| Basu, S; Nair, N | 2 |
| Fischer, BM; Højgaard, L; Klausen, TL; Kristjansen, PE; Ley, CD; Mortensen, J; Olsen, MW | 1 |
| Inoue, K; Inoue, Y; Koyama, K; Matsuoka, T; Nakamura, K; Okamura, T; Okuma, T; Oyama, Y; Toyoshima, M; Yamamoto, A | 1 |
| Civelek, AC; Khayyat, N; Memisoglu, E; Naunheim, KS; Osman, MM; Piotrowski, B; Reimers, HJ | 1 |
| Connolly, LP; Gauger, PG; Hurwitz, CA; Kunter, G; Mackie, GC; Mody, RJ; Ribeiro, RC; Rodriguez-Galindo, C; Schteingart, DE; Shulkin, BL; Wallis, JW; Worden, FP | 1 |
| García, JR; Huguet, M; Lomeña, F; Simo, M; Ysamat, M | 1 |
| Maublant, J; Naalsund, A | 1 |
| Weber, WA; Wieder, H | 1 |
| Ebihara, A; Kaji, M; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Carrerea, D; Ferran, N; Gámez, C; Guirao, S; Leon, AF; Lopez, M; Martin-Comin, J; Martinez-Ballarin, I; Ricart, Y; Roca, M | 1 |
| Dou, Y; Raja, S; Roscoe, KJ; Tronic, B | 1 |
| Masaoka, T; Sato, T; Shiono, S; Yanagawa, N | 1 |
| Kohlfürst, S; Lind, P | 1 |
| Ebihara, A; Goya, T; Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Orikasa, H; Uno, K; Watanabe, K; Yamazaki, K | 1 |
| Bénard, F; Langlois, MF; Leboeuf, R | 1 |
| Muzik, O; Peng, F; Rabkin, G | 1 |
| Appelbaum, D; Doi, K; Li, F; Li, Q; Nie, Y; Pu, Y | 1 |
| Aflalo-Hazan, V; Frétault, J; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Raileanu, I; Talbot, JN | 1 |
| De Winter, O; Goethals, I; Noens, L; Smeets, P | 1 |
| Chung, SK; Chung, YA; Hyun, J; Kin, SH; Park, HJ; Sohn, HS; Yoo, IeR | 1 |
| Bang, YJ; Chung, JK; Heo, DS; Im, SA; Kang, WJ; Kim, DW; Kim, TY; Kim, YW; Lee, KH; Lee, SH | 1 |
| Choe, G; Chung, JH; Chung, JK; Kim, SE; Lee, MC; Lee, WW; Park, SY; Sung, SW | 1 |
| Bryant, AS; Cerfolio, RJ; Klemm, KM; Ojha, B | 1 |
| Inoue, Y; Koyama, K; Matsuoka, T; Nakamura, K; Okamura, T; Okuma, T; Oyama, Y; Wada, Y; Watanabe, Y; Yamamoto, A | 1 |
| Bares, R; Budach, W; Eschmann, SM; Friedel, G; Hehr, T; Kotzerke, J; Paulsen, F; Reimold, M; Scheiderbauer, J | 1 |
| Englmeier, KH; Schaefer, JF; Seemann, MD | 1 |
| Broemeling, LD; Bruzzi, JF; Gladish, GW; Macapinlac, HA; Marom, EM; Mawlawi, O; Munden, RF; Podoloff, DA; Truong, MT | 1 |
| Berthelsen, AK; Daugaard, G; Fischer, BM; Hansen, HH; Langer, SW; Lassen, U; Loft, A; Mortensen, J | 1 |
| Bryant, AS; Cerfolio, RJ | 4 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Oriuchi, N | 1 |
| Baram, D; Bilfinger, TV; Salhab, KF | 1 |
| Choi, JY; Kim, BT; Kim, H; Kim, J; Kim, S; Kwon, OJ; Lee, KS; Shim, SS; Shim, YM | 1 |
| Chawla, S; Conti, PS; Iagaru, A; Menendez, L | 1 |
| Aflalo-Hazan, V; Balogova, S; Gounant, V; Grahek, D; Gutman, F; Kerrou, K; Lavole, A; Mayaud, C; Montravers, F; Raileanu, I; Talbot, JN | 1 |
| Fukuda, H; Iwasaki, T; Katsura, H; Kawahara, K; Nakagawa, K; Nakane, S | 1 |
| Herth, F; Kirsch, CM; Stoelben, E | 1 |
| Geinitz, H; Molls, M; Nieder, C; Schill, S; Schratzenstaller, U; Thamm, R; Zimmermann, FB | 1 |
| Bruzzi, JF; Macapinlac, HA; Marom, EM; Mawlawi, O; Munden, RF; Podoloff, DA; Truong, MT | 1 |
| Hany, TF; Husarik, DB; Schaefer, NG; Steinert, H; Strobel, K | 1 |
| Harpole, DH; McCall, LM; Posther, KE; Putnam, JB; Reed, CE; Rusch, VW; Siegel, BA | 1 |
| Krohn, KA; Linden, HM; Livingston, RB; Mankoff, DA | 1 |
| Bodenstein, C; Czernin, J; Dubinett, S; Dumont, RA; Herschman, H; Phelps, ME; Seimbille, Y; Su, H; Weber, W | 1 |
| Kaji, M; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 2 |
| Chung, JH; Chung, JK; Eo, JS; Jang, SJ; Kim, SE; Lee, MC; Lee, WW; Park, SY; So, Y; Sung, SW | 1 |
| Aliredjo, RP; Boerman, OC; de Geus-Oei, LF; Frielink, C; Krabbe, PF; Oyen, WJ; van Krieken, JH; Verhagen, AF | 1 |
| Gangarosa, LM; Khandani, AH; Socinski, MA; Stinchcombe, TE | 1 |
| Fu, Y; Ishiguro, T; Sadatou, T; Shibamoto, K; Shimokawa, N | 1 |
| Acikgoz, G; Alavi, A; Cermik, TF; Houseni, M; Intenzo, CM; Kim, SM | 1 |
| Endoh, K; Gotoh, M; Hasegawa, T; Higuchi, M; Kanno, R; Suzuki, H; Teranishi, Y | 1 |
| Gotoh, M; Igai, H; Yokomise, H | 1 |
| Christensen, JA; Hartman, TE; Lowe, VJ; Mullan, BP; Nathan, MA; Swensen, SJ | 1 |
| Groeschel, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer-Schuler, A | 1 |
| Franc, BL; Jablons, DM; Odisho, AY; Raz, DJ | 1 |
| Berthelsen, AK; Daugaard, G; Fischer, BM; Hansen, HH; Langer, SW; Lassen, U; Loft, A; Mortensen, J; Petersen, BI | 1 |
| Demmy, T; Fischer, G; Glinianski, M; Lamonica, D; Nwogu, C; Tan, D | 1 |
| Bryant, AS; Cerfolio, RJ; Miller, DL; Pereira, SJ | 1 |
| Grosu, AL; Kremp, S; Nestle, U | 1 |
| Bhat, S; Bhatt, B; Camazine, B; Erickson, RA; Gupta, R; Jadhav, Y; Khan, A; Khode, R; Mukhopadhyay, P; Reddy, R; Shah, RS; Sharma, A; Sikka, P; Singh, P; Smith, DD; Yaqub, Y; Zheng, Q | 1 |
| Goor, C; Legrand, C; Manegold, C; Schramel, F; Surmont, V; van Klaveren, RJ; Van Meerbeeck, JP; Van Schil, P | 1 |
| Biehl, KJ; Bradley, JD; Dehdashti, F; El Naqa, I; Jin, JY; Kong, FM; Mutic, S; Siegel, BA | 1 |
| Barrington, SF; Davies, A; O'Doherty, M; Paschalides, C; Tan, C; Treasure, T; Utley, M | 1 |
| Bares, R; Budach, W; Eschmann, SM; Friedel, G; Hehr, T; Langen, HJ; Paulsen, F; Reimold, M | 1 |
| Akhurst, T | 1 |
| Bar Shalom, R; Ben-Nun, A; Best, AL; Orlovsky, M | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JS; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Blumstein, NM; Buck, AK; Hombach, V; Kropf, C; Krüger, S; Mottaghy, FM; Pauls, S; Reske, SN; Schelzig, H; Schumann, C | 1 |
| Katayanagi, K; Kawano, M; Kobayashi, T; Tsunezuka, Y | 1 |
| Bares, R; Budach, W; Dittmann, H; Eschmann, SM; Friedel, G; Hehr, T; Langen, HJ; Paulsen, F; Reimold, M | 1 |
| Cherk, MH; Foo, SS; Knight, SR; Murone, C; O'Keefe, GJ; Papenfuss, AT; Poon, AM; Sachinidis, JI; Saunder, TH; Scott, AM | 1 |
| Ginsberg, MS; Grewal, RK; Heelan, RT | 1 |
| Badran, K; Hoha, CK; Obrzut, S; Pham, RH; Vera, DR | 1 |
| Liang, ZY; Liu, X; Zhang, JM; Zheng, X; Zhou, NK | 1 |
| Bryant, AS; Cerfolio, RJ; Garver, RI; Robert, F; Scott, E; Sharma, M; Spencer, SA | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R | 1 |
| Coronado Poggio, M; Couto Caro, RM; Frutos Esteban, L; Lillo García, ME; Marín Ferrer, MD; Martín Curto, LM | 1 |
| Farukhi, I; Hughes, RS; Oz, OK; Shie, P | 1 |
| Ames, ED; Bhargava, P; Brown, J; Kang, P; Shin, V | 1 |
| Brambilla, D; Catalano, G; de Braud, F; De Pas, TM; Leo, F; Paganelli, G; Putzu, C; Solli, PG; Spaggiari, L; Veronesi, G | 1 |
| Pfannschmidt, J | 1 |
| Bradley, K; Gondi, V; Howard, A; Khuntia, D; Mehta, M; Ritter, M; Tomé, W | 1 |
| Black, QC; Grills, IS; Kestin, LL; Martinez, AA; Wong, CY; Yan, D | 1 |
| Chung, SK; Kim, SH; O, JH; Sohn, HS; Yoo, IeR | 1 |
| Cook, GJ; Devaraj, A; Hansell, DM | 1 |
| Allen, MS; Aubry, MC; Daniels, CE; Jett, JR; Lowe, VJ | 1 |
| Kawano, M; Shimizu, Y; Takayanagi, T; Tanaka, N; Tsunezuka, Y | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Kadowaki, M; Miyamori, I; Mizuno, S; Morikawa, M; Nakanishi, M; Sasaki, M; Uesaka, D; Umeda, Y | 1 |
| Chung, JH; Chung, JK; Kim, SE; Kim, YK; Lee, DS; Lee, MC; Lee, WW; Nguyen, XC; Park, SY; So, Y; Sung, SW | 1 |
| Blackstone, EH; Lauer, MS; Murthy, SC; Okereke, IC; Rice, TW | 1 |
| Alavi, A; Bhutani, C; Dadparvar, S; Dhurairaj, T; Kumar, R; Reddy, S; Xiu, Y; Yang, H; Yu, JQ; Zhuang, H | 1 |
| Kathula, SK; Mantil, J | 1 |
| Krüger, S; Mottaghy, FM; Pauls, S | 1 |
| Boersma, L; Bosmans, G; De Ruysscher, D; Dekker, A; Houben, R; Lambin, P; Minken, A; Ollers, M; van Baardwijk, A; van Kroonenburgh, M; Wanders, S | 1 |
| Donald Blaufox, M; Isasi, CR; Keller, SM; Khandani, AH; Whitney, KD | 1 |
| Allen-Auerbach, M; Brown, M; Czernin, J; Dahlbom, M; Fueger, BJ; Goldin, J; Kim, SK; Schiepers, C | 1 |
| Chatziioannou, AF; Chow, PL; De, A; Deroose, CM; Gambhir, SS; Loening, AM; Ray, P | 1 |
| Bellón Guardia, M; Gómez Río, M; Llamas Elvira, JM; Pedraza Muriel, V; Ramos Font, C; Rodríguez Fernández, A; Sánchez-Palencia Ramos, A; Torné Poyatos, P | 1 |
| Aquino, SL; Fischman, AJ; Halpern, EF; Kuester, LB | 1 |
| Gong, M; Li, CL; Yang, JG; Zou, LF | 1 |
| Argiris, A; Gooding, W; Kut, V; Spies, S; Spies, W | 1 |
| Bova, D; Emami, B; Halama, J; Hong, R; Sethi, A | 1 |
| Blumstein, NM; Brambs, HJ; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Hohl, K; Hombach, V; Krüger, S; Möller, P; Mottaghy, FM; Pauls, S; Reske, SN; Sunder-Plassmann, L | 1 |
| Choi, JY; Chung, MJ; Kim, BT; Kim, H; Kim, HY; Kim, YK; Kwon, OJ; Lee, KS; Shim, YM; Yi, CA | 1 |
| Delaloye, AB; Doenz, F; Koljevic-Markovic, A; Orcurto, MV; Prior, JO | 1 |
| Ahn, MI; Je, SK; Kim, CH; Park, YH | 1 |
| Chen, JH; Dai, HH; Du, JJ; Liu, Y; Meng, L; Zhang, L; Zhang, ZJ | 1 |
| Bollow, M; Darwiche, K; Ewig, S; Gatermann, S; Totzeck, B | 1 |
| Fletcher, JW; Forquer, JA; Hoopes, DJ; Lin, PF; Lo, SS; McGarry, RC; Tann, M; Timmerman, RD | 1 |
| Antonelli, L; D'Urso, S; Nicolì, P; Orlacchio, A; Schillaci, O; Sergiacomi, G; Simonetti, G | 1 |
| Bentzen, SM; Boersma, L; Bosmans, G; Buijsen, J; De Ruysscher, D; Dehing-Oberije, C; Dekker, A; Hochstenbag, M; Houben, R; Lambin, P; van Baardwijk, A; van Kroonenburgh, M; van Suylen, RJ; Wanders, S | 1 |
| Alvey, S; Gabrielson, E; Gabrielson, K; Hagemann, RL; Kuhajda, FP; Lee, JS; Orita, H; Pomper, MG | 1 |
| Stroobants, SS; Vansteenkiste, JF | 1 |
| Govindan, R; Pillot, G; Siegel, BA | 1 |
| Baandrup, U; Madsen, HH; Palshof, T; Pedersen, U; Pilegaard, HK; Rasmussen, F; Rasmussen, K; Rasmussen, TR; Rehling, M | 1 |
| Bruzzi, JF; Erasmus, JJ; Munden, R; Sabloff, B; Truong, M; Zinner, R | 1 |
| Chen, SQ; Yu, JM | 1 |
| Endo, K; Hisada, T; Ishizuka, T; Kaira, K; Mori, M; Oriuchi, N; Otani, Y; Sunaga, N; Yanagitani, N | 1 |
| Buscombe, J; O'Rourke, E | 1 |
| Iwasaki, T; Kawahara, K; Nagano, T; Nakagawa, K | 1 |
| Choi, JY; Chong, S; Chung, MJ; Kim, BT; Lee, JY; Lee, KS; Oh, DK; Yi, CA | 1 |
| Bell, B; Solis, V; Vinson, AE; Williams, HT | 1 |
| Berthelsen, AK; Hillingsoe, J; Kirkegaard, P; Larsen, PN; Loft, A; Mogensen, AM; Rappeport, ED; Rasmussen, A; Thomsen, C; von der Recke, P; Wettergren, A | 1 |
| Strauss, HW | 1 |
| Bendayan, D; Fox, BD; Kramer, MR; Shechtman, I; Shitrit, D | 1 |
| Hanna, WT; Hubner, KF; Long, MJ; Nahmias, C; Townsend, DW; Wahl, LM | 1 |
| Bundschuh, RA; Essler, M; Martínez, MJ; Martínez-Moeller, A; Nekolla, SG; Schwaiger, M; Ziegler, SI | 1 |
| Mahajan, P; Wong, CY; Yan, D | 1 |
| Cascini, GL; Greco, C; Rosenzweig, K; Tamburrini, O | 1 |
| Chen, S; Cheng, TK; Ho, CL; Yeung, DW | 1 |
| Abe, S; Ikeda, M; Ishigaki, T; Ito, S; Iwano, S; Kato, K; Makino, N; Naganawa, S; Nakano, S; Nishino, M; Tadokoro, M | 1 |
| Buell, U; De Ruysscher, D; Dehing-Oberije, C; Dooms, C; Hochstenbag, M; Lambin, P; Pastorekova, S; Rupa, D; Stroobants, S; van Baardwijk, A; van Suylen, RJ; Vansteenkiste, J; Verbeken, E | 1 |
| Berlangieri, SU; Byrne, AJ; Clarke, CP; Knight, SR; Lee, ST; Mitchell, P; O'Keefe, GJ; Pathmaraj, K; Poon, AM; Scott, AM; Tabone, K | 1 |
| Bong, JS; Cheng, V; Chundru, S; Fink-Bennett, D; Gaskill, M; Grills, I; Kestin, L; Martinez, AA; Schmidt, J; Wong, CY; Yan, D | 1 |
| Derman, AY; Haramati, LB; Jain, VR; Jana, S; Levin, M; Merav, A; Sperling, D | 1 |
| Bandoh, S; Chang, SS; Haba, R; Ishikawa, S; Kanaji, N; Kushida, Y; Nakano, J; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Akhurst, T; Downey, RJ; Gonen, M; Park, B; Rusch, V | 1 |
| Adachi, S; Iwanaga, K; Kitamura, Y; Mimura, T; Ohbayashi, C; Okada, M; Sakuma, T; Tauchi, S; Watanabe, H | 1 |
| Huang, LL; Liang, TJ; Nie, YX; Qin, SL; Wang, Q; Wang, Y; Yue, MG; Zhang, CQ; Zhao, YM | 1 |
| Fujii, H; Goto, K; Kubota, K; Murakami, K; Nagase, S; Nawano, S; Niho, S; Nishiwaki, Y; Ohmatsu, H; Saijo, N; Sekiguchi, R; Yoh, K | 1 |
| Fazio, F; Giovacchini, G; Grimaldi, A; Mansueto, M; Messa, C; Pepe, G; Torbica, A | 1 |
| Aquino, S; Lanuti, M; Lee, SI; Miller, JC; Shepard, JA; Thrall, JH | 1 |
| Czernin, J; Phelps, ME; Weber, WA | 1 |
| Bastian, P; Freeman, JD; Hawes, SE; Nguyen, HQ; Salskov, A; Stern, J; Vallières, E; Vesselle, H; Wiens, L; Wood, DE | 1 |
| Coleman, RE; Gauger, J; Herndon, JE; Patz, EF | 1 |
| Hamanaka, N; Hata, Y; Homma, S; Isobe, K; Kato, N; Kimura, K; Sasamoto, S; Shimizu, K; Takagi, K | 1 |
| Chang, WC; Hung, YC; Kao, CH; Shen, HP | 1 |
| Altorki, NK; Korst, RJ; Lee, PC; Liss, Y; Meherally, DN; Port, JL | 1 |
| Fleshman, JW; Strasberg, SM; Yang, YY | 1 |
| Abenhardt, W | 1 |
| Chen, DW; Cheng, YL; Huang, TW; Lee, SC; Tsai, WC; Tzao, C | 1 |
| Asadpour, B; Breuer, C; Eble, MJ; Gagel, B; Kaiser, HJ; Krohn, T; Pinkawa, M; Piroth, M; Reinartz, P; Schmachtenberg, A; Stanzel, S | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Duvvi, H; Ohata, N; Ohki, M; Omura, Y; Shimotsuura, Y | 1 |
| Hemandas, AK; Hickish, T; Robson, NK; Talbot, RW | 1 |
| Al-Nahhas, A; Ambrosini, V; D'Errico, A; Fabbri, M; Fanti, S; Fini, M; Franchi, R; Nanni, C; Pettinato, C; Rubello, D; Spinelli, A; Trepidi, S; Zompatori, M | 1 |
| Chetty, IJ; Eisbruch, A; Frey, KA; Hayman, JA; Kessler, M; Kong, FM; Lawrence, TS; Normolle, D; Quint, LE; Ten Haken, RK | 1 |
| Ackerly, T; Andrews, J; Ball, D; Binns, D; D'Costa, I; Everitt, S; Hicks, RJ; Lau, E; Macmanus, M; Weih, L | 1 |
| Campistron, M; Chabbert, V; Courbon, F; Didier, A; Laroumagne, S; Mazières, J; Prévot, G; Rochaix, P; Rouquette, I; Têtu, L | 1 |
| Chin, K; Finger, PT; Kurli, M; Reddy, S; Tena, LB | 1 |
| Dilege, S; Ece, T; Erelel, M; Halac, M; Mudun, A; Sonmezoglu, K; Toker, A; Turkmen, C; Yilmazbayhan, D | 1 |
| Al-Sarraf, N; Doddakula, K; Wedde, T; Young, V | 1 |
| Al-Sarraf, N; Aziz, R; Doddakula, K; Gately, K; McGovern, E; Wilson, L; Young, V | 1 |
| Comans, EF; Craanen, ME; Paul, MA; Smit, EF | 1 |
| Barth, TF; Blumstein, NM; Schelzig, H; Zarbis, N | 1 |
| Dahele, MR; Ung, YC | 1 |
| Gosselin, R; Kelles, A; Maddens, S; Tournoy, KG; Van Maele, G; van Meerbeeck, JP | 1 |
| Tian, L; Wang, F; Wang, Z; Xie, H; Xu, J; Yao, W | 1 |
| Kaji, H; Kanegae, K; Kimura, K; Kuge, Y; Nakano, I; Okamoto, S; Shiga, T; Tamaki, N; Zhao, S | 1 |
| Harada, A; Hayasaka, K; Ito, K; Katoh, T; Kawabata, Y; Matsuura, T; Nakashima, K; Nihashi, T; Sakata, K; Yagi, T | 1 |
| Dooms, C; Stroobants, S; Vansteenkiste, J; Wynants, J | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Freudenberg, LS; Rosenbaum, SJ | 1 |
| Amrein, PC; Hales, CA; Kradin, RL; Meyer, GS; Sharma, A | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindie, E; Misset, JL; Moretti, JL; Toubert, ME; Vercellino, L | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Higashino, T; Kotani, Y; Koyama, H; Nishimura, Y; Nogami, M; Ohno, Y; Sugimura, K; Takenaka, D; Yoshikawa, T; Yoshimura, M | 1 |
| Fukuda, H | 1 |
| Akhurst, T; Kris, MG; Miller, VA; Milton, DT; Moore, E; Pao, W; Riely, GJ; Rizvi, NA; Schwartz, LH; Tyson, L; Zhao, B | 1 |
| Abraham, PJ; Burnett, OL; Festic, E; Johnson, MM; Young, PM | 1 |
| Buscombe, J; Cook, G; Eisen, T; Gleeson, F; O'Brien, M; Peake, MD; Rowell, NP; Seymour, R; Spiro, SG | 1 |
| Donington, JS; Graves, EE; Hara, W; Lavori, PW; Le, QT; Lee, P; Loo, BW; Maxim, PG; Quon, A; Wakelee, HA; Weerasuriya, DK | 1 |
| Gerbaudo, VH; Julius, B | 1 |
| Corstens, FH; de Geus-Oei, LF; Hermsen, R; Krabbe, PF; Oyen, WJ; Pruim, J; Timmer-Bonte, JN; van der Heijden, HF; van Hoorn, BA; Visser, EP; Willemsen, AT | 1 |
| Angulo-Zereceda, D; Mokhlesi, B; Yaghmai, V | 1 |
| Corstens, FH; de Geus-Oei, LF; Oyen, WJ; van der Heijden, HF | 1 |
| Bootsma, G; De Ruysscher, D; Dehing-Oberije, C; Geraedts, W; Hochstenbag, M; Lambin, P; Pitz, C; Rahmy, A; Simons, J; Steck, H; Teule, J; Thimister, P; van der Weide, H | 1 |
| Hall, NC; Kloos, RT | 1 |
| Koyama, H; Nogami, M; Ohbayashi, C; Ohno, Y; Sugimura, K; Takenaka, D; Yoshikawa, T; Yoshimura, M | 1 |
| Erasmus, JJ; Macapinlac, HA; Swisher, SG | 1 |
| Ballestín, C; Berrendero, JR; Cuezva, JM; García-García, E; López-Encuentra, A; López-Ríos, F; Ortega, AD; Pozo-Rodríguez, F; Sánchez-Aragó, M | 1 |
| Kunst, PW; Lee, P; Paul, MA; Senan, S; Smit, EF | 1 |
| Asakura, M; Bandoh, S; Ishikawa, S; Kanaji, N; Kimura, N; Nishiyama, Y; Ohkawa, M; Okuda, M; Yamamoto, Y | 1 |
| Endo, K; Hisada, T; Ishizuka, T; Kaira, K; Mori, M; Oriuchi, N; Sunaga, N; Tomizawa, Y; Yanagitani, N | 1 |
| Collins, CD | 1 |
| Alavi, A; Alkhawaldeh, K; Bural, G; Kumar, R | 1 |
| Graeter, TP; Groeschel, A; Hellwig, D; Kirsch, CM; Schaefers, HJ; Sybrecht, GW; Ukena, D | 1 |
| Dang, TP; Davies, AM; de Vries, DJ; Eberhard, DA; Garland, LL; Herbst, RS; Johnson, BE; Lutzker, SG; Lyons, B; Melenevsky, Y; Mendelson, D; Miller, VA; Natale, RB; Schiller, JH; Van den Abbeele, AD | 1 |
| Fleckenstein, JL | 1 |
| Conejo-Mir, JS; Congregado-Loscertales, M; Holgado, C; Loscertales, J; Moya, F; Muñoz, MA | 1 |
| Hasselblatt, M; Marquart, C; Schröder, J; Schueller, P; Wassmann, H; Weckesser, M | 1 |
| Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Touge, H; Yano, S | 1 |
| Fu, Z; Guo, HB; Han, AQ; Liu, LP; Yang, GR; Yu, JM | 1 |
| Dalesio, O; de Jong, WK; Groen, HJ; Oyen, WJ; Pruim, J; van der Heijden, HF | 1 |
| Fujii, M; Kiura, K; Takeda, H; Takigawa, N; Tanimoto, M | 1 |
| DeLellis, RA; Mayo-Smith, WW; Prince, EA; Yoo, DC | 1 |
| Boersma, L; Bosmans, G; De Ruysscher, D; Dekker, A; Lambin, P; Ollers, M; van Baardwijk, A; Wanders, S | 1 |
| Grohé, C; Ko, Y; Palmedo, H; Tasci, S | 1 |
| Bellón Guardia, ME; Gómez Río, M; Llamas Elvira, JM; Pedraza Muriel, V; Ramos Font, C; Rodríguez Fernández, A; Sánchez-Palencia Ramos, A | 1 |
| Baek, H; Byun, BH; Cheon, GJ; Choe, DH; Kang, HJ; Koh, JS; Lee, JC; Na, II; Park, JH; Ryoo, BY; Yang, SH | 1 |
| Han, J; Jeong, SY; Kim, BT; Kim, J; Kim, TS; Lee, KS; Shim, YM | 1 |
| Kim, J; Kim, S; Kostakoglu, L; Machac, J; Mocherla, B; Roayaie, S | 1 |
| Debruyne, C; Philippé, J; Van de Wiele, C; van Meerbeeck, JP; VandeVyver, F | 1 |
| Bentzen, SM; Boersma, L; De Ruysscher, D; Geraedts, W; Hochstenbag, M; Lambin, P; Minken, A; Pitz, C; Simons, J; van Haren, E; Verschueren, T; Wanders, R | 1 |
| Giaccone, G | 1 |
| Evans, WK; Gulenchyn, K; Lacchetti, C; Maziak, DE; Smith, CA; Ung, YC; Vanderveen, JA | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Plotkin, M; Ruf, J; Schönberger, S; Steffen, I; Stöver, B; Völker, T | 1 |
| Nakagawa, M; Osaki, T; Oyama, T; Takama, T | 1 |
| Chong, S; Lee, KS | 1 |
| Bae, YA; Chung, MJ; Han, J; Kim, BT; Kim, TS; Ko, YH; Lee, KS | 1 |
| Cavalcanti, JL; Macapinlac, HA; Mehran, RJ; Núñez, RF; Yeung, HW | 1 |
| Chang, CC; Chang, TT; Chen, YW; Chiu, SS; Huang, MY; Lee, CS; Liao, YM | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, JK; Lee, JD; Rha, SY; Yoon, KT; Yun, M | 1 |
| Lin, E | 1 |
| An, YS; Hwang, SC; Oh, YJ; Sheen, SS; Yoon, JK | 1 |
| Choi, JY; Kim, BT; Kim, S; Kwon, OJ; Lee, KS; Sung, YM; Yang, SO | 1 |
| Cheon, GJ; Choi, CW; Jung, JH; Kang, JH; Kim, JY; Kim, KM; Lee, TS; Lim, SM; Woo, SK | 1 |
| Alard, S; Berghmans, T; Buvat, I; Castaigne, C; Dusart, M; Hossein-Foucher, C; Lafitte, JJ; Mascaux, C; Meert, AP; Moreau, M; Paesmans, M; Patz, EF; Roelandts, M; Scherpereel, A; Sculier, JP | 1 |
| Isowa, N; Maeda, R; Miura, H; Onuma, H | 1 |
| Chung, JH; Kim, SE; Kim, YK; Lee, WW; Park, SY; Song, YS | 1 |
| Chen, YW; Chou, SH; Hou, MF; Hsieh, JS; Huang, MY; Lin, CL | 1 |
| Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
| Chen, P; Feng, H; Ma, L; Tan, Y; Tian, J; Wu, W; Xin, J; Yang, X; Yu, L; Zhao, Z | 1 |
| Alazraki, N; Coleman, RE; Fletcher, JW; Gould, M; Kymes, SM; Lee, K; Lowe, VJ; Marn, C; Segall, G; Thet, LA | 1 |
| Akin, ML; Filiz, AI; Kurt, Y; Sücüllü, I; Urhan, M | 1 |
| Li, G; Zhang, Y; Zhuang, H | 1 |
| Nguyen, BD; Roarke, MC | 1 |
| Hinterthaner, M; Stamatis, G | 1 |
| Liptay, MJ | 1 |
| Aerts, HJ; Bosmans, G; De Ruysscher, D; Dekker, AL; Lambin, P; Oellers, MC; van Baardwijk, AA | 1 |
| Carlos, RC; Cronin, P; Dwamena, BA; Kelly, AM | 1 |
| Bonardel, G; Bonnichon, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Mantzarides, M; Margery, J; Marotel, C; Rivière, F; Staub, E; Vaylet, F | 1 |
| Beneyton, V; Karamanoukian, D; Meyer, P; Niederst, C; Noël, G; Schumacher, C | 1 |
| Macapinlac, HA | 1 |
| Price, P; Rembielak, A | 1 |
| DU, SD; Huang, JF; Huo, L; Lu, X; Mao, YL; Sang, XT; Yang, ZY; Zhong, SX | 1 |
| Bae, YA; Choe, BK; Chung, MJ; Jeong, SY; Kim, BT; Kim, TS; Lee, KS; Shin, KM | 1 |
| Marom, EM; Truong, MT | 1 |
| Al-Sarraf, N; Gately, K; Lucey, J; McGovern, E; Wilson, L; Young, V | 1 |
| Chang, YC; Chen, KC; Cheng, MF; Lee, JM; Lee, YC; Wang, J; Wu, YW; Yen, RF | 1 |
| Ahn, MI; Choi, JJ; Jeon, JS; Park, MY; Park, YH | 1 |
| Duclos, A; Giammarile, F; Hau, NH; Ravel, AC; Souquet, PJ | 1 |
| Dehdashti, F; Gao, F; Goodgame, B; Govindan, R; Meyers, BF; Patterson, A; Pillot, GA; Shriki, J; Siegel, BA; Yang, Z; Zoole, J | 1 |
| Baggstrom, MQ; Gao, F; Goodgame, B; Govindan, R; Morgensztern, D | 1 |
| Decoster, L; Nackaerts, K; Stroobants, S; Vansteenkiste, J; Verbeken, E | 1 |
| Bellomi, M; Bertolotti, R; Leo, F; Maisonneuve, P; Mulshine, JL; Paganelli, G; Pelosi, G; Preda, L; Scanagatta, P; Solli, P; Spaggiari, L; Veronesi, G | 1 |
| De Leyn, P; Dooms, C; Nackaerts, K; Stroobants, S; Vansteenkiste, J; Verbeken, E | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lazúrová, I; Ling, A; Pacak, K; Reynolds, JC; Timmers, HJ; Whatley, MA; Widimsky, J; Zelinka, T | 1 |
| Fukasawa, I; Hagiwara, S; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Chung, JH; Kim, SE; Lee, WW; Nguyen, XC; Park, SY; So, Y | 1 |
| Maele, GV; Praet, M; Ryck, FD; Tournoy, KG; van Meerbeeck, JP; Vanwalleghem, L; Vermassen, F | 1 |
| Englmeier, KH; Seemann, MD | 1 |
| Bosmans, G; De Ruysscher, D; Geskes, G; Hochstenbag, M; Lambin, P; van Baardwijk, A; van Kroonenburgh, M; van Suylen, RJ | 1 |
| Alavi, A; Basu, S; Houseni, M; Kung, J; Tidmarsh, GF; Zhuang, H | 1 |
| Borger, J; Bosmans, G; De Ruysscher, D; Dekker, A; Dingemans, AM; Hochstenbag, M; Houben, R; Lambin, P; Oellers, M; Offermann, C; Snoep, G; Teule, J; van Baardwijk, A; van Loon, J; Wanders, R | 1 |
| Boterberg, T; Goethals, I; Ost, P; Rottey, S; Smeets, P; Stragier, B | 1 |
| Martinez, S; McAdams, HP; Youens, KE | 1 |
| Dong, ZM; Feng, Q; Hawes, SE; Jordan, CD; Kiviat, NB; Lu, H; Stern, JE; Vesselle, H; Wiens, L | 1 |
| Coan, AD; Coleman, RE; Herndon, JE; Hoagland, LF; Hoang, JK; Patz, EF | 1 |
| Gelblum, D; Greco, C; Jackson, A; Rosenzweig, KE; Sura, S; Yorke, ED | 1 |
| Cornet, J; Coulon, C; Distexhe, J; Hanin, FX; Lonneux, M; Noirhomme, P; Poncelet, AJ | 1 |
| Bergot, E; Paparel, P; Zalcman, G | 1 |
| Ikeda, K; Katahira, K; Kawanaka, K; Mori, T; Nomori, H; Shiraishi, S; Yamashita, Y | 1 |
| Byun, BH; Cheon, GJ; Choe, DH; Kang, HJ; Kim, CH; Koh, JS; Lee, JC; Lim, SM; Na, II; Ryoo, BY; Yang, SH | 1 |
| Geus-Oei, LF; Oyen, WJ | 1 |
| De Grève, J; De Mey, J; Decoster, L; Everaert, H; Meysman, M; Neyns, B; Nieboer, K; Schallier, D | 1 |
| Ichinose, Y; Maruyama, R; Nishiyama, K; Okamoto, T; Seto, T; Suemitsu, R; Wataya, H | 1 |
| Nguyen, NC; Osman, MM; Sayed, MM; Taalab, K | 1 |
| Halac, M; Karyagar, S; Karyagar, SS; Mulazimoglu, M; Ozpacaci, T | 1 |
| Cox, JD; Erasmus, JJ; Kased, N; Komaki, R | 1 |
| Benson, MJ; Carden, CP; Larkin, JM; Montes, A; Myerson, JS; O'Brien, ME; Popat, S | 1 |
| Block, MS; Vassallo, R | 1 |
| Asai, T; Kinouchi Shimizu, N; Oku, N; Shimizu, K; Tsukada, H | 1 |
| Lucignani, G | 1 |
| Bashir, H; Nunan, TO; Shabo, G | 1 |
| Meng, X; Mu, DB; Sun, XD | 1 |
| Corstens, FH; de Geus-Oei, LF; Kaanders, JH; Kienhorst, L; Oyen, WJ; Philippens, ME; Visser, EP | 1 |
| Alloisio, M; Cappuzzo, F; Ceresoli, GL; Di Tommaso, L; Incarbone, M; Infante, M; Inzirillo, F | 1 |
| Chan, SC; Chang, JT; Chin, SC; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| El-Haddad, G; Lilien, DL; Patterson, JC; Takalkar, AM | 1 |
| Bockisch, A; Eberhardt, W; Gauler, T; Krbek, T; Kuehl, H; Levegruen, S; Poettgen, C; Stamatis, G; Stuschke, M; Teschler, H; Theegarten, D | 1 |
| Akaki, S; Gobara, H; Higaki, F; Hiraki, T; Kanazawa, S; Mimura, H; Okumura, Y; Sato, S; Tsuda, T | 1 |
| DePalo, L; Gribetz, A; Kim, CK; Kim, SC; Knesaurek, K; Krellenstein, D; Krynyckyi, BR; Machac, J; Schultz, B; Teirstein, A | 1 |
| Precht, LM; Vallières, E | 1 |
| Koyama, H; Maniwa, Y; Nishimura, Y; Nogami, M; Ohbayashi, C; Ohno, Y; Sugimura, K; Takenaka, D | 1 |
| Goodman, PC; Herndon, J; Lowe, VJ; Patz, EF | 1 |
| Cronin, BF; Flower, MA; Horwich, A; McCready, VR; Ott, RJ; Pratt, BE; Wilson, CB; Young, HE | 1 |
| Coleman, RE; Duhaylongsod, FG; Lowe, VJ; Patz, EF; Vaughn, AL; Wolfe, WG | 2 |
| Ball, D; Bohdiewicz, PJ; Dworkin, H; Juni, JE | 1 |
| Alavi, A; Buchpiguel, C; Chin, BB; Zukerberg, BW | 1 |
| Alexander, C; Berberich, R; Holle, LH; Oberhausen, E; Ruth, T; Sybrecht, GW; Trampert, L; Ukena, D | 1 |
| Dewan, NA; Gobar, LS; Gupta, NC; Reeb, SD; Scott, WJ | 1 |
| Bishop, J; Frank, A; Gobar, L; Gupta, N; Jaeger, S; Lefkowitz, D; Lynch, H; Mailliard, J; Scott, W; Sunderland, J | 1 |
| Dewan, NA; Gobar, LS; Hauser, LG; Scott, WJ; Sugimoto, JT; Sunderland, JJ | 1 |
| Bassa, P; Endo, K; Inoue, T; Kim, EE; Komaki, R; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Coleman, RE; DeLong, DM; Hoffman, JM; Lowe, VJ | 1 |
| Minn, H; Quint, LE; Wahl, RL; Zasadny, KR | 1 |
| Buonocore, E; Cotten, DW; Gould, HR; Hübner, KF; Singh, SK | 1 |
| Bischoff, HG; Knopp, MV | 1 |
| Aerts, R; Beets, G; De Roo, M; Filez, L; Kerremans, R; Mortelmans, L; Penninckx, F; Schiepers, C | 1 |
| Dewan, NA; Gupta, NC; Reeb, SD; Schwabe, JL; Scott, WJ; Sugimoto, JT | 1 |
| Coleman, RE; DeLong, DM; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
| Dussek, J; Gee, T; Griffin, S; Lewis, P; Malsey, M; Marsden, P; Nunan, T | 1 |
| Alpert, NM; Babich, JW; Choi, NC; Fischman, AJ; Hamberg, LM; Hunter, GJ | 1 |
| Greenough, RL; Meyer, CR; Orringer, MB; Quint, LE; Wahl, RL; White, RI | 1 |
| Goodman, PC; Harris, LK; Hoffman, JM; Lowe, VJ; Paine, SS; Patz, EF | 1 |
| Irimura, T; Koike, C; Okada, S; Oku, N; Sugawara, M; Tsukada, H | 1 |
| Couson, F; Donath, A; Junod, AF; Lemoine, R; Louis, O; Nicod, L; Slosman, DO; Spiliopoulos, A | 1 |
| Burrowes, P; Coleman, RE; Goodman, PC; Hoffman, JM; Lowe, VJ; Paine, SS; Patz, EF | 1 |
| Glaspy, JA; Hawkins, R; Hoh, CK; Phelps, ME | 1 |
| Aberle, DR; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Phelps, ME; Razavi, MK; Rege, SD | 1 |
| Choi, NC; Fischman, AJ; Hunter, GJ; McLoud, TC | 1 |
| Dewan, NA; Frick, MP; Gupta, NC; Phalen, JJ; Redepenning, LS | 1 |
| Ackermann, RJ; Meyer, MA; Sisson, JC; Wahl, RL | 1 |
| Braun, U; Feinendegen, LE; Herzog, H; Kuwert, T; Langen, KJ; Nebeling, B; Rota Kops, E | 1 |
| Chin, R; Choplin, RH; Haponik, EF; Hudspeth, AS; Keyes, JW; Reed, JC; Wallenhaupt, S; Ward, R | 1 |
| McClaughry, P; Meyer, MA | 1 |
| Eades, CG; Fahey, FH; Gage, HD; Harkness, BA; Keyes, JW; Pelizzari, CA; Yu, JN | 1 |
| Blahd, W; Brown, C; Khonsary, A; Mandelkern, M; Santiago, SM; Sazon, DA; Soo Hoo, GW; Williams, AJ | 1 |
| Delbeke, D; Knight, SB; Sandler, MP; Stewart, JR | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Ishida, T; Kuwabara, Y; Masuda, K; Murayama, S; Sasaki, M; Sugio, K; Yoshida, T | 1 |
| Han, J; Jang, HJ; Kwon, OJ; Lee, KS; Rhee, CH; Shim, YM | 1 |
| Anscher, MS; Hebert, ME; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
| Gunel, E; Gupta, NC; Maloof, J | 1 |
| Alpert, NM; Choi, NC; Fischman, AJ; Hamberg, LM; Hunter, GJ | 1 |
| Larcos, G; Maisey, MN | 1 |
| Miyauchi, T; Wahl, RL | 1 |
| Wagner, HN | 3 |
| Bury, T; Corhay, JL; D'Harcour, JB; Limet, R; Paulus, P; Radermecker, MF; Rigo, P; Weber, T | 1 |
| Hawkins, RA; Hoh, CK; Huang, SC; Phelps, ME; Wu, HM; Yao, WJ | 1 |
| Gambhir, SS; Hoh, CK; Madar, I; Maddahi, J; Phelps, ME | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Kawashima, A; Kuwabara, Y; Masuda, K; Omagari, J; Sasaki, M; Yoshida, T | 1 |
| Hughes, JM | 1 |
| Bury, T; Dowlati, A; Hustinx, R; Paulus, P; Radermecker, M; Rigo, P | 1 |
| Kison, PV; Quint, LE; Wahl, RL; Zasadny, KR | 1 |
| Bischoff, H; Knopp, MV; Oberdorfer, F; Rimac, A; van Kaick, G | 1 |
| Ide, M; Shohtsu, A; Takagi, S; Yasuda, S | 1 |
| Buonocore, E; Dickey, J; Gould, HR; Hübner, KF; Smith, GT; Stephens, S; Thie, J | 1 |
| Kubota, K | 2 |
| Albert, A; Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Limet, R; Paulus, P; Radermecker, M; Rigo, P; Schoffers, J; Weber, T | 1 |
| Allemann, F; Berthold, T; Engel, H; Hauser, M; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Coleman, RE; Delong, DM; Duhaylongsod, FG; Hoffman, JM; Lowe, VJ; Patz, EF; Wolfe, WG | 1 |
| Adam, MJ; Celler, A; Champion, P; Coupland, DB; Evans, KG; Finley, RJ; Kwong, JS; Lyster, DM; Müller, NL; Worsley, DF | 1 |
| Bazzicalupo, L; Fiore, F; Gravina, A; Mainolfi, C; Maurea, S; Panico, MR; Salvatore, M; Wang, H | 1 |
| Lamki, LM | 1 |
| Coleman, RE; Erasmus, JJ; Goodman, PC; Herndon, J; McAdams, HP; Murray, JG; Patz, EF | 1 |
| Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN; Storck, M; Sunder-Plassmann, L | 1 |
| Deloar, HM; Fujiwara, T; Hayashi, Y; Itoh, M; Kanamaru, R; Miyake, M; Nakamura, T; Takahashi, H; Watabe, H; Yoshioka, T | 1 |
| Schiepers, C | 1 |
| Makler, PT | 1 |
| Altmann, A; Haberkorn, U; Kaick, GV; Klenner, T; Oberdorfer, F; Stöhr, M; Strauss, LG; Wallich, R | 1 |
| Cronin, V; Galantowicz, P; Nabi, HA | 1 |
| Fukuda, H; Kubota, K; Saitou, Y; Takahashi, J; Tanida, T; Yamada, K; Yamada, S | 1 |
| Burdon, TA; Hagberg, RC; Pompili, MF; Segall, GM; Stark, P | 1 |
| Dewan, NA; Gobar, LS; Reeb, SD; Ryschon, K; Scott, WJ; Shehan, CJ | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Lapela, M; Leskinen, S; Lindholm, P; Minn, H | 1 |
| De Leyn, PR; Dupont, PJ; Mortelmans, LA; Nackaerts, KL; Stroobants, SG; Vansteenkiste, JF; Verschakelen, JA | 1 |
| Carreras Delgado, JL | 1 |
| Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Hustinx, R; Paulus, P; Radermecker, M; Rigo, P | 1 |
| Higashi, K; Nambu, Y; Nishikawa, T; Oguchi, M; Okimura, T; Seki, H; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Calvo, R; López Cabrerizo, MP; Martín, C; Martínez Roca, M; Maurel, J; Rosell, R | 1 |
| Dietlein, M; Scheidhauer, K; Schicha, H; Theissen, P; Voth, E | 1 |
| Bakheet, SM; Powe, J | 1 |
| Coleman, RE; Delbeke, D; Fletcher, JW; Gobar, L; Heiberg, EV; Hubner, K; Karis, J; Kirchner, P; Lawson, M; Lowe, VJ; Patz, EF; Valk, P | 1 |
| Carreras Delgado, JL; Torres García, AJ | 1 |
| Cheon, EM; Han, J; Kim, BT; Kim, Y; Kwon, OJ; Lee, KS; Rhee, CH; Shin, MH; Yoon, SB | 1 |
| Björnsson, EH; Gustafsson, GR; Lamberg, K; Långström, B; Nettelbladt, OS; Sundin, AE; Valind, SO | 1 |
| Badawi, RD; Lodge, MA; Marsden, PK | 1 |
| Ahuja, V; Coleman, RE; Erasmus, JJ; Goodman, PC; McAdams, HP; Patz, EF | 1 |
| Deters, EC; Gross, MD; Kison, PV; Shreve, PD; Steventon, RS; Wahl, RL | 1 |
| Recker, B; Torizuka, T; Wahl, RL; Zasadny, KR | 1 |
| Bingham, JB; Fletcher, CD; Lucas, JD; McKee, PH; O'Doherty, MJ; Smith, MA; Wong, JC | 1 |
| Bogaert, J; De Leyn, PR; Demedts, MG; Deneffe, GJ; Dupont, PJ; Lerut, TE; Maes, A; Mortelmans, LA; Nackaerts, KL; Stroobants, SG; Vansteenkiste, JF; Verschakelen, JA | 1 |
| Higashi, K; Noguchi, T; Oguchi, M; Okimura, T; Seki, H; Taniguchi, M; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Berlangieri, SU; Clarke, CP; Daniel, FJ; Feigen, M; Kiffer, JD; Knight, SR; Quong, G; Schumer, W; Scott, AM | 1 |
| Lowe, VJ; Naunheim, KS | 1 |
| Fujiwara, T; Fukuda, H; Imran, MB; Itoh, M; Kubota, K; Yamada, K; Yamada, S | 1 |
| Kapucu, LO; Keenan, RJ; Luketich, JD; Meltzer, CC; Townsend, DW | 1 |
| Bury, Th | 1 |
| Barreto, A; Barthelemy, N; Bury, T; Daenen, F; Ghaye, B; Rigo, P | 1 |
| al Roubaie, Z; Chapot, C; Kirsch, CM | 1 |
| Ahuja, V; Coleman, RE; Herndon, J; Patz, EF | 1 |
| Bakheet, SM; Bakri, Y; Ezzat, A; Powe, J | 1 |
| Bruchhaus, H; Hillinger, S; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Eary, JF; Graham, MM; Grierson, JR; Kozawa, SM; Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Mankoff, DA; Shields, AF; Zheng, M | 1 |
| Bishop, H; Gill, H; Graeber, G; Gupta, N; Hurst, J; Stephens, T | 1 |
| Bogaert, JG; De Leyn, PR; De Wever, WF; Dupont, PJ; Maes, FP; Nuyts, JL; Stroobants, SG; Vansteenkiste, JF; Verbeken, EK | 1 |
| Al-Sugair, A; Coleman, RE | 1 |
| Bendriem, B; De Dreuille, O; Foehrenbach, H; Gaillard, JF; L'Her, P; Maszelin, P; Merlet, P; Syrota, A; Vaylet, F | 1 |
| Präuer, HW; Römer, W; Schwaiger, M; Treumann, T; Weber, WA; Ziegler, SI | 1 |
| Gross, MD; Shreve, PD; Steventon, RS | 1 |
| Burt, R | 1 |
| Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H | 1 |
| De Leyn, PR; Dupont, PJ; Stroobants, SG; Vansteenkiste, JF; Verbeken, EK | 1 |
| Gambhir, SS; Scott, WJ; Shepherd, J | 1 |
| Franzius, C; Schober, O; Sciuk, J | 1 |
| Bruchhaus, H; Hillinger, S; Largiadèr, F; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Artus, JC; Herry, JY; Lumbroso, J; Maublant, J; Muratet, JP; Talbot, JN; Vuillez, JP | 1 |
| Bishop, HA; Graeber, GM; Gupta, NC; Rogers, JS | 1 |
| Hatazawa, J; Kawamura, M; Orino, K; Sazawa, Y; Suzuki, I | 1 |
| Graeber, GM; Gupta, NC; Murray, GF | 1 |
| Ali, A; Cai, J; Chu, JC; Nguyen, C; Recine, D; Rodebaugh, R; Saxena, VA; Sharma, M | 1 |
| Bartenstein, P; Enterrottacher, A; Häussinger, KE; King, B; Krapf, M; Lichte, H; Neverve, J; Präuer, HW; Schwaiger, M; Sklarek, J; Thetter, O; Treumann, T; Weber, WA; Ziegler, SI | 1 |
| Drane, WE; Fenton, JJ; Harman, EM; Mastin, ST; Quesenberry, L | 1 |
| Brown, RS; Flint, A; Kison, PV; Leung, JY; Wahl, RL; Zasadny, KR | 1 |
| Johkoh, T; Kusuoka, H; Miyoshi, S; Nakamura, H; Nishimura, T; Tatsumi, M; Tomiyama, N; Watanabe, Y; Yutani, K | 1 |
| Abdel-Dayem, HM; Caputo, G; Gates, M; Hines, H; Khanvali, B; Leung, AN; Liebig, JR; Parker, A; Sfakianakis, G; Sollitto, R; Stokkel, MP; Swaney, CM; Wagner, HN; Weber, W; Weir, GJ; Young, C | 1 |
| Dussek, JE; Maisey, MN; O'Doherty, MJ; Saunders, CA | 1 |
| Coleman, RE | 5 |
| Hellwig, D; Kirsch, CM; Licht, N; Motaref, B; Nestle, U; Nieder, C; Niewald, M; Schmidt, S; Schnabel, K; Sybrecht, GW; Ukena, D; Walter, K | 1 |
| Hellwig, A; Hellwig, D; Kirsch, CM; Leutz, M; Palm, I; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Büll, U; Cremerius, U; Kaiser, HJ; Reinartz, P; Sabri, O; Schreckenberger, M; Zimny, M | 1 |
| Brink, I; Moser, E; Nitzsche, EU; Schumacher, T | 1 |
| Hoekstra, CJ; Hoekstra, OS; Postmus, PE; Smit, EF; Teengs, JP | 1 |
| Nishimura, A; Ohira, S; Shinohara, M; Tomita, M | 1 |
| Cho, BY; Choi, CW; Chung, JK; Hong, SW; Lee, DS; Lee, JS; Lee, MC; Lim, SM; So, Y; Youn, YK | 1 |
| Endo, K | 1 |
| Coleman, RE; Culhane, DK; Erasmus, JJ; Goodman, PC; Herndon, JE; Marom, EM; McAdams, HP; Patz, EF | 1 |
| Graz, KF; Manns, MP; Meier, PN; Mix, H; Petrich, T; van den Hoff, J; Wagner, S; Widjaja, A | 1 |
| De Leyn, PR; Demedts, MG; Deneffe, GJ; Dupont, PJ; Mortelmans, LA; Stroobants, SG; Vansteenkiste, JF; Verbeken, EK | 1 |
| Kawabe, J; Koyama, K; Ochi, H; Okamura, T; Shakudo, M; Shimonishi, Y; Wanibuchi, H; Yamada, R | 1 |
| Amano, S; Aoki, J; Aoyagi, K; Endo, K; Inoue, T; Kunio, M; Oriuchi, N; Sato, T; Suzuki, H; Tomaru, Y; Tomiyoshi, K | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
| Berlangieri, SU; Clarke, CP; Fitt, GJ; Hennessy, OF; Knight, SR; McKay, WJ; Scott, AM; Tochon-Danguy, HJ | 1 |
| Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA | 1 |
| Bakker, PF; Heine, R; Lammers, JW; Schlösser, NJ; Stokkel, MP; Van Rijk, PP | 1 |
| Erasmus, JJ; Patz, EF | 1 |
| Han, M; Hwang, S; Kim, S; Lee, C; Pai, M; Park, CH | 1 |
| Carretta, A; Del Maschio, A; Fazio, F; Gilardi, MC; Landoni, C; Lucignani, G; Magnani, P; Messa, C; Rizzo, G; Vanzulli, A; Zannini, P | 1 |
| Aramendia, JM; Brugarolas, A; Crespo, A; Gámez, C; Nicolás, A; Richter, JA; Torre, W | 1 |
| Buchmann, I; Buck, A; Elsner, K; Gfrörer, W; Guhlmann, CA; Kotzerke, J; Reske, SN; Schirrmeister, H | 1 |
| Biersack, HJ; Briele, B; Grünwald, F; Ruhlmann, J; Willkomm, P | 1 |
| Bleckmann, C; Bohuslavizki, KH; Buchert, R; Clausen, M; Dose, J; Jänicke, F; Klutmann, S; Mester, J | 1 |
| Czernin, J; Farquhar, TH; Gambhir, SS; Hoffman, EJ; Hoh, CK; Hsu, C; Llacer, J; Qi, J; Seltzer, MA; Silverman, DH | 1 |
| Barthelemy, N; Bartsch, P; Bury, T; Corhay, JL; Daenen, F; Duysinx, B; Ghaye, B; Rigo, P | 1 |
| Kase, S; Sasaki, M; Sugimachi, K; Sugio, K; Yamazaki, K | 1 |
| Arisaka, Y; Higashi, K; Nambu, Y; Oguchi, M; Sakurai, A; Seki, H; Tonami, H; Ueda, Y; Yagishita, M; Yamamoto, I | 1 |
| Collins, BT; Dunphy, FR; Lowe, VJ | 1 |
| Shreve, PD | 1 |
| Brown, C; Juillard, G; Mandelkern, M; Mark, R; Rege, S; Sadeghi, A; Safa, A; Santiago, S; Tran, L; Weng, E | 1 |
| Connolly, J; Herndon, J; Patz, EF | 1 |
| Bishop, HA; Graeber, GM; Gupta, NC | 1 |
| Calvo, R; Crespo-Jara, A; García-Velloso, MJ; Martí-Climent, JM; Peñuelas, I; Richter, JA; Villar, LM | 1 |
| Hellwig, AP; Hellwig, D; Kirsch, CM; Leutz, M; Palm, I; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Al-Amro, A; Bakheet, SM; Larsson, SG; Mahassin, Z; Powe, J; Saleem, M | 1 |
| Beitler, JJ | 1 |
| Bruun, E; Hansen, IL | 1 |
| Alavi, A; Duarte, PS; Li, P; Pourdehnad, M; Zhuang, H | 1 |
| Baier, P; Dingeldey, A; Einert, A; Farthmann, EH; Imdahl, A; Mix, M; Nitzsche, EU; Reinhardt, MJ | 1 |
| Bury, T; Rigo, P | 1 |
| Erasmus, JJ; Marom, EM; Patz, EF | 1 |
| Bartsch, P; Bury, T; Corhay, JL; Duysinx, B; Rigo, P | 1 |
| O'Doherty, MJ | 1 |
| Farrell, MA; Herndon, JE; McAdams, HP; Patz, EF | 1 |
| Buchter, A; Hellwig, D; Kirsch, CM; Sommerfeld, A; Ukena, D; Zell, L | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU | 1 |
| De Leyn, PR; De Wever, W; Gatti, GG; Huyskens, DP; Kutcher, GJ; Stroobants, SG; Vansteenkiste, JF; Vanuytsel, LJ; Verbeken, EK | 1 |
| Coleman, RE; Erasmus, JJ; Goodman, PC; McAdams, HP; Patz, EF; Rossi, SE | 1 |
| Antoine, JC; Bouhour, F; Camdessanché, JP; Cinotti, L; Confavreux, C; Honnorat, J; Michel, D; Renault-Mannel, V; Tilikete, C; Vighetto, A | 1 |
| Fidler, V; Groen, HJ; Koëter, GH; Meuzelaar, JJ; Mooyaart, EL; Pieterman, RM; Pruim, J; Vaalburg, W; van Putten, JW | 1 |
| Berlangieri, SU; Scott, AM | 1 |
| Bar-Shalom, R; Blaufox, MD; Valdivia, AY | 1 |
| Beyer, T; Brun, T; Byars, L; Charron, M; Jerin, J; Kinahan, PE; Nutt, R; Roddy, R; Townsend, DW; Young, J | 1 |
| Fernandez, O; Galbis, J; Garcia-Velloso, MJ; Richter, J; Torre, W | 1 |
| Erdi, AK; Erdi, YE; Humm, JL; Larson, SM; Macapinlac, H; Rosenzweig, KE; Yorke, ED | 1 |
| Papatheofanis, FJ | 1 |
| Adams, S; Hör, G; Nickel, E | 1 |
| Hara, T; Inagaki, K; Kosaka, N; Morita, T | 1 |
| Allaoua, M; Barghouth, G; Goerres, GW | 1 |
| Dietlein, M; Gossmann, A; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Stützer, H | 1 |
| Dhital, K; Dussek, J; O'Doherty, MJ; Saunders, CA; Seed, PT | 1 |
| Frank, J; Grosse, S; Guhlmann, A; Halter, G; Liewald, F; Storck, M | 1 |
| Grosse, S; Guhlmann, A; Halter, G; Liewald, F; Reske, S; Storck, M; Sunder-Plassmann, L | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
| Ayabe, K; Higashi, K; Katsuda, S; Nambu, Y; Oguchi, M; Sakurai, A; Seki, H; Shikata, H; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Ak, I; Pauwels, EK; Stokkel, MP | 1 |
| Kohlmyer, SG; Li, M; Pugsley, JM; Schmidt, RA; Vallires, E; Vesselle, H; Wood, DE | 1 |
| Agress, H | 1 |
| Carreras, JL; Domper, M; Expósito, R; Jiménez-Vicioso, A; Montz, R; Ortega, A; Pérez-Castejón, MJ | 1 |
| Bousson, V; Breau, JL; de Beco, V; Groiselle, C; Hillali, Y; Moretti, JL; Safi, N; Tamgac, F; Valeyre, D; Weinmann, P | 1 |
| Chu, J; Delaney, G; Kiat, H; Lin, P; Pocock, N | 1 |
| Kim, S; Pai, M; Park, CH; Whang, KH; Yoon, SN | 1 |
| Dietlein, M; Gandjour, A; Lauterbach, KW; Moka, D; Schicha, H; Theissen, P; Weber, K | 2 |
| Futatsubashi, M; Kanno, T; Kasamatsu, N; Momiki, S; Nobezawa, S; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E | 1 |
| Goldberg, M; Unger, M | 1 |
| Fujibayashi, Y; Itoh, H; Sadato, N; Sugimoto, K; Takahashi, N; Tsuchida, T; Waki, A; Welch, MJ; Yonekura, Y | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Ito, H; Miyamori, I; Mizuno, S; Okamura, S; Totani, Y; Wakabayashi, M; Yonekura, Y | 2 |
| Aigner, RM; Karpf, E; Schwarz, T; Wurzinger, G | 1 |
| Ball, DL; Binns, DS; Hicks, RJ; Hogg, A; Kalff, V; MacManus, MP; McKenzie, AF; Ware, RE | 1 |
| Benard, F; Boileau, R; Mongeau, CJ; Turcotte, E; Verreault, J | 1 |
| Fujii, H; Ide, M; Kubo, A; Mochizuki, Y; Nakahara, T; Shohtsu, A; Takahashi, W; Yasuda, S | 1 |
| Case, L; Chin, R; Dunagan, D; Haponik, E; Harkness, B; McCain, T; Oaks, T | 1 |
| Donckier, JE; Pochet, JM; Roelants, V | 1 |
| Higashi, K; Katsuda, S; Murakami, M; Nambu, Y; Oguchi, M; Sakurai, A; Seki, H; Taki, S; Tonami, H; Ueda, Y; Wang, XM; Xu, L; Yamamoto, I | 1 |
| Akiyama, Y; Hara, T; Inagaki, K; Kudo, K; Morita, T; Soma, T; Suzuki, T; Takeda, Y; Tnabe, M; Yano, M | 1 |
| de Dreuille, O; Dot, JM; Foehrenbach, H; Gaillard, JF; Grassin, F; Guigay, J; L'Her, P; Margery, J; Maszelin, P; Vaylet, F | 1 |
| Breuer, R; Chisin, R; Rubinstein, R | 1 |
| Chisin, R; Larson, SM; Macapinlac, HA; Ramos, CD; Yeung, HW | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Carette, MF; Cosset, JM; Deniaud-Alexandre, E; Giraud, P; Grahek, D; Housset, M; Julia, F; Montravers, F; Rosenwald, JC; Talbot, JN; Touboul, E | 1 |
| Crotty, E; Patz, EF | 1 |
| Ho, YJ; Hung, GU; Kao, CH; Shiau, YC; Tsai, SC; Yen, RF | 1 |
| Hahm, DS; Kim, SE; Na, DL; Park, JM | 1 |
| Angelides, S; Dixon, J; Roman, MR; Rossleigh, MA; Walker, BM | 1 |
| Abdel-Dayem, HM; Ajoedi, ND; Ansari, SM; Dede, F; Heiba, SI; Jana, S | 1 |
| Alavi, A; Yamamoto, AJ; Zhuang, H | 1 |
| Bhola, R; Lin, EC | 1 |
| Kato, T; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Nakada, K; Shiga, T; Tamaki, N; Tsukamoto, E; Yoshinaga, K | 1 |
| de Vries, EG; Groen, HJ; Jager, PL; Piers, DA; Pieterman, RM; van der Leest, A; van Putten, JW | 1 |
| Boellaard, R; Lammertsma, AA; van Lingen, A | 1 |
| Dworkin, HJ; Wong, CO | 1 |
| Borges-Neto, S; Ravizzini, GC; Wagner, M | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Brink, I; Digel, W; Henke, M; Herget, G; Mix, M; Moser, E; Nitzsche, E; Reinhardt, M; Schumacher, T | 1 |
| Al Suhaibani, H; Bakheet, S; Kerr, IG; Manji, MF; Powe, J; Subhi, J | 1 |
| Ball, DL; Hicks, RJ; Hogg, A; MacManus, MP; Matthews, JP; McKenzie, AF; Ware, RE; Wirth, A | 1 |
| Cho, BY; Chung, JK; Jang, JJ; Jeong, JM; Lee, DS; Lee, MC; Lee, YJ; Min, JJ | 1 |
| Goldstraw, P; Kutlu, CA; Maisey, M; Pastorino, U | 1 |
| Bielack, S; Daldrup-Link, HE; Franzius, C; Jürgens, H; Rummeny, EJ; Schober, O; Sciuk, J | 1 |
| Akaizawa, T; Fukuda, H; Itoh, M; Kubota, K; Ono, S; Ozaki, K; Tashiro, M; Yamada, K; Yamaguchi, K | 1 |
| Fujibayashi, Y; Itoh, H; Kubota, T; Maruyama, I; Nishizawa, S; Tsuchida, T; Waki, A; Yamamoto, T; Yonekura, Y; Yoshida, M | 1 |
| Alavi, A; Ghesani, N; Yamamoto, AJ; Zhuang, H | 1 |
| Brink, I; Hasse, J; Imdahl, A; Jenkner, S; Moser, E; Nitzsche, E; Stoelben, E | 1 |
| Fuentes, MA; Griffiths, MR; Miles, KA | 1 |
| Bishop, HA; Graeber, GG; Gupta, NC; Hobbs, GR; Tamim, WJ | 1 |
| Cronin, BF; Hallett, WA; Marsden, PK; O'Doherty, MJ | 1 |
| Huber, RM; Thomas, M | 1 |
| Gröschel, A; Hellwig, D; Kirsch, CM; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Bamberg, M; Hellwig, D; Kirsch, CM; Paulsen, F; Ukena, D | 1 |
| Coche, E; Lonneux, M; Noirhomme, P; Poncelet, AJ; Weynand, B | 1 |
| Coates, G; Nahmias, C; O'Donovan, N; Otero, C; Pelling, M; Skehan, SJ | 1 |
| Laking, G; Price, P | 1 |
| Koizumi, M; Maekawa, K; Miyazaki, C; Osawa, H; Tanaka, A; Tanaka, T; Watanabe, N | 1 |
| Ball, DL; Hicks, RJ; Kalff, V; Khaw, P; Mac Manus, MP; Matthews, JP; McKenzie, A; Rischin, D; Salminen, E; Wirth, A | 1 |
| Bushnell, DL; Kahn, D; Kernstine, KH; Madsen, MT; McLaughlin, K; Menda, Y | 1 |
| Mac Manus, M; Salminen, E | 2 |
| Beggs, AD; Curran, KM; Fogelman, I; Hain, SF; Maisey, MN; O'Doherty, MJ | 1 |
| Bomanji, J; Cheze-LeRest, C; Costa, DC; Ell, PJ; Gacinovic, S; Visvikis, D | 1 |
| Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Seki, H; Taki, S; Taniguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Coleman, RE; Hagge, RJ; Wong, TZ | 1 |
| Haberkorn, U | 2 |
| Delbeke, D; Komori, T | 1 |
| Bartley, SC; Gundlapalli, S; Mountz, JM; Ojha, B | 1 |
| Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Pötzi, C; Schmaljohann, J; Staudenherz, A; Vierhapper, H | 1 |
| Ball, DL; Hicks, RJ; Kalff, V; MacManus, MP; Matthews, JP; McKenzie, AF; Ware, RE | 1 |
| Ball, DL; Hicks, RJ; Hogg, A; Kalff, V; MacManus, MP; Matthews, JP; McKenzie, AF; Ware, RE | 1 |
| Balon, H; Bohdiewicz, P; Chmielewski, GW; Dickinson, C; Dworkin, HJ; Fink-Bennett, D; Hill, JC; Nuñez, R; Pursel, SE; Ravikrishnan, KP; Welsh, RJ; Wong, CY | 1 |
| Balogh, JM; Caldwell, CB; Danjoux, CE; Ehrlich, LE; Ganguli, SN; Mah, K; Ung, YC | 1 |
| Hung, GU; Kao, CH; Tsai, SC | 1 |
| Pandit, N; Yeung, HW | 1 |
| de Dreuille, O; Foehrenbach, H; Gaillard, JF; Grassin, F; Guigay, J; L'her, P; Margery, J; Maszelin, P; Vaylet, F | 1 |
| Alavi, A; Aronchick, JM; Lee, J | 1 |
| Fujino, K; Hashikawa, K; Nishimura, T; Paul, AK; Tatsumi, M; Yutani, K | 1 |
| Chen, T; Hayashi, K; Ichiya, Y; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Sasaki, M; Yoshida, T | 1 |
| Angelberger, P; Dudczak, R; Füger, B; Kletter, K; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Patri, P; Raderer, M; Traub, T; Virgolini, I; Wogritsch, S | 1 |
| Harper, PG; Karapetis, CS; Strickland, AH; van der Walt, JD; Yip, D | 1 |
| Baumann, M; Fleckenstein, J; Hellwig, D; Kirsch, CM; Nestle, U; Rübe, C; Ukena, D; Walter, K | 1 |
| Dong, J; Guan, Y; He, S | 1 |
| Lee, D; Marn, CS; Rosenthal, EL; Taylor, R; Teknos, TN | 1 |
| Corstens, FH; Jager, GJ; Langenhoff, BS; Neeleman, N; Oyen, WJ; Ruers, TJ; Strijk, S; Wobbes, T | 1 |
| Arisaka, Y; Higashi, K; Nambu, Y; Oguchi, M; Sakuma, T; Seki, H; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Choi, NC; Fischman, AJ; Lynch, TJ; Mathisen, DJ; Ryu, JS | 1 |
| Colder, CD; Herder, GJ; Hoekstra, OS; Postmus, PE; Smit, EF; Teule, GJ; van den Bergh, JH; van Mansom, I; van Mourik, JC; van Velthoven, PC; Verboom, P | 1 |
| Braban, LE; Chui, CS; Erdi, AK; Erdi, YE; Hu, YC; Humm, JL; Larson, SM; Macapinlac, HA; Rosenzweig, K; Squire, OD; Yorke, ED | 1 |
| Akhurst, T; Bains, M; Downey, RJ; Ginsberg, MS; Ginsberg, RJ; Gonen, M; Korst, R; Larson, SM; Rusch, VW | 1 |
| Brown, CK; Bushnell, DL; Graham, MM; Kahn, DJ; Kernstine, KH; Madsen, MT; Mclaughlin, KA; Menda, Y; Rossi, NP | 1 |
| Elsinga, PH; Groen, HJ; Pieterman, RM; Pruim, J; Que, TH; Vaalburg, W; van Putten, JW; Willemsen, AT | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Albes, JM; Dohmen, BM; Schott, U; Schülen, E; Wehrmann, M; Ziemer, G | 1 |
| Balogh, JM; Caldwell, CB; Danjoux, CE; Ehrlich, LE; Ganguli, SN; Mah, K; Tirona, R; Ung, YC | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; Martín Urreta, JC | 1 |
| Ball, DL; Binns, DS; Hicks, RJ; Kalff, V; MacManus, MP; McKenzie, AF; Pitman, AG; Ware, RE | 1 |
| Conte, PF; Dani, D; Donati, S; Gennari, A; Giorgetti, A; Landucci, E; Mariani, G; Pisani, P; Poli, M; Puccini, G; Salvadori, B; Salvadori, PA; Sorace, O | 1 |
| Bomanji, JB; Costa, DC; Ell, PJ | 1 |
| Ball, DL; Binns, D; Ciavarella, F; Hicks, RJ; Hogg, A; Kalff, V; MacManus, MP; McKenzie, A; Salminen, E; Ware, R; Wirth, A | 1 |
| Aquino, SL; Asmuth, JC; Fischman, AJ; Moore, RH; Weise, SB | 1 |
| Aitken, CL; Kramer, EL; Maguire, GQ; Mahmoud, F; McGuinness, G; Noz, ME | 1 |
| Griffiths, P; Masoomi, MA; Siraj, QH | 1 |
| Grahek, D; Kerrou, K; Mayaud, C; Montravers, F; Regnard, JF; Talbot, JN; Younsi, N | 1 |
| Bertin, F; Bonnaud, F; Ducloux, T; Gaillard, S; Laskar, M; Melloni, B; Monteil, J; Vandroux, JC; Vergnenegre, A; Vincent, F | 1 |
| Bartsch, P; Bury, T; Corhay, JL; Daenen, F; Duysinx, B | 1 |
| Cabrera Villegas, A; Ciria Santos, JP; Martín Urreta, JC | 1 |
| Askienazy, S; Bok, B; Grall, Y; Meignan, M; Misset, JL; Rain, JD; Talbot, JN | 1 |
| Nabi, HA; Zubeldia, JM | 1 |
| Morakinyo, T; Nguyen, DT | 1 |
| Lee, MH; Oh, YJ; Park, CH | 1 |
| Kahn, D; Menda, Y | 1 |
| Boers, M; Comans, EF; Diepenhorst, FW; Hoekstra, OS; Postmus, PE; Schreurs, AJ; Smit, EF; Stallaert, RA; Teule, GJ; van den Bergh, JH; van Mourik, JC; van Tinteren, H; van Velthoven, PC; Verboom, P | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, ME; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Sonzogni, A; Spaggiari, L; Veronesi, G | 1 |
| Herndon, JE; Marom, EM; Patz, EF; Sarvis, S | 1 |
| Croft, DR; Galvin, J; Gross, T; Kern, JA; Kernstine, K; Kirchner, P; McLennan, G; Mullan, B; Peterson, MW; Trapp, J | 1 |
| Gomez, P; Lapiere, CM; Limet, R; Nusgens, B; Rigo, P; Sakalihasan, N; Van Damme, H | 1 |
| Bares, R; Budach, W; Dohmen, BM; Eschmann, SM; Friedel, G; Harer-Mouline, C; Paulsen, F | 1 |
| Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
| Floresca, J; Graham, MM; Juweid, M; Malik, J; Menda, Y; Reddy, MP | 1 |
| Gabalski, EC; Gona, JM; Husain, S; Myers, LL; Nabi, H; Wax, MK | 1 |
| Czernin, J; Gambhir, SS; Meta, J; Phelps, ME; Rao, J; Schiepers, C; Seltzer, MA; Silverman, DH; Valk, PE; Yap, CS | 1 |
| Chitkara, RK; Sarinas, PS | 1 |
| Acostamadiedo, J; Adler, LP; Chin, R; Douglas Case, L; Dunagan, DP; Haponik, EF; Harkness, BA; McCain, TW; Miller, AA | 1 |
| Lassen, U | 1 |
| Campbell, H; Saunders, M; Wong, WL | 1 |
| Ikeda, H; Murakami, K; Nawano, S | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L; Várady, E | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Miklovicz, T; Repa, I; Sinkovics, I; Szakáll, S | 1 |
| Garg, K; Lynch, DA | 1 |
| Burger, C; Goerres, GW; Kamel, EM; Steinert, HC; von Schulthess, GK | 1 |
| de Perrot, M; Orrit, J; Robert, J; Spiliopoulos, A; Triponez, F | 1 |
| Alavi, A; Cuchiara, A; Hickeson, M; Matthies, A | 1 |
| Erdi, YE; Humm, JL; Larson, SM; Ling, CC; Macapinlac, HA; Nehmeh, SA; Rosenzweig, KE; Schoder, H; Squire, OD | 1 |
| Blaufox, MD; Keller, SM; Khandani, AH | 1 |
| Härkönen, P; Kangas, L; Kellokumpu-Lehtinen, P; Klemi, P; Lähde, M; Minn, H; Sipilä, H; Vuorinen, J | 1 |
| Ido, T; Ishiwata, K; Itoh, J; Iwata, R; Kameyama, M; Tada, M; Takahashi, T; Tomura, M | 1 |
| Cho, BJ; Chung, SK; Haynie, TP; Kim, CG; Kim, EE; Moser, RP; Podoloff, DA; Tilbury, RS; Yang, DJ; Yung, WK | 1 |
| Dewan, NA; Frank, AR; Frick, MP; Gupta, NC; Mailliard, JA; Phalen, JJ; Redepenning, LS; Rothberg, ML; Sunderland, JJ | 1 |
| Bischoff, H; Knopp, MV; Oberdorfer, F; van Kaick, G | 1 |
| Fukumura, T; Ichiya, Y; Jingu, K; Kuwabara, Y; Masuda, K; Otsuka, M; Tahara, T; Yoshikai, T | 1 |
| Conti, PS; Strauss, LG | 1 |
| Abe, Y; Fujiwara, T; Fukuda, H; Hatazawa, J; Ido, T; Itoh, M; Kubota, K; Matsuzawa, T; Tada, M; Yamaguchi, K | 1 |
| Fujiwara, T; Hatazawa, J; Ido, T; Ishiwata, K; Ito, M; Iwata, R; Kubota, K; Matsuzawa, T | 1 |
| Abe, Y; Fujiwara, T; Fukuda, H; Itoh, M; Kawai, H; Kubota, K; Matsuzawa, T; Miyazawa, H; Yamaguchi, K; Yamaguchi, T | 1 |
368 review(s) available for fluorodeoxyglucose f18 and Lung Neoplasms
| Article | Year |
|---|---|
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Impact of Follow-up 18F-FDG PET on the Management in Patients With Lung Cancer: A Meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local | 2021 |
Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC).
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Injury; Lung Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiosurgery | 2022 |
Prognostic Value of MTV and TLG of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Tumor Burden | 2021 |
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2022 |
FDG PET/CT for Evaluation of Immunotherapy Response in Lung Cancer Patients.
Topics: B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2022 |
PET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective.
Topics: Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Positron-Emission Tomography; Precision Medicine; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2022 |
Diagnostic Accuracy of F18-fluorodeoxyglucose Positron Emission Tomography- computed Tomography for the Detection of Non-small Cell Lung Cancer Recurrence: A Systematic Review and Meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
[What dose escalation in the treatment of locally advanced non-small cell lung cancer?]
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2022 |
Current research topics in FAPI theranostics: a bibliometric analysis.
Topics: Bibliometrics; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Precision Medicine; Quinolines | 2023 |
Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
[A Resected Case of Mesenteric Nodal Metastases from Small Cell Lung Carcinoma].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2022 |
Diagnosis value of
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
CT and PET/CT findings of primary pulmonary malignant melanoma: a case report and literature review.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
PET/CT in treatment response assessment in lung cancer. When should it be recommended?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Perianal Paget
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Paget Disease, Extramammary; Positron Emission Tomography Computed Tomography | 2023 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
[Pulmonary carcinoids and carcinoids of the small intestine].
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2020 |
Topics: Carcinoma, Non-Small-Cell Lung; Fiducial Markers; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Treatment Outcome | 2020 |
PET/CT and the Response to Immunotherapy in Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors | 2020 |
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
FDG PET/CT in the Staging of Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2020 |
Advances in Lung Cancer Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Dynamic contrast-enhanced computed tomography for the diagnosis of solitary pulmonary nodules: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multiple Pulmonary Nodules; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2020 |
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging | 2020 |
Radiotherapy Planning and Molecular Imaging in Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2020 |
Benefits of positron emission tomography scans for the evaluation of radiotherapy.
Topics: Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
Correlation between fluorodeoxyglucose hotspots on preradiotherapy PET/CT and areas of cancer local relapse: Systematic review of literature.
Topics: Anatomic Landmarks; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Patient Positioning; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies | 2020 |
Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of
Topics: Animals; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2020 |
Endobronchial pulmonary blastoma - an unusual presentation of a rare lung malignancy and review of literature.
Topics: Adult; Aftercare; Biopsy; Bronchoscopy; Chest Pain; Cough; Fluorodeoxyglucose F18; Hemoptysis; Humans; Lung Neoplasms; Male; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Pulmonary Blastoma | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
Topics: B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period | 2021 |
Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Small Cell Lung Carcinoma | 2021 |
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies | 2021 |
Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centres.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Waiting Lists | 2021 |
Rare Pulmonary Tumors and Carcinoma Mimickers; Experience from an Interventional Radiology Unit with Radiologic-pathologic Correlation- A Pictoral Essay.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiology, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
The first report of co-existence of pulmonary tuberculosis and lung malignancy in a kidney transplant recipient: a case report and literature review.
Topics: Adenocarcinoma; China; Ethambutol; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Isoniazid; Kidney Transplantation; Lung; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Thoracic Surgery, Video-Assisted; Treatment Outcome; Tuberculosis, Pulmonary | 2021 |
PET/CT Variants and Pitfalls in Gynecological Cancers.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Update on Molecular Imaging and Precision Medicine in Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals | 2021 |
Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors.
Topics: Afatinib; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 2017 |
Comparison of Gadolinium-enhanced MRI and 18FDG PET/PET-CT for the diagnosis of brain metastases in lung cancer patients: A meta-analysis of 5 prospective studies.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Gadolinium; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Correlations of 18F-FDG and 18F-FLT uptake on PET with Ki-67 expression in patients with lung cancer: a meta-analysis.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
Topics: Biopsy; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Solitary Pulmonary Nodule | 2017 |
Role of interim
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Role of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in the Evaluation of Suspicious Pulmonary Nodules.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
The utility of 18F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer: a PRISMA-compliant meta-analysis.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2017 |
Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Topics: Comorbidity; Fluorodeoxyglucose F18; Granulomatous Disease, Chronic; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Tuberculosis | 2018 |
Treatment Planning for Radiation Therapy.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2018 |
Prognostic Value of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2018 |
Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin | 2018 |
Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2018 |
Wolf in Sheep's Clothing: Primary Lung Cancer Mimicking Benign Entities.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2017 |
Advanced PET imaging in oncology: status and developments with current and future relevance to lung cancer care.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2018 |
Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems.
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Solitary Pulmonary Nodule | 2018 |
MRI for solitary pulmonary nodule and mass assessment: Current state of the art.
Topics: Animals; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thorax | 2018 |
MR Imaging of Pleural Neoplasms.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2018 |
Concurrent benign metastasizing leiomyoma in the lung and lumbar spine with elevated standardized uptake value level in positron-emission tomography computed tomography: A case report and literature review.
Topics: Diagnosis, Differential; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Tamoxifen; Uterine Neoplasms | 2018 |
Standardized Uptake Values Derived from
Topics: B7-H1 Antigen; Cyclin D1; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Lung Neoplasms; Microvessels; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53 | 2018 |
A systematic review of the prognostic value of texture analysis in
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Prognosis | 2018 |
Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: A case report and literature review.
Topics: Adult; Biopsy; Dyspnea; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Hemangioendothelioma, Epithelioid; Hemangiosarcoma; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2018 |
Pleural tumours and tumour-like lesions.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play?
Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Neoplasms | 2019 |
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pain; Patient Care Planning; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium | 2018 |
Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tumor Burden | 2019 |
CT, MRI, and F-18 FDG PET for the detection of non-small-cell lung cancer (NSCLC): A protocol for a network meta-analysis of diagnostic test accuracy.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Protocols; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Network Meta-Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.
Topics: Artificial Intelligence; Big Data; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2018 |
Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Imaging; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2019 |
Fluorine 18-FDG PET/CT and Diffusion-weighted MRI for Malignant versus Benign Pulmonary Lesions: A Meta-Analysis.
Topics: Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Sensitivity and Specificity | 2019 |
The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.
Topics: Acetates; Carcinoid Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
[Application of Metabolic Parameters Measured by ¹⁸F-FDG PET/CT in the Evaluation of the Prognosis of Non-small Cell Lung Cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Application of
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Lung Cancer Recurrence:
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities.
Topics: Adenocarcinoma; Algorithms; Calcinosis; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2013 |
Use of high-resolution computed tomography and positron emission tomography/computed tomography in the management of stage IA adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
A resected case of solitary pulmonary capillary hemangioma showing pure ground glass opacity.
Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemangioma, Capillary; Humans; Lung Neoplasms; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
A case of desmoid-type fibromatosis arising after thoracotomy for lung cancer with a review of the english and Japanese literature.
Topics: Female; Fibroma; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Thoracic Neoplasms; Thoracic Wall; Thoracotomy; Tomography, X-Ray Computed | 2014 |
¹⁸F-FDG-PET/CT in malignant mesothelioma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18FDG PET-CT for detecting gastric cancer recurrence after surgical resection: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.
Topics: Adrenal Gland Neoplasms; Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[Highly conformal radiotherapy of primary and secondary lung malignancies].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Radiotherapy, Conformal | 2013 |
Role of positron emission tomography-computed tomography in pulmonary neoplasms.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Patient Care Planning; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Lung cancer: positron emission tomography/computed tomography and the new staging system.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[State of the art in nuclear imaging for the diagnosis of bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Thyroid Neoplasms | 2013 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
Topics: Animals; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2014 |
[(18)F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysis.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Functional imaging biomarkers for assessing response to treatment in liver and lung metastases.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
[Lung infarction--a diagnostic challenge in the oncologic patient?].
Topics: Angiography; Cardiac-Gated Imaging Techniques; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lung Neoplasms; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Multidetector Computed Tomography; Neoplastic Cells, Circulating; Pneumonia; Positron-Emission Tomography; Prognosis; Pulmonary Infarction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Imaging and management of a small cell lung cancer metastasis/adrenal adenoma collision tumor: a case report and review of the literature.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Topics: Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Choroid Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Intravitreal Injections; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.
Topics: Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2014 |
18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
[Challenges of imaging as a biomarker in drug research and drug].
Topics: Animals; Biomarkers; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiosurgery; Survival Rate | 2014 |
Role of imaging in diagnosis, staging and follow-up of lung cancer.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.
Topics: Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Meta-analysis of (18) fluorodeoxyglucose positron emission tomography-CT for diagnosis of lung malignancies in patients with head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2015 |
Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2015 |
Metabolic imaging in non-small-cell lung cancer radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Organs at Risk; Patient Selection; Positron-Emission Tomography; Precision Medicine; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2014 |
Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2015 |
[Radiological evaluation of the tumour response after lung stereotactic radiotherapy].
Topics: Aftercare; Algorithms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiation Pneumonitis; Radiopharmaceuticals; Radiosurgery; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Imaging of thoracic cavity tumors.
Topics: Carcinoma; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mediastinal Neoplasms; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2014 |
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.
Topics: Diagnosis, Differential; Endemic Diseases; Fluorodeoxyglucose F18; Humans; Infections; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2014 |
PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2015 |
PET/MRI in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Pulmonary nodule characterization, including computer analysis and quantitative features.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
The evolving role of molecular imaging in non-small cell lung cancer radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Lung cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
[18F]Fluorodeoxyglucose PET in Thoracic Malignancies.
Topics: Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymus Neoplasms | 2014 |
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tumor Burden | 2015 |
[Positron emission tomography and stereotactic body radiation therapy for lung cancer: From treatment planning to response evaluation].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery | 2015 |
Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors.
Topics: Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings.
Topics: Atherosclerosis; Breast Neoplasms; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
The role of new PET tracers for lung cancer.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Present and future roles of FDG-PET/CT imaging in the management of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2016 |
Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiotherapy Planning, Computer-Assisted; Thoracic Neoplasms | 2016 |
Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2016 |
Advances in diagnosis and treatment of metastatic cervical cancer.
Topics: Bone Neoplasms; Brain Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleura; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?
Topics: Ablation Techniques; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Observer Variation; Oncologists; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiologists; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Dynamic contrast enhanced CT in nodule characterization: How we review and report.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2016 |
FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
Topics: Algorithms; Early Detection of Cancer; Fluorodeoxyglucose F18; Incidental Findings; Lung; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.
Topics: Antineoplastic Agents; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Mortality; Neoplasm Staging; Neuroendocrine Tumors; Outcome Assessment, Health Care; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2018 |
A meta-analysis to evaluate the diagnostic value of dual-time-point F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of pulmonary nodules.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Odds Ratio; Positron Emission Tomography Computed Tomography; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2017 |
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Radiography; Tomography, Emission-Computed; Ultrasonography | 2008 |
Cross-sectional evaluation of thoracic lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Mediastinal Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Thoracic Neoplasms; Thymus Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
[Metabolic imaging--PET, PET/CT--in oncologic surgery].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Procedures, Operative; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Tomography, X-Ray Computed | 2009 |
Prognosis and reevaluation of lung cancer by positron emission tomography imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2009 |
Measuring response with FDG-PET: methodological aspects.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms | 2009 |
Positron emission tomography in lung cancer.
Topics: Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Imaging features of primary extranodal lymphomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms | 2009 |
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The role of positron emission tomography in the management of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
[Response judgement - conventional versus new methods].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cone-Beam Computed Tomography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Patient Care Team; Positron-Emission Tomography; Quality of Life; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Rate; Tomography, Spiral Computed; Treatment Outcome | 2009 |
Molecular imaging of pulmonary cancer and inflammation.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Imaging; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
State-of-the-art lung cancer radiation therapy.
Topics: Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Survival Rate; Tomography, X-Ray Computed | 2009 |
18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.
Topics: Animals; Breast Neoplasms; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Biology; Radionuclide Imaging | 2009 |
[Positron emission tomography and evaluation of response to targeted therapies].
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Hypoxia; Cell Proliferation; Choline; ErbB Receptors; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lipid Metabolism; Lung Neoplasms; Neoplasms; Neovascularization, Pathologic; Piperazines; Positron-Emission Tomography; Protein Biosynthesis; Protein Kinases; Pyrimidines; Radiopharmaceuticals; Receptors, Androgen; Receptors, Estrogen; TOR Serine-Threonine Kinases | 2009 |
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tissue Distribution; Treatment Outcome | 2009 |
FDG-PET/CT in lung cancer: an update.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Lung Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies | 2010 |
Sentinel node and positron emission tomography mapping in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Coloring Agents; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Rosaniline Dyes; Technetium | 2009 |
Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Part
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2010 |
PET and PET-CT in radiation treatment planning for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
[PET/CT for diagnostics and therapy stratification of lung cancer].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Differential; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
The use of FDG-PET to target tumors by radiotherapy.
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Assessing extracranial tumors using diffusion-weighted whole-body MRI.
Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
[What is the role of FDG-PET in thoracic oncology in 2010?].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2011 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
[PET/CT in lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2011 |
A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, Emission-Computed | 2011 |
Pulmonary epithelioid hemangioendothelioma.
Topics: Adult; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Biopsy; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Immunohistochemistry; Lung Neoplasms; Multiple Pulmonary Nodules; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2011 |
Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
The role of positron emission tomography in management of small cell lung cancer.
Topics: Biomarkers, Pharmacological; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Treatment Outcome | 2011 |
Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Meta-Analysis as Topic; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
[Contribution of FDG-PET in the management of pediatric sarcomas in 2011].
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoma | 2011 |
MRI in lung cancer: a pictorial essay.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2011 |
18F-2-Deoxy-d-Glucose positron emission tomography-computed tomography in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Computed tomography and 18F-fluoro-2-deoxyglucose positron emission tomography findings of primary pulmonary follicular dendritic cell sarcoma: case report and a literature review.
Topics: Dendritic Cell Sarcoma, Follicular; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
[Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
[Interest of FDG-PET for lung cancer radiotherapy].
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
Nuclear medicine and molecular imaging of the pediatric chest: current practical imaging assessment.
Topics: Adolescent; Child; Child, Preschool; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart; Heart Diseases; Humans; Infant; Iodine Radioisotopes; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Molecular Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Compounds; Thymus Neoplasms; Tomography, X-Ray Computed; Xenon Radioisotopes | 2011 |
Novel molecular imaging in lung and pleural diseases.
Topics: Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lung Diseases; Lung Neoplasms; Male; Molecular Imaging; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
PET scans in radiotherapy planning of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
The use and misuse of positron emission tomography in lung cancer evaluation.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Fluorodeoxyglucose F18; Health Services Misuse; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2011 |
Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: a review of existing evidence.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Molecular Targeted Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2012 |
Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2012 |
Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non--small-cell lung cancer.
Topics: Biomarkers, Pharmacological; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2012 |
Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2012 |
(18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2012 |
[Role of FDG-PET scanning in stage IIIAN2 non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Intrapulmonary neurofibroma independent of neurofibromatosis type 1.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neurofibroma; Neurofibromatosis 1; Pneumonectomy; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iofetamine; Lung Neoplasms; Magnetic Resonance Imaging; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in non-small cell lung cancer: comparison of TB and non-TB endemic regions.
Topics: Carcinoma, Non-Small-Cell Lung; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2012 |
The role of surgery for locally advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Tomography, X-Ray Computed | 2012 |
Low-sensitivity FDG-PET studies: less common lung neoplasms.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Sensitivity and Specificity | 2012 |
Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity.
Topics: Breast Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Endoscopy; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Potential value of dual-time-point ¹⁸F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Time Factors | 2012 |
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
Primary paraganglioma of the lung: a case report and literature review.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Tumors of the pulmonary artery and veins.
Topics: Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Veins; Radiographic Image Enhancement; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2012 |
LUCIS: lung cancer imaging studies.
Topics: Area Under Curve; Cohort Studies; Early Detection of Cancer; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Metastasis; Perfusion Imaging; Positron-Emission Tomography; Radiography, Thoracic; Reproducibility of Results; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2012 |
Oncological applications of positron emission tomography for evaluation of the thorax.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma; Mesothelioma; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thorax; Thymus Gland; Thymus Neoplasms | 2013 |
Positron emission tomography: lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[A proposal for the rational use of the PET in oncology].
Topics: Brain Neoplasms; Colorectal Neoplasms; Consensus; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spain; Tomography, Emission-Computed | 2002 |
The solitary pulmonary nodule: aggressive excisional strategy.
Topics: Biopsy, Needle; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Radiographic Image Enhancement; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2002 |
[Cost-effective PET investigations in oncology].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2002 |
Positron emission tomography (PET) and combined imaging modalities for staging lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Value of FDG-PET in the management of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
[18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Cell Division; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2003 |
[Combined functional and morphological imaging with PET/CT systems].
Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Value of whole-body FDG PET in management of lung cancer.
Topics: Drug Therapy, Computer-Assisted; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in bronchopulmonary and pleural cancers].
Topics: Bronchial Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleural Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Positron emission tomography scanning in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2003 |
[Positron emission tomography in oncology].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Multidetector-row CT of the solitary pulmonary nodule.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[(18)F]-FDG PET and localized fibrous mesothelioma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Radiopharmaceuticals; Spain; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET scanning in lung cancer: current status and future directions.
Topics: Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
New radiotherapy technologies.
Topics: Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Radiosurgery; Radiotherapy; Tomography, Emission-Computed | 2003 |
Diagnosis of occult bone metastases: positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Positron emission tomography scanning for the diagnosis and management of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Neoplastic Processes; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[Positron-emission tomography in oncology].
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Clinical utility of FDG PET.
Topics: Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Tomography, Emission-Computed | 2004 |
Positron emission tomography in the management of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Screening for lung cancer.
Topics: Adenocarcinoma; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mass Screening; Radiography, Thoracic; Smoking; Solitary Pulmonary Nodule; Sputum; Tomography, Emission-Computed; Tomography, Spiral Computed | 2004 |
Role of surgery in patients with stage IV melanoma.
Topics: Brain Neoplasms; Decision Making; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Melanoma; Neoplasm Staging; Palliative Care; Radiography; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed | 2004 |
The role of FDG-PET in the management of non-small cell lung carcinoma.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 2004 |
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Role of FDG-PET in the diagnosis and management of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[18Fluoro-deoxy-glucose positron emission tomography (18FGT-PET) and lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2004 |
FDG PET: advantages for staging the mediastinum?
Topics: Carcinoma, Non-Small-Cell Lung; Cost Savings; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mediastinum; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Value of FDG PET in the management of NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Defining target volumes for non-small cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, Emission-Computed | 2004 |
Response to radiation.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Research Design; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Neoplasms; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Time Factors | 2005 |
[The use of FDG-PET scanning in lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Positron emission tomography and bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clodronic Acid; Diphosphonates; Etidronic Acid; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Imidazoles; Lung Neoplasms; Pamidronate; Positron-Emission Tomography; Predictive Value of Tests; Therapeutic Equivalency; Zoledronic Acid | 2005 |
Clinical evaluation and staging of patients who have lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography | 2005 |
State-of-the-Art FDG-PET imaging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Imaging for lung cancer restaging.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Utility of 18F-FDG PET in evaluating cancers of lung.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
[Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2005 |
Critical review of PET-CT for radiotherapy planning in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
[The PET medical checkup considered from the viewpoint of radiological protection].
Topics: England; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiation Protection; Safety; Tomography, X-Ray Computed | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
PET/CT in oncology: a major technology for cancer care.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
PET in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Movement; Neoplasm Staging; Positron-Emission Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity | 2005 |
The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Advances in positron emission tomographic imaging of lung cancer.
Topics: Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
CT and PET imaging in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
[Current status of 18F-FDG PET in predicting outcome of cancer therapy].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Treatment Outcome | 2004 |
PET evaluation of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Risk Assessment; Risk Factors; Solitary Pulmonary Nodule | 2006 |
Monitoring chemotherapy and radiotherapy of solid tumors.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Monitoring, Physiologic; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Uterine Cervical Neoplasms | 2006 |
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2006 |
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Topics: Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; Whole Body Imaging | 2006 |
[PET in primary pulmonary or pleural cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Diagnosis of non-small-cell lung carcinoma (NSCLC)].
Topics: Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Endoscopy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals | 2006 |
Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 2006 |
Lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lung; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Risk Factors; Sex Factors; Time Factors; Tomography, X-Ray Computed | 2007 |
Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2007 |
PET/CT in non-small cell lung cancer staging-promises and problems.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Cost-Benefit Analysis; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
PET scan in lung cancer: current recommendations and innovation.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results | 2006 |
Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results | 2006 |
[Advances in research on biological target volume and conformal intensity-modulated radiotherapy].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2006 |
Is 18F FDG PET-CT cost effective in lung cancer?
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
Topics: Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Tomography, X-Ray Computed; Tumor Burden | 2007 |
Evaluating pulmonary nodules.
Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2007 |
Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Staging of lung cancer.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Impact of PET on radiation therapy planning in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2007 |
PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
[Interests and perspectives of PET-CT for breast cancer: review of the literature].
Topics: Bone Neoplasms; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Ensuring the right PET scan for the right patient.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Referral and Consultation; Tomography, X-Ray Computed | 2008 |
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
Topics: Carcinoma, Medullary; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Whole Body Imaging | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
PET and PET/CT with F-18 fluoride in bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technology Assessment, Biomedical | 2007 |
Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lu
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Survival Analysis | 2008 |
[Role of mediastinoscopy and repeat mediastinoscopy today].
Topics: Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Sentinel node mapping in lung cancer: the Holy Grail?
Topics: Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2008 |
Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Topics: Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
[Positron emission tomography in the diagnosis and follow up of non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[New technologies in lung cancer radiotherapy].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal | 2007 |
Clinical applications of positron emission tomography/computed tomography treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
The role of PET in target localization for radiotherapy treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Irradiation; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Predictive and prognostic value of FDG-PET.
Topics: Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2008 |
Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
The power of synergy in the mediastinal staging of lung cancer.
Topics: Biopsy, Fine-Needle; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Positron emission tomography scanning is coming to a hospital near you soon!
Topics: Colorectal Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; United Kingdom | 2008 |
Thallium-201 uptake in lung cancer.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Octreotide; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.
Topics: Deoxyglucose; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Use of positron emission tomography in oncology.
Topics: Brain Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1993 |
18F-fluorodeoxyglucose PET scans in lung cancer.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Tomography, Emission-Computed | 1996 |
[Diagnosis of early cancer with positron emission tomography].
Topics: Carbon Radioisotopes; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Methionine; Tomography, Emission-Computed | 1996 |
Metabolic imaging by positron emission tomography in oncology.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasms; Radiography; Tomography, Emission-Computed | 1997 |
Positron emission tomography in lung cancer.
Topics: Carcinoma, Bronchogenic; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1998 |
[Drug clinics. How I study the solitary pulmonary nodule].
Topics: Biopsy; Biopsy, Needle; Bronchoscopy; Calcinosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiography, Interventional; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Applications of PET in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography].
Topics: Adult; Aged; Carcinoma, Bronchogenic; Equipment Design; Female; Fluorodeoxyglucose F18; France; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
[Role of 18F-FDG positron emission tomography in surgical evaluation].
Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
PET in lung cancer.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 1999 |
[Progress of nuclear oncology].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Radionuclide Imaging; Technetium; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Positron emission tomography imaging in the thorax.
Topics: Blood Glucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 1999 |
[Positron emission tomography for detection of lymph node metastases in lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
Topics: Aged; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Middle Aged; Peptides; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
[Contribution of positron emission tomography for the management of lung cancer].
Topics: Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Lung cancer and positron emission tomography with fluorodeoxyglucose.
Topics: Combined Modality Therapy; Costs and Cost Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Survival Rate; Tomography, Emission-Computed | 2000 |
PET in oncology I--lung, breast, soft tissue sarcoma.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2000 |
[Diagnostic value of positron emission tomography (PET) in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Urogenital Neoplasms | 2000 |
Nuclear medicine imaging of lung cancer.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
PET imaging in oncology.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; United States | 2000 |
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Lung cancer. Diagnostic tools.
Topics: Biopsy, Needle; Bronchoalveolar Lavage; Bronchoscopy; Clinical Trials as Topic; Fluorescence; Fluorodeoxyglucose F18; Genes, Tumor Suppressor; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Mediastinoscopy; Multicenter Studies as Topic; Oligonucleotides, Antisense; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sputum; Thoracic Surgery, Video-Assisted; Thoracoscopy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
[Positron emission tomography in thoracic radiography].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiography, Thoracic; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Tomography, Emission-Computed | 2001 |
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; MEDLINE; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Positron emission tomography: brain tumors and lung cancer.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Interest in 18-FDG positron emission tomography in radiotherapy planning: example of lung cancer radiotherapy].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography (PET) of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
PET in lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Positron emission tomography (PET) in clinical oncology. Part II].
Topics: Adult; Aged; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphoma; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Clinical role of positron emission tomography in oncology.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation].
Topics: Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[18FDG-PET applications in thoracic oncology].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Forecasting; Humans; Lung Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Clinical applications of (18)F-FDG in oncology.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Solitary Pulmonary Nodule; Somatostatin | 2002 |
FDG-PET imaging in the management of non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2002 |
PET and SPECT in the management of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiography; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Imaging in lung cancer: positron emission tomography scan.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography (PET)--evaluation of 'indeterminate pulmonary lesions'.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; United Kingdom | 2002 |
[Cost-effective PET scans in oncology].
Topics: Breast Neoplasms; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; United States | 2002 |
[Positron emission tomography of the thorax. The current clinical status].
Topics: Carcinoma, Bronchogenic; Deoxyglucose; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Tomography, Emission-Computed | 1992 |
The applications of PET in clinical oncology.
Topics: Brain Neoplasms; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1991 |
269 trial(s) available for fluorodeoxyglucose f18 and Lung Neoplasms
| Article | Year |
|---|---|
Noninvasive Method for Predicting the Expression of Ki67 and Prognosis in Non-Small-Cell Lung Cancer Patients: Radiomics.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Dosage | 2023 |
Standard deviation of CT radiomic features among malignancies in each individual: prognostic ability in lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Studies as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Independent association of metabolic tumor response on FDG-PET with pulmonary toxicity following risk-adaptive chemoradiation for unresectable non-small cell lung cancer: Inherent radiosensitivity or immune response?
Topics: Carboplatin; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunity; Lung Neoplasms; Paclitaxel; Pneumonia; Positron Emission Tomography Computed Tomography; Radiation Pneumonitis; Radiation Tolerance | 2023 |
Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Machine Learning; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Predictive and Prognostic Value of
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Nucleoside-Phosphate Kinase; Positron Emission Tomography Computed Tomography; Predictive Value of Tests | 2019 |
In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography | 2019 |
Does Tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Correlation between Skip N2 Metastases and SUV
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2020 |
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Sorafenib | 2020 |
Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Tumor Burden | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule | 2021 |
Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results | 2021 |
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiotherapy, Conformal; Survival Analysis; Treatment Outcome | 2017 |
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2017 |
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Risk Assessment; Survival Analysis | 2017 |
An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Patient-Centered Care; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Treatment Outcome | 2017 |
Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Pilot Projects; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spectroscopy, Near-Infrared | 2017 |
Correlation of early PET findings with tumor response to molecular targeted agents in patients with advanced driver-mutated non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Crizotinib; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Quinazolines; Treatment Outcome | 2017 |
Italian Tailored Assessment of Lung Indeterminate Accidental Nodule by Proposing a Segmental Pet/Computed Tomography (s-Pet/Ct): Rationale And Study Design of a Retrospective, Multicenter Trial.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Italy; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Research Design; Retrospective Studies; Solitary Pulmonary Nodule; Whole Body Imaging | 2018 |
Multifunctional Assessment of Non-Small Cell Lung Cancer: Perfusion-Metabolic Correlation.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Tumor Burden | 2018 |
Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2018 |
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
Topics: Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Positron Emission Tomography Computed Tomography; Survival Analysis | 2018 |
18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies | 2018 |
A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Dosage | 2018 |
Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; Radiotherapy, Conformal; Research Design; Survival Rate; Young Adult | 2018 |
What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.
Topics: Brain Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2018 |
Comparing Two Imaging Methods for Follow-Up of Lung Cancer Treatment: A Randomized Pilot Study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Switzerland; Tomography, X-Ray Computed | 2019 |
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Planning, Computer-Assisted | 2019 |
Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tumor Burden | 2018 |
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2019 |
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Germany; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2019 |
Preliminary clinical assessment of dynamic
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve | 2019 |
Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Care Team; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reading; Retrospective Studies; Whole Body Imaging | 2019 |
Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Rate | 2019 |
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nadroparin; Neoplasm Recurrence, Local; Neoplasm Staging; Pemetrexed; Pneumonectomy; Positron-Emission Tomography | 2019 |
Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.
Topics: Adult; Aged; Aged, 80 and over; Brazil; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Estonia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; India; Jordan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Pakistan; Positron Emission Tomography Computed Tomography; Prospective Studies; Quality Control; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Treatment Outcome; Turkey; Vietnam | 2019 |
Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Topics: Adult; Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Denmark; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2013 |
Impact of 18F-FDG-PET/CT on treatment strategy in colorectal cancer lung metastasis before lung radiofrequency ablation.
Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiofrequency Therapy; Tomography, X-Ray Computed | 2013 |
Stereotactic body radiation therapy for unbiopsied early-stage lung cancer: a multi-institutional analysis.
Topics: Aged; Biopsy; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Observer Variation; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2013 |
18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Topics: Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Iohexol; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Misonidazole; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.
Topics: Ablation Techniques; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radio Waves; Radiofrequency Therapy; Reference Standards; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome | 2013 |
Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Treatment Outcome | 2014 |
Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Recurrence; Tomography, X-Ray Computed | 2014 |
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Thorax; Tomography, X-Ray Computed | 2014 |
[¹⁸F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Radiography; Radiopharmaceuticals; Survival Rate; Time Factors | 2014 |
Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Paclitaxel; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Treatment Outcome | 2014 |
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2).
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results | 2014 |
Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Timing of metabolic response monitoring during erlotinib treatment in non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Quinazolines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
(18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Remission Induction; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Non-Small-Cell Lung; Cell Count; Cell Proliferation; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neutrophils; Organ Specificity; Platinum; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed | 2014 |
A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals | 2014 |
Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinib.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Dideoxynucleosides; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Survival Analysis | 2015 |
Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promising outlook.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microwaves; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2015 |
Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiosurgery; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tissue Distribution; Tumor Burden | 2014 |
Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Emphysema; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiration; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Evaluating tumor response of non-small cell lung cancer patients with ¹⁸F-fludeoxyglucose positron emission tomography: potential for treatment individualization.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Precision Medicine; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome | 2015 |
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carcinoma, Non-Small-Cell Lung; DNA Mutational Analysis; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiosurgery; Radiotherapy Planning, Computer-Assisted | 2015 |
Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction.
Topics: Aged; Aorta; Biological Transport; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2015 |
[Oligoprogression].
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Quinazolines; Radiosurgery; Radiotherapy Dosage; Retreatment; Survival Rate; Treatment Failure | 2015 |
Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Nitroimidazoles; Oxygen; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2016 |
Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Irradiation; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2016 |
Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure | 2015 |
Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Denmark; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography | 2015 |
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Survival Analysis; Treatment Failure | 2016 |
Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Tuberculosis | 2016 |
Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography | 2016 |
Differential analysis of local and regional failure in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cetuximab; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2016 |
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Demography; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results | 2016 |
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Europe; Female; Fluorodeoxyglucose F18; Humans; Internationality; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Treatment Outcome | 2016 |
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment: Secondary Analysis of a Randomized Trial for Resectable St
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis | 2016 |
Percutaneous radiofrequency ablation for patients with malignant lung tumors: a phase II prospective multicenter study (JIVROSG-0702).
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2016 |
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Nitroglycerin; Paclitaxel; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vasodilator Agents | 2017 |
Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated | 2016 |
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden; United States | 2017 |
FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning--an intraindividual comparison.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Posture; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Treatment Outcome | 2009 |
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Fiber Optic Technology; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Patient Selection; Positron-Emission Tomography; Radiation Dosage; Research Design; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed | 2008 |
The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Radiography, Thoracic; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2009 |
Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Dosage; Regression Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2009 |
Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Regression Analysis; Survival Rate; Treatment Outcome | 2009 |
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.
Topics: Calcinosis; Carcinoma, Non-Small-Cell Lung; Contrast Media; Endemic Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Sensitivity and Specificity; Tomography, X-Ray Computed; Tuberculosis | 2009 |
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery | 2010 |
Positron emission tomography in staging early lung cancer: a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Brain; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Correlation of ¹⁸F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer.
Topics: Adult; Aged; Antigens, CD34; Biological Transport; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Lung Neoplasms; Male; Microtubule-Associated Proteins; Middle Aged; Positron-Emission Tomography; Survival Rate; Survivin | 2009 |
Single 20-second acquisition of deep-inspiration breath-hold PET/CT: clinical feasibility for lung cancer.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Inhalation; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2009 |
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Everolimus; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Time Factors; TOR Serine-Threonine Kinases | 2009 |
Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Regression Analysis; Thiosemicarbazones | 2009 |
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiosurgery; Salvage Therapy; Survival Analysis; Tomography, Emission-Computed | 2010 |
Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Biological Transport; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
(18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2010 |
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study.
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Phantoms, Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; France; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Kinase Inhibitors; Receptor, IGF Type 1; Treatment Outcome | 2011 |
Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Quinazolines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2010 |
Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Adenoid Cystic; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imatinib Mesylate; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography, Thoracic; Radiopharmaceuticals; Remission Induction; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Decision Making; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Palliative Care; Patient Care Planning; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.
Topics: Angiogenesis Inhibitors; Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies | 2011 |
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.
Topics: Biological Transport; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Erlotinib Hydrochloride; Feasibility Studies; Fluorodeoxyglucose F18; Guideline Adherence; Humans; Internationality; Lung Neoplasms; Positron-Emission Tomography; Quality Control; Quinazolines; Treatment Outcome | 2011 |
18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiosurgery; Treatment Outcome | 2011 |
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Survival Analysis; Thymidine | 2011 |
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Genes, erbB-1; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Prognosis; Quinazolines | 2011 |
Value of 4-dimensional 18F-FDG PET/CT in the classification of pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve | 2011 |
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thoracotomy; Tomography, X-Ray Computed | 2011 |
Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2011 |
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; International Agencies; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Registries; Retrospective Studies; Sarcoma; Survival Rate; Time Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2011 |
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The value of ¹⁸F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Tumor Burden | 2011 |
Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Japan; Lung Neoplasms; Male; Microtomy; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT.
Topics: Aged; Biopsy, Fine-Needle; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Radiation-Induced; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Radiography, Interventional; Radiopharmaceuticals; Risk Assessment; Smoking; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2012 |
Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed; Tumor Burden | 2011 |
SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate | 2012 |
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.
Topics: Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Quinazolines; Time Factors; Treatment Outcome | 2011 |
A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeks.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Pharmacological; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Quinazolines; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2012 |
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Application of ¹⁸F-FDG PET/CT in pulmonary disease: a report of 419 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2012 |
Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2012 |
False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Quinazolines; Survival Analysis; Time Factors | 2012 |
Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Topics: Aged; Aged, 80 and over; Blood Circulation; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Microvessels; Middle Aged; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Multimodal Imaging; Nuclear Medicine; Occupational Exposure; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Safety; Tomography, X-Ray Computed | 2012 |
FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Proton Therapy; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dideoxynucleosides; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Quinazolines; Treatment Outcome | 2012 |
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diffusion Magnetic Resonance Imaging; Early Detection of Cancer; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Niacinamide; Paclitaxel; Phenylurea Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sorafenib; Tomography, X-Ray Computed | 2013 |
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Genes, erbB-1; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines | 2013 |
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Pyridines; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Lung metastases treated with image-guided stereotactic body radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Life Tables; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Whole-Body Irradiation | 2002 |
Prognostic value of [18F]FDG-PET imaging in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; United States | 2003 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Comparison of [18F]FDG-PET and L-3[123I]-iodo-alpha-methyl tyrosine (I-123 IMT)-SPECT in primary lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
PET-CT: accuracy of PET and CT spatial registration of lung lesions.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
PET-FDG as predictor of therapy response in patients with colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Radiopharmaceuticals; Risk Assessment; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung.
Topics: Adult; Aged; Aged, 80 and over; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiosurgery; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer.
Topics: Adult; Aged; Carcinoma; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Lung Neoplasms; Male; Microfilament Proteins; Middle Aged; Muscle Proteins; Radiopharmaceuticals; Retinoblastoma Protein; Tomography, Emission-Computed; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2003 |
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Palliative Care; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thoracic Neoplasms; Time Factors | 2003 |
11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
Topics: Acetates; Aged; Aged, 80 and over; Carbon; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2004 |
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Male; Neoplasm Staging; Netherlands; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Quality Control; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Comparative impact of standard approach, FDG PET and FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Management; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
Positron emission tomography of incidentally detected small pulmonary nodules.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.
Topics: Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioma; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Cell Division; Drug Resistance, Multiple; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.
Topics: Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
FDG-PET in staging lung cancer: how does it change the algorithm?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2004 |
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluoroscopy; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Iohexol; Leiomyosarcoma; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germinal Center; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Topics: Abdominal Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Gamma-camera 18F-FDG PET in diagnosis and staging of patients presenting with suspected lung cancer and comparison with dedicated PET.
Topics: Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2004 |
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2004 |
Quantitative assessment of truncal FDG-PET examination with postinjection transmission scan--comparison with preinjection transmission scan.
Topics: Aged; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Injections, Intravenous; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique | 2004 |
Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation.
Topics: Algorithms; Cell Count; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Image Enhancement; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Clinical relevance of imaging proliferative activity in lung nodules.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Solitary Pulmonary Nodule | 2005 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Methionine; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Treatment Outcome | 2004 |
Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals | 2005 |
Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2005 |
[Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; France; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Pilot Projects; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Solitary Pulmonary Nodule; Somatostatin; Tomography, Emission-Computed, Single-Photon | 2005 |
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2005 |
Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals | 2005 |
Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study.
Topics: Adult; Aged; Aged, 80 and over; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors | 2005 |
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2006 |
Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.
Topics: Blood Flow Velocity; Contrast Media; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, X-Ray Computed | 2006 |
Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Monitoring; Europe; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Survival Analysis | 2005 |
Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer.
Topics: Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Thorax | 2006 |
Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT.
Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2006 |
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Deoxycytidine; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Misonidazole; Positron-Emission Tomography; Prospective Studies; Pulmonary Embolism; Radiopharmaceuticals; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2006 |
Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinum; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2006 |
Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Tomography, Emission-Computed, Single-Photon | 2006 |
Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiosurgery; Radiotherapy Dosage; Survival Analysis | 2006 |
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome | 2007 |
Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed | 2007 |
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Confidence Intervals; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Probability; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Risk Assessment; Survival Analysis; Treatment Outcome; Tumor Burden; Vinblastine; Vinorelbine | 2007 |
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2007 |
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Netherlands; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2007 |
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biopsy; Carcinoma, Non-Small-Cell Lung; Dimerization; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Protein Structure, Tertiary; Receptor, ErbB-2; Time Factors; Treatment Outcome | 2007 |
Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Movement; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Respiration; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2008 |
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Esophagus; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Conformal; Survival Analysis | 2008 |
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2007 |
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Time Factors | 2009 |
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Tomography, Emission-Computed | 1996 |
Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Deoxyglucose; Double-Blind Method; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Cell Growth Factors; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1996 |
Performance study of a miniature gamma ray scintillation vivo probe for tumor localization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Citrates; Deoxyglucose; Endoscopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Tomography, Emission-Computed | 1997 |
Prospective investigation of positron emission tomography in lung nodules.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, Emission-Computed | 1998 |
FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchoscopy; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.
Topics: Case-Control Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Models, Anatomic; Neoplasms; Radiopharmaceuticals; Reference Standards; Tomography, Emission-Computed; Tomography, X-Ray | 1999 |
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET of pleural effusions in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Preoperative staging of non-small-cell lung cancer with positron-emission tomography.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2000 |
High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Advantage of delayed whole-body FDG-PET imaging for tumour detection.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mesothelioma; Neoplasms; Radiopharmaceuticals; Sarcoidosis; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2001 |
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2001 |
Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Models, Anatomic; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Topics: Adult; Aged; Colorectal Neoplasms; Decision Making; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Vinblastine | 2002 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Thoracotomy; Time Factors; Tomography, Emission-Computed; Unnecessary Procedures | 2002 |
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
2871 other study(ies) available for fluorodeoxyglucose f18 and Lung Neoplasms
| Article | Year |
|---|---|
The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; MicroRNAs; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2021 |
Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2021 |
Commentary: A Guiding Light in the Night?: Maximum Standardized Uptake Value Associated With High-Risk Features in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2022 |
An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients.
Topics: Artificial Intelligence; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2022 |
Detection of clinically silent brain lesions in [18F]FDG PET/CT study in oncological patients: analysis of over 10,000 studies.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Brain; Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neuroimaging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Synchronous Recurrence of Metachronous Lung Cancer and Hodgkin Lymphoma Within an Axillary Lymph Node Isolated on 18F-FDG PET/CT.
Topics: Adult; Aged, 80 and over; Axilla; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thorax | 2022 |
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided; Ultrasonography | 2021 |
Peripheral pulmonary mucous gland adenoma with a cavity mimicking lung cancer.
Topics: Adenocarcinoma; Adenoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2022 |
The importance of anatomical localization of non-small cell lung carcinoma in predicting mediastinal lymph node metastasis.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Prognosis; Tomography, X-Ray Computed | 2021 |
The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis.
Topics: Computational Biology; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Iron Oxide Nanoparticles; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2021 |
Isotoxic investigation of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2021 |
Solitary Isolated Dural Metastasis From Lung Adenocarcinoma Mimicking Meningioma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Positron Emission Tomography Computed Tomography | 2022 |
Pre-surgical assessment of mediastinal lymph node metastases in patients having ≥ 30 mm non-small-cell lung cancers.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2021 |
Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2022 |
Pulmonary Sarcomatoid Carcinoma With Epiglottis and Ileum Metastasis Detected by 18F-FDG PET/CT.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Epiglottis; Fluorodeoxyglucose F18; Humans; Ileum; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Prognostic Radiological Tools for Clinical Stage IA Pure Solid Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2021 |
Maximum Standardized Uptake Value: An Additional Feature for Stratifying Early-Stage Lung Cancer Patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2022 |
A Case of Lung Abscess Mimicking Lung Cancer.
Topics: Bronchoscopy; Fluorodeoxyglucose F18; Humans; Lung; Lung Abscess; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2021 |
Accuracy of
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Retrospective Studies; United States | 2022 |
Voxel-Based Analysis of the Relation of 3'-Deoxy-3'-[
Topics: Animals; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Heterografts; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Nude; Positron-Emission Tomography; Water | 2022 |
Impact of time of flight and point spread function on quantitative parameters of lung lesions in
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies | 2021 |
Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Diagnostic Performance of the Herder Model in Veterans Undergoing PET Scans for Pulmonary Nodule Evaluation.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule; Veterans | 2021 |
Distant Metastasis Patterns of Lung Cancer on Positron Emission Tomography/Computed Tomography Association with Age and Histological Subtype.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2021 |
Diagnostic yield of CT-guided lung biopsies: how can we limit negative sampling?
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Thyroid Metastasis in Whole-Body 18F-FDG PET/CT Restaging of Small Cell Lung Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Thyroid Gland | 2022 |
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study.
Topics: Communicable Disease Control; COVID-19; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Pandemics; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
Topics: Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2022 |
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer
Topics: Carcinoma, Non-Small-Cell Lung; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms | 2022 |
Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; United Kingdom | 2022 |
Relationship between 18F-FDG PET/CT radiometabolic markers and EGFR mutation, positive ALK Expression in patients with non-small cell lung cancer.
Topics: Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Which will carry more weight when CTR > 0.5, solid component size, CTR, tumor size or SUVmax?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer.
Topics: Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Importance of
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Relationship between
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult | 2022 |
Editorial Comment: Evolving Indications for FDG PET/MRI in Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Small Cell Lung Carcinoma | 2022 |
Tumorous tissue characterization using integrated 18F-FDG PET/dual-energy CT in lung cancer: Combining iodine enhancement and glycolytic activity.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Neoplasm Staging; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Visual Assessment of 18F-FDG Uptake on PET to Predict Survival Benefit to PD-1 Blockade in Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Retrospective Studies | 2022 |
The CT and PET/CT findings in primary pulmonary lymphoepithelioma-like carcinoma with pathological correlation: a study of 215 cases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; RNA, Small Interfering; Tomography, X-Ray Computed | 2022 |
Differentiation of Reactive Lymph Nodes and Tumor Metastatic Lymph Nodes With 68Ga-FAPI PET/CT in a Patient With Squamous Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Microenvironment | 2022 |
Unusual Diffuse Ground-Glass Opacities in the Lungs on 18F-FDG PET/CT: A Case of Melanoma With Pulmonary Metastasis.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
18FDG PET-Positive Congenital Pulmonary Airway Malformation Mimicking Lung Cancer.
Topics: Cystic Adenomatoid Malformation of Lung, Congenital; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
Parotid gland metastasis of lung adenocarcinoma identified on surveillance
Topics: Adenocarcinoma of Lung; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
18F-FDG PET/CT Findings in a Patient With Primary Primitive Neuroectodermal Tumor of the Lung.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Necrosis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Test-retest repeatability and interobserver variation of healthy tissue metabolism using 18F-FDG PET/CT of the thorax among lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thorax | 2022 |
Predictive value of multiple metabolic and heterogeneity parameters of
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2022 |
Precise characterization of a solitary pulmonary nodule using tumor shadow disappearance rate-corrected F-18 FDG PET and enhanced CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule | 2022 |
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2022 |
SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
A few-shot U-Net deep learning model for lung cancer lesion segmentation via PET/CT imaging.
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2022 |
BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in Lung Cancer Patients.
Topics: Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
[Biphasic Pulmonary Blastoma without Recurrence for Six Years After Surgery:Report of a Case].
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pulmonary Blastoma; Tomography, X-Ray Computed | 2022 |
[Diffuse Pulmonary Meningotheliomatosis Needed to be Differentiate from Metastatic Lung Tumor:Report of a Case].
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Tomography, X-Ray Computed | 2022 |
Evaluation of Amide Proton Transfer-Weighted Imaging for Lung Cancer Subtype and Epidermal Growth Factor Receptor: A Comparative Study With Diffusion and Metabolic Parameters.
Topics: Amides; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Protons; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Value of
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
Topics: Fluorodeoxyglucose F18; Glutamic Acid; Humans; Lung Neoplasms; Multiple Pulmonary Nodules; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Synergistic impact of motion and acquisition/reconstruction parameters on
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Retrospective Studies | 2022 |
A Solitary Spinal Cord Metastasis From Lung Cancer Displayed on 18 F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms | 2022 |
Evaluation of response to stereotactic body radiation therapy for nonsmall cell lung cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiosurgery; Recurrence; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Treatment Outcome | 2022 |
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.
Topics: B7-H1 Antigen; Biopsy; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Changes in post-treatment cardiac PET avidity predict overall survival in lung cancer patients treated with chemoradiation: Secondary analysis of the ACRIN 6668/RTOG 0235 clinical trial.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2022 |
A Frequently Missed Pulmonary Infarction: Clinical and 18F-FDG PET/CT Manifestation of Hilar Tumor-Induced Pulmonary Infarction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Infarction; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Solitary Periaortic Tuberculous Granuloma Mimicking Neoplastic Disease on 18 F-FDG PET/CT.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Tuberculosis | 2022 |
Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Diagnostic Value of Nodal Staging of Lung Cancer With Usual Interstitial Pneumonia Using PET.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2022 |
Different Prognostic Values of Dual-Time-Point FDG PET/CT Imaging Features According to Treatment Modality in Patients with Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Imaging Characteristics and Prognostic Value of Isolated Pulmonary Metastasis from Colorectal Cancer Demonstrated with
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
Topics: Adult; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
An 18 F-FDG-PET-Positive Mucoid Impaction With Ring Enhancement on CT Mimicking Lung Cancer.
Topics: Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Delineating and sparing functional nephrons for radiotherapy in the case of lymphoma with polycystic kidney disease.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Nephrons; Polycystic Kidney Diseases; Radiopharmaceuticals | 2022 |
Commentary: Lest we biopsy: Positron emission tomography-computed tomography as a tool to achieve a "greater good" in the diagnosis and management of the resectable anterior mediastinal mass.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Role of fluorodeoxyglucose-positron emission tomography in predicting the pathological response and prognosis after neoadjuvant chemoradiotherapy for locally advanced non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Prognostic value of node-to-primary tumor maximum standardized uptake value ratio in T1-4N1-3M0 non-small cell lung cancer patients treated with concurrent chemo-radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Prognosis; Retrospective Studies | 2022 |
Identifying the individual metabolic abnormities from a systemic perspective using whole-body PET imaging.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Whole Body Imaging | 2022 |
PET of Fibroblast-Activation Protein for Cancer Staging: What We Know and What We Need to Learn.
Topics: Biliary Tract Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.
Topics: Adenocarcinoma of Lung; China; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Endobronchial ultrasound-guided transbronchial needle aspiration facilitating diagnosis of sarcoidosis in a breast cancer patient with multiple lymphadenopathy: a case report.
Topics: Aged; Breast Neoplasms; Bronchoscopy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenopathy; Mastectomy; Mediastinum; Receptors, Interleukin-2; Sarcoidosis | 2022 |
FDG PET/CT in Eosinophilic Solid and Cystic Renal Cell Carcinoma With Lung Metastases.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Necrosis on pre-radiotherapy 18F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Predictive value of quantitative metabolic tumor volume and metabolic index analysis in lung cancer stereotactic radiotherapy with F-18 FDG PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tumor Burden | 2022 |
Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome.
Topics: ACTH Syndrome, Ectopic; Aged; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin | 2022 |
[Progressive massive fibrosis in pneumoconiosis is mimicking lung malignancy on (18)F-FDGPET-CT: two cases report].
Topics: Fibrosis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumoconiosis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Contribution of Metabolic Tumor Volume and Total Lesion Glycolysis to Predict Prognosis in Early-Stage Lung Cancer at Preoperative Staging.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2022 |
Clinical Effects of PET-CT Before Definite Concurrent Chemoradiotherapy in Patients With Unresectable Stage IIIA-IIIB Squamous Cell Carcinoma of the Lungs.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2022 |
Potential advantages of FDG-PET radiomic feature map for target volume delineation in lung cancer radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Editorial for "Computed DWI Results in Superior Capability for N-Stage Assessment of Non-Small Cell Lung Cancer than that of Actual DWI, STIR Imaging and FDG-PET/CT".
Topics: Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Automated classification of PET-CT lesions in lung cancer: An independent validation study.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancer.
Topics: Adenocarcinoma; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Pulmonary actinomycosis mimicking lung cancer on
Topics: Actinomycosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2022 |
The correlation between PD-L1 expression and metabolic parameters of
Topics: B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Imidazoles; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases.
Topics: Carcinoma, Hepatocellular; Drugs, Investigational; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Skull; Sorafenib; Tegafur | 2022 |
Negative Correlation Between
Topics: Animals; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Lung Neoplasms; Mice; Oligopeptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Programmed Cell Death 1 Receptor | 2022 |
PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming.
Topics: Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Lung Neoplasms; Particulate Matter; Positron Emission Tomography Computed Tomography | 2022 |
[Solitary Mixed Squamous and Glandular Papilloma of the Peripheral Lung:Report of a Case].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Papilloma; Positron-Emission Tomography | 2022 |
Assessment of Correlation between Dual-Energy Ct (De-Ct)-Derived Iodine Concentration and Local Flourodeoxyglucose (Fdg) Uptake in Patients with Primary Non-Small-Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Prognostic impact of the tumor volume doubling time in clinical T1 non-small cell lung cancer with solid radiological findings.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Glycolysis; Homeodomain Proteins; Humans; Lung; Lung Neoplasms; MicroRNAs; Positron Emission Tomography Computed Tomography; RNA, Long Noncoding; Transcription Factors | 2023 |
Comparison of lung cancer aggressiveness in patients who never smoked compared to those who smoked.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Smoke | 2022 |
Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization.
Topics: Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies | 2022 |
Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
FDG PET/CT in Isolated Nasal Cavity Metastasis From Squamous Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Nasal Cavity; Positron Emission Tomography Computed Tomography | 2022 |
Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Carcinoembryonic Antigen; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
The Value of 18F-FDG PET/CT in the Diagnosis of Tuberculous Pleurisy and in the Differential Diagnosis between Tuberculous Pleurisy and Pleural Metastasis from Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleura; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tuberculosis, Pleural | 2022 |
Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
Topics: Anaplastic Lymphoma Kinase; Bayes Theorem; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography | 2022 |
Prognostic Potential of Metabolic Activity on 18 F-FDG Accumulation in Advanced NSCLC Receiving Combining Chemotherapy Plus PD-1 Blockade.
Topics: Albumins; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Rare form of metastasis: lung cancer metastases to inguinal hernia sac detected by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Correlation of [18F]FDG PET activity with expressions of Ki-67 in non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Combination of
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Predictive Value of
Topics: Adenocarcinoma of Lung; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2023 |
Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Machine Learning; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non-Small Cell Lung Cancer from Tuberculosis.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; Cell-Free Nucleic Acids; DNA, Neoplasm; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tuberculosis | 2023 |
Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study.
Topics: Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors.
Topics: Adolescent; China; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Recurrence, Local | 2022 |
Systematic endoscopic staging of mediastinum to determine impact on radiotherapy for locally advanced lung cancer (SEISMIC): protocol for a prospective single arm multicentre interventional study.
Topics: Carcinoma, Non-Small-Cell Lung; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Multicenter Studies as Topic; Neoplasm Staging; Prospective Studies | 2022 |
[Growing Mixed Squamous Cell and Glandular Papilloma Difficult to Differentiate from Primary Lung Cancer:Report of a Case].
Topics: Aged; Epithelial Cells; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Papilloma; Tomography, X-Ray Computed | 2022 |
[Postoperative Recurrent Lung Cancer Successfully Treated with Alternate Day Administration of Gefitinib].
Topics: ErbB Receptors; Exanthema; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2022 |
Invasive area to tumor ratio is a significant prognostic factor for non-small cell lung cancer.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies | 2022 |
Factors affecting the life expectancy in malignant pleural mesothelioma: Our 10 years of studies and experience.
Topics: Female; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Pleural Diseases; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meningeal Neoplasms; Neoplasms, Unknown Primary; Peru; Positron Emission Tomography Computed Tomography | 2022 |
Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
A whole-body FDG-PET/CT Dataset with manually annotated Tumor Lesions.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Predictive value of intratumor metabolic and heterogeneity parameters on [
Topics: Adenocarcinoma of Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Editorial for "Predictive Value of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2023 |
PET morphology helps distinguish solitary and solid pulmonary tuberculosis from non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis, Pulmonary | 2023 |
What is the effect of tumor diameter, lymph node metastases, and SUVmax value on prognosis in limited-stage small cell lung cancer?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Nocardia Infection With Adrenal Gland Abscess Mimicking Metastatic Lung Cancer on FDG PET/CT.
Topics: Abscess; Adrenal Gland Diseases; Adrenal Glands; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Nocardia Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Complete Metabolic Response in Adenocarcinoma Lung With Lymphangitic Carcinomatosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes.
Topics: Adenocarcinoma; Bayes Theorem; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
Consistency and prognostic value of preoperative staging and postoperative pathological staging using
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Early Reduction of Glucose Consumption Is a Biomarker of Kinase Inhibitor Efficacy Which Can Be Reversed with GLUT1 Overexpression in Lung Cancer Cells.
Topics: Antineoplastic Agents; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Lung Neoplasms; Positron-Emission Tomography; Protein Kinase Inhibitors | 2023 |
Comments on "dynamic
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
[Primary Pericardial Malignant Mesothelioma:Report of a Case].
Topics: Aged; Calbindin 2; Claudin-4; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Keratins; Lung Neoplasms; Mediastinal Neoplasms; Mesothelioma; Mesothelioma, Malignant; Thymus Neoplasms | 2022 |
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cell Proliferation; Fluorodeoxyglucose F18; Glycolysis; Humans; Ki-67 Antigen; Lung; Lung Neoplasms; Middle Aged; Molecular Imaging; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Tumor Burden | 2023 |
Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2022 |
18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of Biochemically Recurrent Prostatic Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2022 |
The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC.
Topics: Anaplastic Lymphoma Kinase; Carcinoma; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
A suspected case of intertrabecular systemic bone metastasis of small-cell lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2023 |
Predicting pathological highly invasive lung cancer from preoperative [
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease.
Topics: Carcinoma, Non-Small-Cell Lung; Entropy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Investigation of small lung lesion detection for lung cancer screening in low dose FDG PET imaging by deep neural networks.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neural Networks, Computer; Positron-Emission Tomography | 2022 |
Commentary: The Role of PET Scan Uptake in Determining Prognosis in Early-Stage Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2023 |
Application of 18 F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
Topics: Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Whole-Body PET Imaging: A Catalyst for Whole-Person Research?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2023 |
The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Role of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcopenia; Tumor Burden | 2023 |
Prognostic role of baseline
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Benign lymphoid hyperplasia mimicking oligometastasis from non-small cell lung cancer after stereotactic ablative radiotherapy.
Topics: Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung Neoplasms; Male; Radiosurgery | 2022 |
Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; S100 Calcium-Binding Protein A4 | 2023 |
F-18 FDG PET/CT findings of intrathoracic lymphadenopathy in EBUS-TBNA-proven anthracosis.
Topics: Anthracosis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenopathy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Invasive mucinous adenocarcinoma of the lung: clinicopathological features,
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Increased FAPI Activity in Pulmonary Tuberculosis.
Topics: Biological Transport; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphadenopathy; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Tuberculosis, Pulmonary | 2023 |
Lhermitte-Duclos Disease Related With Cowden Syndrome Mimicking Metastatic Lung Cancer on FDG PET/CT.
Topics: Cerebellar Neoplasms; Female; Fluorodeoxyglucose F18; Hamartoma; Hamartoma Syndrome, Multiple; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2023 |
Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Do fine needle aspirate cytomorphological features correlate with positron emission tomography findings of metastatic non-small cell lung carcinoma in lymph nodes?
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2023 |
Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: A prospective study.
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Tumor Hypoxia | 2023 |
18FDG PET/CT Tumoral and Neurologic Therapeutic Response in a Case of Anti-GABABR Paraneoplastic Limbic Encephalitis.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2023 |
The Humeral Metastasis as the Initial Presentation of Lung Adenocarcinoma Revealed by 18F-FDG PET/CT.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
FDG PET/CT in a Case of Lung Adenocarcinoma With Diffuse Cavitary Intrapulmonary Metastases.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Retroperitoneal Inflammation Detected on FDG PET/CT in Patient on Long-Term Immunotherapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Immunotherapy; Inflammation; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Inflammation after catheterisation mimicking tumour with squamous cell lung carcinoma in positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Deep learning model integrating positron emission tomography and clinical data for prognosis prediction in non-small cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Predicting the pathological invasiveness of early lung adenocarcinoma prior to surgery using Deauville criteria: reliability and validity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies | 2023 |
Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2023 |
Usefulness of 18 F-FDG PET/computed tomography metabolic parameters in predicting sarcopenia and prognosis of treatment-naive patients with non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Quality of Life; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2023 |
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
The value of preoperative positron emission tomography/computed tomography in differentiating the invasive degree of hypometabolic lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Focal
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies | 2023 |
Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status.
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Entropy; Fluorodeoxyglucose F18; Genomics; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2023 |
Topics: Angiotensin-Converting Enzyme 2; Animals; Fluorodeoxyglucose F18; Gallium Radioisotopes; HEK293 Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Positron Emission Tomography Computed Tomography | 2023 |
Respiratory muscle metabolic activity on PET/CT correlates with obstructive ventilatory defect severity and prognosis in patients undergoing lung cancer surgery.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Respiratory Muscles; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Predictive value of
Topics: Bone Diseases; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Hydrolases; Lung Neoplasms; Metabolic Diseases; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Retrospective Studies | 2023 |
Primary tumor SUV
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2023 |
Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer
Topics: Animals; Fluorodeoxyglucose F18; Francisella tularensis; Gallium Radioisotopes; Inflammation; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Rabbits | 2023 |
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients.
Topics: Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Liver Transplantation; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Correlation of
Topics: Adenocarcinoma of Lung; Biomarkers; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Tumor Microenvironment | 2023 |
Brain FDG PET for visualizing the relation between impaired lung function and cognitive decline in lung cancer: a preliminary study.
Topics: Aged; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Lung; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Metabolic patterns on [
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2023 |
Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Multivariate analysis based on the maximum standard unit value of
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
The value on SUV-derived parameters assessed on
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron Emission Tomography Computed Tomography | 2023 |
Characteristics of fibrotic-foci-like lung adenocarcinoma on 18 F-FDG PET/computed tomography and HRCT.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Pulmonary Tuberculosis with Elevated CEA and Positive PET-CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule; Tuberculosis, Pulmonary | 2023 |
Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Washout-Computed Tomography Discriminates Pulmonary "Fat-poor" Hamartomas From Neuroendocrine Neoplasms: A Simple Method in the Radiomics Era.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes.
Topics: Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Programmed Cell Death 1 Receptor | 2023 |
Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images.
Topics: Carcinoma, Non-Small-Cell Lung; Computers; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Value of preoperative
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial: Should dose intensification be discontinued or should accelerated schemes r
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Bladder Distention Demonstrating Vesicourachal Diverticulum on 18 F-FDG PET/CT Images of a Lung Cancer Patient.
Topics: Diverticulum; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Urinary Bladder | 2023 |
Atypical radiological onset of lung cancer: An exceptional PET/CT image.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
FDG PET/CT Findings of Malignant Rhabdoid Tumor Arising From a Renal Allograft.
Topics: Allografts; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Transplantation; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdoid Tumor | 2023 |
[Pulmonary Tumorlet Associated with Atypical Mycobacterium].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Middle Aged; Nontuberculous Mycobacteria; Positron-Emission Tomography | 2023 |
Initial Evaluation of [
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2023 |
Differential diagnosis of lung cancer and tuberculosis based on 18 F-fluorodeoxyglucose PET/CT multi-time points imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis | 2023 |
Impact of Follow-up 18F-FDG PET on the Management in Patients With Lung Cancer: A Meta-analysis: Erratum.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Unexpected Origin of Lung Metastases: Rare Colon Leiomyosarcoma Detected by 18 F-FDG PET/CT.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Retrospective Studies; Tumor Burden | 2023 |
Detection of the gene mutation of epidermal growth factor receptor in lung adenocarcinoma by radiomic features from a small amount of PET data.
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Diagnostic value of [ 68 Ga]Ga-Pentixafor versus [ 18 F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
Bilateral Pulmonary Enteric Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer.
Topics: Carcinoma, Squamous Cell; ErbB Receptors; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mutation; Paranasal Sinuses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2023 |
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Risk Factors | 2023 |
The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Development of lung cancer risk prediction models based on F-18 FDG PET images.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Clinical utility of [
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenopathy; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Metastatic Pulmonary Desmoplastic Small Round Cell Tumor on FDG PET/CT.
Topics: Adult; Desmoplastic Small Round Cell Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Increased
Topics: Animals; Cat Diseases; Cats; Fluorodeoxyglucose F18; Lung Neoplasms; Pneumonia, Lipid; Positron-Emission Tomography | 2023 |
18 F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
A Prospective Study Comparing Dosimetry between Computed Tomography (CT) based Radiation Planning and Positron Emission Computed Tomography (PET-CT) based Radiation Planning in Treatment of Non-Metastatic Non Small Cell Lung Carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Electrons; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2023 |
Efficacy evaluation of neoadjuvant immunotherapy plus chemotherapy for non-small-cell lung cancer: comparison of PET/CT with postoperative pathology.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2023 |
[
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2023 |
Error mitigation enables PET radiomic cancer characterization on quantum computers.
Topics: Computers; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Understanding the Value of FAPI versus FDG PET/CT in Primary and Metastatic Lung Cancer.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines | 2023 |
Exploring the correlation between HER2 alterations and
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
18 F-FDG PET/CT to Spare Malignancy in a Rare Case of Lung Endometriosis.
Topics: Adult; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aspartate-tRNA Ligase; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Small Cell Carcinoma of the Ureter With Early Recurrence and Multiple Metastases Shown on 18 F-FDG PET/CT.
Topics: Adult; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Ureter | 2023 |
18 F-FDG PET/CT Imaging of Pulmonary Hamartomas : Metabolic and Functional Characterization.
Topics: Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
A comparison of 18 F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study.
Topics: Adenocarcinoma of Lung; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Retrospective Studies | 2023 |
Pembrolizumab-Associated Pneumonitis Resembling Lymphangitic Carcinomatosis in a Melanoma Patient.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Melanoma; Middle Aged; Pneumonia; Positron Emission Tomography Computed Tomography | 2023 |
Syphilis Mimicking Malignant Pulmonary Tumor With Nodal and Bone Metastasis on 18 F-FDG PET/CT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syphilis | 2023 |
Rate of benign nodule resection in a lung cancer screening program.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
A novel [
Topics: Animals; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor | 2023 |
FDG-Avid Granulomatous Lymphocytic Interstitial Lung Disease With Common Variable Immunodeficiency.
Topics: Adult; Common Variable Immunodeficiency; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Comparative analysis of batch correction methods for FDG PET/CT using metabolic radiogenomic data of lung cancer patients.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Asymptomatic Penetrating Atherosclerotic Ulcer Findings on 18 F-FDG PET/CT.
Topics: Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Penetrating Atherosclerotic Ulcer; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Prognostic Impact of Cancer Inflammation Prognostic Index for Non-small Cell Lung Cancer.
Topics: Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2023 |
Early Prediction of Radiotherapeutic Efficacy in a Mouse Model of Non-Small Cell Lung Carcinoma Using
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Spatial mapping of tumor heterogeneity in whole-body PET-CT: a feasibility study.
Topics: Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Combination of tumor asphericity and an extracellular matrix-related prognostic gene signature in non-small cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Precision Medicine; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
[Organizing Pneumonia with Difficult Differentiation from Lung Cancer:Report of a Case].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Organizing Pneumonia; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tumor Burden | 2020 |
Intravascular Large B-Cell Lymphoma Presenting with Hypoxemia without any Abnormalities on Standard Imaging Studies.
Topics: Aged; Biopsy; Dyspnea; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography | 2019 |
Positron Emission Tomography in T3/T4 Non-Small Cell Lung Cancer After Induction Chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Treatment Outcome; Whole Body Imaging | 2019 |
Development and Validation of a
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2020 |
Atypical diagnosis for typical lung carcinoid.
Topics: Aged; Bronchoscopy; Carcinoid Tumor; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule | 2019 |
Effects of alterations in positron emission tomography imaging parameters on radiomics features.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
Bone Marrow and Tumor Radiomics at
Topics: Aged; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2019 |
Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Gliosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging | 2019 |
Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Respiration; Risk Assessment; Risk Factors; Treatment Outcome; Young Adult | 2020 |
Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET/CT: A case report.
Topics: Aged; Carcinoma; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphangitis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Fluorodeoxyglucose F18; Gamma Rays; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Neoplasm Staging; Pemetrexed; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Proportional Hazards Models; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Taxoids; Tumor Burden; Vinorelbine | 2019 |
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2019 |
Acne vulgaris with false-positive signals on
Topics: Acne Vulgaris; Endodermal Sinus Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testicular Neoplasms; Young Adult | 2020 |
Nivolumab-induced Pancreatitis: An Immune-related Adverse Event.
Topics: Aged; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Nivolumab; Pancreatitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Commentary: How to predict disaster?
Topics: Disasters; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms | 2020 |
Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation.
Topics: Adenocarcinoma of Lung; Clonal Evolution; ErbB Receptors; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Treatment Outcome | 2020 |
Clinical significance of pulmonary nodules in decision-making and management of patients diagnosed with esophageal cancer.
Topics: Chemoradiotherapy; Clinical Decision-Making; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; United Kingdom | 2020 |
Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on
Topics: Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Mutation; Positron Emission Tomography Computed Tomography; ROC Curve | 2020 |
PET-CT for Evaluating Breast Cancer Yields Incidental Finding in the Lung.
Topics: Aged; Biopsy; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymphatic Metastasis; Mammography; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Primary Leiomyosarcoma of the Bronchus: 18F-FDG PET/CT Findings.
Topics: Adult; Bronchi; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Correlations between the metabolic profile and
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Value of pre-therapy
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography | 2020 |
Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions.
Topics: Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Support Vector Machine | 2019 |
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2020 |
Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy.
Topics: Carbon; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2020 |
Gossypiboma Mimicking Fluorodeoxyglucose-avid Lung Nodule.
Topics: Coronary Artery Bypass; Device Removal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Foreign Bodies; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2020 |
Prognostic value of dual-point fluorine-18 fluorodeoxyglucose PET imaging, partial volume correction and glucose transporter-1 expression in resected nonsmall cell lung cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Analysis | 2020 |
Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small cell lung cancer treated with induction chemotherapy.
Topics: Adenocarcinoma of Lung; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2020 |
Lung visualisation on PET/MRI: implementing a protocol with a short echo-time and low flip-angle volumetric interpolated breath-hold examination sequence.
Topics: Algorithms; Breath Holding; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Comparison Between
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nivolumab; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Radiomics of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Retrospective Studies | 2020 |
Artificial Intelligence in PET/CT Is about to Make Whole-Body Tumor Burden Measurements a Clinical Reality.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Burden | 2020 |
Homological radiomics analysis for prognostic prediction in lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Pattern Recognition, Automated; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiometry; Reproducibility of Results; Treatment Outcome; Wavelet Analysis | 2020 |
18F-FDG Uptake of Localized Malignant Peritoneal Mesothelioma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Prognostic value of
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2020 |
The Effect of Carbogen Breathing on
Topics: A549 Cells; Animals; Carbon Dioxide; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Hypoxia; Immunohistochemistry; Lung; Lung Neoplasms; Mice; Mice, Nude; Oxygen; Positron-Emission Tomography; Tissue Distribution | 2019 |
Correlation between combining
Topics: Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins | 2020 |
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Organ Size; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Xenograft Model Antitumor Assays | 2019 |
Two cases of granuloma mimicking local recurrence after pulmonary segmentectomy.
Topics: Aged; Carcinoembryonic Antigen; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Polyglycolic Acid; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sutures | 2020 |
Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors.
Topics: Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Interobserver agreement of the visual Herder scale for the assessment of solitary pulmonary nodules on 18F Fluorodeoxyglucose PET/computed tomography.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule | 2020 |
Influx rate constant of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron-Emission Tomography | 2020 |
99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence?
Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Organotechnetium Compounds; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography | 2020 |
18F-FDG PET/CT Evaluation of Crizotinib and Lorlatinib Therapy in Metastatic ROS-1-Positive Non-Small Cell Lung Cancer.
Topics: Aminopyridines; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluorodeoxyglucose F18; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pyrazoles; Radiopharmaceuticals | 2020 |
"Hot Lung" Sign in Pulmonary Intravascular Large B-Cell Lymphoma on 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Treatment patterns and survival after 18F-fluorodeoxyglucose positron emission tomography/computed tomography-guided local consolidation therapy for oligometastatic non-small cell lung cancer: a two-center propensity score-matched analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Consolidation Chemotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Propensity Score; Radiopharmaceuticals; Retrospective Studies | 2020 |
Tongue metastasis was the first sign of malignant pleural mesothelioma detected by PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tongue | 2020 |
Evaluating response to immunotherapy with
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Tumor Burden | 2020 |
18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results | 2020 |
Risk stratification of symptomatic brain metastases by clinical and FDG PET parameters for selective use of prophylactic cranial irradiation in patients with extensive disease of small cell lung cancer.
Topics: Brain Neoplasms; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Risk Assessment; Small Cell Lung Carcinoma | 2020 |
The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nivolumab; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2020 |
Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging Genomics; Lung; Lung Neoplasms; Machine Learning; Male; Mutation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2021 |
Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Area Under Curve; B7-H1 Antigen; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
Topics: Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate | 2020 |
Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis | 2020 |
Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Young Adult | 2020 |
SUVmax of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2020 |
Topics: Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.
Topics: Biomarkers; Calibration; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Phantoms, Imaging; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Software; Tomography, X-Ray Computed | 2020 |
[A Case of an Elderly Male with Breast Cancer with Synchronous Triple Cancer of the Lung and Stomach].
Topics: Aged, 80 and over; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lung Neoplasms; Male; Mastectomy; Neoplasms, Multiple Primary; Stomach Neoplasms | 2019 |
Enhanced glucose metabolism mediated by CD147 is associated with
Topics: Adenocarcinoma of Lung; Animals; Apoptosis; Basigin; Cell Differentiation; Cell Movement; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
A model of malignant risk prediction for solitary pulmonary nodules on
Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Solitary Pulmonary Nodule | 2020 |
Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Less is more in radiotherapy target volume planning: lessons from the PET-plan trial.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2020 |
Ciliated muconodular papillary tumor of the lung: 18F-FDG PET/CT findings of 15 cases.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Exposure; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2020 |
Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
Topics: Adult; Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Retrospective Studies; Risk Factors | 2020 |
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Topics: Aged; Betacoronavirus; Carcinoma, Non-Small-Cell Lung; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; SARS-CoV-2 | 2020 |
Topics: B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Transcriptome; Tumor Microenvironment | 2020 |
Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Young Adult | 2020 |
Outcome of PET-Negative Solid Pulmonary Nodules: A Retrospective Study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule | 2021 |
Prediction of FDG-PET stage and uptake for non-small cell lung cancer on non-contrast enhanced CT scans via fractal analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Fractals; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Optimal image guidance for tumor biopsy in non-small-cell lung cancer.
Topics: Biomarkers; Biopsy; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
The Use of Positron Emission Tomography in Coronavirus Disease 2019 Cases.
Topics: Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; SARS-CoV-2 | 2020 |
Primary bone lymphoma of the thoracic vertebra in a patient with metastatic lung cancer.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2020 |
Fusion of FDG-PET Image and Clinical Features for Prediction of Lung Metastasis in Soft Tissue Sarcomas.
Topics: Adult; Aged; Computational Biology; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2020 |
SUR for mediastinal metastatic lymph node status in non-small-cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum | 2020 |
Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2020 |
Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis.
Topics: Adult; Aged; Aspirin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Microenvironment | 2020 |
Impact of respiratory motion correction on lesion visibility and quantification in thoracic PET/MR imaging.
Topics: Aged; Aged, 80 and over; Artifacts; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Mechanics | 2020 |
[Target volume reduction by
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards | 2020 |
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prostatic Neoplasms; Urea | 2020 |
Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 Lesions.
Topics: Algorithms; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2021 |
A Case of Localized Malignant Peritoneal Mesothelioma With Lung Cancer Detected by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2020 |
Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
Topics: Aged; Biopsy; Clinical Decision-Making; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiation Dosage; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Pulmonary artery enlargement on routine staging
Topics: Aged; Aorta; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Hypertrophy; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Radiopharmaceuticals; Retrospective Studies; Sex Factors | 2020 |
Value of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tuberculosis | 2021 |
A Case of Localized Malignant Peritoneal Mesothelioma Evaluated by 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2020 |
Using CT texture analysis to differentiate between peripheral lung cancer and pulmonary inflammatory pseudotumor.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Plasma Cell Granuloma, Pulmonary; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; ROC Curve | 2020 |
Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2021 |
Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Phenotype; Positron Emission Tomography Computed Tomography | 2020 |
Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2021 |
Pulmonary Adenocarcinoma Metastasis to the Breast Unexpectedly Discovered on Re-staging
Topics: Adenocarcinoma of Lung; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mammography; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2020 |
Segmentation in Non-Small Cell Lung Tumors Using 18F-FDG PET/CT: Tips and Rules.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CT.
Topics: Aged; Aortitis; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Nivolumab; Positron Emission Tomography Computed Tomography | 2020 |
Multi-observer concordance and accuracy of the British Thoracic Society scale and other visual assessment qualitative criteria for solid pulmonary nodule assessment using FDG PET-CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Solitary Pulmonary Nodule | 2020 |
[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors | 2020 |
Relationship between SP142 PD-L1 Expression and
Topics: B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography | 2020 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in descending necrotizing mediastinitis and cervical vertebral osteomyelitis in a cancer patient: A case report.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cervical Vertebrae; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinitis; Osteomyelitis; Positron Emission Tomography Computed Tomography | 2020 |
Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiosurgery; Retrospective Studies; Time Factors | 2020 |
Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2020 |
Analysis of solitary pulmonary nodule after surgical resection in patients with 18F-FDG positron emission tomography integrated computed tomography in the preoperative work-up.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2021 |
Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies | 2021 |
Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Tumor metabolic volume by
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Outcome | 2020 |
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chemotherapy, Adjuvant; Deep Learning; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pneumonectomy; Positron-Emission Tomography; Progression-Free Survival; Retrospective Studies; RNA-Seq; Tumor Burden; Tumor Microenvironment | 2020 |
Diagnostic Yield of 18F-FDG PET After Lung Transplantation: A Single-center, Retrospective Cohort Study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome | 2021 |
Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Patient Selection; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2021 |
Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Adding the temporal domain to PET radiomic features.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Time Factors | 2020 |
Impact of Glucose Uptake of Noncancerous Lung Area in Respiratory Events for Lung Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Young Adult | 2021 |
Correlation between preoperative
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Postoperative Period; Preoperative Period; Prognosis; Survival Rate; Time Factors | 2021 |
Unusual 18F-FDG PET-CT finding of paraneoplasic polymyositis in a patient with lung epidermoïd carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Polymyositis; Positron Emission Tomography Computed Tomography | 2020 |
Value of interim
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Progression-Free Survival; Retrospective Studies | 2020 |
Pilot Study: Texture Analysis of PET Imaging Demonstrates Changes in
Topics: Brain; Brain Neoplasms; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pilot Projects; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2021 |
Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiometry; ROC Curve; Treatment Outcome; Tumor Burden | 2020 |
Machine learning based on clinico-biological features integrated
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Postoperative Complications; Preoperative Care; Prognosis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2021 |
The potential of
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Identification and Resolution of Asymptomatic COVID-19 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Evaluation of Lung Cancer.
Topics: Colitis; COVID-19; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; SARS-CoV-2 | 2021 |
COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Survival Rate | 2020 |
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Burden | 2020 |
Detection of pseudoprogression with [
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2021 |
Long-term Survival with 18-Fluorodeoxyglucose Positron Emission Tomography-directed Therapy in Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
FDG-Avid Lung Nodule Formation by the Use of Hemostatic Powder: A Potential Cause of False-Positive FDG PET/CT.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Hemostatics; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Powders | 2021 |
New Data-Driven Gated PET/CT Free of Misregistration Artifacts.
Topics: Artifacts; Body Mass Index; Data Science; Exhalation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Lung Neoplasms; Organ Motion; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Exposure; Radiotherapy Dosage; Respiratory Mechanics; Time Factors; Tomography, X-Ray Computed | 2021 |
Can alternative PET reconstruction schemes improve the prognostic value of radiomic features in non-small cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Assessment | 2021 |
Machine learning-based diagnostic method of pre-therapeutic
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
The relationship between
Topics: Aged; Body Composition; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Inflammation; Lung Neoplasms; Male; Malnutrition; Middle Aged; Nutritional Status; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Analysis | 2020 |
[Experience with High-grade Fetal Lung Adenocarcinoma;Report of a Case].
Topics: Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided | 2020 |
Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2021 |
Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; ErbB Receptors; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Protein Kinase Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors | 2020 |
Total-body dynamic PET/CT of micro-metastatic lymph node in a patient with lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2021 |
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis.
Topics: Abdominal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
PET standardized uptake values of primary lung cancer for comparison with tumor volume doubling times.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Quantifying intratumor heterogeneity of lung neoplasms with radiomics.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Fractals; Humans; Lung Neoplasms; Tomography, X-Ray Computed | 2021 |
Endotracheal, Endobronchial, and Vocal Cords Metastases From Lung Cancer Detected by 18F-FDG PET/CT.
Topics: Bronchial Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tracheal Neoplasms; Vocal Cords | 2021 |
Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Monocytes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2021 |
The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Movement; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Thioguanine; Tumor Burden | 2021 |
Whole-body parametric [
Topics: Embolism; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2021 |
A comparison study of dual-energy spectral CT and 18F-FDG PET/CT in primary tumors and lymph nodes of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Association between
Topics: Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Texture analysis of iodine maps and conventional images for k-nearest neighbor classification of benign and metastatic lung nodules.
Topics: Female; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2021 |
Prognostic impact of maximum standardized uptake value on
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
An Unusual Case of Esophageal Carcinosarcoma on 18F-FDG PET/CT.
Topics: Carcinosarcoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?
Topics: Aged; Carcinoma; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; High-Throughput Nucleotide Sequencing; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Impact of EBUS-TBNA in addition to [
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive models.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2021 |
Positron Emission Tomography in Segmentectomy for cT1N0M0 Nonsmall Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden | 2021 |
Large adrenal mass heralding the diagnosis of occult extra-adrenal malignancy in two patients.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2021 |
Analysis of the F-18 FDG PET/CT features of pulmonary sclerosing pneumocytoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung.
Topics: Cauda Equina Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2021 |
Multiblock Discriminant Analysis of Integrative
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tumor Burden | 2021 |
Lung Adenocarcinoma Presenting as a Soft Tissue Metastasis to the Shoulder: A Case Report.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Sarcoma; Shoulder | 2021 |
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2023 |
Imaging Biomarkers in Lung Cancer with
Topics: Biomarkers; Fluorides; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals | 2021 |
Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Recurrent feature fusion learning for multi-modality pet-ct tumor segmentation.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Administration Schedule; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tumor Microenvironment | 2021 |
Mediastinum-type lung cancer on 68Ga-FAPI PET/CT with cardiac insufficiency as the first symptom.
Topics: Fluorodeoxyglucose F18; Heart Failure; Humans; Lung Neoplasms; Mediastinal Neoplasms; Mediastinum; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors.
Topics: Aged; Aged, 80 and over; Cachexia; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Treatment Outcome | 2021 |
Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Preoperative 2-[
Topics: Ampulla of Vater; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2021 |
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Imaging; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2021 |
The dynamics and prognostic value of FDG PET-metrics in weekly monitoring of (chemo)radiotherapy for NSCLC.
Topics: Benchmarking; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
High-resolution radioluminescence microscopy of FDG uptake in an engineered 3D tumor-stoma model.
Topics: Endothelial Cells; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Microscopy; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Correlation between PET/CT findings and pathological features of mediastinal lymph nodes in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Performance Evaluation of a Deep Learning System for Differential Diagnosis of Lung Cancer With Conventional CT and FDG PET/CT Using Transfer Learning and Metadata.
Topics: Aged; Deep Learning; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Metadata; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2021 |
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Non-Small-Cell Lung; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Tumor Burden | 2021 |
Paraneoplastic Limbic Encephalitis Secondary to SCLC on 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2021 |
Usefulness of dynamic fluorodeoxyglucose positron emission tomography/computed tomography in diagnosing pulmonary arteriovenous malformation mimicking a lung tumour.
Topics: Arteriovenous Malformations; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2021 |
[Effectiveness of Osimertinib for Postoperative Recurrence of Lung Cancer with L861Q Activating EGFR Mutation:Report of a Case].
Topics: Acrylamides; Aged; Aniline Compounds; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2021 |
[Surgical Cases of Solitary Lesion after Surgery for Primary Lung Cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2021 |
FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Expressed Sequence Tags; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Workflow | 2021 |
Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and
Topics: Angiogenesis Inhibitors; Animals; Annexin A5; Apoptosis; Cell Proliferation; Fluorodeoxyglucose F18; Glucose; Heterografts; Humans; Lung Neoplasms; Mice; Optical Imaging; Positron Emission Tomography Computed Tomography | 2021 |
Editorial Comment: Metabolic Tumor Volume on FDG PET/CT for Predicting Lymphovascular Invasion of Non-Small Cell Lung Cancer-Proceed With Caution.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Burden | 2021 |
Prospective Evaluation of the First Integrated Positron Emission Tomography/Dual-Energy Computed Tomography System in Patients With Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Lung cancer combined with diffuse peritoneal and mesenteric amyloidosis detected on 18F-FDG PET/CT: A case report.
Topics: Aged; Amyloidosis; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesentery; Omentum; Pneumonectomy; Positron Emission Tomography Computed Tomography | 2021 |
Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2021 |
Prognostic role of standard uptake value according to pathologic features of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2022 |
Pulmonary sarcoidosis masquerading as metastatic breast cancer: a case report.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Sarcoidosis, Pulmonary | 2021 |
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Radiofrequency ablation for treatment of thyroid follicular neoplasm with low SUV in PET/CT study.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiofrequency Ablation; Thyroid Gland; Thyroid Neoplasms | 2021 |
PET positive lung mass in a patient with rectal cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2021 |
Osteogenic and brain metastases after non-small cell lung cancer resection.
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Quality of Life; Retrospective Studies | 2021 |
62-year-old woman with PET-positive solitary pulmonary nodule.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Solitary Pulmonary Nodule | 2021 |
Clinical and surgical approaches for malignant pulmonary lesions after a previous extrapulmonary malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
The predictive power of artificial intelligence on mediastinal lymphnode metastasis.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2021 |
The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre.
Topics: Adenocarcinoma; Aged; Australia; Biopsy; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Hypermetabolic pulmonary lesions on FDG-PET/CT: Tularemia or neoplasia?
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tularemia | 2021 |
Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis".
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Panniculitis; Positron Emission Tomography Computed Tomography | 2022 |
The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Retrospective Studies | 2022 |
Diffuse Linear Pattern of Pericardial FDG Activity in Pericardial Metastasis From Squamous Cell Lung Carcinoma.
Topics: Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Pericarditis, Tuberculous | 2022 |
Lung Cancer Risk in Suspicious Lung Nodules With Negative Positron Emission Tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging | 2022 |
Radiomics and functional imaging in lung cancer: the importance of radiological heterogeneity beyond FDG PET/CT and lung biopsy.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Fully Integrated Quantitative Multiparametric Analysis of Non-Small Cell Lung Cancer at 3-T PET/MRI: Toward One-Stop-Shop Tumor Biological Characterization at the Supervoxel Level.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography | 2021 |
Differentiation of bland versus tumor thrombus in a lung cancer patient with an implanted central venous access device and a superior vena cava syndrome: 18F-FDG PET/CT findings.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Superior Vena Cava Syndrome; Thrombosis | 2022 |
Macrovasculature and positron emission tomography (PET) standardized uptake value in patients with lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
[18F]FDG PET-CT findings in an unusual case of synchronous double primary lung cancer of different histologies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Lung Cancers Associated With Cystic Airspaces: Natural History, Pathologic Correlation, and Mutational Analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Evolution of [
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage | 2017 |
Increased 18F-FDG Uptake in Multiple Muscles in a Patient With Violent Cough.
Topics: Aged; Biological Transport; Cough; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Muscles; Positron Emission Tomography Computed Tomography | 2017 |
Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Time Factors | 2017 |
Spatial Evidential Clustering With Adaptive Distance Metric for Tumor Segmentation in FDG-PET Images.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Cluster Analysis; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography | 2018 |
[Combined use of thin-section CT and
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
[Pulmonary carcinoid tumors].
Topics: Aged; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Theranostic Nanomedicine | 2017 |
Dose painting by means of Monte Carlo treatment planning at the voxel level.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Monte Carlo Method; Photons; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2017 |
The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Tumor Burden | 2017 |
Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ROC Curve; Transcription Initiation, Genetic | 2017 |
Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
[Solitary Peripheral Pulmonary Squamous Cell Papilloma;Diagnostic Significance of 18F-fluorodeoxyglucose Positron Emission Tomography Findings].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Papilloma; Positron-Emission Tomography | 2017 |
Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function.
Topics: Aorta; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Reference Standards | 2017 |
FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study.
Topics: Aged; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Contrast Media; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
A 33-Year-Old Woman With a Fluorodeoxyglucose-Avid Left Lower Lobe Mass.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2017 |
Measurement uncertainty of lesion and reference mediastinum standardized uptake value in lung cancer.
Topics: Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Reference Standards; Uncertainty | 2017 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Pleural Effusion, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracoscopy | 2017 |
Prognostic value of pre-treatment
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2017 |
The Impact of a Bayesian Penalized Likelihood Reconstruction Algorithm on the Evaluation of Indeterminate Pulmonary Nodules by Dual-Time Point 18F-FDG PET/CT.
Topics: Algorithms; Bayes Theorem; Biological Transport; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Time Factors | 2017 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cohort Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hydroxybenzoates; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Topics: Academic Medical Centers; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cause of Death; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Survival Analysis | 2017 |
Percutaneous radiofrequency ablation of lung metastases from colorectal carcinoma under C-arm cone beam CT guidance.
Topics: Aged; Aged, 80 and over; Catheter Ablation; Colorectal Neoplasms; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography, Interventional; Radiopharmaceuticals | 2017 |
Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
Topics: Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2017 |
Influence of PET reconstruction technique and matrix size on qualitative and quantitative assessment of lung lesions on [18F]-FDG-PET: A prospective study in 37 cancer patients.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2017 |
GLUT-1 expression of pulmonary mixed squamous cell and glandular papilloma may be associated with high SUVmax on fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Complex and Mixed; Papilloma; Positron-Emission Tomography | 2017 |
First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Autoantibodies; Autoantigens; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; HLA-DR Antigens; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stimulating; Iodide Peroxidase; Iron-Binding Proteins; Killer Cells, Natural; Lung Neoplasms; Male; Melanoma; Middle Aged; Monocytes; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Function Tests; Thyroiditis; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult | 2017 |
Reply: Repeatability of Quantitative Whole-Body
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Supraclavicular schwannoma mimicking a lymphadenopathy in a lung cancer patient: PET/CT findings.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Clavicle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphadenopathy; Male; Neurilemmoma; Positron Emission Tomography Computed Tomography | 2017 |
Maximizing Benefits and Minimizing Harms of Lung Cancer Screening: A Teachable Moment.
Topics: Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multiple Pulmonary Nodules; Radiopharmaceuticals; Referral and Consultation; Risk Assessment; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2017 |
Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colitis, Ischemic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Rituximab; Sex Factors; Tomography, X-Ray Computed; Vincristine | 2017 |
Solitary Choroidal Metastasis From Lung Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2017 |
An amazing cause of false PET positivity: Diagnosed after a lung cancer surgery.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2017 |
Coexistence of Mediastinal Castleman Disease with Spindle Cell Carcinoma of the Lung.
Topics: Aged; Carcinoma; Castleman Disease; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Surgical Procedures; Tomography, X-Ray Computed | 2017 |
Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals | 2017 |
Analysis of radiation measurement of FDG radiopharmaceuticals and the development of medical image processing techniques.
Topics: Adult; Aged; Aged, 80 and over; Carcinogenesis; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Radiation Dosage; Radiopharmaceuticals; Tissue Distribution | 2017 |
High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, CD; Biomarkers, Tumor; Cadherins; Cell Adhesion Molecules; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2017 |
Can Laws Be a Potential PET Image Texture Analysis Approach for Evaluation of Tumor Heterogeneity and Histopathological Characteristics in NSCLC?
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
Topics: Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Small Cell Lung Carcinoma; Tumor Burden | 2018 |
The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer.
Topics: Aged; Anaplastic Lymphoma Kinase; Biopsy, Large-Core Needle; Carcinoma, Non-Small-Cell Lung; Clavicle; Endoscopic Ultrasound-Guided Fine Needle Aspiration; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Receptor Protein-Tyrosine Kinases; Reproducibility of Results; Retrospective Studies | 2017 |
Impact of EBUS-TBNA on PET-CT Imaging of Mediastinal Nodes.
Topics: Biopsy, Fine-Needle; Denmark; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Ultrasonography, Interventional | 2017 |
Is post-treatment standardized uptake value a prognostic factor in unresectable non-small cell lung carcinoma?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2017 |
Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2017 |
Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.
Topics: Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Metabolic tumor burden quantified on [
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Tumor Burden | 2017 |
Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Prospective Studies; Protons; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2018 |
Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2017 |
Role of various semiquantitative parameters of 18F-FDG PET/CT studies for interim treatment response evaluation in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; ROC Curve; Treatment Outcome; Tumor Burden | 2017 |
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Diagnostic classification of solitary pulmonary nodules using dual time
Topics: Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Machine Learning; Male; Positron Emission Tomography Computed Tomography; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2017 |
A new method to assess pulmonary changes using
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage | 2017 |
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Carcinoma, Squamous Cell; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Regression Analysis; Retrospective Studies; Small Cell Lung Carcinoma | 2017 |
Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non-Small Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve | 2017 |
Prognostic and predictive role of [
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pemetrexed; Pleurodesis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
CT and PET/CT fusion for lung cancer biopsy planning.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Benefits of respiratory-gated 18F-FDG PET acquisition in lung disease.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Respiratory-Gated Imaging Techniques | 2018 |
A comparative analysis of dual-phase dual-energy CT and FDG-PET/CT for the prediction of histopathological invasiveness of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiography, Dual-Energy Scanned Projection; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2017 |
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
Topics: Adult; Aged; Carcinoid Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2017 |
Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiosurgery; Reproducibility of Results; ROC Curve; Treatment Outcome | 2017 |
Spontaneous regression of FDG/PET positive lung adenocarcinoma in an elderly man.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Regression, Spontaneous; Neoplasm Staging | 2017 |
Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2018 |
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Topics: Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Probability; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Solitary Pulmonary Nodule; Tumor Burden | 2018 |
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals | 2018 |
Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cluster Analysis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis | 2017 |
The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2018 |
Early Multiple Primary Lung Cancer without Fluorodeoxyglucose Uptake on Positron Emission Tomography-Computed Tomography and Displaying Different
Topics: ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2017 |
[Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2017 |
Impact of pixel-based machine-learning techniques on automated frameworks for delineation of gross tumor volume regions for stereotactic body radiation therapy.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Machine Learning; Male; Neural Networks, Computer; Pattern Recognition, Automated; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Time Factors; Tumor Burden | 2017 |
Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method.
Topics: Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Tumor Burden | 2018 |
A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis.
Topics: Aged, 80 and over; Biomarkers, Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Suppressor Proteins; Ubiquitin Thiolesterase | 2017 |
Simultaneous Brain and Lung Histiocytic Sarcoma Revealed on 18F-FDG PET/CT.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Histiocytic Sarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Motion; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy Setup Errors; Respiratory-Gated Imaging Techniques | 2018 |
Prognostic value of combining a quantitative image feature from positron emission tomography with clinical factors in oligometastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2018 |
Endobronchial epithelial-myoepithelial carcinoma of the lung.
Topics: Aged, 80 and over; Bronchial Neoplasms; Bronchoscopy; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Radiopharmaceuticals | 2018 |
Artifactual Hepatic Metastasis on FDG PET/CT Secondary to Cryoablation for Adrenal Metastasis.
Topics: Adrenal Gland Neoplasms; Aged; Artifacts; Cryosurgery; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2018 |
68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Renal Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT.
Topics: Adaptation, Physiological; Adenocarcinoma; Adenocarcinoma of Lung; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Nivolumab; Positron Emission Tomography Computed Tomography | 2018 |
Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Topics: Aged; Asymptomatic Diseases; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Weight Loss | 2018 |
A SUV
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Propensity Score; Radiopharmaceuticals; Radiosurgery; Survival Rate | 2018 |
Differences in lung injury after IMRT or proton therapy assessed by
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Injury; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Proton Therapy; Radiation Dosage; Radiation Injuries; Radiation Pneumonitis; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2018 |
Tattoo-Induced False-Positive FDG PET/CT Interpretation while Staging for Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Tattooing | 2018 |
Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2018 |
Comparison of different automated lesion delineation methods for metabolic tumor volume of 18F-FDG PET/CT in patients with stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Tumor Burden | 2017 |
Incidental Detection of Synchronous Lung Melanoma on 18F-FDG PET/CT in a Patient With Parotid Gland Myoepithelial Carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Melanoma; Middle Aged; Myoepithelioma; Parotid Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
[A man in his 50s with dizziness, double vision and walking difficulties].
Topics: Carcinoma, Small Cell; Diplopia; Dizziness; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2018 |
CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Chemotherapy, Adjuvant; Colonic Neoplasms; Colonoscopy; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Keratin-20; Keratin-7; Lung; Lung Neoplasms; Male; Pneumonectomy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
PET-SUV Max and Upstaging of Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Retrospective Studies | 2019 |
Intense 18F-FDG activity in aortoiliac bypass graft mimicking infection: A case report.
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iliac Artery; Incidental Findings; Lung Neoplasms; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Small Cell Lung Carcinoma; Vascular Grafting | 2018 |
An assessment of
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2018 |
The Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2018 |
A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Pulmonary actinomycosis mimicking a lung metastasis from esophageal cancer; a case report.
Topics: Actinomycosis; Aged; Biopsy, Needle; Diagnosis, Differential; Endoscopy, Digestive System; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pleural Effusion; Pneumonia, Bacterial; Positron Emission Tomography Computed Tomography | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Tomography, X-Ray Computed | 2018 |
To be or not to be central-does this really matter?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Spinal Cord | 2018 |
Prominent Pulmonary Metastases Without Concurrent Intra-abdominal Metastasis in a Case of Ovarian Carcinoma.
Topics: Abdominal Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Time Factors; Treatment Outcome | 2018 |
Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Treatment Outcome | 2018 |
Adrenal Hemangioma Definite Diagnosis on CT, MRI, and FDG PET in a Patient With Primary Lung Cancer.
Topics: Adrenal Gland Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hemangioma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prognostic significance of
Topics: Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis | 2018 |
Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
PET imaging reveals EGFR mutation status.
Topics: ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron-Emission Tomography | 2018 |
Rapid Contour-based Segmentation for
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Software | 2018 |
Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Sarcoma, Ewing | 2018 |
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Systematic Compared With Targeted Staging With Endobronchial Ultrasound in Patients With Lung Cancer.
Topics: Adult; Aged; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Spain | 2018 |
FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Prognosis; Retrospective Studies | 2018 |
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
Topics: Aged; Aged, 80 and over; B7-H1 Antigen; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Female; Fluorodeoxyglucose F18; Forkhead Transcription Factors; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunity; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; T-Lymphocytes, Regulatory | 2018 |
Imaging of Metastatic Epithelioid Trophoblastic Tumor With 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Pregnancy; Radiopharmaceuticals | 2018 |
Performance Comparison Between
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2018 |
[Role of PET/CT in primitive non-small cell bronchopulmonary cancer].
Topics: Aged; Aged, 80 and over; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Morocco; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2017 |
Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Perfusion Imaging; Positron Emission Tomography Computed Tomography | 2018 |
Predictive value of dual-time
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2018 |
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies | 2018 |
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Cancer-Associated Fibroblasts; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Profiling; Glucose Transporter Type 1; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycolysis; Glycosylation; Hexosamines; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Microenvironment | 2018 |
Adrenal Histoplasmosis.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Rapidly growing pulmonary ground-glass nodule caused by metastatic melanoma lacking uptake on 18F-FDG PET-CT.
Topics: Adult; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in Seven Patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Combined Modality Therapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Microwaves; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Tumor Burden; Young Adult | 2018 |
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2018 |
Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging.
Topics: Adenoma, Pleomorphic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteolysis; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Salivary Glands; Tomography, X-Ray Computed | 2018 |
Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Standards; Tumor Burden | 2018 |
A case report of benign metastasizing leiomyoma of the lung: FDG-PET-CT findings and the utility of uterine needle biopsy.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Neoplasms | 2016 |
CT-guided percutaneous core biopsy for assessment of morphologically normal adrenal glands showing high FDG uptake in patients with lung cancer.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer.
Topics: Aged; Aged, 80 and over; Bone Marrow; Dose-Response Relationship, Radiation; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Spine; Tomography, X-Ray Computed | 2019 |
Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Databases, Factual; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2018 |
Computed Tomographic Studies of Noncalcified Nodules Related to Neuroendocrine Lung Tumor Using 68Gallium-Tagged Somatostatin Variant for Improvement in Diagnosis: A Non-Experimental, Non-Randomized, Cross-Sectional Study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Gallium; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2018 |
18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Genomics; Humans; Lung Neoplasms; Male; Middle Aged; Oncogenes; Positron-Emission Tomography; Prognosis; Tumor Hypoxia | 2018 |
Effects of a Ketogenic Diet on [
Topics: Animals; Blood Glucose; Diet, Ketogenic; Disease Models, Animal; Fluorodeoxyglucose F18; Lung Neoplasms; Mice, Inbred C57BL; Positron-Emission Tomography; Tomography, X-Ray Computed | 2019 |
Single-source Dual-energy CT as a Part of
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Surgical outcomes in 13 patients with bronchopulmonary carcinoid tumors including one recurrent oncocytic carcinoid tumor.
Topics: Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Comparison of SUVmax and SUVpeak based segmentation to determine primary lung tumour volume on FDG PET-CT correlated with pathology data.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Netherlands; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tumor Burden | 2018 |
Integrated texture parameter of 18F-FDG PET may be a stratification factor for the survival of nonoperative patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2018 |
Diagnosis of Multiple Primary Intestinal-Type Adenocarcinoma in the Lung by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
Computational delineation and quantitative heterogeneity analysis of lung tumor on 18F-FDG PET for radiation dose-escalation.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Male; Middle Aged; Organs at Risk; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2018 |
Recurrent inflammatory myofibroblastic tumour of the lung: FDG PET/CT scan findings.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Muscle Tissue; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Maxillofacial Spindle Cell Sarcoma With Lung Metastases on FDG PET/CT Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Sarcoma | 2018 |
FDG PET/CT of Cardiac Angiosarcoma With Pulmonary Metastases.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
[Is 18F-PET-CT the First Choice for Preoperative Screening
for Ia Non-small Cell Lung Cancer?]
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Period | 2018 |
[Fetal Adenocarcinoma of the Lung].
Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2018 |
[Pulmonary Enteric Adenocarcinoma;Report of a Case].
Topics: Adenocarcinoma of Lung; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
[Pulmonary Cryptcoccosis Mimicking Malignant Tumor;Report of a Case].
Topics: Aged; Cryptococcosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Fungal; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes.
Topics: Adenocarcinoma; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Color; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Support Vector Machine | 2018 |
Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2019 |
Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thorax; Tomography, X-Ray Computed; Young Adult | 2018 |
2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography | 2018 |
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Proto-Oncogene Mas; Radiopharmaceuticals | 2018 |
Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; ROC Curve; Solitary Pulmonary Nodule | 2018 |
Correlation of quantified metabolic activity in nonsmall cell lung cancer with tumor size and tumor pathological characteristics.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Tumor Burden | 2018 |
CT-guided Biopsy for the Diagnosis of Pulmonary Epithelioid Hemangioendothelioma Mimicking Metastatic Lung Cancer.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Image-Guided Biopsy; Lung; Lung Neoplasms; Male; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Aged; Asymptomatic Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Tumor Burden | 2019 |
Metabolic positron emission tomography parameters predict failure patterns in early non-small-cell lung cancer treated with stereotactic body radiation therapy: a single institution experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiosurgery; Retrospective Studies | 2018 |
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography | 2019 |
The Value of
Topics: Bone and Bones; Carcinoembryonic Antigen; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Spinal Neoplasms | 2019 |
Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Increased Skeletal Muscle FDG Uptake Due to Sexual Activity on PET/CT in a Middle Age Woman.
Topics: Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sexual Behavior | 2018 |
Discovery of pre-therapy 2-deoxy-2-
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Survival Analysis | 2019 |
[Typical Carcinoid of the Lung with Abnormal Elevation of Serum Pro-gastrin-releasing Peptide (ProGRP)].
Topics: Adult; Biomarkers, Tumor; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve | 2018 |
Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Risk Factors; Tertiary Care Centers; Tomography, X-Ray Computed | 2018 |
Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiometry; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2018 |
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Topics: Aged; Biological Transport; Calibration; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Reference Standards; Retrospective Studies | 2019 |
A smart and operator independent system to delineate tumours in Positron Emission Tomography scans.
Topics: Algorithms; Brain Neoplasms; Diagnosis, Computer-Assisted; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Observer Variation; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2018 |
Pretreatment
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Parenchymal Tissue; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Survival Rate; Treatment Outcome | 2018 |
A Case of Liver Injury Mimicking Metastasis After Gamma Knife Therapy for Lung Cancer: Evaluating by 18F-FDG PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery | 2018 |
Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Treatment Outcome | 2019 |
A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Photons; Positron Emission Tomography Computed Tomography; Proton Therapy; Radiation Pneumonitis; Radiopharmaceuticals | 2019 |
The role of F-18 FDG PET/CT in differentiating benign from malignant pulmonary masses and accompanying lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2018 |
Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Dose Hypofractionation; Radiotherapy, Intensity-Modulated; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Textural analysis demonstrates heterogeneous [
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Significance of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden | 2019 |
Quantitative radiomics: Validating image textural features for oncological PET in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Medical Oncology; Monte Carlo Method; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
[Inflammatory Pulmonary Myofibroblast Tumor Suspected of Pulmonary Metastasis of the Lung Cancer;Report of a Case].
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Myofibroblasts; Myofibroma; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2018 |
Non‑invasive monitoring of cisplatin and erlotinib efficacy against lung cancer in orthotopic SCID mouse models by small animal FDG‑PET/CT and CT.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mice; Mice, SCID; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2019 |
18F-FDG PET/CT Revealing Constrictive Pericarditis as the Only Manifestation of Malignant Mesothelioma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pericarditis, Constrictive; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Standardization of image reconstruction parameters for dynamic fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Quality Control; Reference Standards; Signal-To-Noise Ratio | 2018 |
The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study.
Topics: Clinical Competence; Cooperative Behavior; Education, Medical; Fiducial Markers; Fluorodeoxyglucose F18; Humans; Interdisciplinary Communication; Lung Neoplasms; Observer Variation; Positron Emission Tomography Computed Tomography; Radiation Oncologists; Radiotherapy Planning, Computer-Assisted; Radiotherapy Setup Errors; Radiotherapy, Image-Guided; Simulation Training; Tumor Burden | 2019 |
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2019 |
Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
Topics: Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
Delineation of lung cancer with FDG PET/CT during radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy Planning, Computer-Assisted | 2018 |
EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis.
Topics: A549 Cells; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; NADPH Oxidase 4; Positron Emission Tomography Computed Tomography; Reactive Oxygen Species; Retrospective Studies; ROC Curve | 2019 |
Focal mass-like cardiac uptake on oncologic FDG PET/CT: Real lesion or atypical pattern of physiologic uptake?
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Unsupervised Machine Learning | 2018 |
Prognostic Impact of Intratumoral Heterogeneity Based on Fractal Geometry Analysis in Operated NSCLC Patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fractals; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Biodistribution and Tumor Uptake of
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Liver; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2018 |
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Area Under Curve; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2019 |
Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: FDG Uptake and Risk Stratification.
Topics: Adult; Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Response Evaluation Criteria in Solid Tumors; Risk Assessment | 2019 |
Identification of multiple cardiac metastases from nonsmall-cell lung cancer by 18F-FDG PET/CT: A case report.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
[Mimics of lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Infant, Newborn; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2019 |
A Rare Case of Neutrophil-Rich, ALK-Negative Anaplastic Large Cell Lymphoma in the Lung Mimicking a Pulmonary Abscess on 18F-FDG PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2019 |
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Liberation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents | 2018 |
Prognostic Value and Clinical Impact of Pretreatment FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epithelial Cells; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Lipid give and take.
Topics: Fluorodeoxyglucose F18; Humans; Lipids; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Case of Solitary Peritoneal Metastasis From Atypical Bronchopulmonary Carcinoid on 18F-FDG PET/CT.
Topics: Adult; Biopsy, Fine-Needle; Bronchi; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2019 |
Comparison of the
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule | 2019 |
18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nestin; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2019 |
Usefulness of new flex-rigid pleuroscopy in the diagnosis of malignant pleural mesothelioma.
Topics: Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracoscopy; Tomography, X-Ray Computed | 2019 |
Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography useful to discriminate metachronous lung cancer from metastasis in patients with oncological history?
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2020 |
PET/CT Findings of Granulomatosis With Polyangiitis Presenting as a Solitary Pulmonary Nodule and Mimicking Lung Cancer.
Topics: Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule | 2020 |
Primary Pulmonary Paraganglioma Revealed by FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Paraganglioma, Extra-Adrenal; Positron Emission Tomography Computed Tomography | 2019 |
Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Topics: Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies | 2019 |
18FDG PET/CT & arterial inflammation: predicting cardiovascular events in lung cancer.
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Arteritis; Atherosclerosis; Calcinosis; Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Risk Factors | 2019 |
[Rare differential diagnosis of PET-positive pulmonary lesions].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2019 |
Diagnostic performances of 68Ga-DOTATOC versus 18Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Neoplasms; Male; Octreotide; Organometallic Compounds; Pneumonectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2019 |
Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies | 2019 |
Correlation between EGFR mutation status and F
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Non-Smokers; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Regression Analysis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Positron Emission Tomography Computed Tomography; Thoracic Surgery, Video-Assisted | 2019 |
18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases.
Topics: Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor.
Topics: Aged; Antineoplastic Agents, Immunological; Biliary Tract Diseases; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Immunotherapy; Lung Neoplasms; Male; Nivolumab; Positron Emission Tomography Computed Tomography; Radiography, Abdominal; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2019 |
[
Topics: Antineoplastic Agents, Immunological; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Keratinocytes; Lung Neoplasms; Male; Melanoma; Middle Aged; Nivolumab; Positron Emission Tomography Computed Tomography; Prurigo; Radiopharmaceuticals; Skin Neoplasms | 2019 |
Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Software; Texas | 2019 |
18F-FDG PET/CT Findings in Disseminated Genital Herpes in an Immunocompetent Patient With Anaplastic Lymphoma Kinase Rearranged Advanced Nonsmall Cell Lung Cancer.
Topics: Adult; Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Herpes Genitalis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Malignant Perivascular Epithelioid Cell Tumor of Lung on FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Perivascular Epithelioid Cell Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Alveolar soft part sarcoma metastatic to the breast: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cheek; Child; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mastectomy, Segmental; Positron-Emission Tomography; Sarcoma, Alveolar Soft Part; Skull Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
[Health economics analysis for 18F-fluorodeoxyglucose positron-emission tomography compared with computed tomography in lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
[18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment | 2019 |
Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2019 |
Dynamic Contrast-enhanced Area-detector CT vs Dynamic Contrast-enhanced Perfusion MRI vs FDG-PET/CT: Comparison of Utility for Quantitative Therapeutic Outcome Prediction for NSCLC Patients Undergoing Chemoradiotherapy.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
Topics: Diagnosis, Differential; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tumor Burden | 2019 |
Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas.
Topics: Adenocarcinoma of Lung; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sex Factors | 2019 |
Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cancer Pain; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2019 |
The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Molecular Imaging; Morpholines; Osteoclasts; Positron Emission Tomography Computed Tomography; Single Photon Emission Computed Tomography Computed Tomography; Treatment Outcome; X-Ray Microtomography | 2019 |
Xanthomatous Interstitial Pneumopathy: Chemotherapy- or Contrast Substance Related Change?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Xanthomatosis | 2020 |
Pre-treatment
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Machine Learning; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis | 2019 |
Comparison of prognostic values of primary tumor and nodal
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Sarcoidosis; Whole Body Imaging | 2019 |
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung; Lung Neoplasms; Male; Middle Aged; Observer Variation; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Young Adult | 2019 |
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2019 |
[A Case of Pulmonary Enteric Adenocarcinoma with Soleus Muscle Metastasis].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron Emission Tomography Computed Tomography | 2019 |
An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions.
Topics: Adrenal Gland Neoplasms; Aged; Biopsy; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Lipids; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Utility of Metabolic Parameters on FDG PET/CT in the Classification of Early-Stage Lung Adenocarcinoma: Prediction of Pathological Invasive Size.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors | 2019 |
Impact of free-breathing CT on quantitative measurements of static and quiescent period-gated PET Images.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Movement; Positron-Emission Tomography; Prospective Studies; Respiration; Respiratory-Gated Imaging Techniques | 2019 |
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; ROC Curve; Treatment Outcome | 2019 |
Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2019 |
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Survival Analysis; Thyroid Gland; Thyroiditis; Thyrotropin; Thyroxine; Triiodothyronine | 2019 |
Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Retroperitoneal Fibrosis | 2019 |
Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Photons; Pneumonia; Positron Emission Tomography Computed Tomography; Proton Therapy; Radiation Injuries; Retrospective Studies | 2019 |
Impact of intensity discretization on textural indices of [
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2019 |
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Response to "Comment on "metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2″".
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Positron Emission Tomography Computed Tomography | 2019 |
Comment on "Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2".
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
Topics: Adenocarcinoma of Lung; ATPases Associated with Diverse Cellular Activities; Cell Movement; Cell Proliferation; Cells, Cultured; Chromones; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Proto-Oncogene Proteins c-akt | 2019 |
Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CT.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2019 |
PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Pneumonia; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Analysis; Treatment Outcome | 2019 |
Comparison of
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies | 2019 |
[Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies | 2019 |
Evaluation of intra-tumoral blood feeding to predict the effect of induction therapy in patients with locally advanced lung cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Regression Analysis; Retrospective Studies | 2019 |
Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2022 |
Alveolar Sarcoidosis With Intense FDG Uptake, Mimicking Multi-focal Pneumonia and Infiltrative Lung Malignancy.
Topics: Adenocarcinoma; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary | 2019 |
FDG PET/CT in a Case of Primary Pulmonary Ewing Sarcoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma, Ewing | 2019 |
FDG PET/CT Findings of Unsuspected Pulmonary Epithelioid Angiosarcoma Manifested as a Brain Metastasis.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Incidental Findings; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography | 2019 |
FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
Topics: Antineoplastic Protocols; Bone Neoplasms; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2019 |
Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Leukocyte Count; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Neutrophils; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2019 |
Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT.
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Grading; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2019 |
The effect of a novel Bayesian penalised likelihood PET reconstruction algorithm on the assessment of malignancy risk in solitary pulmonary nodules according to the British Thoracic Society guidelines.
Topics: Aged; Algorithms; Bayes Theorem; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; Solitary Pulmonary Nodule | 2019 |
Evaluation of maximum standardized uptake value at fluorine-18 fluorodeoxyglucose positron emission tomography as a complementary T factor in the eighth edition of lung cancer stage classification.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Practice Guidelines as Topic; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Hypermetabolic Bone on
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Integrating manual diagnosis into radiomics for reducing the false positive rate of
Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2019 |
The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumoconiosis; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2020 |
The association between 18F-fluorodeoxyglucose PET intratumoral metabolic heterogeneity and pathological parameters in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult | 2019 |
[Basaloid Squamous Cell Carcinoma;Report of a Case].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 2019 |
Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression.
Topics: Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Keratin-7; Lung Neoplasms; Lymph Nodes; Lymphangiogenesis; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Micrometastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Receptors, Vascular Endothelial Growth Factor; Statistics, Nonparametric; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A | 2013 |
Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tuberculosis, Pulmonary | 2013 |
A false positive fluorodeoxyglucose lymphadenopathy in a patient with pulmonary carcinoid tumor and previous breast reconstruction after bilateral mastectomy.
Topics: Biopsy; Breast Neoplasms; Carcinoid Tumor; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Lymphatic Diseases; Mammaplasty; Mastectomy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Silicone Gels; Tomography, X-Ray Computed | 2014 |
NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies.
Topics: Aged; Antigens, Neoplasm; Area Under Curve; Biomarkers, Tumor; Biopsy, Needle; Body Fluids; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Cytodiagnosis; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2013 |
Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
Textiloma mimicking superior sulcus tumor: positron emission tomography/computed tomography findings of a pseudotumor.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Foreign Bodies; Humans; Lung Neoplasms; Male; Medical Errors; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Surgical Sponges; Thoracotomy; Tomography, X-Ray Computed | 2014 |
Potential pitfall of FDG PET/CT in assessing residual masses postchemotherapy.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2013 |
Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Time Factors | 2013 |
Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
FDG-PET imaging in patients with pulmonary carcinoid tumor.
Topics: Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Solitary Pulmonary Nodule | 2013 |
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma.
Topics: Adenocarcinoma; Case-Control Studies; Cell Proliferation; ErbB Receptors; Fluorodeoxyglucose F18; Genotype; Humans; Lung Neoplasms; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Survival Rate | 2013 |
Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT.
Topics: Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Topics: Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2013 |
Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed | 2013 |
A case report of intrapulmonary schwannoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Recurrent dermatofibrosarcoma protuberans with pulmonary metastases presenting twelve years after initial diagnosis: 18F-FDG PET/CT imaging findings.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
Usefulness of (18)F-FDG PET/CT in a rare case of malignant pseudothyroiditis.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Thyroiditis; Tomography, X-Ray Computed | 2014 |
The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Mammography; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms; Ultrasonography, Mammary | 2013 |
High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
Topics: Aged; Ambulatory Care; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume.
Topics: Contrast Media; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Movement; Phantoms, Imaging; Positron-Emission Tomography; Respiration | 2013 |
A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Phyllodes Tumor; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
False-positive finding of brain metastasis on (18)F-FDG PET imaging due to early subacute ischemic stroke.
Topics: Brain Ischemia; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiography; Stroke | 2013 |
Serendipitous discovery of non-sestamibi-avid squamous cell lung cancer invading the heart during myocardial perfusion imaging.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Myocardium; Neoplasm Invasiveness; Radiography; Technetium Tc 99m Sestamibi | 2013 |
A rare case of non-small cell lung cancer metastasizing to the pituitary gland: detection with (18)F-FDG PET-CT.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2014 |
The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Impact of PET staging in limited-stage small-cell lung cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate | 2013 |
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tumor Burden | 2013 |
A rare case of primary pulmonary epithelioid angiosarcoma detected by (18)F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2014 |
FDG uptake in the chest wall of a patient with small-cell lung cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Thoracic Wall | 2013 |
Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Thoracic Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2013 |
[Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2013 |
A 40-year-old woman with multiple lung nodules.
Topics: Adult; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hypertension; Kidney Failure, Chronic; Leiomyoma; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Thoracoscopy; Tomography, X-Ray Computed; Uterine Neoplasms | 2013 |
The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Standards | 2013 |
Comparing respiratory gated with delayed scans in the detection of colorectal carcinoma hepatic and pulmonary metastases with 18F-FDG PET-CT.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Time Factors; Tomography, X-Ray Computed | 2014 |
Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Tumor Burden | 2013 |
Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
Topics: Colorectal Neoplasms; Data Interpretation, Statistical; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multicenter Studies as Topic; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2013 |
Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
Topics: Aged; Biological Transport; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Utility of high-definition FDG-PET image reconstruction for lung cancer staging.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2013 |
Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Salivary Gland Neoplasms; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed | 2013 |
A rare case of mucinous cystadenoma of the lung mimicking malignancy at 18F-FDG PET/CT.
Topics: Cystadenoma, Mucinous; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Unexpected symptoms after rhTSH administration due to occult thyroid carcinoma metastasis.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyrotropin Alfa | 2013 |
FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2013 |
Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Topics: Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Normal Distribution; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2013 |
A novel minimally invasive technique to create a rabbit VX2 lung tumor model for nano-sized image contrast and interventional studies.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Iohexol; Liposomes; Lung Neoplasms; Nanocapsules; Neoplasm Transplantation; Optical Imaging; Particle Size; Rabbits; Radionuclide Imaging; Tumor Burden; X-Ray Microtomography | 2013 |
Abscopal [corrected] effects after conventional and stereotactic lung irradiation of non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiosurgery | 2013 |
An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Carcinoma, Non-Small-Cell Lung; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2013 |
A rare case of synchronous fetal type adenocarcinoma and mucinous adenocarcinoma of the lung evaluated by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Rabbits; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
PET motion compensation for radiation therapy using a CT-based mid-position motion model: methodology and clinical evaluation.
Topics: Algorithms; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Movement; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiration; Tomography, X-Ray Computed | 2013 |
Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2013 |
Variability of total lesion glycolysis by 18F-FDG-positive tissue thresholding in lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2013 |
Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiosurgery; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides.
Topics: Adult; Biopsy; Cord Blood Stem Cell Transplantation; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Skin; Skin Neoplasms; Tomography, X-Ray Computed; Transplantation Conditioning | 2013 |
A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinoscopy; Middle Aged; Models, Statistical; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2013 |
Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
A solitary mixed squamous cell and glandular papilloma of the lung.
Topics: Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Complex and Mixed; Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell; Papilloma; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Four-dimensional (4D) motion detection to correct respiratory effects in treatment response assessment using molecular imaging biomarkers.
Topics: Algorithms; Biomarkers; Calibration; Datasets as Topic; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Molecular Imaging; Motion; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography | 2014 |
Differentiation of lung neoplasms with lepidic growth and good prognosis from those with poor prognosis using computer-aided 3D volumetric CT analysis and FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Cone-Beam Computed Tomography; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Acute Disease; Aged; Aged, 80 and over; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.
Topics: Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2013 |
Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies | 2013 |
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[Sensitivity of PET with 18F-fluorodesoxyglucose in the diagnosis of neuroendocrine tumors of the lungs].
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2013 |
Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Motion; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2013 |
Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Lung Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2014 |
Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis.
Topics: Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Survival Rate; Syndrome; Tomography, X-Ray Computed | 2013 |
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2013 |
Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tumor Burden | 2013 |
Neural networks for nodal staging of non-small cell lung cancer with FDG PET and CT: importance of combining uptake values and sizes of nodes and primary tumor.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neural Networks, Computer; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Variation in background intensity affects PET-based gross tumor volume delineation in non-small-cell lung cancer: the need for individualized information.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2013 |
18F-FDGPET/CT: diabetes and hyperglycaemia.
Topics: Diabetes Complications; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Repetition of FDG PET study in the same day after appropriate patient preparation revealed two new cancer localizations: a case report.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Time Factors; Urinary Bladder Neoplasms | 2013 |
Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography | 2014 |
A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.
Topics: Algorithms; Analysis of Variance; Fluorodeoxyglucose F18; Lung Neoplasms; Lymph Nodes; Mediastinum; Movement; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiration; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2013 |
The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Iris metastasis in a patient with small cell lung cancer: incidental detection with 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Iris Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzylidene Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Inflammation Mediators; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Nude; Multimodal Imaging; Phosphorylation; Piperidones; Positron-Emission Tomography; Signal Transduction; Time Factors; Tomography, X-Ray Computed; Transcription Factor RelA; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Automated method for extraction of lung tumors using a machine learning classifier with knowledge of radiation oncologists on data sets of planning CT and FDG-PET/CT images.
Topics: Algorithms; Artificial Intelligence; Automation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Knowledge; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Support Vector Machine; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
Topics: Aged; Antigens, CD34; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kaplan-Meier Estimate; Lung Neoplasms; Male; Microvessels; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
PET/CT findings for bone marrow carcinosis because of lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Bone Marrow Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Pulmonary cryptococcosis and cryptococcal osteomyelitis mimicking primary and metastatic lung cancer in (18)F-FDG PET/CT.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Osteomyelitis; Positron-Emission Tomography | 2014 |
PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Topics: Aged; Coordination Complexes; Cytokines; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones | 2013 |
Enhanced CT and FDG PET/CT in malignant solitary fibrous tumor of the lung.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Solitary Fibrous Tumors; Tomography, X-Ray Computed | 2014 |
The difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Radionuclide Imaging; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2014 |
¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dihydrouracil Dehydrogenase (NADP); Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Microvessels; Middle Aged; Neovascularization, Pathologic; Neuroendocrine Tumors; Orotate Phosphoribosyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymidylate Synthase; Thymus Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery | 2016 |
FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dideoxynucleosides; Docetaxel; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Tumor Burden; Tumor Cells, Cultured | 2013 |
Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2013 |
Lesion detection and characterization with context driven approximation in thoracic FDG PET-CT images of NSCLC studies.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Tumor Suppressor Protein p53 | 2013 |
FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma.
Topics: Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Vascular Access Devices | 2014 |
Preoperative 18F-fluorodeoxyglucose positron emission tomography can predict the tumor malignancy of small peripheral lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
A rare case of pulmonary malignant granular cell tumor detected with 18F-FDG PET/CT imaging.
Topics: Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lung Neoplasms; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.
Topics: Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Feasibility study of FDG PET/CT-derived primary tumour glycolysis as a prognostic indicator of survival in patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The clinical impact of the sum of the maximum standardized uptake value on the pretreatment with F-FDG-PET/CT in small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2014 |
18F-deoxyglucose uptake in stage I non-small-cell lung cancer: time to move to randomized trials.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Radiosurgery; Randomized Controlled Trials as Topic | 2014 |
Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies | 2014 |
(18)F-FDG PET/CT scan in malignant priapism with diffuse pulmonary adenocarcinoma metastatic invasion of both corpus spongiosum and cavernosum.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Penile Neoplasms; Positron-Emission Tomography; Priapism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma in Situ; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.
Topics: Aged; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; NF-kappa B; Positron-Emission Tomography; Prognosis; Recurrence; Tissue Array Analysis; Up-Regulation | 2014 |
Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Decision Making; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Topics: Antigens, CD34; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2014 |
Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiat
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins c-bcl-2; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate; Tomography, X-Ray Computed | 2014 |
Serial changes of FDG uptake and diagnosis of suspected lung malignancy: a lesion-based analysis.
Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2014 |
High-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for recurrent primary mediastinal malignant germ cell tumor: a case report.
Topics: Adolescent; Antineoplastic Agents; Biopsy; Brachiocephalic Veins; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Recurrence; Subclavian Vein; Tomography, X-Ray Computed; Treatment Outcome; Vena Cava, Superior | 2014 |
[Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2013 |
A graph-based approach for the retrieval of multi-modality medical images.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2013 |
Detection of lung cancer by FDG-PET cancer screening program: a nationwide Japanese survey.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Health Surveys; Humans; Lung Neoplasms; Male; Middle Aged; National Health Programs; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positro
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2014 |
[Value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in early diagnosis of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2013 |
FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Topics: Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Detection of skeletal muscle metastases on initial staging of lung cancer: a retrospective case series.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Ultrasonography, Doppler, Duplex | 2014 |
A case of pleural epithelioid sarcoma of proximal type presenting as malignant pleural mesothelioma.
Topics: Biomarkers, Tumor; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
FDG-PET images of acrometastases.
Topics: Fluorodeoxyglucose F18; Foot; Hand; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Whole Body Imaging | 2014 |
High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiosurgery; Radiotherapy Planning, Computer-Assisted | 2014 |
Performance of FDG PET/ceCT in the evaluation of patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Ipilimumab; Kidney Transplantation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Mycophenolic Acid; Platinum Compounds; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Skin Neoplasms; Tacrolimus; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Models, Statistical; Positron-Emission Tomography; Respiration; Respiratory-Gated Imaging Techniques; Signal-To-Noise Ratio; Tomography, X-Ray Computed | 2014 |
The hypermetabolic mushroom: superior vena cava syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Small Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Smoking; Superior Vena Cava Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2014 |
Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
Topics: Adult; Aged; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2014 |
Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Italy; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Rate; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
A rare case of primary pulmonary synovial sarcoma in a pediatric patient evaluated by (18)F-FDG PET/CT.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoma, Synovial; Tomography, X-Ray Computed | 2014 |
Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Topics: Aged; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
18F-FDG PET scanning in pulmonary amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Risk Factors; Tomography, X-Ray Computed | 2014 |
Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Cisplatin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Irinotecan; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Non-contiguous spinal tuberculosis with a previous presumptive diagnosis of lung cancer spinal metastases.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2014 |
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2014 |
Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Non-invasive monitoring of anticancer effects of cisplatin on lung cancer in an orthotopic SCID mouse model using [¹⁸F] FDG PET-CT.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Ciliary body metastasis in a patient with non-small cell lung carcinoma--incidental detection with 18F-FDG PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Ciliary Body; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Uveal Neoplasms | 2014 |
Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Clinical Competence; Combined Modality Therapy; Cooperative Behavior; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Interdisciplinary Communication; Lung Neoplasms; Male; Observer Variation; Positron-Emission Tomography; Professional Competence; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Positive positron emission tomography/computed tomography scan and multiple pulmonary nodules: an unusual diagnosis.
Topics: Aged, 80 and over; Amyloidosis; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic impact of 18F-FDG uptake on PET in non-small cell lung cancer patients with postoperative recurrence following platinum-based chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum Compounds; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2014 |
[Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis].
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cyclotrons; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heterografts; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2014 |
PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Topics: Adolescent; Adult; Aged; Algorithms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Diseases; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Random Allocation; Reproducibility of Results; Respiration; Tomography, X-Ray Computed; Young Adult | 2014 |
Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia.
Topics: Biopsy, Needle; Bone Marrow; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiopharmaceuticals | 2014 |
Avoidance of false-positive findings on ¹⁸F-FDG-PET/CT using PET/ultrasound fusion: displaced laryngeal silicone implant versus recurrent cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Migration; Humans; Laryngeal Neoplasms; Lung Neoplasms; Positron-Emission Tomography; Prostheses and Implants; Radiography; Radiopharmaceuticals; Silicones; Ultrasonography | 2014 |
Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
Prognostic importance of volumetric measurements in stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Software; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate | 2016 |
Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
Topics: Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2016 |
Prognostic impact of [18F]fluorodeoxyglucose positron emission tomography scanning in the era of molecular oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
Topics: Adenocarcinoma; Aged; Cough; Deglutition Disorders; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Respiratory Sounds; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Vascular Neoplasms; Vena Cava, Superior | 2015 |
Reply to J.-S. Ryu et al and A.T. Berman et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Predicting survival in non-small-cell lung cancer using positron emission tomography: several conclusions from multiple comparisons.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
A potential diagnostic role of dual-phase 18F-FDG PET/CT scanning.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, Emission-Computed | 2014 |
(18)F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer.
Topics: Adenocarcinoma; Biopsy; Bronchioles; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies | 2014 |
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.
Topics: Animals; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dideoxynucleosides; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Mice; Positron-Emission Tomography | 2014 |
Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.
Topics: Age Factors; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2014 |
Influence of thyroid transcription factor-1 on fluorodeoxyglucose uptake and prognosis of non-small cell lung cancer.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Transcription Factors | 2014 |
Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2014 |
Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; China; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
How should synchronous multiple primary adenocarcinomas of the lung be resected?
Topics: Adenocarcinoma; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Multiple Primary; Pneumonectomy; Positron-Emission Tomography; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.
Topics: Adult; Aged; Aged, 80 and over; Arizona; Biopsy; Chi-Square Distribution; Coccidioidomycosis; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Fungal; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multiple Pulmonary Nodules; Multivariate Analysis; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
PET-CT in the assessment of lung cancer at Rikshospitalet from 2007-2011.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Topics: Aged; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lower Extremity; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasms, Second Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chemoradiotherapy; Dideoxynucleosides; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed | 2014 |
Respiratory motion reduction in PET/CT using abdominal compression for lung cancer patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pressure; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2014 |
Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Tumor thrombus in the renal vein from an adrenal metastasis of lung cancer: 18FDG PET/CT findings.
Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Renal Veins; Tomography, X-Ray Computed; Venous Thromboembolism | 2014 |
Metastasis to the thyroid from non-small cell carcinoma of the lung: findings in (18)F-FDG PET/CT study.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Remission Induction; ROC Curve; Treatment Outcome | 2014 |
Routine use of dual time ¹⁸F-FDG PET for staging of preoperative lung cancer: does it affect clinical management?
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2014 |
Comparison between endobronchial ultrasound-guided transbronchial needle aspiration and 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of postoperative nodal recurrence in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Ultrasonography, Interventional | 2015 |
Calyceal diverticulum: a benign imitator of serious pathology.
Topics: Aged; Diagnosis, Differential; Diverticulum; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney Diseases, Cystic; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2014 |
Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis | 2014 |
Diffuse metastasis to the thyroid: unique ultrasonographic finding and clinical correlation.
Topics: Aged; Bile Duct Neoplasms; Biopsy, Fine-Needle; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Lung Neoplasms; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Function Tests; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2014 |
Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Pulmonary Atelectasis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2014 |
Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot Experience.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2015 |
Primary Epstein-Barr virus infection diffusing F18-fluorodeoxyglucose-positron emission tomography/computed tomography response monitoring of Hodgkin's disease: a case report.
Topics: Asymptomatic Infections; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymph Nodes; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed; Young Adult | 2014 |
Interpretation of suspect head and neck fixations seen on PET/CT in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
The microenvironment in the human lung partly determines the site of the first metastasis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Microenvironment | 2014 |
Time sensitivity factor of single pulmonary nodule: a new cancer characteristic metabolic parameter by (18) F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Solitary Pulmonary Nodule; Time Factors | 2014 |
Early detection of disease progression after palliative chemotherapy in NSCLC patients by (18)F-FDG-PET.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Germany; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2014 |
Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tomography, X-Ray Computed | 2014 |
Roles of Ki-67, p53, transforming growth factor-β and lysyl oxidase in the metastasis of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Protein-Lysine 6-Oxidase; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2014 |
Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis; Tomography, X-Ray Computed; Veins; Vena Cava, Inferior; Venous Thromboembolism; Young Adult | 2014 |
18F-FDG PET/CT in a seldom case of primary duodenal dermatofibrosarcoma protuberans with lung and skeletal metastases.
Topics: Bone Neoplasms; Dermatofibrosarcoma; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Adhesive capsulitis mimicking metastasis on 18F-FDG-PET/CT.
Topics: Aged; Bursitis; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Shoulder Joint; Tomography, X-Ray Computed | 2015 |
Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Survival Analysis; Thyroid Neoplasms | 2014 |
Increasing cardiac ¹⁸F-fluorodeoxyglucose (FDG) uptake on PET-CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: a myth or a reality?
Topics: Female; Fluorodeoxyglucose F18; Heart; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery | 2014 |
Differential background clearance of fluorodeoxyglucose activity in normal tissues and its clinical significance.
Topics: Administration, Oral; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Time Factors; Tissue Distribution; Whole Body Imaging | 2014 |
[Gene-targeted radiation therapy mediated by radiation-sensitive promoter in lung adenocarcinoma and the feasibility of micro-PET/CT in evaluation of therapeutic effectiveness in small animals].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Baculoviridae; Cell Line, Tumor; Combined Modality Therapy; Early Growth Response Protein 1; Fluorodeoxyglucose F18; Genetic Therapy; Genetic Vectors; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Peptide Fragments; Plasminogen; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Promoter Regions, Genetic; Random Allocation; Recombinant Proteins; Tomography, X-Ray Computed; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
Prediction of recurrence for non-small cell lung cancer by combined analysis of molecular markers and 18F 2-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tissue Array Analysis | 2014 |
FDG-PET/CT scan in a skin metastasis from lung cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2014 |
Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.
Topics: Aged; Algorithms; Automation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Respiration; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Invited commentary.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons.
Topics: Biopsy, Fine-Needle; Bronchoscopy; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Quality-Adjusted Life Years; Solitary Pulmonary Nodule; Surgeons; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2014 |
Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors.
Topics: Aged; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Ability of 18-fludeoxyglucose positron emission tomography/CT to detect incidental cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Non-small-cell lung cancer resectability: diagnostic value of PET/MR.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Comparison of primary target volumes delineated on four-dimensional CT and 18 F-FDG PET/CT of non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
A pleomorphic carcinoma of the lung producing multiple cytokines and forming a rapidly progressive mass-like opacity.
Topics: Carcinoma; Cytokines; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Perfusion Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT in a case of parasite infection mimicking lung and breast malignancy.
Topics: Animals; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Helminthiasis; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Embolism; Female; Fluorodeoxyglucose F18; Humans; Indoles; Keratins; Leukocyte Common Antigens; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.
Topics: Adult; Aged; Aged, 80 and over; Austria; Biopsy; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Germany; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Radiotherapy Dosage; Risk | 2015 |
Recurrence and metastasis of lung cancer demonstrate decreased diffusion on diffusion-weighted magnetic resonance imaging.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Symporters; Tumor Microenvironment | 2014 |
Time sensitivity-corrected retention index: an enhanced metabolic index from 18F-FDG PET to differentiate between benign and malignant pulmonary nodules.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2014 |
Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Validation of nonrigid registration in pretreatment and follow-up PET/CT scans for quantification of tumor residue in lung cancer patients.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Regression Analysis; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The effect of tumor size on the imaging diagnosis: a study based on simulation.
Topics: Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2014 |
Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Anaplastic Lymphoma Kinase; Biomarkers, Tumor; Case-Control Studies; Female; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Tomography, X-Ray Computed | 2015 |
Pulmonary tumor embolism derived from stomach cancer observation with serial 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Heterogeneity in [18F]fluorodeoxyglucose positron emission tomography/computed tomography of non-small cell lung carcinoma and its relationship to metabolic parameters and pathologic staging.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2014 |
Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.
Topics: Aged; Area Under Curve; Early Detection of Cancer; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Smoking; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
[A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Prognosis; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Young Adult | 2014 |
Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.
Topics: Adult; Aged; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Professional Competence; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Erlotinib-induced cutaneous toxicity: findings on 18F-FDG PET/CT imaging.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Skin Diseases; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT of schwannomas arising in the brachial plexus mimicking lymph node metastasis: report of two cases.
Topics: Aged; Brachial Plexus; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neurilemmoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Hypertensive crisis after endoscopic ultrasound-guided fine-needle aspiration of the right adrenal gland.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Hypertension; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imidazoles; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2014 |
Primary pulmonary synovial sarcoma requiring differentiation from pulmonary metastasis of tibial adamantinoma: a case report.
Topics: Adamantinoma; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Positron-Emission Tomography; Postoperative Care; Sarcoma, Synovial; Tibia; Tomography, X-Ray Computed | 2014 |
[False positive result of 18F-FDG PET in patient with lung cancer due to sarcoid-like reaction in regional lymph nodes].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Sarcoidosis | 2014 |
Comparison of a free-breathing CT and an expiratory breath-hold CT with regard to spatial alignment of amplitude-based respiratory-gated PET and CT images.
Topics: Aged; Artifacts; Breath Holding; Exhalation; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Positron-Emission Tomography; Random Allocation; Respiration; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2014 |
Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Signal Transduction; Tomography, X-Ray Computed | 2014 |
[PET-CT features of the lung benign lesions misdiagnosed as lung cancer].
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
A 72-year-old woman with a persistent cough and abnormal chest X-ray.
Topics: Aged; Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Resection of a solitary pulmonary metastasis from prostatic Adenocarcinoma misdiagnosed as a Bronchocele: usefulness of 18F-choline and 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2014 |
Standardized uptake value differences between primary and metastatic lesions in ¹⁸F-FDG PET/CT of patients with lung cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
[Management of respiratory motion in FDG-PET/CT: respiratory-gated and deep-inspiration breath-hold techniques].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Pulmonary artery angiosarcoma on 18F-FDG PET/CT masquerading as pulmonary embolism.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Topics: Adult; Chondroma; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies | 2014 |
Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2014 |
In-treatment assessment of response in locally advanced NSCLC: paving the way for personalized medicine.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography | 2014 |
Monte-Carlo simulations of clinically realistic respiratory gated (18)F-FDG PET: application to lesion detectability and volume measurements.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Monte Carlo Method; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Respiratory Mechanics | 2015 |
Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer.
Topics: Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Probability; Tomography, X-Ray Computed | 2015 |
Prognostic Significance of the Standardized Uptake Value on Positron Emission Tomography in Patients with Multiple Clinical-N0 Lung Cancers.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Relative low glycometabolism may also occur in invasive lung adenocarcinoma with visceral pleural invasion: case report and comments.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Are the simplified methods to estimate Ki in 18F-FDG PET studies feasible in clinical routine? Comparison between three simplified methods.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
The method and efficacy of support vector machine classifiers based on texture features and multi-resolution histogram from (18)F-FDG PET-CT images for the evaluation of mediastinal lymph nodes in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Support Vector Machine; Tomography, X-Ray Computed | 2015 |
Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2015 |
Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, X-Ray Computed | 2015 |
The early predictive value of a decrease of metabolic tumor volume in repeated (18)F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Regression Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Early assessment of metabolic response by 18F-FDG PET during concomitant radiochemotherapy of non-small cell lung carcinoma is associated with survival: a retrospective single-center study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
The role of FDG-PET/CT in detecting unsuspected and unknown distant metastasis in the initial staging of NSCLC.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2014 |
Differences in the prognostic significance of the SUVmax between patients with resected pulmonary Adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2014 |
The use of positron emission tomography/computed tomography imaging in radiation therapy: a phantom study for setting internal target volume of biological target volume.
Topics: Abdomen; Fluorodeoxyglucose F18; Head; Humans; Lung; Lung Neoplasms; Neck; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Risk Factors; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2015 |
Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In regard to Shusharina et al.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2014 |
Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In reply to Saraiya et al.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2014 |
Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Ribs; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2015 |
The value of endobronchial ultrasound transbronchial needle aspiration in normal positron emission tomography in lung cancer.
Topics: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Staging; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
A rare case of primary paranasal sinus angiosarcoma with pulmonary metastasis detected by 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Multimodal Imaging; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinum; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Malignant transformation of a lacrimal gland pleomorphic adenoma with pulmonary metastases.
Topics: Adenoma, Pleomorphic; Aged; Carcinoma, Adenoid Cystic; Cell Transformation, Neoplastic; Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2015 |
Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer--reply.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2015 |
What are the radiologic findings predictive of indolent lung adenocarcinoma?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Health Status; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2015 |
Preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types.
Topics: Adult; Aged; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Comparison of metabolic and anatomic response to chemotherapy based on PERCIST and RECIST in patients with advanced stage non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG-PET/CT imaging of drug-induced metabolic changes in genetically engineered mouse lung cancer models.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Genetic Engineering; Lung Neoplasms; Mice; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2015 |
A novel partial volume effects correction technique integrating deconvolution associated with denoising within an iterative PET image reconstruction.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Signal-To-Noise Ratio | 2015 |
Mycosis fungoides involving the lungs detected by (18)F-FDG PET/CT.
Topics: Aged; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
False-positive 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) scans mimicking malignancies.
Topics: Adult; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Brown fat FDG uptake abolished by radiotherapy.
Topics: Adipose Tissue, Brown; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2015 |
Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Time Factors | 2015 |
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Topics: Aged; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Tissue Distribution | 2015 |
Asymmetric muscle activity on (18)F-FDG PET/CT.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Topics: Adult; Aged; Artifacts; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
Topics: Autoradiography; Biopsy; Bone Neoplasms; Calibration; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Logistic Models; Lung Neoplasms; Needles; Positron-Emission Tomography; Probability; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diet; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2015 |
18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
Topics: ACTH Syndrome, Ectopic; Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pituitary ACTH Hypersecretion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2015 |
FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Topics: Adult; Aged; Analgesics, Opioid; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiotherapy; Retrospective Studies; Treatment Outcome | 2015 |
Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
(18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Heterogeneity in [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography of non-small cell lung carcinoma and its relationship to metabolic parameters and pathologic staging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2015 |
Sclerosing hemangioma of the lung mimicking pulmonary metastasis.
Topics: Biomarkers, Tumor; Biopsy; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Case of the season: management of the subsolid pulmonary nodule.
Topics: Adenocarcinoma; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies | 2015 |
Unexpectedly fludeoxyglucose (18F) avid well-differentiated adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
[Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2015 |
FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2015 |
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
[Comparative analysis of integrated (99m)Tc-MIBI-SPECT/localizable CT and integrated ¹⁸F-FDG-PET/CT for differential diagnosis of solitary pulmonary nodules].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
Analysis on early detection of lung cancer by PET/CT scan.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meta-Analysis as Topic; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
A new method of detecting pulmonary nodules with PET/CT based on an improved watershed algorithm.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine; Tomography, X-Ray Computed | 2015 |
[Positron emission tomography/computed tomography for lung cancer staging].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.
Topics: Adenocarcinoma; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Databases, Factual; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2015 |
Pulmonary tularaemia: all that looks like cancer is not necessarily cancer - case report of four consecutive cases.
Topics: Adult; Biopsy; Bronchoscopy; Diagnosis, Differential; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonia, Bacterial; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tularemia | 2015 |
Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; ROC Curve; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Treatment Outcome | 2015 |
Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tomography, X-Ray Computed | 2015 |
Preliminary comparison of diffusion-weighted MRI and PET/CT in predicting histological type and malignancy of lung cancer.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
Utility of respiratory-gated small-animal PET/CT in the chronologic evaluation of an orthotopic lung cancer transplantation mouse model.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mice; Movement; Multimodal Imaging; Positron-Emission Tomography; Respiration; Respiratory-Gated Imaging Techniques; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[The role of PET in lung cancer staging].
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
Topics: Aged; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Thoracoscopy; Tomography, X-Ray Computed | 2015 |
18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Young Adult | 2016 |
Beware of the "Bronchocele," Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article "Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms | 2015 |
Reply to "18F-Choline PET-CT in the Management of Lung Cancer and Mucinous Tumors?".
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms | 2015 |
Clear cell "sugar" tumor of the lung: benign or malignant?
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2015 |
Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using ¹⁸F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Rats; Treatment Outcome | 2015 |
Marked Hematopoiesis Masquerading Multiple Bone Metastasis in a Lung Cancer Patient With Myelodysplastic Syndrome.
Topics: Bone Marrow; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Myelodysplastic Syndromes; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed | 2015 |
A Case of Massive Bone Metastases From Lung Cancer Detected Only by 18F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2015 |
Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hungary; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Topics: Aged; Aged, 80 and over; Artifacts; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Movement; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiosurgery; Respiration; Retrospective Studies; Treatment Outcome | 2015 |
Would you bet on PET? Evaluation of the significance of positive PET scan results post-microwave ablation for non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2015 |
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies | 2015 |
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiosurgery; Treatment Outcome | 2015 |
Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Lupus Erythematosus, Systemic; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2015 |
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Administration Schedule; Drug Resistance, Neoplasm; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Mice, Nude; Protein Kinase Inhibitors; Quinazolines; Radionuclide Imaging; Radiopharmaceuticals; Signal Transduction; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays | 2015 |
The Value of Establishing the Quantitative Accuracy of PET/CT Imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Optimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
Prognostic Significance of Intratumoral Metabolic Heterogeneity on 18F-FDG PET/CT in Pathological N0 Non-Small Cell Lung Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Extremities; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2015 |
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2015 |
Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cluster Analysis; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography | 2015 |
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Unnecessary Procedures | 2015 |
Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2016 |
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Resistance, Neoplasm; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gefitinib; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Quinazolines; Survival Rate | 2015 |
Ultrasonography-Guided Core Biopsy of Supraclavicular Lymph Nodes for Diagnosis of Metastasis and Identification of Epidermal Growth Factor Receptor (EGFR) Mutation in Advanced Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2015 |
Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.
Topics: Coccidioidomycosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Tract Infections; Tomography, X-Ray Computed | 2015 |
Incidental head and neck findings on 18F-fluoro-deoxy-glucose positron emission tomography computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Cooperative Behavior; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Interdisciplinary Communication; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prescriptions; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 2015 |
Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer p
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
STatistically Assigned Response Criteria in Solid Tumors (STARCIST).
Topics: Algorithms; Biomarkers, Pharmacological; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Neoplasms; Normal Distribution; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis.
Topics: Biomarkers, Tumor; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT of Bronchial Mucous Gland Adenoma.
Topics: Adenoma; Bronchi; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Localized Airspace Consolidation of Pulmonary Alveolar Proteinosis Mimicking Malignant Lesions in 18F-FDG PET/CT Imaging: One Case Report.
Topics: Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Alveolar Proteinosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Time Factors | 2015 |
Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.
Topics: Aged; Aged, 80 and over; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Misonidazole; Pilot Projects; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sex Factors; Smoking; Tomography, X-Ray Computed | 2015 |
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2016 |
The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2015 |
Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mammography; Mastectomy; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings.
Topics: Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging; Young Adult | 2015 |
Quantification of Intratumoral Metabolic Macroheterogeneity on 18F-FDG PET/CT and Its Prognostic Significance in Pathologic N0 Squamous Cell Lung Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Biopsy; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Respiratory Function Tests; Survival Rate; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The relative value of 18F-FDG PET interpretation criteria in generating a probabilistic approach for characterization of pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Probability; Risk Assessment; Surveys and Questionnaires; Tomography, X-Ray Computed | 2015 |
Primary Pulmonary Synovial Sarcoma in a Tertiary Referral Center: Clinical Characteristics, CT, and 18F-FDG PET Findings, With Pathologic Correlations.
Topics: Adult; Biopsy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Sarcoma, Synovial; Tertiary Care Centers; Tomography, X-Ray Computed | 2015 |
Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tumor Burden | 2016 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Regression Analysis; Retrospective Studies; ROC Curve; Survival Analysis; Tumor Burden | 2015 |
Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
[The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals | 2015 |
The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
Topics: Adult; Aged; Aged, 80 and over; China; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Prognostic value of early response assessment using 18F-FDG PET/CT in chemotherapy-treated patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Improving the Spatial Alignment in PET/CT Using Amplitude-Based Respiration-Gated PET and Respiration-Triggered CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Mechanics; Tomography, Emission-Computed; Tomography, Spiral Computed | 2015 |
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Prognostic Value of FDG Uptake in Stage I Non-Small-Cell Lung Cancer: Fact or Bias?
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Lung positron emission tomography with FDG in patients with haematological malignancies and acute respiratory failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Lung; Lung Diseases, Fungal; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiratory Insufficiency; Sarcoma, Kaposi; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2016 |
18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncology.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2017 |
Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The impact of respiratory gated positron emission tomography on clinical staging and management of patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC).
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Inflammation; Kinetics; Lung Neoplasms; Mice; Mice, Inbred C57BL; Positron-Emission Tomography | 2015 |
Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2017 |
Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Multimodal Imaging; Pneumoconiosis; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Organs at Risk; Positron-Emission Tomography; Radiation Dosage; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Respiratory-Gated Imaging Techniques; Retrospective Studies | 2016 |
Pulmonary Artery Sarcoma Detected on 18F-FDG PET/CT With Unusual Findings.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2015 |
Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Incidental Detection of Femoral Pseudoaneurysm at 18F-FDG PET/CT.
Topics: Aged; Aneurysm, False; Femoral Artery; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT Metabolic Activity in a Patient With Solitary Extramedullary Plasmacytoma of the Lung.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Enhancing 18F-FDG-PET/CT analysis in lung cancer patients. Is CT-CT image fusion helpful in predicting pleural involvement? A pilot study.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Observer Variation; Pilot Projects; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Tumor growth-inhibitory effect of an angiotensin-converting enzyme inhibitor (captopril) in a lung cancer xenograft model analyzed using 18F-FDG-PET/CT.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Mice; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2016 |
Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oncogene Proteins, Fusion; Phenotype; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Collision of lymphoepithelioma-like carcinoma and adenocarcinoma of the lung: a case report.
Topics: Adenocarcinoma; Biomarkers, Tumor; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Squamous Cell; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
A Rare Case of Primary Pulmonary Glomus Tumor.
Topics: Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glomus Tumor; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dyspnoea in a 72-year-old woman.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Dyspnea; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Positron-Emission Tomography | 2015 |
FDG uptake at the bronchial stump after curative lobectomy for non-small cell lung cancer.
Topics: Aged; Bronchi; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Period; Radiopharmaceuticals | 2016 |
Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.
Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Effectiveness of the addition of the brain region to the FDG-PET/CT imaging area in patients with suspected or diagnosed lung cancer.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
False-positive Uptake on Positron Emission Tomography/Computed Tomography Immediately After Lung Biopsy: A Case Report.
Topics: Biopsy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve | 2016 |
A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
SUVpeak Performance in Lung Cancer: Comparison to Average SUV from the 40 Hottest Voxels.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2016 |
Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Dexamethasone Suppression FDG PET/CT for Differentiating between True- and False-Positive Pulmonary and Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer: A Pilot Study of FDG PET/CT after Oral Administration of Dexamethasone.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Squamous Cell; Cohort Studies; Dyrk Kinases; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nuclear Proteins; Primary Cell Culture; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA, Messenger; Ubiquitin-Protein Ligases | 2015 |
Mediastinal schwannoma with atypical localization diagnosed by endobronchial ultrasound.
Topics: Aged; Bronchoscopy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Mediastinum; Neurilemmoma; Positron Emission Tomography Computed Tomography; S100 Proteins; Ultrasonography | 2017 |
Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Disease-Free Survival; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2015 |
Primary pulmonary monophasic synovial sarcoma: Evading diagnosis.
Topics: Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Frozen Sections; Humans; Immunohistochemistry; Lung Neoplasms; Male; Molecular Diagnostic Techniques; Multimodal Imaging; Pleural Effusion, Malignant; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Synovial; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome | 2016 |
A 79-Year-Old Man With Interstitial Lung Disease and Cryptic Area of High 18 Fluorodeoxyglucose Uptake in Left Upper Lobe.
Topics: Adenocarcinoma; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasms, Second Primary; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Incidental gastrointestinal 18F-Fluorodeoxyglucose uptake associated with lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation.
Topics: Aged; Apnea; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Respiration, Artificial; Respiratory Mechanics; Solitary Pulmonary Nodule | 2016 |
18F-FDG PET/Contrast-Enhanced CT for Initial Staging and Strategic Treatment of Non-Small Cell Lung Cancer: A Prospective Study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Sarcoidosis misdiagnosed as malignant tumors: a case report.
Topics: Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2015 |
18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Denmark; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
FDG PET/CT allowing detection and follow-up of tumor cell transplantation.
Topics: Cell Transplantation; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2016 |
Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2016 |
Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Coordination Complexes; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Thiosemicarbazones | 2016 |
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiation Injuries | 2016 |
Diffuse Pleural Myeloid Sarcoma Mimicking Malignant Mesothelioma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Sarcoma, Myeloid; Young Adult | 2016 |
Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Whole Body Imaging | 2016 |
Metabolic-structural concordance in paraneoplastic limbic encephalitis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG.
Topics: Carcinoma, Non-Small-Cell Lung; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Chest Pain; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Retrospective Studies; Rib Fractures; Sensitivity and Specificity; Statistics as Topic; Thoracic Wall; Treatment Outcome | 2015 |
Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Small Cell Lung Carcinoma | 2016 |
Trends in the Use of (18)F-Fluorodeoxyglucose PET Imaging in Surveillance of Non-Small-Cell Lung and Colorectal Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Decision Making; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medicare; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; SEER Program; United States | 2016 |
False-Positive Axillary Lymph Nodes Due to Silicone Adenitis on (18)F-FDG PET/CT in an Oncological Setting.
Topics: Axilla; Breast Implants; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenitis; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Transgender Persons | 2016 |
Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2016 |
[(18) F]-Fluorodeoxy-d-glucose uptake-positive seborrhoeic keratosis on positron emission tomography may result from high expression of glucose transporter.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Keratosis, Seborrheic; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Early lesion-specific (18)F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals | 2016 |
Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy.
Topics: Aged; Bayes Theorem; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Tumor Burden | 2016 |
18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Topics: Adult; Carcinoid Tumor; Carcinoma, Neuroendocrine; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiosurgery; Retrospective Studies; Treatment Outcome | 2016 |
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
Topics: Adult; Aged; Coordination Complexes; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Octreotide; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Receptors, CXCR4; Receptors, Somatostatin; Small Cell Lung Carcinoma | 2016 |
Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2016 |
The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Small Cell Lung Carcinoma | 2016 |
Potential Use of (18)F-fluorodeoxyglucose Positron Emission Tomography-Based Quantitative Imaging Features for Guiding Dose Escalation in Stage III Non-Small Cell Lung Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Reference Values | 2016 |
Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden | 2016 |
Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Preoperative Period; Prospective Studies; Radiopharmaceuticals; ROC Curve | 2016 |
Unusual Presentation of Elastofibroma Dorsi on 18F-FDG-PET/CT: A Case Report.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Fibrous Tissue; Neoplasms, Second Primary; Pleural Effusion; Positron-Emission Tomography; Thoracic Neoplasms | 2016 |
Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
Topics: Aged; Aged, 80 and over; Cohort Studies; Confounding Factors, Epidemiologic; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Overuse; Medicare; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; SEER Program; Sensitivity and Specificity; Survival Analysis; United States | 2016 |
Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiation Oncology; Radiology; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tumor Burden | 2016 |
Validation of dose painting of lung tumours using alanine/EPR dosimetry.
Topics: Alanine; Electron Spin Resonance Spectroscopy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2016 |
The Value of 18F-FDG PET/CT in Diagnostic Procedure of Intravascular Large B-Cell Lymphoma Presenting Fever of Unknown Origin and Pulmonary Hypertension as an Initial Manifestation.
Topics: Biopsy; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vascular Neoplasms | 2016 |
18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
[Asymptomatic skeletal muscle metastases from non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Prognosis | 2015 |
Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis | 2016 |
Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Protein Kinase Inhibitors; Treatment Outcome; Tumor Burden | 2016 |
Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
Topics: Aged; Aged, 80 and over; Cohort Studies; Emphysema; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Pneumonectomy; Positron-Emission Tomography; Radiosurgery; Radiotherapy; Respiratory Function Tests; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Prognostic significance of standardised uptake value (SUV
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Serum Albumin; Small Cell Lung Carcinoma | 2017 |
Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Bronchoscopy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Thoracotomy | 2016 |
The effect of respiratory induced density variations on non-TOF PET quantitation in the lung.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Motion; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiration; Thorax; Tomography, X-Ray Computed | 2016 |
F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drainage; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2016 |
FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
CT, MRI, and 18F-FDG PET/CT Findings in Untreated Pulmonary and Hepatic B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Over a Five-Year Period: A Case Report.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2016 |
Validation of Software Gating: A Practical Technology for Respiratory Motion Correction in PET.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Software Validation; Solitary Pulmonary Nodule | 2016 |
An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2016 |
Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2016 |
A Case of Lung Squamous Cell Carcinoma With Duodenal Metastasis on FDG PET/CT.
Topics: Carcinoma, Non-Small-Cell Lung; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Contribution of ¹⁸Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Base Sequence; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sequence Analysis, DNA; Thyroid Nuclear Factor 1; Transcription Factors | 2016 |
Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Epithelial-Mesenchymal Transition; Female; Fluorodeoxyglucose F18; Genomics; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2016 |
[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sex Factors; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2016 |
18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Reproducibility of Results; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2016 |
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole Body Imaging | 2016 |
[Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2016 |
FDG PET/CT in Hepatoid Adenocarcinoma of the Lung.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions.
Topics: Algorithms; Bayes Theorem; Calibration; Esophageal Neoplasms; Esophagus; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Models, Anatomic; Pattern Recognition, Automated; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Background based Gaussian mixture model lesion segmentation in PET.
Topics: Algorithms; Cluster Analysis; Computer Simulation; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Models, Anatomic; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
18F-NaF PET/CT Imaging of Brain Metastases.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2016 |
Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy.
Topics: Adult; Aged; Algorithms; Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proportional Hazards Models | 2016 |
Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial.
Topics: Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; United States | 2016 |
[Establishment of a predicting model to evaluate the probability of malignancy or benign in patients with solid solitary pulmonary nodules].
Topics: Biomarkers, Tumor; CA-125 Antigen; Calcinosis; China; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multivariate Analysis; Pleura; Probability; Retrospective Studies; ROC Curve; Smoking; Solitary Pulmonary Nodule; Thorax | 2016 |
FDG PET/CT Imaging of Prostate Carcinosarcoma.
Topics: Carcinoma, Squamous Cell; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transurethral Resection of Prostate; Urinary Retention | 2016 |
18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
Topics: Biomarkers, Tumor; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2016 |
Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
Topics: Aged; Aged, 80 and over; California; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Margins of Excision; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2016 |
Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
Topics: Aged; Aged, 80 and over; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies | 2016 |
Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal Radiotherapy.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiosurgery; Salvage Therapy | 2016 |
Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multiple Pulmonary Nodules; Observer Variation; Positron Emission Tomography Computed Tomography; Retrospective Studies; Spain; Tomography, X-Ray Computed | 2016 |
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cytokines; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunologic Factors; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2016 |
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Pneumonitis; Radiosurgery; Radiotherapy Dosage; Retrospective Studies | 2016 |
18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
Topics: Bone Neoplasms; Calcium; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Primary Liver Carcinosarcoma and 18F-FDG PET/CT.
Topics: Abdominal Neoplasms; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
Topics: Aged; Algorithms; Breath Holding; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Whole Body Imaging | 2016 |
The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Signal-To-Noise Ratio | 2016 |
Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2016 |
Primary Sarcomatoid Carcinoma of the Lung: Radiometabolic ((18)F-FDG PET/CT) Findings and Correlation with Clinico-Pathological and Survival Results.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Rate | 2016 |
Estimation of Recurrence Risk After Normal (18)F-FDG PET/CT in Nonsmall-Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Risk Factors | 2016 |
Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2016 |
Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Comorbidity; Disease Management; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; United States | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Europe; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Pattern Recognition, Automated; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve | 2016 |
Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2016 |
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Grading; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
A case report of metastasis of malignant mesothelioma to the retromolar trigone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Calbindin 2; Cisplatin; Deoxycytidine; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Mouth Neoplasms; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiography, Panoramic; Radiotherapy, Adjuvant | 2016 |
[Is FDG TEP CT practice changing in the management of sarcomas in adults?].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity | 2016 |
Primary Pulmonary Mucinous Adenocarcinoma Was Better Visualized on Delayed FDG PET/CT Imaging.
Topics: Adenocarcinoma, Mucinous; Adult; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2016 |
Cardiac metastasis from lung cancer mimicking as perfusion defect on N-13 ammonia and FDG myocardial viability PET/CT scan.
Topics: Ammonia; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Nitrogen Radioisotopes; Positron Emission Tomography Computed Tomography | 2017 |
The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers.
Topics: Aged; Aged, 80 and over; Algorithms; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies | 2016 |
Reproducibility and uptake time dependency of volume-based parameters on FDG-PET for lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tumor Burden | 2016 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
PET/CT fusion in radiotherapy planning for lung cancer--Case reports.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2016 |
Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging.
Topics: Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Gefitinib; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Organ Culture Techniques; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Rats; Rats, Inbred Lew | 2016 |
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Survival Rate | 2016 |
Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.
Topics: Biological Transport; Brain; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiometry; ROC Curve | 2017 |
Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2016 |
Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
Topics: Adenocarcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT: A Potential Pitfall.
Topics: Bone Neoplasms; Cell Transformation, Neoplastic; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Thorax | 2016 |
Detection of a primary tumor in the area of the renal artery with 18F-FDG PET/CT in a patient with metastatic undifferentiated sarcoma and a history of mid-aortic syndrome: A case report.
Topics: Aortic Diseases; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pelvic Bones; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Renal Artery; Sarcoma; Vascular Neoplasms | 2016 |
Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
Topics: Adult; Aged; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms | 2016 |
The role of
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Serum Albumin | 2017 |
FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophil Infiltration; Nivolumab; Pemetrexed; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyrimidines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Sulfones | 2016 |
Ten Years of Chronic Cough in a 64-Year-Old Man With Multiple Pulmonary Nodules.
Topics: Carcinoid Tumor; Chronic Disease; Cough; Dyspnea; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Residual Volume; Time Factors; Tomography, X-Ray Computed; Total Lung Capacity; Vital Capacity | 2016 |
[Role of functional imaging in the definition of target volumes for lung cancer radiotherapy].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2016 |
How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol.
Topics: Cost-Benefit Analysis; Europe; Fluorodeoxyglucose F18; Lung Neoplasms; Medical Oncology; Nuclear Medicine; Patient Selection; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Multicenter external validation of two malignancy risk prediction models in patients undergoing 18F-FDG-PET for solitary pulmonary nodule evaluation.
Topics: Aged; Area Under Curve; Bayes Theorem; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Radiopharmaceuticals; Retrospective Studies; Risk; Risk Assessment; ROC Curve; Solitary Pulmonary Nodule | 2017 |
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunotherapy; Lacrimal Apparatus Diseases; Lung Neoplasms; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Soft Tissue Neoplasms; Splenic Neoplasms; Stomach Neoplasms; Treatment Outcome | 2016 |
Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Treatment Outcome; Tumor Burden | 2016 |
Correlation of HIF-1α/HIF-2α expression with FDG uptake in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Basic Helix-Loop-Helix Transcription Factors; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged | 2016 |
Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2016 |
(18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Image-Guided; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
Quantitative Accuracy and Lesion Detectability of Low-Dose
Topics: Adult; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiation Dosage; Radiation Exposure; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Segmental
Topics: Cost-Benefit Analysis; Europe; Fluorodeoxyglucose F18; Lung Neoplasms; Medical Oncology; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2017 |
Optimized workflow and imaging protocols for whole-body oncologic PET/MRI.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging; Workflow | 2016 |
Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
Topics: Aged; Computer Simulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasm Staging; Organ Sparing Treatments; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Tumor Burden | 2016 |
A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tumor Burden | 2016 |
Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Mice, Nude; Mice, SCID; Molecular Imaging; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2017 |
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Case With Long-term Follow-up.
Topics: Aged; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperplasia; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Neuroendocrine Cells; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
A Novel Framework for Automated Segmentation and Labeling of Homogeneous Versus Heterogeneous Lung Tumors in [
Topics: Algorithms; Automation; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Image Processing, Computer-Assisted; Linear Models; Lung Neoplasms; Positron-Emission Tomography; Staining and Labeling | 2017 |
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Granulomatous Inflammation Mimicking High-Grade Malignancy on FDG-PET/CT.
Topics: Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Cholinergic PET imaging in infections and inflammation using
Topics: Acetylcholinesterase; Adult; Aged; Animals; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cholinesterase Inhibitors; Donepezil; Female; Fluorodeoxyglucose F18; Humans; Indans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Middle Aged; Piperidines; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Staphylococcal Infections; Swine; Vesicular Acetylcholine Transport Proteins | 2017 |
Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Association Between microRNA-125a rs12976445 C>T Polymorphism and 18F-Fluorodeoxyglucose (18FDG) Uptake: Clinical and Metabolic Response in Patients with Non-Small Cell Lung Cancer.
Topics: A549 Cells; Base Sequence; Carcinoma, Non-Small-Cell Lung; Demography; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Luciferases; Lung Neoplasms; Male; MicroRNAs; Middle Aged; Polymorphism, Single Nucleotide; Transfection; Vascular Endothelial Growth Factor A | 2016 |
18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2016 |
Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2016 |
Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Cancer Care Facilities; Child; Databases, Factual; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Immobilization; Inventions; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Young Adult | 2017 |
Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2017 |
18F-FDG-PET/CT study after lung biopsy in suspected lung cancer patients: time is of the essence.
Topics: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors | 2017 |
[Organizing Pneumonia with High Radiotracer Concentration on Fluorodeoxyglucose-positron Emission Tomography, Mimicking Pleural Dissemination of Lung Cancer;Report of a Case].
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Pleural Neoplasms; Pneumonectomy; Pneumonia; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Effect of tomographic operator inaccuracies and respiratory motion on PET/CT lung nodule images smearing.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Movement; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Respiration; Signal-To-Noise Ratio; Solitary Pulmonary Nodule | 2017 |
Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2017 |
[Surgery of colorectal lung metastases : Results of a survey in Germany].
Topics: Colorectal Neoplasms; Contraindications; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Metastasectomy; Pneumonectomy; Positron-Emission Tomography; Prognosis; Surveys and Questionnaires; Tomography, X-Ray Computed; United Kingdom | 2017 |
FDG-PET parameters predicting mediastinal malignancy in lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymph Nodes; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; ROC Curve; Spain | 2016 |
Repeatability of Quantitative Whole-Body
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Clinical respiratory motion correction software (reconstruct, register and averaged-RRA), for
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Motion; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Respiration | 2017 |
Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
Topics: A549 Cells; Animals; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2016 |
Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate | 2017 |
Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
Prognostic value of pretreatment volume-based quantitative
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Dynamic contrast-enhanced perfusion area-detector CT assessed with various mathematical models: Its capability for therapeutic outcome prediction for non-small cell lung cancer patients with chemoradiotherapy as compared with that of FDG-PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome | 2017 |
18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
eComment. Surgery for isolated adrenal metastasis from non-small-cell lung cancer: the role of preoperative PET/CT scan".
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
The predictive value of
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; ROC Curve; Time Factors; Treatment Failure; Tumor Burden | 2017 |
Registration and Summation of Respiratory-Gated or Breath-Hold PET Images Based on Deformation Estimation of Lung from CT Image.
Topics: Artifacts; Breath Holding; Computer Simulation; Contrast Media; Exhalation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Motion; Phantoms, Imaging; Positron-Emission Tomography; Respiration; Tomography, X-Ray Computed | 2016 |
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Benzeneacetamides; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Glutaminase; Glutamine; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Radiopharmaceuticals; RNA Interference; Thiadiazoles; Transplantation, Heterologous | 2017 |
Lung Nodule with Increasing Fluorodeoxyglucose Uptake in a Patient with a History of Lung Carcinoma and Talc Pleurodesis Evaluated by EBUS-TBNA On-Site Assessment.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Pleural Effusion; Pleurodesis; Radiopharmaceuticals; Talc; Tomography, X-Ray Computed | 2017 |
Need for Glucose Correction for
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sex Factors; Smoking; Young Adult | 2017 |
Costal chondrosarcoma requiring differential diagnosis from metastatic tumor.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Bone Neoplasms; Chondrosarcoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteotomy; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Carbonic Anhydrase IX; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Nasal-Tip Metastasis on 18F-FDG PET/CT Scan in a Patient With Squamous Lung Carcinoma.
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nose Neoplasms; Positron Emission Tomography Computed Tomography | 2017 |
Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
Safety and efficacy of microwave ablation for medically inoperable colorectal pulmonary metastases: Single-centre experience.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microwaves; Positron Emission Tomography Computed Tomography; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2017 |
Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung.
Topics: Action Potentials; Carcinoma, Large Cell; Electrophysiology; Fluorodeoxyglucose F18; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Neural Conduction; Positron-Emission Tomography; Skin Temperature; Smoking; Tomography, X-Ray Computed | 2008 |
Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, X-Ray Computed; United Kingdom | 2008 |
Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Time | 2008 |
Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole-Body Counting | 2008 |
Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Evaluation of lung lesions using FDG gamma-camera PET equipped with a one-inch crystal.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
F-18 FDG PET/CT imaging of submandibular gland oncocytoma.
Topics: Adenoma, Oxyphilic; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lip Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Submandibular Gland Neoplasms; Tomography, X-Ray Computed | 2008 |
The effects of bone erosion from aortic aneurysm on the regional uptake of FDG.
Topics: Aged; Aortic Aneurysm; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Positron-Emission Tomography; Thoracic Vertebrae; Tomography, X-Ray Computed | 2008 |
Imaging characteristics of heterotopic mesenteric ossification on FDG PET and Tc-99m bone SPECT.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Ossification, Heterotopic; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon | 2008 |
Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
Topics: Adenocarcinoma; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Mesothelioma; Neoplasm Metastasis; Neoplasms, Second Primary; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Effective radiotherapy of primary tumors and metastasis with 18F-2-deoxy-2-fluoro-D-glucose in C57BL/6 mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gentian Violet; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals | 2008 |
18F FDG-PET/CT findings in recurrent respiratory papillomatosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Papilloma; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed | 2008 |
Can FDG-PET be used to predict growth of stage I lung cancer?
Topics: Aged; Aged, 80 and over; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Deep-inspiration breath-hold PET/CT of lung cancer: maximum standardized uptake value analysis of 108 patients.
Topics: Aged; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Inhalation; Lung Neoplasms; Lutetium; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Silicates; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2009 |
Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma.
Topics: Adenoma, Pleomorphic; Aged; Biomarkers, Tumor; Bone Marrow Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Hyperplasia; Lumbar Vertebrae; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms | 2008 |
Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
Topics: Adult; Aged; Algorithms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Solitary Pulmonary Nodule; Statistics, Nonparametric; Tuberculosis, Pulmonary | 2008 |
Esophageal and laryngeal cancer incidentally found on [18F]fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden | 2008 |
18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma.
Topics: Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2008 |
[Biodistribution and positron emission tomography imaging of 11C-acetate in murine model of lung carcinoma].
Topics: Acetates; Animals; Carbon Radioisotopes; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Lung Neoplasms; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Positron-Emission Tomography; Random Allocation; Tissue Distribution | 2008 |
[Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Topics: Adenocarcinoma; Age Distribution; Age Factors; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sex Distribution; Sex Factors; Smoking; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2008 |
Fluorodeoxyglucose positron emission tomography integrated with computed tomography to determine resectability of primary lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
[A case of Ewing's sarcoma of the right femur associated with pulmonary metastases detected by fluorodeoxyglucose positron emission tomography].
Topics: Adult; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Sarcoma, Ewing | 2008 |
Re: Prognostic value of FDG uptake in early stage non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Central photopenic lesions on FDG-PET scan in a patient with peripheral T cell lymphoma.
Topics: Alcoholism; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
(18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.
Topics: Adenocarcinoma; Aged; Bone Marrow; Carcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors | 2008 |
Lung cancer: new opportunities--changing algorithm in staging.
Topics: Algorithms; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography | 2008 |
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Topics: Aged; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2008 |
Patterns of FDG uptake in post-thoracotomy surgical scars in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cicatrix; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Treatment Outcome; Whole Body Imaging | 2008 |
[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2008 |
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Mesothelioma; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2008 |
Prognostic significance of 18 F-fluorodeoxyglucose - positron emission tomography after treatment in patients with limited stage small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Combined Modality Therapy; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2008 |
A novel approach to positron emission tomography in lung cancer.
Topics: Aged, 80 and over; Biopsy, Needle; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Sensitivity and Specificity; Thoracotomy; Treatment Outcome; Whole Body Imaging | 2008 |
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule | 2008 |
Intravascular large B-cell lymphoma with FDG accumulation in the lung lacking CT/(67)gallium scintigraphy abnormality.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Middle Aged; Neoplasm Invasiveness; Prognosis; Radionuclide Imaging; Splenomegaly; Tomography, X-Ray Computed | 2009 |
EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology.
Topics: Adenocarcinoma; Adult; Aged; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Dosage; Humans; Image Interpretation, Computer-Assisted; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Recurrent laryngeal nerve palsy on integrated positron emission tomography-computed tomography.
Topics: Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrent Laryngeal Nerve; Tomography, X-Ray Computed; Vocal Cord Paralysis; Vocal Cords | 2008 |
Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
Topics: Aged; Breast Neoplasms, Male; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2008 |
Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2008 |
The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Logistic Models; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2008 |
Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2009 |
A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography.
Topics: Adenocarcinoma; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urinary Bladder Neoplasms; Whole Body Imaging | 2008 |
F-18 FDG PET in a patient with polycythemia vera.
Topics: Aged; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Myeloid Progenitor Cells; Polycythemia Vera; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
False-positive finding on FDG-PET/CT after injectable elastomere implant (Vox implant) for vocal cord paralysis.
Topics: Dimethylpolysiloxanes; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx, Artificial; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Silicone Elastomers; Tomography, X-Ray Computed; Vocal Cord Paralysis | 2008 |
Increased 18F-FDG uptake in the posterior ocular bulb is associated with brain metastasis: a retrospective study.
Topics: Brain Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2008 |
Potential of magnetization transfer MRI for target volume definition in patients with non-small-cell lung cancer.
Topics: Artifacts; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 2008 |
Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.
Topics: Automation; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Thoracic Neoplasms; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
F-18 FDG PET-CT imaging of intestinal metastasis from primary lung cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Isolated asymptomatic skeletal muscle metastasis in a potentially resectable non-small cell lung cancer: detection with FDG PET-CT scanning.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Long-Term Care; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Respiration-averaged CT for attenuation correction in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiration; Tomography, X-Ray Computed | 2009 |
11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Skip metastasis to abdominal lymph nodes from lung adenocarcinoma.
Topics: Abdomen; Adenocarcinoma; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[A case of solitary splenic metastasis following operation for pulmonary pleomorphic carcinoma: detected at an early stage by FDG-PET].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Splenic Neoplasms | 2008 |
Extraosseous myxoid chondrosarcoma with pulmonary and nodal metastases on FDG PET-CT.
Topics: Aged; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Topics: Aged; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Models, Statistical; Nomograms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Severity of Illness Index; Sex Factors; Survival Analysis; Survival Rate; Tumor Burden | 2009 |
Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
Topics: Bronchial Neoplasms; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Male; Metaplasia; Middle Aged; Neoplasms, Second Primary; Ossification, Heterotopic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT.
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Fatal Outcome; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Respiratory-gated positron emission tomography and breath-hold computed tomography coupling to reduce the influence of respiratory motion: methodology and feasibility.
Topics: Artifacts; Contrast Media; Equipment Design; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2009 |
Coiling of major aortopulmonary collateral arteries with agenesis of the left pulmonary artery prior to pneumonectomy.
Topics: Aged; Aortography; Balloon Occlusion; Blood Loss, Surgical; Collateral Circulation; Combined Modality Therapy; Congenital Abnormalities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Pneumonectomy; Preoperative Care; Pulmonary Artery; Radiography, Thoracic; Risk Assessment; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Image of the month. FDG-PET in paraneoplastic limbic encephalitis.
Topics: Carcinoma, Small Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; DNA, Neoplasm; ErbB Receptors; Female; Fluorodeoxyglucose F18; Genetic Testing; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2010 |
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Antigens, CD34; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Vascular Endothelial Growth Factor A | 2009 |
Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.
Topics: Adolescent; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radionuclide Imaging; Retrospective Studies | 2009 |
Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Transbronchial needle aspiration in lung cancer patients suitable for operation with positive mediastinal positron emission tomography.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Treatment Outcome | 2009 |
PET for the evaluation of solitary pulmonary nodules.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?
Topics: Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tumor Burden | 2009 |
[Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antigens, CD34; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Microvessels; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
[(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[The role of (18)F-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2009 |
The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.
Topics: Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Risk; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancer
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Focal increased activity in the liver on 18F-FDG PET scan secondary to brachiocephalic vein and superior vena cava obstruction.
Topics: Brachiocephalic Veins; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Superior Vena Cava Syndrome; Tomography, X-Ray Computed | 2008 |
Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
Topics: Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Young Adult | 2009 |
Curative wedge resection for non-invasive bronchioloalveolar carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Respiratory Function Tests; Tomography, X-Ray Computed | 2009 |
Quantification of tryptophan transport and metabolism in lung tumors using PET.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tryptophan | 2009 |
Characterization of hilar and mediastinal foci on 18F-FDG PET: new variables.
Topics: Algorithms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Mediastinum; Positron-Emission Tomography; Tuberculosis, Pulmonary | 2009 |
The effect of 18F-FDG-PET/CT respiratory gating on detected metabolic activity in lung lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[The usefulness of whole body FDG-PET/CT in patients with brain metastasis].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Invited commentary.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3 cm in size.
Topics: Adenocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution | 2009 |
Benign metastasizing leiomyoma of the lung: PET findings.
Topics: Biopsy, Needle; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms | 2009 |
Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning.
Topics: Algorithms; Area Under Curve; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2010 |
Osteoblastic bone flare on F18-FDG PET in non-small cell lung cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapy.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Osteoblasts; Positron-Emission Tomography; Risk Assessment; Treatment Outcome | 2009 |
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
Topics: Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
A patient with micropapillary thyroid carcinoma and macronodular lung metastasis: stable disease for eight years without treatment.
Topics: Biopsy, Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Neck Dissection; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2009 |
[The maximum standardized uptake value (18)F-FDG PET is independent of the immunohistochemical expression of platelet derived endothelial growth factor in patients with non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine Phosphorylase | 2009 |
Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors.
Topics: Adult; Aged; Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inhalation; Lung Neoplasms; Male; Middle Aged; Movement; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Radionuclide Imaging; Retrospective Studies; Young Adult | 2010 |
Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2009 |
Lung sequestration and Pott disease masquerading as primary lung cancer with bone metastases on FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Spondylitis; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2009 |
Elevated FDG uptake in right middle segmental bronchus impacted with foreign body.
Topics: Bronchi; Bronchoscopy; Cough; Diagnostic Imaging; Fluorodeoxyglucose F18; Foreign Bodies; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Lung parasite ova granuloma mimicking lung malignancy on FDG PET-CT.
Topics: Animals; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cells, Foreign-Body; Granuloma; Humans; Lung; Lung Neoplasms; Middle Aged; Paragonimus; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, X-Ray Computed | 2009 |
High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2009 |
Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Neoplasm Staging; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2009 |
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Chorea, transverse myelitis, neuropathy and a distinctive MRI: paraneoplastic manifestations of probable small cell lung cancer.
Topics: Aged; Chorea; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Myelitis, Transverse; Peripheral Nervous System Diseases; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2009 |
Personnel radiation dose considerations in the use of an integrated PET-CT scanner for radiotherapy treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Technology, Radiologic; Tomography, Emission-Computed; Tomography, X-Ray Computed; Workforce | 2009 |
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team.
Topics: Adult; Aged; Aged, 80 and over; Bronchoscopy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Team; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2009 |
[A case of lung cancer producing granulocyte colony-stimulating factor with a significantly high uptake in the bones observed by a FDG-PET scan].
Topics: Bone and Bones; Carcinoma; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2009 |
Detection of prostatic glandular adenocarcinoma during staging of non-small-cell lung carcinoma with F-18 FDG PET.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT findings in a case of undifferentiated embryonal sarcoma of the liver with lung and adrenal gland metastasis in a child.
Topics: Adrenal Gland Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
Pulmonary tumor thrombotic microangiopathy: FDG-PET/CT findings.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Thrombosis; Tomography, X-Ray Computed | 2009 |
F-18 fluorodeoxyglucose PET/CT findings in active hiccups.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Hiccup; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Body Weight; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2009 |
The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Blood Vessels; Body Weight; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Databases as Topic; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracotomy | 2009 |
18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: a single-institution retrospective analysis.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Genetic Testing; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2010 |
Assessment of dual-time-point 18F-FDG-PET imaging for pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Time Factors | 2009 |
Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Combined Modality Therapy; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Dual primary subclavicular angiosarcoma and lung cancer imaging with C-11 acetate PET and FDG PET.
Topics: Acetates; Adenocarcinoma; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
PET imaging in patients with coal workers pneumoconiosis and suspected malignancy.
Topics: Aged; Anthracosis; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2009 |
Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; X-Ray Film | 2010 |
The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Records; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Impact of FDG-PET-induced treatment choices on long-term outcome in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Belgium; Carcinoma, Non-Small-Cell Lung; Choice Behavior; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2010 |
Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer.
Topics: Aged; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2009 |
Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2009 |
Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2009 |
Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Moon; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2010 |
Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings.
Topics: Aged; Artifacts; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Positron-Emission Tomography; Pulmonary Embolism; Tomography, X-Ray Computed | 2009 |
[Usefulness of FDG-PET for diagnosis of lung cancer associated with interstitial pneumonia].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2009 |
Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Follicular thyroid carcinoma with an eggshell calcification: report of 3 cases.
Topics: Adenocarcinoma, Follicular; Aged; Biopsy, Needle; Bone Neoplasms; Calcinosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Ultrasonography, Doppler, Color | 2009 |
Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2009 |
Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Registries; Respiratory Function Tests; Stereotaxic Techniques; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Predictive Value of Tests; Prospective Studies; Quinazolines; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Logistic Models; Lung Neoplasms; Male; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2009 |
Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2009 |
[Impact of FDG-PET on radiation therapy: economic results of a STIC study].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Lung Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
Topics: Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2009 |
An unusual cause of bone marrow 18-fluorodeoxyglucose uptake.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2009 |
[Large cell neuroendocrine carcinoma of the lung].
Topics: Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2009 |
Brain mapping of patients with lung cancer and controls: inquiry into tumor-to-brain communication.
Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Cell Communication; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
[The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers].
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2009 |
[Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Topics: Acetates; Adolescent; Adult; Aged; Brain Abscess; Brain Neoplasms; Carbon; Carbon Radioisotopes; Child; Craniopharyngioma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
Extensive FDG uptake in accessory muscles of respiration in a patient with shortness of breath.
Topics: Abdominal Muscles; Aged; Dyspnea; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Small bowel metastasis from lung cancer detected on FDG PET/CT.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT imaging in a case of primary choriocarcinoma in the retroperitoneum.
Topics: Adult; Choriocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed | 2009 |
Ventriculoperitoneal shunt catheter and cerebral spinal fluid infection initially detected by FDG PET/CT scan.
Topics: Aged; Catheterization; Cerebral Cortex; Equipment Contamination; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pelvis; Peritonitis; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Spinal Canal; Staphylococcal Infections; Tomography, X-Ray Computed; Ventriculoperitoneal Shunt | 2009 |
Incremental value of integrated FDG-PET/CT in evaluating indeterminate solitary pulmonary nodule for malignancy.
Topics: Adult; Aged; Aged, 80 and over; Demography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
Invasive inflammatory myofibroblastic tumor of the lung.
Topics: Adolescent; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Lung Neoplasms; Male; Radiography, Thoracic; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.
Topics: Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2010 |
11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness.
Topics: Acetates; Adenocarcinoma; Carbon; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Effect of variation in relaxation parameter value on LOR-RAMLA reconstruction of 18F-FDG PET studies.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Lymph Nodes; Phantoms, Imaging; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals | 2009 |
Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
[Clinical significance of (18)F-FDG PET-CT in evaluation of the therapeutic efficacy of chemotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
[Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Respiratory papillomatosis of lung and F-18 FDG PET-CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Papilloma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[18F-FDG PET/CT for the detection of primary tumors metastasizing to lymph nodes of the neck].
Topics: Adolescent; Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Nasopharyngeal Neoplasms; Neck; Positron-Emission Tomography; Pyriform Sinus; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Topics: Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium; Heterocyclic Compounds; History, 18th Century; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
[Assessment of diagnostic criteria for FDG-PET cancer screening program according to the interpretation of FDG-PET and combined examination].
Topics: Breast Neoplasms; Colonic Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mass Screening; Occult Blood; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Biological correlates of the maximum 18-fluoro-2-deoxy-glucose uptake on positron emission tomography in non-small cell lung carcinoma after induction chemotherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction | 2009 |
Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.
Topics: Bone Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Disease Susceptibility; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2010 |
Pulmonary sclerosing haemangioma mimicking lung cancer on PET scan.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Sclerosing Hemangioma | 2009 |
(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Remission Induction; Tomography, X-Ray Computed; Tumor Burden | 2010 |
[Endobronchial hamartoma suspected lung cancer due to false positive of fluorodeoxyglucose-positron emission tomography; report of a case].
Topics: Bronchial Diseases; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET scan findings in patients with Loeffler's syndrome.
Topics: Adult; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Eosinophilia; Tomography, X-Ray Computed | 2009 |
Hypertrophic pulmonary osteoarthropathy diagnosed by FDG PET-CT in a patient with lung adenocarcinoma.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Osteoarthropathy, Secondary Hypertrophic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Intradural intramedullary spinal cord metastasis due to mesothelioma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Neurosurgical Procedures; Positron-Emission Tomography; Spinal Cord; Spinal Cord Neoplasms; Thoracotomy; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2010 |
Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; China; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Standard uptake value predicts survival in non-small cell lung cancer.
Topics: Aged; Algorithms; Biopsy; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Smoking; Tomography, X-Ray Computed | 2009 |
Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2009 |
Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2009 |
[A case of pulmonary actinomycosis in which differentiation of primary and metastatic lung cancers was difficult].
Topics: Actinomycosis; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
[Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers].
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2009 |
Diffuse cavitary lung lesions.
Topics: Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2009 |
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed | 2010 |
Prognostic value of 18-FDG uptake in early stage NSCLC.
Topics: Aged; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Time Factors; Treatment Outcome | 2009 |
The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Iohexol; Lung Neoplasms; Photons; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2010 |
[Lung cancer detected by fluorodeoxyglucose-positron emission tomography/computed tomography in the course of Mycobacterium avium infection; report of a case].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Rate | 2009 |
Postsurgical atypical F-18 fluorodeoxyglucose positron emission tomography uptake.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[PET-CT in evaluation of pulmonary nodule--case report].
Topics: Adenocarcinoma, Clear Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Fluorodeoxyglucose uptake predicts survival in a CT screening trial.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mass Screening; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Rate | 2009 |
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Smoking; Survival Rate; Time Factors; Tomography, X-Ray Computed | 2009 |
Micropapillary pattern in lung adenocarcinoma: aspect on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Phytotherapy; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[A case of pulmonary hyalinizing granuloma with high-grade uptake on FDG-PET mimicking metastatic lung cancer].
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
[A case of non-tuberculosis mycobacterium and lung cancer showing solitary nodular shadow].
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mycobacterium avium-intracellulare Infection; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2009 |
Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2009 |
Nonrigid versus rigid registration of thoracic 18F-FDG PET and CT in patients with lung cancer: an intraindividual comparison of different breathing maneuvers.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiography, Thoracic; Respiration; Retrospective Studies; Thorax; Tomography, X-Ray Computed | 2009 |
A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2010 |
High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
18F-FDG PET imaging of progressive massive fibrosis.
Topics: Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2010 |
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Long-Term Care; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Usefulness of fluoro-2-deoxyglucose positron emission tomography for investigating unexplained rising carcinoembryonic antigen levels that occur during the postoperative surveillance of lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals | 2009 |
[Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
A pulmonary sclerosing hemagioma with an increasing uptake on PET.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Sclerosing Hemangioma; Radiography; Radiopharmaceuticals; Treatment Outcome; Young Adult | 2009 |
Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2010 |
[Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2009 |
Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Interesting image. Situs inversus totalis in newly diagnosed lymphoma: additional value of hybrid imaging.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Situs Inversus; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Interesting image. Extrapulmonary small cell carcinoma in prostate: detection with F-18 FDG PET/CT.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Interesting image. Two primary colon cancers shown on FDG PET/CT performed to evaluate possible lung metastases from bladder cancer.
Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2010 |
Interesting image. Ameboma mimicking lung cancer on FDG PET/CT.
Topics: Amebiasis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases, Parasitic; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2010 |
[Efficacy of fluoro-2-deoxyglucose positron emission tomography imaging in response evaluation of patients with small cell lung cancer (pilot study)].
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2009 |
Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Granular cell tumor of the lung.
Topics: Adult; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lung Neoplasms; Positron-Emission Tomography; Treatment Outcome | 2010 |
Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Monte Carlo Method; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Software | 2010 |
Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT.
Topics: Aged; Automation; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2010 |
Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
Topics: Aged; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
FDG-PET in diagnostic work-up of pulmonary artery sarcomas.
Topics: Adult; Aged; Chronic Disease; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Sarcoma; Thromboembolism; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Incidental detection of renal transplantation urinary leakage on FDG-PET/CT imaging for evaluation of lung metastases.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Transplantation; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urination Disorders | 2009 |
[Pulmonary malignant melanoma: primary or metastatic?].
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Metastatic colon cancer to the lung with no detectable primary tumor, mimicking advanced primary lung cancer on F-18 FDG PET/CT imaging.
Topics: Aged, 80 and over; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Tracheobronchial papillomatosis with diffuse cavitary lung lesions.
Topics: Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
[Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Spiral Computed | 2009 |
Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring].
Topics: Adult; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
The use of PET images for radiotherapy treatment planning: an error analysis using radiobiological endpoints.
Topics: Endpoint Determination; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Prognostic implication of dual-phase PET in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Regression Analysis; Retrospective Studies; Tumor Burden | 2010 |
A rare cause of fever and PET-positive nodules in the lungs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bronchoscopy; Female; Fever; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Lymphomatoid Granulomatosis; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Clinical utility of three-dimensional integrated 18F-fluorodeoxyglucose positron-emission tomography/computed tomography virtual mediastinoscopy.
Topics: Aged; Aged, 80 and over; Biopsy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.
Topics: Aged; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Motion; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Mucins; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Remission Induction; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Pulmonary hyalinizing granuloma mimicking multiple lung metastases: report of fluorodeoxyglucose positron emission findings.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted | 2010 |
Prognostic stratification using F-18 FDG PET/CT in patients with advanced stage (stage III and IV) non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Drug Therapy; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiotherapy, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Carcinoma of the lung misinterpreted as pulmonary sequestration on contrast CT but correctly identified on FDG PET/CT.
Topics: Aged; Bronchopulmonary Sequestration; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
[Comparison of the biodistribution and PET imaging with (11)C-PDT and (18)F-FDG in the mouse model of lung adenocarcinoma].
Topics: Adenocarcinoma; Animals; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Kidney; Liver; Lung Neoplasms; Mice; Myocardium; Podophyllotoxin; Positron-Emission Tomography; Tissue Distribution | 2010 |
Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2010 |
Volume or position changes of primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Movement; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Tumor Burden | 2011 |
Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Validation Studies as Topic | 2010 |
Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution | 2010 |
Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies | 2010 |
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2011 |
Benign metastasizing leiomyoma identified using 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Uterine Neoplasms | 2010 |
Target definition of moving lung tumors in positron emission tomography: correlation of optimal activity concentration thresholds with object size, motion extent, and source-to-background ratio.
Topics: Computer Simulation; Equipment Design; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Motion; Movement; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Radiography, Thoracic; Scattering, Radiation; Surface Properties; Tomography, X-Ray Computed | 2010 |
Parotid incidentaloma detected during thoracic PET imaging: how should these lesions be managed?
Topics: Adenolymphoma; Adenoma, Pleomorphic; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2010 |
Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2010 |
Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
Topics: Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Reoperation; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
[Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Whole Body Imaging; Young Adult | 2010 |
Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Goblet Cells; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Radiation therapy-related ataxia associated with FDG-PET cerebellar hypometabolism.
Topics: Ataxia; Brain; Carcinoma, Small Cell; Cerebellar Diseases; Female; Fluorodeoxyglucose F18; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiotherapy; Ultrasonography | 2010 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
Impact of 18F-fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra-pulmonary small-cell cancer.
Topics: Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.
Topics: Aged; Aged, 80 and over; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; ROC Curve | 2010 |
Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cellular Structures; Female; Fibrosis; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Necrosis; Positron-Emission Tomography | 2010 |
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA, Neoplasm; Female; Fluorodeoxyglucose F18; Genotype; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2010 |
Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Limitation of F-18 fluorodeoxyglucose positron emission tomography in the detection of metastatic adenocarcinoma of brain combining intratumoral hemorrhage.
Topics: Adenocarcinoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intracranial Hemorrhages; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography | 2010 |
Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thoracotomy | 2010 |
Impact of whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2010 |
Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2011 |
Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis.
Topics: Biomarkers, Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
The registration of diagnostic versus planning fluorodeoxyglucose positron emission tomography/computed tomography in radiotherapy planning for non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2010 |
Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Prognosis; Recurrence; Retrospective Studies; Risk; Vascular Endothelial Growth Factor D | 2010 |
Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Nuclear Medicine; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiation Oncology; Radiology; Radiopharmaceuticals; Reproducibility of Results; Sample Size; Tomography, X-Ray Computed; Tumor Burden | 2010 |
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography | 2010 |
Unusual gallbladder metastasis from non-small-cell lung cancer detected by F-18 FDG PET/CT with intravenous contrast enhancement.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Pulmonary light and heavy chain deposition disease: a pitfall for lung cancer evaluation with F-18 FDG PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
Topics: Aged; Aged, 80 and over; Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2011 |
Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Esophagus; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lung Neoplasms; Lymphatic Irradiation; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2011 |
[A study on the application of 18F-FDG-PET-CT for the radiotherapy of patients with stage III non-small cell lung cancer].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2010 |
Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Irradiation; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 2011 |
Multiple FDG-avid sclerosing hemangiomas mimicking pulmonary metastases in a case of soft tissue sarcoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2010 |
Metabolic super scan in F-FDG PET/CT imaging.
Topics: Carcinoma, Small Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hemoptysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
[The role of positron emission tomography in the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Retrospective Studies | 2010 |
Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Japan; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2010 |
Pleomorphic carcinoma of the lung with intrapulmonary aerogenic metastases on FDG PET.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Whole Body Imaging | 2010 |
Chest wall and axillary lymph node FDG uptake associated with cancer vaccine therapy for lung cancer.
Topics: Aged; Axilla; Cancer Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Recurrence; Small Cell Lung Carcinoma; Thoracic Wall; Tomography, X-Ray Computed | 2010 |
Incidental detection of a pulmonary adenocarcinoma on low-dose computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT.
Topics: Adenocarcinoma; Aged; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Myocardial Reperfusion; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
New indication for preoperative marking of small peripheral pulmonary nodules in thoracoscopic surgery.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Japan; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Young Adult | 2010 |
[The fluorodeoxyglucose-positron emission tomography (FDG-PET) findings and surgical strategy for pulmonary sclerosing hemangioma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule | 2010 |
A statistical clustering approach to visualizing the relationship between early and delayed images in whole-body FDG-PET.
Topics: Aged; Aged, 80 and over; Cluster Analysis; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Whole Body Imaging | 2009 |
Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tuberculosis, Pulmonary | 2010 |
Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Prediction of residual metabolic activity after treatment in NSCLC patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiation-Sensitizing Agents; Radiotherapy, Conformal; Retrospective Studies; Treatment Failure | 2010 |
[(18)F]Fluorodeoxyglucose positron emission tomography-computerized tomography and lung cancer: a significant referral bias exists.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Referral and Consultation; Selection Bias; Sensitivity and Specificity; Survival Analysis | 2011 |
Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2010 |
Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Odontogenic Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Tomography, X-Ray Computed | 2010 |
Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer.
Topics: Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis.
Topics: Australia; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Endosonography; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Mediastinoscopy; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
Increased fluoro-deoxy-D-glucose uptake on positron emission tomography-computed tomography postbronchoalveolar lavage: a potential cause of radiologic misinterpretation.
Topics: Bronchoalveolar Lavage; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2011 |
Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Excitatory Amino Acid Transporter 2; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 3; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2011 |
[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dyspnea; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Odds Ratio; Positron-Emission Tomography; Radiation Pneumonitis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Topics: Adult; Aged; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
Utility of fluorodeoxyglucose-positron emission tomography in the identification of new lesions in lung cancer patients for the assessment of therapy response.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Reference Standards; Reproducibility of Results; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Metastatic colon carcinoma in a preexisting thyroid nodule.
Topics: Adenocarcinoma; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroid Nodule | 2010 |
Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2012 |
Inter-comparison of 18F-FDG PET/CT standardized uptake values in Korea.
Topics: Adolescent; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Korea; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2011 |
VEGF-A and its isoform VEGF₁₂₁ mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2011 |
Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET.
Topics: Aged; Aged, 80 and over; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Neoplasm Invasiveness; Netherlands; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.
Topics: Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
[Tumor diagnosis with PET-CT. Are false hopes raised in cancer patients? (interview by Ute Kempf)].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insurance Coverage; Lung Neoplasms; Male; National Health Programs; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2010 |
Localization of metastatic parathyroid carcinoma by 18F FDG PET scanning.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging | 2010 |
Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients wit
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
A case of sclerosing hemangioma evaluated with diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Biopsy, Needle; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sclerosis; Tomography, X-Ray Computed | 2010 |
Target delineation of gross tumor volume for radiation therapy planning using fusion images of ¹⁸F-fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk; Tomography, Emission-Computed; Treatment Outcome; Young Adult | 2010 |
Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results | 2010 |
Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Metastatic meningioma: positron emission tomography CT imaging findings.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?: in regard to Devic et al. (Int J Radiat Oncol Biol Phys 2010).
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. In regard to van Loon et al. (Int J Radiat Oncol Biol Phys 2010;77:329-336).
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging.
Topics: Aged; Aged, 80 and over; Anatomic Landmarks; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Organs at Risk; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma; Spinal Cord; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer.
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2010 |
Unexpected small bowel intussusception caused by lung cancer metastasis on 18F-fluorodeoxyglucose PET-CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Intussusception; Jejunal Diseases; Jejunal Neoplasms; Laparotomy; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Salvage Therapy | 2010 |
Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
Topics: Adult; Aged; Aged, 80 and over; Constriction, Pathologic; Contrast Media; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Probability; Pulmonary Atelectasis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Intestinal metastasis from non-small-cell lung cancer initially detected by ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biopsy; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Double-Balloon Enteroscopy; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Jejunal Neoplasms; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
[Prognostic value of (18)F-fluorodeoxyglucose uptake in patients with non-small cell lung cancer treated by concurrent chemoradiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Vinblastine; Vinorelbine | 2010 |
Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Is fluorine 18 fluorodeoxyglucose positron emission tomography scanning a suitable diagnostic test for histologically active large-vessel vasculitis?
Topics: Aged; Aneurysm; Aorta; Brachiocephalic Trunk; Carcinoma, Non-Small-Cell Lung; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Vasculitis | 2011 |
[18F-fluorodeoxyglucose positron emission tomography (FDG-PET) negative poorly differentiated adenocarcinoma of lung with mediastinal lymph node metastases].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Increased glucose uptake by seborrheic keratosis detected by positron emission tomography.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Keratosis, Seborrheic; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
18F-FDG-PET/CT findings in primary pulmonary mixed squamous cell and glandular papilloma.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Glandular and Epithelial; Papilloma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
[Q & A. A case showing notable accumulation of FDG in the stomach in PET following surgery of lung cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Helicobacter Infections; Helicobacter pylori; Humans; Lung Neoplasms; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Stomach Diseases | 2010 |
Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomography.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed | 2011 |
Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Latent Tuberculosis; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
[Experimental study of CT guided ³²P-CP-PLLA microparticle implantation in the treatment of rabbit VX2 lung tumor].
Topics: Animals; Apoptosis; Brachytherapy; Chromium Compounds; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Phosphates; Phosphorus Radioisotopes; Positron-Emission Tomography; Rabbits; Random Allocation; Tomography, X-Ray Computed | 2011 |
Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.
Topics: Amino Acid Substitution; Animals; Binding, Competitive; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Nude; Molecular Imaging; Mutant Proteins; Mutation; Positron-Emission Tomography; Protein Binding; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2011 |
Nested stromal epithelial tumor of the liver--liver transplantation and follow-up.
Topics: Adolescent; Epithelial Cells; Fatal Outcome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Multimodal Imaging; Neoplasms, Complex and Mixed; Positron-Emission Tomography; Radiopharmaceuticals; Stromal Cells; Tomography, X-Ray Computed | 2011 |
Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours.
Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Movement; Phantoms, Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Retrospective Studies; Tumor Burden | 2011 |
Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2011 |
The usefulness of fully three-dimensional OSEM algorithm on lymph node metastases from lung cancer with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Differential uptake of 18F-FDG in patients with synchronous lung cancers.
Topics: Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Smoking | 2011 |
18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Lung Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Pyrazines; Receptor, IGF Type 1; Receptor, Insulin; Xenograft Model Antitumor Assays | 2011 |
Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography, Thoracic; Respiratory-Gated Imaging Techniques; Retrospective Studies; Thorax; Tumor Burden | 2011 |
Relationship between pretreatment FDG uptake and local control after stereotactic body radiotherapy in stage I non-small-cell lung cancer: the preliminary results.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed; Treatment Failure | 2011 |
Seizures and radionecrosis from non-small-cell lung cancer presenting as increased fluorodeoxyglucose uptake on positron emission tomography.
Topics: Anticonvulsants; Brain Injuries; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Seizures | 2011 |
Repeat FDG-PET for predicting pathological tumor response and prognosis after neoadjuvant treatment in nonsmall cell lung cancer: comparison with computed tomography.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Multiple muscle metastases from lung cancer detected by FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Muscle Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, Emission-Computed | 2011 |
The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Surveys and Questionnaires | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Clinical Images: Hippokrates confirmed by positron emission tomography.
Topics: Adenocarcinoma; Comorbidity; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Osteoarthropathy, Primary Hypertrophic; Periostitis; Positron-Emission Tomography | 2011 |
Primary lung cancer arising from the wall of a giant bulla in which positron emission tomography was useful for preoperative diagnosis.
Topics: Blister; Carcinoma, Large Cell; Chemotherapy, Adjuvant; Fatal Outcome; Fluorodeoxyglucose F18; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
PET/CT with 3'-deoxy-3'-[18F]fluorothymidine for lung cancer patients receiving carbon-ion radiotherapy.
Topics: Aged; Aged, 80 and over; Carbon; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
PET and PET-CT of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed | 2011 |
PET-CT in radiotherapy for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed | 2011 |
Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cohort Studies; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Point Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2011 |
PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
Topics: Adult; Aged; Biopsy; Boston; Case-Control Studies; Catheter Ablation; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The appearance of cardiac metastasis from squamous cell carcinoma of the lung on F-18 FDG PET/CT and post hoc PET/MRI.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Movement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Respiration; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.
Topics: Aged; Aged, 80 and over; Cancer Care Facilities; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Ontario; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Radiotherapy, Image-Guided; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Topics: Adenocarcinoma; Aged; Anthracosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Coal; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
Prediction of survival and cancer recurrence using F-18 FDG PET/CT in patients with surgically resected early stage (Stage I and II) non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis | 2011 |
Autocontouring versus manual contouring.
Topics: Algorithms; Automation; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Should CT play a greater role in preventing the resection of granulomas in the era of PET?
Topics: Aged; Carcinoma, Bronchogenic; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Risk Assessment; Risk Factors; ROC Curve; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Tumor Microenvironment | 2012 |
Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Equipment Design; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Quality of Health Care; Radiopharmaceuticals; Reproducibility of Results; Thoracotomy; Tomography, X-Ray Computed; Turkey | 2011 |
Preferred method for the diagnostic evaluation of ground-glass opacities.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Sensitivity of diffusion weighted imaging for the assessment of metastatic lymph nodes.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Aspergillosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
How to comprehend the meaning of ADC value on DWI sequence.
Topics: Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2012 |
F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed; Trachea | 2011 |
Focal cerebral hypermetabolism due to nonconvulsive status epilepticus mimicking metastasis in staging a patient with lung cancer by FDG PET/CT.
Topics: Aged; Brain Diseases, Metabolic; Brain Neoplasms; Diagnosis, Differential; Epilepsy, Generalized; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed | 2011 |
F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
Topics: Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Observer Variation; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tumor Burden | 2011 |
Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla.
Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Japan; Lung Diseases; Lung Neoplasms; Multiple Pulmonary Nodules; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Radiological experience needed when assessing PET/CT imaging.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Radiologists urge FDA to accept PET-based tumor response criteria in clinical trials.
Topics: Biomarkers, Tumor; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Molecular Targeted Therapy; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; United States; United States Food and Drug Administration; Workforce | 2011 |
[Bifocal lung cancer: the same histology?].
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Impact of time-of-flight PET on whole-body oncologic studies: a human observer lesion detection and localization study.
Topics: Body Size; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Positron-Emission Tomography; ROC Curve; Time Factors; Whole Body Imaging | 2011 |
Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule; Survival Analysis; Tumor Burden; Young Adult | 2011 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
Topics: Area Under Curve; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tumor Burden | 2011 |
Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiration; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Recombinant Proteins; Sorafenib; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2011 |
Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Pulmonary mucosa-associated lymphoid tissue lymphoma with a pulmonary arteriovenous fistula.
Topics: Arteriovenous Fistula; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Veins; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2011 |
Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity.
Topics: Carcinoma, Non-Small-Cell Lung; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2011 |
Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2011 |
Benign intrapulmonary schwannoma: aspect on F-18 fluorodeoxyglucose PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Simultaneous occurrence of typical carcinoid and non-small-cell lung cancer in the same lung lobe: value of nuclear medicine.
Topics: Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography | 2011 |
Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Combined Modality Therapy; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2011 |
Mediastinal incidentalomas.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lung Neoplasms; Lymph Nodes; Lymphatic Diseases; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
Can Hyperpolarized Helium MRI add to radiation planning and follow-up in lung cancer?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Helium; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
[A case of Paragonimus westermani with elevated FDG uptake into a pulmonary nodular lesion and right hilar and mediastinal lymph nodes on FDG-positron-emission tomography].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Middle Aged; Paragonimiasis; Positron-Emission Tomography | 2011 |
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Likelihood Functions; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tennessee | 2011 |
Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2011 |
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tumor Burden | 2011 |
Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Pulmonary Fibrosis; Radiation Pneumonitis; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tomography, X-Ray Computed | 2011 |
18F-FDG uptake in primary lung cancer as a predictor of intratumoral vessel invasion.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies | 2011 |
[Positron emission tomography with 18F-FDG and cancer response to chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Drug Monitoring; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Single-session radiofrequency ablation of bilateral lung metastases.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Iopamidol; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Retreatment; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2012 |
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2011 |
The standardize uptake value: light and shade of positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Equipment Design; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Quality of Health Care; Radiopharmaceuticals; Reproducibility of Results | 2011 |
Lymph node involvement in T1 non-small-cell lung cancer: do not miss radical lymphadenectomy.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals | 2012 |
[18-FDG PET-scan of intrathoracic gossypiboma during the monitoring of lung cancer].
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lung Diseases; Lung Neoplasms; Male; Monitoring, Physiologic; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Reoperation; Risk Factors; Smoking; Surgical Sponges; Treatment Outcome | 2011 |
PET-CT in the staging and treatment of non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Pulmonary Atelectasis; Tomography, X-Ray Computed | 2011 |
Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Turkey | 2012 |
Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
Topics: Adolescent; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Middle Aged; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2012 |
Collision lung cancer on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Images of a case of Carney triad by combined F-18 FDG PET/CT.
Topics: Adolescent; Chondroma; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Diagnosis of synchronous isolated splenic metastasis from lung adenocarcinoma: complementary role of FDG PET/CT and diffusion-weighted MRI.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Diffusion; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed | 2011 |
Pituitary FDG uptake in a patient of lung cancer with bilateral adrenal metastases causing adrenal cortical insufficiency.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pituitary Gland; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomogr
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2011 |
Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.
Topics: Cell Cycle; Cell Proliferation; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Kinetics; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Thymidine Kinase; Time Factors | 2011 |
Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Respiration; Tomography, X-Ray Computed | 2011 |
Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2011 |
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Deoxycytidine; Fluorodeoxyglucose F18; Gemcitabine; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Treatment Outcome | 2011 |
Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Italy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neurosurgical Procedures; Odds Ratio; Pneumonectomy; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
A method of adjusting SUV for injection-acquisition time differences in (18)F-FDG PET imaging.
Topics: Adult; Aged; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kinetics; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2011 |
A pheochromocytoma with high adrenocorticotropic hormone and a silent lung nodule.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Non-small cell lung cancer: prognostic importance of positive FDG PET findings in the mediastinum for patients with N0-N1 disease at pathologic analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2011 |
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2012 |
Poor FDG avidity in a case of metastatic pulmonary choriocarcinoma.
Topics: Adult; Choriocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radionuclide Imaging | 2011 |
Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment.
Topics: Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2011 |
FDG PET/CT differentiating two malignant tumors in the same patient.
Topics: Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Sarcoma, Synovial; Spinal Neoplasms; Tomography, X-Ray Computed | 2012 |
False positive fixation of fluorodeoxyglucose positron emission tomography after correction of a vocal cord paralysis.
Topics: Dimethylpolysiloxanes; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Prostheses and Implants; Radiopharmaceuticals; Recurrence; Vocal Cord Paralysis | 2011 |
Prediction of response to targeted therapies in lung cancer using dynamic imaging: still far from clinical implementation.
Topics: Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Quinazolines | 2011 |
Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Survival Rate | 2011 |
A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophils; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
Spontaneous regression of primary lung cancer arising from an emphysematous bulla.
Topics: Blister; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Regression, Spontaneous; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Emphysema; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Multimodality FDG PET/CT appearance of pulmonary tuberculoma mimicking lung cancer and pathologic correlation in a tuberculosis-endemic country.
Topics: Adult; China; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Pulmonary | 2011 |
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT).
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Treatment Outcome | 2011 |
Congenital triple kidney in a patient evaluated by F-18 FDG PET/CT for oncologic reason.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Kidney; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Anthracotic solitary pulmonary nodule imitating lung malignancy on F-18 FDG PET/CT imaging.
Topics: Aged; Anthracosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; User-Computer Interface | 2011 |
N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients wi
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning.
Topics: Aged; Ambulatory Care; Bronchoscopy; Female; Fluorodeoxyglucose F18; Health Planning Guidelines; Heterocyclic Compounds; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Netherlands; Organometallic Compounds; Positron-Emission Tomography; Referral and Consultation; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
Topics: Brachial Plexus; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Esophagus; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Spinal Cord; Treatment Outcome | 2011 |
The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneum; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
MUC1 expression in pulmonary metastatic tumors: a comparison of primary lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Metastasectomy; Middle Aged; Mucin-1; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Young Adult | 2012 |
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques.
Topics: Adenocarcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Metabolic pattern of glomic tumor by F-18 FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Glomus Tumor; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Osteoblastic healing response: discordant PET/CT findings.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Osteoblasts; Positron-Emission Tomography; Quinazolines; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].
Topics: Biopsy; Bone Neoplasms; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Octreotide; Positron-Emission Tomography; Ribs; Sacrum; Spinal Neoplasms; Tomography, X-Ray Computed | 2011 |
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Prognosis; Quinazolines; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
Topics: Adenocarcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2011 |
[Comparison of the biodistribution of four contrast agents in nude mice bearing NCI-H358 human lung cancer and evaluation of their value in diagnostic imaging].
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thiocarbamates; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Combined Modality Therapy; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2012 |
Characterization of adrenal metastatic cancer using FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Carcinoma; China; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Hyperplasia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden | 2012 |
Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to vestibular schwannoma suspected on preoperative [18F]-fluorodeoxyglucose positron emission tomography imaging.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Neuroma, Acoustic; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2012 |
[The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Heart; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Spinal Cord; Spine; Tomography, X-Ray Computed | 2011 |
Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Topics: Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Biopsy, Fine-Needle; Diagnosis, Differential; Dyspnea; Female; Fluorodeoxyglucose F18; Humans; Hypertension; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiography, Thoracic; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Vascular Neoplasms; Warfarin | 2011 |
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Illinois; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2012 |
Bronchial atresia on FDG PET/CT: imaging characteristics of a rare pulmonary pseudonodule.
Topics: Bronchi; Bronchography; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Pulmonary Atresia; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation.
Topics: Aged; Aged, 80 and over; Catheter Ablation; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): an analysis of 649 cases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Cyclooxygenase 2; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Proteins; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
[Addisonian crisis caused by metastatic lung cancer. Report of one case].
Topics: Addison Disease; Adenocarcinoma; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
An immunoglobulin G4-related disease mimicking postoperative lung cancer recurrence.
Topics: Aged; Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G; Lung Neoplasms; Lymphatic Diseases; Male; Mikulicz' Disease; Multimodal Imaging; Neoplasm Recurrence, Local; Plasma Cells; Pleura; Positron-Emission Tomography; Prednisolone; Submandibular Gland; Tomography, X-Ray Computed | 2012 |
Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Correlation between matrix metalloproteinase 9 and 18F-2-fluoro-2-deoxyglucose-positron emission tomography as diagnostic markers of lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bronchoalveolar Lavage Fluid; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung Neoplasms; Male; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Vital Capacity | 2012 |
Radiation-induced myositis mimicking chest wall tumor invasion in two patients with lung cancer: a PET/CT study.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Myositis; Neoplasm Invasiveness; Positron-Emission Tomography; Radiation Injuries; Thoracic Wall; Tomography, X-Ray Computed | 2012 |
The appearance of osseous PEComa on F-18 FDG PET/CT.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Survival Analysis | 2012 |
Bioevaluation study of 32P-CP-PLLA particle brachytherapy in a rabbit VX2 lung tumor model.
Topics: Animals; Brachytherapy; Disease Models, Animal; Fluorodeoxyglucose F18; Lactic Acid; Lung Neoplasms; Phosphorus Radioisotopes; Polyesters; Polymers; Rabbits; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tumor Burden | 2012 |
A revision of the organ radiation doses from 2-fluoro-2-deoxy-D-glucose with reference to tumour presence.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Whole Body Imaging | 2012 |
Metabolic-morphologic discordant solitary skeletal muscle metastasis on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography scan in synchronous lung and esophageal cancer: a lesson.
Topics: Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Muscle Neoplasms; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Invited commentary.
Topics: Adenocarcinoma; Biomarkers, Tumor; Cyclooxygenase 2; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
(18)F-FDG PET/CT and (99m)Tc-MDP imaging of non-small cell lung carcinoma osseous metastases.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Kinetic analysis of 18F-FLT PET in lung tumors.
Topics: Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Models, Biological; Neoplasms; Positron-Emission Tomography; Radioisotope Dilution Technique; Thoracic Neoplasms; Thymidine Kinase; Tomography, Emission-Computed | 2012 |
A proposed new imaging pathway for patients with suspected lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
Topics: Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
[Clinicopathological study of small lung cancer (diameter of 2 cm or less) by uptake value of 18F-fluorodeoxyglucose].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2012 |
[The clinic value of (18)F-FDG PET/CT imaging in differentiation of malignant from benign disease in lung].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Indazoles; Lung Neoplasms; Mice; Mice, SCID; Phenylurea Compounds; Positron-Emission Tomography; Receptor Protein-Tyrosine Kinases; Xenograft Model Antitumor Assays | 2012 |
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Topics: Adult; Aged; Blood Volume; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
[The value of extra-lung lesions on ¹⁸F-FDG PET/CT in improving diagnosis of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2012 |
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist?
Topics: Adult; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Syndrome; Thrombotic Microangiopathies | 2012 |
Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET/CT.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Pleural Neoplasms; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Pulmonary cryptococcosis and tuberculoma mimicking primary and metastatic lung cancer in 18F-FDG PET/CT.
Topics: Adult; Cryptococcosis; Fluorodeoxyglucose F18; Humans; Lung Diseases, Fungal; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculoma; Tuberculosis, Pulmonary | 2011 |
Sarcomatoid carcinoma (carcinosarcoma) of the lung mimics malignant pleural mesothelioma on 18F-FDG PET/CT: a report of 2 cases.
Topics: Aged; Carcinosarcoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Survival Analysis; Time Factors; Tumor Burden | 2012 |
Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer.
Topics: Aged; Alberta; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Cost-Benefit Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Palliative Care; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Transcutaneous computed bioconductance measurement in lung cancer: a treatment enabling technology useful for adjunctive risk stratification in the evaluation of suspicious pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; Electric Conductivity; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Risk Assessment; ROC Curve; Skin; Spirometry; Tomography, Spiral Computed | 2012 |
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Genes, p53; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Mutation; Pharmacogenetics; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Randomized Controlled Trials as Topic; ras Proteins; Reproducibility of Results; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG PET/CT metabolic tumour volume in small-cell lung cancer: better staging and prognostic stratification for an improved therapeutic strategy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery | 2012 |
Diffuse metastases of lung adenocarcinoma with EGFR mutation.
Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; ErbB Receptors; Exons; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, erbB-1; Humans; Lung Neoplasms; Middle Aged; Mutation; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiography; Sequence Deletion; Spinal Neoplasms | 2012 |
Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Aortography; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Semi-automatic analysis of standard uptake values in serial PET/CT studies in patients with lung cancer and lymphoma.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
The characteristics of FDG PET/CT imaging in pulmonary Langerhans cell sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Langerhans Cell Sarcoma; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
[Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2012 |
Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Recent progress in positron emission tomography concerning diagnosis and treatment of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Discriminant Analysis; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Quinazolines; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2012 |
Combined use of 68Ga-DOTATATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome.
Topics: ACTH Syndrome, Ectopic; Aged; Carcinoid Tumor; Carcinoma, Bronchogenic; Drug Combinations; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Organometallic Compounds; Pituitary ACTH Hypersecretion; Radionuclide Imaging | 2012 |
¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Tumor Burden | 2012 |
The role of positron emission tomography following radiosurgical treatment of malignant lung lesions.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Mediastinal staging of lung cancer: novel concepts.
Topics: Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinoscopy; Mediastinum; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2012 |
[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.
Topics: Aged; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Radiation Pneumonitis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Recombinant Fusion Proteins | 2012 |
It is never too late: ultra-late recurrence of melanoma with distant metastases.
Topics: Aged; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Patella; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Registries; Retrospective Studies; Survival Rate; Tumor Burden; Whole Body Imaging | 2013 |
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2012 |
Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
Topics: Aged; Biopsy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Pulmonary sarcoidosis mimicking multiple pulmonary metastases.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Preoperative pathological diagnosis of lung cancer: is it always necessary?
Topics: Biopsy; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.
Topics: Aged; Aged, 80 and over; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Case Management; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Palliative Care; Patient Care Team; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis | 2012 |
The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients: analysis of 413 cases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Conversion from FDG-negative to -positive during follow-up in a rare case of pulmonary lymphoepithelioma-like carcinoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
Topics: Adolescent; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Child; China; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Quality of Life; Radiopharmaceuticals; Risk Factors; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
Multi-modality imaging for accurate diagnosis of lipomatous hypertrophy of interatrial septum in a patient with lung cancer and increased FDG uptake on PET.
Topics: Aged; Atrial Septum; Carcinoma, Small Cell; Cardiomegaly; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Fluorodeoxyglucose F18; Humans; Lipomatosis; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genome, Human; Genomic Instability; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Oncogenes; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2012 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cisplatin; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Niacinamide; Paclitaxel; Phenylurea Compounds; Piperidines; Pyridines; Pyrroles; Quinazolines; Radiopharmaceuticals; Sorafenib; Sunitinib; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2012 |
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
Topics: Area Under Curve; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Metagenomics; Microarray Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer.
Topics: Adult; Aged; Cohort Studies; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Parotid Neoplasms; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
[Diagnostic difficulties caused by a pulmonary infiltrate].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2012 |
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2012 |
Comparison of 2-amino-[3-¹¹C]isobutyric acid and 2-deoxy-2-[¹⁸F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation.
Topics: Acute Disease; Aminoisobutyric Acids; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2012 |
Primary adenoid cystic carcinoma of the bronchus in a female teenager.
Topics: Adolescent; Biomarkers, Tumor; Biopsy, Needle; Carcinoma, Adenoid Cystic; Chest Pain; Combined Modality Therapy; Cooperative Behavior; Female; Fluorodeoxyglucose F18; Humans; Interdisciplinary Communication; Lung; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Shoulder Pain; Tomography, X-Ray Computed | 2010 |
Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Octreotide; Positron-Emission Tomography; Prognosis; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Recurrence of lung cancer after radiofrequency ablation detected by PET/CT and contrast enhanced CT scan.
Topics: Adenocarcinoma; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[Development of a predicting model to estimate the probability of malignancy of solitary pulmonary nodules].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2012 |
FDG-PET and chemotherapy for successful diagnosis and treatment of cardiac metastasis from non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Electrocardiography; Female; Fluorodeoxyglucose F18; Glutamates; Guanine; Heart Neoplasms; Humans; Lung Neoplasms; Middle Aged; Pemetrexed; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Metastatic gastric cancer from squamous cell lung carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Japan; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Salvage Therapy; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Systems Integration; Tomography, X-Ray Computed | 2012 |
Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2012 |
Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Odds Ratio; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2012 |
Superscan-like hypermetabolic lesions on delayed FDG PET/CT imaging in a patient with lung cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2012 |
A case of giant cell tumor of sacrum with unusual pulmonary metastases: CT and FDG PET findings.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Tomography, X-Ray Computed | 2012 |
A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology.
Topics: Adult; Choriocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms | 2012 |
Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2012 |
Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Neoplasms, Squamous Cell; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Fever and persistent cough in a 65-year-old patient].
Topics: Aged; Cough; Fever; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Vascular Neoplasms | 2013 |
Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
PET/CT in oncology.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
New strategy for automatic tumor segmentation by adaptive thresholding on PET/CT images.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Unilateral adrenal metastasis from non–small-cell lung cancer demonstrating very high FDG uptake with a standardized uptake value in excess of sixty.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Pulmonary tumor embolism secondary to uterine corpus carcinosarcoma mimicking pulmonary thromboembolism.
Topics: Carcinosarcoma; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Tomography, X-Ray Computed; Uterine Neoplasms | 2012 |
FDG injection site extravasation: potential pitfall of misinterpretation and missing metastases.
Topics: Carcinoma, Non-Small-Cell Lung; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
"Quasi-symmetric" FDG avidity of bilateral salivary glands in Mikulicz disease yielding false-positive staging in lung cancer.
Topics: Aged; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mikulicz' Disease; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Salivary Glands; Tomography, X-Ray Computed | 2012 |
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2013 |
Histiocytic sarcoma in the bronchoalveolar lavage fluid.
Topics: Adult; Bronchoalveolar Lavage Fluid; Fluorodeoxyglucose F18; Histiocytic Sarcoma; Humans; Image-Guided Biopsy; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Pulmonary carcinosarcoma: 18F-FDG PET/CT imaging.
Topics: Adult; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiography, Thoracic; Tomography, X-Ray Computed | 2012 |
[Prognostic factors in non-small cell lung cancer patients and prognostic importance of PET/CT SUV max value].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
[False positive 18F-FDG PET/CT findings mimicking malignant disease in patients with pneumoconiosis (due to three case reports)].
Topics: Aged; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2012 |
Intramedullary metastasis detected with 18F FDG-PET/CT.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
Topics: Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Pulmonary Nodules; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Variability of ¹⁸F-FDG-positive lung lesion volume by thresholding.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [¹⁸F] fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
[Non small cell lung carcinoma - evaluation of tumor heterogeneity using CT texture analysis].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2012 |
Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy.
Topics: Adult; Aged; Carcinoma, Small Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2014 |
Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Thymidine Kinase; Tomography, X-Ray Computed | 2013 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
Topics: Aged; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Metabolism; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2013 |
F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study.
Topics: Aged; Biopsy; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Medical Oncology; Middle Aged; Neoplasm Staging; Perfusion; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2013 |
Lung tumor segmentation in PET images using graph cuts.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Decision Support Systems, Clinical; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2013 |
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Glycolysis; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Treatment Outcome; Tumor Burden | 2013 |
[Diagnostic value of (18)F-labeled NaF positron emission tomography-computed tomography imaging in the detection of bone metastases in patients with lung cancer before treatment].
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
[Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pleural Effusion, Malignant; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
What causes false-negative PET findings for solid-type lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Blood Glucose; Body Weight; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2013 |
Overlapping immunoglobulin G4-related disease and Rosai-Dorfman disease mimicking lung cancer.
Topics: Aged, 80 and over; Autoimmune Diseases; Bronchoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Histiocytosis, Sinus; Humans; Immunoglobulin G; Kidney Diseases; Lung; Lung Neoplasms; Lymph Node Excision; Male; Positron-Emission Tomography; Prednisone; Radiography; Radiopharmaceuticals | 2012 |
Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden | 2013 |
Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer.
Topics: Acute Disease; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose-Response Relationship, Radiation; Esophagitis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2013 |
The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Metastatic lung nodule diagnosed on 18F-FDG PET/CT-guided fine needle aspiration in a patient with renal cell carcinoma.
Topics: Biopsy, Fine-Needle; Carcinoma, Renal Cell; Contrast Media; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Virtual bronchoscopy using FDG-PET/CT images for the evaluation of lung cancer.
Topics: Adult; Aged; Biopsy; Bronchoalveolar Lavage; Bronchoscopy; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
Surgical adhesive may cause false positives in integrated positron emission tomography and computed tomography after lung cancer resection.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Proteins; Radiography; Radionuclide Imaging; Tissue Adhesives | 2013 |
Guidelines for the role of FDG-PET/CT in lung cancer management.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2012 |
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Recurrence; Tomography, X-Ray Computed | 2013 |
Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Disease Progression; Doxorubicin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
[Correlation between regional node metastasis and imageological characteristics in non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Radiography; Radionuclide Imaging; Risk Factors; Tumor Burden | 2012 |
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Multimodal Imaging; Mutation; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Receptor Protein-Tyrosine Kinases; Tomography, X-Ray Computed; Young Adult | 2013 |
Ciliated muconodular papillary tumor of the lung: a newly defined low-grade malignant tumor with CT findings reminiscent of adenocarcinoma.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis.
Topics: Aged; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histoplasmosis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed; United States; United States Department of Veterans Affairs | 2013 |
Segmentation of biological target volumes on multi-tracer PET images based on information fusion for achieving dose painting in radiotherapy.
Topics: Algorithms; Anthropometry; Bayes Theorem; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Hypoxia; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Software | 2012 |
A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Topics: Aged; Aged, 80 and over; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Fibrosis; Radiation Injuries; Radiosurgery; Recurrence; Tomography, X-Ray Computed | 2013 |
Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Contrast Media; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
[Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Illustrative cases of false positive biopsies after stereotactic body radiation therapy for lung cancer based on abnormal FDG-PET-CT imaging.
Topics: Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed | 2013 |
Ipilimumab in cancer patients: the issue of early metabolic response.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Dermatitis; Fluorodeoxyglucose F18; Humans; Ipilimumab; Lung Neoplasms; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2013 |
[Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
18F-FDG imaging of the primary breast leiomyosarcoma and follow-up lung metastasis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Flare response versus disease progression in patients with non-small cell lung cancer.
Topics: Acute Disease; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Tomography, X-Ray Computed | 2013 |
Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Probability; Prospective Studies; Regression Analysis; Sensitivity and Specificity; Treatment Outcome | 2013 |
FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting | 2002 |
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Oxygen Radioisotopes; Prognosis; Tomography, Emission-Computed; Water | 2002 |
Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Japan; Life Expectancy; Lung Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in lung lesions].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[Fluorine-18 fluorodeoxyglucose uptake in patients with primary lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[The usefulness of 11C-Choline-positron emission tomography in the diagnosis of sclerosing hemangioma of the lung--a case report].
Topics: Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Costochondritis mimicking a pulmonary nodule on FDG positron emission tomographic imaging.
Topics: Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiography; Tietze's Syndrome; Tomography, Emission-Computed | 2002 |
Increased FDG uptake in the right cardiac chambers in a patient with pulmonary emphysema.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Heart Diseases; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung Neoplasms; Male; Middle Aged; Pulmonary Emphysema; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
Topics: Aged; Australia; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2002 |
FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Korea; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Statistics as Topic; Survival Rate; Tomography, Emission-Computed | 2002 |
The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.
Topics: Biopsy; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Washington | 2002 |
Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reference Values; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution | 2002 |
Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.
Topics: Adolescent; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Osteosarcoma; Radiopharmaceuticals; Sodium Fluoride; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis.
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Lung Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Uptake of F-18 FDG by a hiatal hernia.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Hernia, Hiatal; Humans; Lung Neoplasms; Male; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Staging of non-small-cell lung cancer and application of FDG-PET. A cost modeling approach.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Male; Middle Aged; Models, Econometric; Neoplasm Staging; Netherlands; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2002 |
How high can the standardized uptake value be?
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tissue Distribution; Urinary Bladder Neoplasms | 2002 |
PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.
Topics: Abdominal Neoplasms; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Microcomputers; Middle Aged; Neoplasm Staging; Neoplasms; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Software; Tomography, Emission-Computed; Tomography, Spiral Computed | 2002 |
[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Probability; Tomography, Emission-Computed | 2002 |
Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma.
Topics: Aged; Carcinoma, Bronchogenic; Dermatomyositis; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Paraneoplastic Syndromes; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Protocols; Cohort Studies; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed | 2003 |
Initial clinical experience using a new integrated in-line PET/CT system.
Topics: Aged; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Where can FDG-PET contribute most to anatomical imaging problems?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings.
Topics: Aged; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pneumonia, Lipid; Radiopharmaceuticals; Sleep Apnea Syndromes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2002 |
Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy.
Topics: Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG positron emission tomographic imaging of a large abdominal aortic aneurysm.
Topics: Aged; Aortic Aneurysm, Abdominal; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The heart or a tumor? Lung cancer in the lower left thorax can mimic myocardial FDG uptake on PET imaging.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed | 2003 |
Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.
Topics: Animals; Blood Glucose; Cysteine; Feasibility Studies; Fluorodeoxyglucose F18; Insulin; Lung Neoplasms; Mice; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Tissue Distribution | 2003 |
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
[Fundamental evaluation of segmented attenuation correction method for clinical FDG-PET studies: simulation of pulmonary mass lesions in phantom studies].
Topics: Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Models, Structural; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
Topics: Bone Marrow Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Ilium; Lung Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography.
Topics: Aged; Aspergillosis; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Diagnostic imaging--recent progress].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Observer Variation; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
Topics: Algorithms; Artifacts; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Mediastinal Neoplasms; Neoplasms; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG positron emission tomographic imaging of thoracic Castleman's disease.
Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed | 2003 |
Hiatal hernia mimics centrally necrotic cancer in the lung on FDG positron emission tomographic imaging.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hernia, Hiatal; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Necrosis; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Free Radicals; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burden.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Tomography, Emission-Computed | 2003 |
Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET-CT image registration in the chest using free-form deformations.
Topics: Algorithms; Artifacts; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Motion; Radiography, Thoracic; Radiopharmaceuticals; Subtraction Technique; Thorax; Tomography, Emission-Computed | 2003 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[FDG dual-head tomography with coincidence imaging and serum tumor marker assays for the assessment of malignancy of pulmonary lesions].
Topics: Adult; Aged; Aged, 80 and over; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
New horizons in oncologic imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetics; Male; Medical Oncology; Nanotechnology; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Oral administration of F-18 FDG to evaluate a single pulmonary nodule by positron emission tomography in a patient with poor intravenous access.
Topics: Administration, Oral; Aged; Digestive System; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Mouth; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tissue Distribution; Tomography, Emission-Computed | 2003 |
[PET-imaging proves giant-cell arteritis as the cause of FUO in a patient with a pulmonary nodule of unknown malignancy].
Topics: Aged; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer.
Topics: Carcinoma, Small Cell; Cicatrix; Diagnosis, Differential; Echocardiography; Endomyocardial Fibrosis; False Positive Reactions; Fluorodeoxyglucose F18; Heart; Heart Neoplasms; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Differentiation of synchronous tumors using FDG positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Pulmonary clostridium perfringens infection detected by FDG positron emission tomography.
Topics: Aged; Aged, 80 and over; Clostridium Infections; Clostridium perfringens; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
Topics: Adult; Aged; Aged, 80 and over; Electrons; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Databases, Factual; Evidence-Based Medicine; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Evaluation of positron emission tomography in diagnosing and staging of lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Topics: Adult; Aged; Bone and Bones; Cell Division; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Kidney; Liver; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder | 2003 |
The role of FDG-PET scan in staging patients with nonsmall cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Carbon Radioisotopes; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tuberculosis, Pulmonary | 2003 |
PET imaging of Sertoli cell tumor in androgen insensitivity syndrome.
Topics: Aged; Androgen-Insensitivity Syndrome; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sertoli Cell Tumor; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron emission tomography in pulmonary cryptococcoma.
Topics: Cryptococcosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases, Fungal; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Radiation-induced esophagitis on FDG PET imaging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Esophagitis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Radiotherapy; Tomography, Emission-Computed | 2003 |
Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography--a preliminary report.
Topics: Adult; Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
[18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients.
Topics: Adult; Female; Fluorodeoxyglucose F18; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Middle Aged; Pregnancy; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
[A case of local recurrence of rectal cancer in which trans-sacral resection and perineal reconstruction by femoral posterior flap were performed].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Perineum; Plastic Surgery Procedures; Radiopharmaceuticals; Rectal Neoplasms; Surgical Flaps; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vagina | 2003 |
99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Pulmonary Fibrosis; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
Application of a neural network to improve nodal staging accuracy with 18F-FDG PET in non-small cell lung cancer.
Topics: Aged; Artificial Intelligence; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neural Networks, Computer; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Spinal Neoplasms; Tomography, Emission-Computed | 2003 |
Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
Topics: Aged; Amyloidosis; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Pneumonia; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
PET scan assessment of chemotherapy response in metastatic paraganglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carotid Body Tumor; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
[A surgeon's view on the importance of positron emission tomography--PET (with emphasis on lung neoplasms)].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission tomography with 2-[18f]fluoro-2-deoxy-D-glucose: can it be used to accurately stage the mediastinum in non-small cell lung cancer as an alternative to mediastinoscopy?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinoscopy; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins | 2003 |
Quantification of tumor vascularity with contrast-enhanced sonography: correlation with magnetic resonance imaging and fluorodeoxyglucose autoradiography in an implanted tumor.
Topics: Animals; Autoradiography; Contrast Media; Fluorocarbons; Fluorodeoxyglucose F18; Fractals; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Microspheres; Radiopharmaceuticals; Ultrasonography | 2004 |
The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Probability; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Pentetate; Tomography, Emission-Computed | 2004 |
Medical economics of whole-body FDG PET in patients suspected of having non-small cell lung carcinoma--reassessment based on the revised Japanese national insurance reimbursement system.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Insurance, Health, Reimbursement; Japan; Lung Neoplasms; Male; Models, Econometric; National Health Programs; Prevalence; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[Study on glucose metabolic rate in non-small cell lung cancer patients with blood stasis syndrome and non-blood stasis syndrome].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
A case of non-small cell lung cancer with false-positive staging by positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carcinosarcoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, Emission-Computed | 2004 |
[Value of fluorine-18 fluorode oxyglucose-positron emission tomography in patients with small cell lung cancer].
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed | 2004 |
Ring-shaped FDG uptake in the right lower lung: is it always a tumor?
Topics: Aged; Artifacts; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer.
Topics: Animals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Lung Neoplasms; Rabbits; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG-PET in radiotherapy treatment planning: Pandora's box?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiation Oncology; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Pilot Projects; Prospective Studies; Pulmonary Atelectasis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Hydropneumothorax on FDG PET imaging.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Hydropneumothorax; Incidental Findings; Lung Neoplasms; Male; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, Emission-Computed | 2004 |
False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications.
Topics: Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Lymph node staging in lung cancer using [18F]FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoid Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Pleural Diseases; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies.
Topics: Adenocarcinoma; Adult; Carcinoembryonic Antigen; Deglutition Disorders; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Muscle Weakness; Neurons; Palliative Care; Paraneoplastic Syndromes, Nervous System; Radionuclide Imaging; Spinal Cord; Stiff-Person Syndrome; Upper Extremity | 2004 |
Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
Topics: Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mass Screening; Prevalence; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Lepidic spread of primary lung adenocarcinoma on FDG-PET.
Topics: Adenocarcinoma; Aged; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Pulmonary Alveoli; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
F-18 FDG positron emission tomography demonstration of pulmonary carcinoid.
Topics: Aged; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Solitary Pulmonary Nodule | 2004 |
GLUT1 expression in tissue and (18)F-FDG uptake.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germinal Center; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
False-positive PET scan in a patient with lipoid pneumonia simulating lung cancer.
Topics: Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pneumonia, Lipid; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Iatrogenic artifacts on whole-body F-18 FDG PET imaging.
Topics: Adult; Artifacts; Breast Neoplasms; Catheterization; Catheters, Indwelling; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intubation; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ostomy; Prostheses and Implants; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
[Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Topics: Adult; Aged; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Nodules, CT-scans and PET-scans: a good partnership.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2004 |
Incidental bronchogenic cyst detected on F-18 FDG positron emission tomography.
Topics: Bronchogenic Cyst; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
Topics: Algorithms; Biophysical Phenomena; Biophysics; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
[Solitary pulmonary nodule without diagnosis: is it indication for F-18-fluoro-deoxyglucose scintigraphy (18-FDG-PET-SCAN)?].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lactic Acid; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Protons; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Survival Analysis | 2004 |
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
Topics: Adult; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed | 2004 |
Meningioma metastatic to the lung detected by FDG positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Solitary Pulmonary Nodule | 2004 |
Caveat emptor: the treachery of work-up bias.
Topics: Adenocarcinoma; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Observer Variation; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Topics: Adenocarcinoma; Aged; Antibodies, Neoplasm; Breast Neoplasms; Carcinoma, Small Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Paraneoplastic Syndromes, Nervous System; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
[Relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung adenocarcinoma].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2004 |
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2004 |
FDG accumulation in inguinal herniation mimicking metastatic disease.
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia.
Topics: Aged; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2004 |
False-positive FDG positron emission tomography in pulmonary amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2004 |
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4-5.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiation Oncology; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Using 18F-fluoro-2-deoxyglucose positron emission tomography to detect primary lung cancer in an isolated choroidal metastasis.
Topics: Choroid Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
Detection of a pulmonary epithelioid hemangioendothelioma by FDG PET scan.
Topics: Aged; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[18F-FDG positron emission tomography for mediastinal staging of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2004 |
A problem in diagnosing N3 disease using FDG-PET in patients with lung cancer--high false positive rate with visual assessment.
Topics: Aged; Carcinoma; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2004 |
Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases.
Topics: Adult; Aged; Biopsy; False Positive Reactions; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Mesothelioma; Middle Aged; Pleural Diseases; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[PET/CT in radiotherapy].
Topics: Blood Glucose; Carcinoma, Bronchogenic; Equipment Design; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2004 |
Defining a radiotherapy target with positron emission tomography.
Topics: Body Weight; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Linear Models; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2004 |
F-18 FDG PET/CT in acute respiratory distress syndrome: a case report.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Distress Syndrome; Subtraction Technique; Tomography, X-Ray Computed | 2004 |
F-18 PET soft tissue uptake in seatbelt injury.
Topics: Adenocarcinoma; Aged; Artifacts; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Seat Belts; Soft Tissue Injuries | 2004 |
Localization of F-18 FDG in Nocardia lung infection.
Topics: Aged; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Nocardia Infections; Pneumonia, Bacterial; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2004 |
Incidental situs inversus visualized with FDG PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Image Enhancement; Incidental Findings; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Situs Inversus; Subtraction Technique; Tomography, X-Ray Computed | 2004 |
Mediastinal staging (take home messages).
Topics: Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Mediastinum; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography, Interventional | 2004 |
Introduction. Non-small cell lung cancer: some important questions to be solved.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiotherapy; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies | 2004 |
Physiological uptake of [18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics?
Topics: Adolescent; Adult; Age Distribution; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck; Netherlands; Organ Specificity; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thorax; Thyroid Neoplasms; Tissue Distribution | 2004 |
18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2004 |
PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Databases, Factual; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Palliative Care; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2005 |
Idiopathic pulmonary fibrosis on F-18 FDG positron emission tomography.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Tongue Neoplasms | 2005 |
PET imaging of concomitant colonic hyperplastic polyp and tubulovillous adenoma.
Topics: Adenoma, Villous; Aged; Aged, 80 and over; Colon; Colonic Neoplasms; Colonic Polyps; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Incidental Findings; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Positron emission tomography helps in excluding distant lesions in a case of mesothelioma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Fluorodeoxyglucose F 18 positron emission tomography scanning in thoracic disease.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Solitary Pulmonary Nodule; Thoracic Diseases | 2004 |
Increased F-18 FDG uptake in the right auricle of a displaced heart: potential cause of a false-positive pathologic mediastinal node.
Topics: Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Cesium attenuation correction of the liver dome revealing hepatic lesion missed with computed tomography attenuation correction because of the respiratory motion artifact.
Topics: Aged; Artifacts; Cesium; Colorectal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Male; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Mechanics; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Vinblastine | 2004 |
The utility of multimodality imaging in anaplastic thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2004 |
A case of small cell carcinoma of the esophagus detected incidentally by FDG-PET.
Topics: Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics as Topic | 2005 |
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
Topics: Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Dose-Response Relationship, Radiation; Esophagus; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenocarcinoma, Mucinous; Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2005 |
Intraluminal FDG uptake in a rectal polyp detected with PET CT: identification of an unsuspected synchronous primary bowel tumor.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Positron-Emission Tomography; Rectal Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2005 |
[Value of FDG PET in diagnosis and management of lung cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Monosaccharide Transport Proteins; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proliferating Cell Nuclear Antigen | 2005 |
FDG-PET in addition to conventional work-up in non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2005 |
Imaging bronchial carcinoma in situ: possible roles for combined positron emission tomography (PET)-CT.
Topics: Aged; Carcinoma in Situ; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography | 2005 |
FDG uptake in brown adipose tissue mimicking an adrenal metastasis: source of false-positive interpretation.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Pancreatic pseudocyst observed on F-18 FDG PET imaging.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Squamous Cell; Pancreatic Neoplasms; Pancreatic Pseudocyst; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[The role of 18F fluorodeoxyglucose triple-head coincidence imaging in the diagnosis of suspected lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
[Clinical value of PET/CT for the diagnosis and management of lung nodules].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2004 |
Early lung cancer detection using spiral computed tomography and positron emission tomography.
Topics: Adult; Age Distribution; Cohort Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Prevalence; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Smoking; Spain; Spirometry; Tomography, Spiral Computed | 2005 |
Integrin alpha v beta 3-targeted imaging of lung cancer.
Topics: Animals; Cell Adhesion; Chromatography, High Pressure Liquid; Copper; Dimerization; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Kinetics; Lung; Lung Neoplasms; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Binding; Protein Structure, Tertiary; Radiopharmaceuticals; Time Factors | 2005 |
Unilateral vocal cord paralysis causes contralateral false-positive positron emission tomography scans of the larynx.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Muscles; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vocal Cord Paralysis | 2005 |
Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule.
Topics: Aged; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; France; Health Care Costs; Humans; Life Expectancy; Lung Neoplasms; Male; Positron-Emission Tomography; Solitary Pulmonary Nodule | 2005 |
Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al. (Int J Radiat Oncol Biol Phys 2004;60:1272-1282).
Topics: Body Weight; Fluorodeoxyglucose F18; Linear Models; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray | 2005 |
Mucoepidermal carcinoma of the lung detected by positron emission tomography in a 5-year-old girl.
Topics: Carcinoma, Mucoepidermoid; Child; Child, Preschool; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals | 2005 |
[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Application of technetium-99m labelled sandostatin Somatostatin receptor imaging in the detection of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Receptors, Somatostatin; Technetium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2005 |
[Application of positron emission tomography in diagnosis and staging for lung cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chemotherapy, Adjuvant; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Radiotherapy, Adjuvant; Tomography, Emission-Computed | 2005 |
Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Papilloma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2005 |
Positron emission tomography: useful in detecting metastatic cancer of unknown primary site.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Treatment Outcome | 2005 |
[A case of adenocarcinoma of lung with idiopathic pulmonary fibrosis, showing 1 8-fluorodeoxyglucose uptake in positron emission tomograhy].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Fibrosis | 2005 |
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Topics: Adenocarcinoma; Adult; Aged; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Linear Models; Lung; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Necrosis; Neoplasm Metastasis; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Time Factors; Tuberculosis | 2005 |
The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2005 |
Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2005 |
Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Radiosurgery; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography | 2005 |
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Case report: Gluteal injection site granulomas: false positive finding on FDG-PET in patients with non-small cell lung cancer.
Topics: Adipose Tissue; Aged; Buttocks; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Injections, Intramuscular; Lung Neoplasms; Male; Middle Aged; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2005 |
Exclusion of lung metastases in placental site trophoblastic tumor using [18F]fluorodeoxyglucose positron emission tomography: a case report.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Trophoblastic Tumor, Placental Site | 2005 |
PET/CT in non-small-cell lung cancer: value of respiratory-gated PET.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
[Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tongue Neoplasms | 2005 |
Mediastinal histoplasmosis: F-18 FDG PET and CT findings simulating malignant disease.
Topics: Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Lung Neoplasms; Mediastinum; Melanoma; Middle Aged; Osteitis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Detection and staging of preinvasive lesions and occult lung cancer in the central airways with 18F-fluorodeoxyglucose positron emission tomography: a pilot study.
Topics: Aged; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Generalised FDG uptake in respiratory muscles after acute respiratory distress.
Topics: Aged; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Distress Syndrome; Respiratory Muscles; Tissue Distribution | 2005 |
Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiation Pneumonitis; Radiation Protection; Radiopharmaceuticals; Retrospective Studies | 2005 |
Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Health Care Costs; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Mediastinum; Models, Economic; Positron-Emission Tomography; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis | 2005 |
18F-FDG PET of clear cell (sugar) tumour of the lung.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
Topics: Aged; Aged, 80 and over; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Observer Variation; Radiopharmaceuticals; Thoracic Wall; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
[Application of 18FDG-PET in the diagnosis of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Growth Processes; Cell Line, Tumor; Cyclophilin A; Fluorodeoxyglucose F18; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; RNA Interference; Transfection | 2005 |
[18-FDG positon emission tomography and distal metastasis from lung cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Femur; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tibia; Whole Body Imaging | 2005 |
Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Spiral Computed | 2005 |
Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Time Factors | 2006 |
Modern treatment of lung cancer: case 3. Non-metastatic bilateral F-18 fluorodeoxyglucose avid adrenal glands in non-small-cell lung cancer.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Plasma Cells; Rituximab; Stomach Neoplasms; Treatment Outcome | 2005 |
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Smoking; Solitary Pulmonary Nodule; Tomography, Spiral Computed | 2005 |
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidence; Lung Neoplasms; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2006 |
Early detection of splenic metastasis of lung cancer by 18F-2-fluoro-2-deoxyglucose positron emission tomography.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Splenic Neoplasms | 2005 |
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lung Neoplasms; Mediastinal Neoplasms; Positron-Emission Tomography; Superior Vena Cava Syndrome | 2005 |
[Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
[Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
Increased F-18 FDG skeletal muscle uptake secondary to altered weight bearing and the use of crutches.
Topics: Adult; Crutches; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Muscle, Skeletal; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Weight-Bearing | 2005 |
The clinical role of CT/PET in oncology: an update.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Tomography, X-Ray Computed | 2006 |
Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Topics: Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Subclavian Vein; Tomography, Emission-Computed; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2006 |
Intracardiac extension of lung cancer demonstrated on PET scanning.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Lung Neoplasms; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Bronchogenic carcinoma associated with rheumatoid arthritis: role of FDG-PET scans.
Topics: Adult; Carcinoma, Bronchogenic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Rheumatoid Nodule; Tomography, Emission-Computed | 2006 |
[Diagnostic value of dual-head 18F-FDG imaging in metastatic lesion with unknown primary tumour].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography | 2005 |
[Surgical approach for lung cancer with multiple pulmonary nodules].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography | 2006 |
Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?
Topics: Adult; Aged; Contrast Media; Exhalation; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inhalation; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Solitary Pulmonary Nodule; Thorax; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes.
Topics: Aged; Biopsy, Needle; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Ultrasonography | 2006 |
Super-resolution in PET imaging.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Addressing glucose sensitivity measured by F-18 FDG PET in lung cancers for radiation treatment planning and monitoring.
Topics: Aged; Algorithms; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lung Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Staging of non-small cell lung cancer (NSCLC).
Topics: Adrenal Gland Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms | 2006 |
Large cell carcinoma with neuroendocrine morphology of the lung.
Topics: Aged; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2006 |
Fluorodeoxyglucose uptake correlates with the growth pattern of small peripheral pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Primary malignant melanoma of the lung: a case report and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Temozolomide; Tomography, X-Ray Computed | 2006 |
Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2006 |
Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2006 |
Positron emission tomography in well differentiated fetal adenocarcinoma of the lung.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
New horizons in staging for non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Proteins; Octreotide; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2006 |
Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Hypercalcemia; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Thrombocytosis | 2006 |
Pneumoconiosis associated with an esophageal ulcer and uptake revealed in FDGPET.
Topics: Aged; Bronchoscopy; Connective Tissue; Esophageal Diseases; Fluorodeoxyglucose F18; Gastroscopy; Humans; Hyperplasia; Immunohistochemistry; Lung Neoplasms; Macrophages, Alveolar; Male; Pneumoconiosis; Positron-Emission Tomography; Radiopharmaceuticals; Ulcer | 2006 |
Is it time to incorporate quantitative functional imaging data, FDG PET in particular, into the response evaluation criteria in solid tumours?
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Outcome Assessment, Health Care; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Severity of Illness Index; Solitary Pulmonary Nodule; Treatment Outcome; United States | 2006 |
How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.
Topics: Carcinoma, Small Cell; Cell Count; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Cutaneous metastatic lung cancer detected with 18F-FDG PET.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2006 |
[Fluorine-18 fluorodeoxyglucose uptake in patients with benign pulmonary nodules].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis, Pulmonary; Solitary Pulmonary Nodule; Tuberculosis, Pulmonary | 2006 |
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Child; Child, Preschool; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2006 |
Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Vena Cava, Inferior; Venous Thrombosis | 2006 |
The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Somatostatin | 2006 |
Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2006 |
[Positron emission tomography (PET)-computed tomography (CT) suggesting small intestinal metastasis from lung cancer; report of a case].
Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Ileus; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Lymph Node Excision; Male; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Cyclin D1; Female; Fluorodeoxyglucose F18; Genes, Tumor Suppressor; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2006 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
Topics: Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lung Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Skull Neoplasms | 2006 |
Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
Topics: Aged; Automation; Diagnosis, Computer-Assisted; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; ROC Curve; Software; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2006 |
[18F-FDG PET and bone scintigraphy to search for bone metastasis of lung cancer].
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2006 |
"Cold" vertebrae on F-18 FDG PET: Causes and characteristics.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioma; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spine | 2006 |
Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Two cases of pulmonary paragonimiasis on FDG-PET CT imaging.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Paragonimiasis; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Statistics, Nonparametric | 2006 |
Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; ROC Curve | 2006 |
18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Topics: Animals; Carcinoma; Catheter Ablation; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Lung; Lung Neoplasms; Neoplasm Transplantation; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2006 |
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Tomography, X-Ray Computed | 2006 |
PET/CT imaging in response evaluation of patients with small cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiography; Radiopharmaceuticals; Risk Assessment; Risk Factors; Statistics, Nonparametric; Tomography, Emission-Computed; Treatment Outcome | 2006 |
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Diseases; Lung Diseases, Fungal; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2006 |
Growing PET positive nodule in a patient with histoplasmosis: case report.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Lung Diseases, Fungal; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2006 |
Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed | 2006 |
Pulmonary suture abscess with false-positive 18F-fluorodeoxyglucose positron emission scan mimicking lung cancer recurrence.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sutures | 2006 |
Incidental findings on integrated PET/CT that do not accumulate 18F-FDG.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2006 |
Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Osteoarthropathy, Secondary Hypertrophic; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.
Topics: Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2006 |
Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response?
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Gefitinib; Glucose; Humans; Lung Neoplasms; Quinazolines; Radionuclide Imaging | 2006 |
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Gefitinib; Glucose; Humans; Lung Neoplasms; Mice; Mice, SCID; Neoplasm Staging; Positron-Emission Tomography; Quinazolines; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2006 |
Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Diabetes Complications; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2006 |
Biological correlates of FDG uptake in non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Lung Neoplasms; Male; Middle Aged; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Detection of unknown primary tumor in a patient with cerebellar metastasis using FDG PET-CT: case report].
Topics: Aged; Cerebellar Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Usefulness of [18F] fluoro-2-deoxyglucose-positron emission tomography-computed tomography (FDG-PET-CT) in the detection of lung cancer recurrence with paraneoplastic neurological syndrome.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer.
Topics: Adult; Aged; Cryptococcosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2006 |
Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted | 2007 |
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis | 2006 |
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis.
Topics: Aged; Bone Marrow; Bone Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Radioguided detection of lymph node metastasis in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Thorax | 2006 |
Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis | 2006 |
Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2007 |
Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2007 |
18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Linear Models; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2006 |
Use of anthropometric factors in 18F-FDG PET bone marrow SUVs.
Topics: Analysis of Variance; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2006 |
FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Time Factors | 2007 |
Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2006 |
[The value of FDG-PET/CT in the evaluation of patients with a pulmonary nodule and a previous malignant disease].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Solitary Pulmonary Nodule; Tomography, Emission-Computed, Single-Photon | 2006 |
Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Topics: Adult; Aged; Carcinoid Tumor; Cell Division; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Intramuscular tumor detected by FDG positron emission tomography scanning following postoperative lung cancer.
Topics: Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lipoma; Lung Neoplasms; Middle Aged; Muscle Neoplasms; Neoplasms, Adipose Tissue; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2007 |
Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Smoking; Tomography, X-Ray Computed | 2006 |
Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2007 |
[Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Tissue Distribution; Xenograft Model Antitumor Assays | 2006 |
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tomography, X-Ray Computed | 2006 |
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures | 2006 |
[Iatrogenic lung microembolism detected by 18FDG PET/CT].
Topics: Adult; Diagnosis, Differential; Endothelium, Vascular; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Iatrogenic Disease; Injections, Intravenous; Lung Neoplasms; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals | 2006 |
Round pneumonia mimicking pulmonary malignancy on F-18 FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Pneumonia; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |
Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2007 |
Invited commentary.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2007 |
11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Aged; Carbon; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2007 |
Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Esophageal Diseases; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2007 |
Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Topics: Adult; Aged; Biopsy; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2007 |
Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mixed Tumor, Malignant; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results | 2007 |
[Evaluation of FDG-PET imaging for the detection of gastrointestinal tract cancer in patients with suspected lung cancer].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Topics: Aged; Analysis of Variance; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2007 |
[18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Time Factors | 2007 |
Chewing gum causing a very high FDG uptake of the tongue on PET scan.
Topics: Aged; Artifacts; Carcinoma, Non-Small-Cell Lung; Chewing Gum; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tongue | 2007 |
[18F-FDG PET/CT in paraneoplastic osteoarthropathy].
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Osteoarthropathy, Secondary Hypertrophic; Palliative Care; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Author's correction. "Incidental findings on integrated PET/CT that do not accumulate 18F-FDG".
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Time Factors | 2007 |
Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer.
Topics: Bronchial Neoplasms; Cell Proliferation; Cesium; Epithelial Cells; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Stromal Cells; Tomography, X-Ray Computed | 2007 |
Accuracy of PET/CT in characterization of solitary pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2007 |
Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging.
Topics: Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Guanine; Herpesvirus 1, Human; Image Processing, Computer-Assisted; Luciferases; Luminescence; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine Kinase; Tomography, X-Ray Computed; Transplantation, Heterologous | 2007 |
FDG-PET and CT features of non-small cell lung cancer based on tumor type.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
[The diagnostic value of FDG coincidence imaging combined with serum tumor marker assays for pulmonary lesions].
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Keratins; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Plasma Cell Granuloma, Pulmonary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2006 |
Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Topics: Bone Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Monitoring, Physiologic; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Observer Variation; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2007 |
Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2007 |
Persistent FDG uptake around an inguinal mesh prosthesis 25 years after implantation.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Lung Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Surgical Mesh | 2007 |
Detection of a small lung cancer hidden in pneumoconiosis with progressive massive fibrosis using F-18 fluorodeoxyglucose PET/CT.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Radionuclide Imaging | 2007 |
[Nocardiosis as a differential diagnosis of a PET-positive pulmonary nodule].
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Therapy, Combination; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Nocardia Infections; Positron-Emission Tomography; Radiography; Radioisotopes; Treatment Outcome | 2007 |
Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2007 |
PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
Topics: Artificial Intelligence; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lung Neoplasms; Male; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancer.
Topics: 4-Butyrolactone; Animals; Disease Models, Animal; Enzyme Inhibitors; Fatty Acid Synthases; Fluorodeoxyglucose F18; Lung Neoplasms; Positron-Emission Tomography; Rats | 2007 |
The value of HRCT and Tc-depreotide in the evaluation of pulmonary lesions.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2006 |
Short-term restaging of patients with non-small cell lung cancer receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bronchoscopy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2007 |
Pulmonary mucinous cystadenocarcinoma: an extremely rare tumor presenting as a cystic lesion of the lung.
Topics: Aged; Cystadenocarcinoma, Mucinous; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Tomography, X-Ray Computed | 2007 |
Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
F-18-FDG-PET/CT leads to diagnosis of cryptococcal pneumonia where recurrent metastatic rhabdomyosarcoma was suspected.
Topics: Child; Cryptococcosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2007 |
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Topics: Abdominal Neoplasms; Adult; Aged; Colonic Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Fluoro-2-deoxy-D-glucose positron emission tomography in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
A "fat chance" it's malignant: lipoid pneumonia simulating lung cancer on PET scan.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pneumonia, Lipid; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Postacquisition detection of tumor motion in the lung and upper abdomen using list-mode PET data: a feasibility study.
Topics: Abdominal Neoplasms; Algorithms; Artifacts; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Dynamic threshold for radiation target volume by PET/CT.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Linear Models; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2007 |
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Thyroid Neoplasms | 2007 |
The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis | 2007 |
Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule | 2007 |
Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Positron-Emission Tomography; Radiotherapy; Reproducibility of Results; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2007 |
Endometrioma presenting as a cavitary lung mass with intense 18F-FDG uptake on PET-CT.
Topics: Cough; Diagnosis, Differential; Endometriosis; Female; Fluorodeoxyglucose F18; Hemoptysis; Humans; Lung; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed | 2007 |
Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2007 |
Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pneumonia; Preoperative Care; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2006 |
Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.
Topics: Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Italy; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Prognostic significance of fluorodeoxyglucose uptake in non-small cell lung cancer. A blurry picture?
Topics: Adenosine Triphosphate; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multivariate Analysis; Prognosis; Radiopharmaceuticals | 2007 |
Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors | 2007 |
[Usefulness of FDG-PET for the diagnosis of postoperative recurrence of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies | 2007 |
Choriocarcinoma with pulmonary metastasis: report of a case of successful treatment with serial FDG-PET follow-up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Uterine Neoplasms | 2007 |
Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2007 |
FDG-PET: an important tool in the diagnosis of lung cancer.
Topics: Abdomen; Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Lung cancer with isolated skip metastasis to an abdominal lymph node.
Topics: Abdomen; Adenocarcinoma; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Reduced glucose uptake with markedly increased gastrin releasing peptide, osteopontine & asbestos found in dark black areas of PET Scan of chest wall in patient with mesothelioma.
Topics: Aged; Asbestos; Fluorodeoxyglucose F18; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Male; Mesothelioma; Osteopontin; Positron-Emission Tomography; Radiopharmaceuticals; Thorax | 2006 |
Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans.
Topics: Adenoma, Villous; Adenomatous Polyps; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET.
Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Feasibility Studies; Female; Fluorodeoxyglucose F18; Lung Neoplasms; Mice; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Probability; Radiotherapy, Conformal; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2007 |
Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2007 |
Adenoid cystic carcinoma of the lung: interest of 18FDG PET/CT in the management of an atypical presentation.
Topics: Aged; Aged, 80 and over; Carcinoma, Adenoid Cystic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Choroid Neoplasms; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Sigmoid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Positron emission tomography staging of pleural deposits following Monaldi's procedure: an accurate reflection or a false staging?
Topics: Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Drainage; False Positive Reactions; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Pleura; Pleurodesis; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Talc; Tomography, X-Ray Computed | 2007 |
Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Interventional | 2007 |
Pecoma of the lung: a benign tumor with extensive 18F-2-deoxy-D-glucose uptake.
Topics: Aged; Cell Differentiation; Epithelioid Cells; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Spiral Computed; Treatment Outcome | 2007 |
18F-FDG PET in planning radiation treatment of non-small cell lung cancer: where exactly is the tumor?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2007 |
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2007 |
Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Pneumoconiosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Metastasis of the gastrointestinal tract: FDG-PET imaging.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Duodenum; Fever; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiography; Recurrence; Renal Insufficiency; Salvage Therapy; Vascular Neoplasms; Vincristine | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Reproducibility of Results; ROC Curve; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
[Clinical significance of integrated PET/CT in the diagnosis of thoracic cancers].
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Everolimus; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Sirolimus; Tomography, X-Ray Computed | 2007 |
Increased radiotracer uptake on positron emission tomography after invasive thoracic procedures: a case series.
Topics: Aged; Bronchoscopy; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thoracoscopy; Time Factors; Tomography, X-Ray Computed | 2007 |
Metabolic tumor burden predicts for disease progression and death in lung cancer.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2007 |
Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
False-positive FDG-PET scan secondary to lipoid pneumonia mimicking a solid pulmonary nodule.
Topics: Aged; Biopsy, Fine-Needle; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonia, Lipid; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Smoking; Solitary Pulmonary Nodule | 2007 |
When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Retrospective Studies; ROC Curve; Survival Analysis; Time Factors; Tomography, X-Ray Computed | 2007 |
Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2008 |
STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2007 |
Positron emission tomography imaging in nonsmall-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2007 |
Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.
Topics: Adult; Aerobiosis; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; HCT116 Cells; Humans; Lung Neoplasms; Male; Middle Aged; Mitochondria; Mitochondrial Proton-Translocating ATPases; Oxidative Phosphorylation; Positron-Emission Tomography | 2007 |
Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2007 |
Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; ErbB Receptors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Quinazolines; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2008 |
Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2008 |
18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2007 |
Maximum standard uptake values of mediastinal nodes on PET and CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2007 |
The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis.
Topics: Adenocarcinoma; Dermatomyositis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
Intramedullary spinal cord metastasis as initial presentation of systemic cancer--report of a rare case.
Topics: Aged; Carcinoma, Bronchogenic; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Magnetic Resonance Imaging; Male; Microsurgery; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord; Spinal Cord Neoplasms | 2007 |
[Case of pulmonary tuberculosis with both a solitary nodule and enlarged lymph nodes showing intense uptake on 18f-fluoro-deoxy glucose positron emission tomography (18FDG-PET) requiring differentiation from lung cancer].
Topics: Antitubercular Agents; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
[Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2007 |
Super scan using positron emission tomography in lung cancer patients.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2007 |
CT and PET appearance of a pigmented "black" adrenal adenoma in a patient with lung cancer.
Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
[Staging of non-small cell lung cancer. Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2007 |
Clinical significance of (18)F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: a retrospective study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2007 |
FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contraindications; Diagnosis, Differential; Eligibility Determination; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Immune Tolerance; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
Topics: Aged; Aged, 80 and over; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2008 |
18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technology Assessment, Biomedical | 2007 |
Pulmonary Paragonimus westermani with false-positive fluorodeoxyglucose positron emission tomography mimicking primary lung cancer.
Topics: Aged; Animals; Bromhexine; Bronchoscopy; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Parasitic; Lung Neoplasms; Paragonimiasis; Paragonimus westermani; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients.
Topics: Adult; Aged; Bronchi; Bronchography; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Incidental finding of prostate cancer and adenomatous colon polyp in a patient with lung cancer.
Topics: Abdomen; Adenomatous Polyps; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Prostatic Neoplasms; Thorax; Tomography, X-Ray Computed | 2007 |
FDG PET/CT findings of epithelioid sarcoma in a pediatric patient.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleural Effusion; Positron-Emission Tomography; Sacrum; Sarcoma; Tomography, X-Ray Computed | 2007 |
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Baastrup's disease (kissing spine) demonstrated by FDG PET/CT.
Topics: Anesthetics, Local; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Diseases; Spine; Tomography, X-Ray Computed | 2008 |
Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Anesthesia condition for (18)F-FDG imaging of lung metastasis tumors using small animal PET.
Topics: Anesthesia; Animals; Female; Fluorodeoxyglucose F18; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed | 2008 |
Pulmonary intestinal-type adenocarcinoma.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Keratin-20; Keratin-7; Lung Neoplasms; Lymph Node Excision; Male; Nuclear Proteins; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sputum; Thoracic Surgery, Video-Assisted; Thyroid Nuclear Factor 1; Tomography, X-Ray Computed; Transcription Factors | 2008 |
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2007 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Pulmonary echinococcosis mimicking multiple lung metastasis of breast cancer: the role of fluoro-deoxy-glucose positron emission tomography.
Topics: Albendazole; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Diagnosis, Differential; Echinococcosis, Pulmonary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2008 |
Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Choroidal and extraocular muscle metastases from non-small-cell lung carcinoma: F-18 FDG PET/CT imaging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Choroid Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Oculomotor Muscles; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2008 |
[The values of (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography in diagnosis of indefinite liver masses].
Topics: Acetates; Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity | 2007 |
Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
Topics: Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer?
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Taiwan; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2008 |
F-18 FDG PET/CT demonstration of thymoma followed by development of lung cancer.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed | 2008 |
[FDG-PET-CT and the diagnosis of malignancy of pulmonary nodules and mass lesions].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; Risk Factors | 2008 |
The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; United States | 2008 |
An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer.
Topics: Appendiceal Neoplasms; Carcinoma, Small Cell; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Topics: Aged; Chi-Square Distribution; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose po
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Models, Biological; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2008 |
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iron-Sulfur Proteins; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed | 2008 |
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Multimodal virtual bronchoscopy using PET/CT images.
Topics: Bronchoscopes; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; User-Computer Interface | 2008 |
Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
Topics: Carcinoma, Small Cell; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.
Topics: Adult; Chest Pain; Diagnosis, Differential; Dyspnea; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Mesothelioma; Pericardium; Positron-Emission Tomography; Pulmonary Edema; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed | 2008 |
Kaposi sarcoma after bilateral lung transplantation.
Topics: Biopsy; Cystic Fibrosis; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Herpesvirus 8, Human; Humans; Lung; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Radiopharmaceuticals; Sarcoma, Kaposi; Tomography, X-Ray Computed | 2008 |
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.
Topics: Aged; Antigens, CD; Apoptosis Regulatory Proteins; Cadherins; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Non-Small-Cell Lung; Core Binding Factor Alpha 2 Subunit; Cyclin-Dependent Kinase Inhibitor p16; Death-Associated Protein Kinases; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Ether-A-Go-Go Potassium Channels; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Receptors, Retinoic Acid; Tomography, Emission-Computed; Tumor Suppressor Proteins | 2008 |
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2008 |
Metastatic brain lesions may demonstrate photopenia on FDG-PET.
Topics: Aged; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2008 |
Prognostic value of FDG uptake in early stage non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2008 |
Sarcoidosis.
Topics: Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2008 |
Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[Lung neoplasms--ultrasonic endoscopy as a first diagnostic tool].
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2008 |
[Benign and malignant solitary pulmonary nodules--PET/CT for differential diagnosis].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2008 |
Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making.
Topics: Carcinoma, Non-Small-Cell Lung; Costs and Cost Analysis; Decision Making; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Pulmonary typical carcinoid tumor and liver metastasis with hypermetabolism on 18-fluorodeoxyglucose PET: a case report.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Spinal cord metastases from lung cancer: detection with F-18 FDG PET/CT.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2008 |
Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.
Topics: Bronchitis; Carcinoma, Medullary; Chronic Disease; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Good vibrations and the power of positron thinking: positron emission tomography and endoscopic ultrasound in staging of mesothelioma-two case reports.
Topics: Combined Modality Therapy; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
Lack of FDG uptake in small cell carcinoma associated with ANNA-1 positive paraneoplastic autonomic neuropathy.
Topics: Aged; Antibodies, Neoplasm; Biopsy; Carcinoma, Small Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Paraneoplastic Polyneuropathy; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Enhanced experimental tumor metastasis with age in senescence-accelerated mouse.
Topics: Aging; Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Idoxuridine; Immunologic Surveillance; Lung Neoplasms; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Nucleic Acid Synthesis Inhibitors; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[Significance of 8F-FDG PET-CT standard uptake value in clinical target delineation for radiotherapy of the primary tumor of non-small cell lung carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2007 |
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Primary pulmonary meningioma: report of a case and review of the literature.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Young Adult | 2008 |
Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2009 |
Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
Topics: Alzheimer Disease; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vinblastine; Vinorelbine | 2007 |
Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor.
Topics: Catheter Ablation; Clinical Protocols; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Probability; Radiopharmaceuticals; ROC Curve; Solitary Pulmonary Nodule | 2008 |
Bronchial obstruction due to Teflon pledgets migration 13 years after lobectomy.
Topics: Aged; Bronchi; Bronchial Diseases; Bronchoscopy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Foreign-Body Migration; Humans; Lung Neoplasms; Male; Pneumonectomy; Polytetrafluoroethylene; Positron-Emission Tomography; Postoperative Complications; Stents; Sutures; Tomography, X-Ray Computed | 2008 |
Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Carcinoma; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Sensitivity and Specificity; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management.
Topics: Abdominal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Seminoma; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed | 1995 |
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Carcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Tomography, Emission-Computed | 1995 |
[18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator].
Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Glycolysis; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; False Positive Reactions; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Recurrence; Reproducibility of Results; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Detecting recurrent or residual lung cancer with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Tomography, Emission-Computed | 1995 |
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
Topics: Aged; Aged, 80 and over; Blood Glucose; Deoxyglucose; Fatty Acids, Nonesterified; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Insulin; Lung Neoplasms; Male; Middle Aged; Observer Variation; Tomography, Emission-Computed | 1995 |
Characterization of chest masses by FDG positron emission tomography.
Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
[Evaluation of pulmonary lesions with positron emission tomography].
Topics: Blood Glucose; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Prospective Studies; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1994 |
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Models, Biological; Time Factors; Tomography, Emission-Computed | 1994 |
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Topics: Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Fibrosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Positron emission tomography analysis of metastatic tumor cell trafficking.
Topics: Animals; Cell Movement; Deoxyglucose; Female; Fluorodeoxyglucose F18; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; Neuraminidase; Rats; Rats, Inbred F344; Tomography, Emission-Computed; Tumor Cells, Cultured | 1994 |
Satellite PET and lung cancer: a prospective study in surgical patients.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hospitals, Satellite; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Thoracic Neoplasms; Tomography, Emission-Computed | 1993 |
Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Tomography, Emission-Computed | 1993 |
Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Topics: Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1993 |
Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
Topics: Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 1993 |
The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.
Topics: Blood Glucose; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Topics: Aged; Carcinoma, Small Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Reversible Tc-99m diphosphonate uptake in gastric tissue associated with malignancy related hypercalcemia. A comparative study using PET FDG whole body imaging.
Topics: Bone Neoplasms; Carcinoma, Bronchogenic; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Stomach; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Intermodality, retrospective image registration in the thorax.
Topics: Aged; Algorithms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Phantoms, Imaging; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biopsy; Case-Control Studies; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1995 |
Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Topics: Adenocarcinoma; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Radiography, Thoracic; Tomography, Emission-Computed | 1996 |
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neurilemmoma; Pneumonia; Predictive Value of Tests; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Tuberculosis, Pulmonary | 1996 |
The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
Topics: Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Cicatrix; Deoxyglucose; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Diseases; Lung Neoplasms; Neoplasm, Residual; Prospective Studies; Remission Induction; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Probability; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1996 |
Simplified measurement of deoxyglucose utilization rate.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Tomography, Emission-Computed | 1996 |
FDG-PET screening for cerebral metastases in patients with suspected malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Testicular Neoplasms; Tomography, Emission-Computed | 1996 |
Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Time Factors; Tomography, Emission-Computed | 1996 |
PET scanning said to save money and improve staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost Savings; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Staging; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1995 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
[Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Quantification of serial tumor glucose metabolism.
Topics: Computer Simulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Models, Biological; Reproducibility of Results; Tomography, Emission-Computed | 1996 |
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Male; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
Topics: Aged; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans.
Topics: Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Tomography, Emission-Computed | 1996 |
[Cancer screening with whole-body FDG PET].
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed | 1996 |
Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cost-Benefit Analysis; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Pulmonary abnormalities and PET data analysis: a retrospective study.
Topics: Adult; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Observer Variation; Retrospective Studies; ROC Curve; Tomography, Emission-Computed | 1997 |
Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
Topics: Deoxyglucose; Diagnosis, Differential; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiography; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed, Single-Photon | 1997 |
Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
Positron emission tomography, bronchogenic carcinoma, and the adrenals.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Biopsy, Needle; Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiography; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Role of positron emission tomography in the staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Tomography, Emission-Computed | 1997 |
Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Lung Neoplasms; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Rats; Thymidine; Transcription, Genetic | 1994 |
Development of oncology protocol using fluorine-18-FDG: one center's experience.
Topics: Blood Glucose; Colonic Neoplasms; Deoxyglucose; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Patient Education as Topic; Practice Guidelines as Topic; Problem Solving; Quality Control; Quality of Health Care; Radiation Oncology; Radiology Information Systems; Radiopharmaceuticals; Rectal Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 1997 |
[Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan].
Topics: Cost-Benefit Analysis; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Topics: Bayes Theorem; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
[Positron-emission tomography in oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
[Positron emission tomography detection of residual disease in a case of lung cancer].
Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Neoplasm, Residual; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Topics: Adult; Aged; Algorithms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Therapy, Computer-Assisted; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer.
Topics: Arthritis, Rheumatoid; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Joints; Lung; Lung Diseases; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
[Positron-emission tomography in the evaluation of lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Localized form of bronchioloalveolar carcinoma: FDG PET findings.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.
Topics: Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Methionine; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
A clinical evaluation of the quantitative accuracy of simultaneous emission/transmission scanning in whole-body positron emission tomography.
Topics: Artifacts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Topics: Adult; Aged; Biopsy; Carcinoid Tumor; Diagnosis, Differential; Disease-Free Survival; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Topics: Abdomen; Abdominal Neoplasms; Adenocarcinoma; Axilla; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neck; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Chromatography, Thin Layer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Phosphorylation; Radiopharmaceuticals; Tomography, Emission-Computed; Tumor Cells, Cultured | 1998 |
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1998 |
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Middle Aged; Neoplasm Staging; Odds Ratio; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pneumonia, Bacterial; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Nuclear medicine: the road to smart medicine and surgery.
Topics: Brain Diseases; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart Diseases; Humans; Lung Neoplasms; Nuclear Medicine; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Diseases | 1998 |
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
[Positron emission tomography and bone scintigraphy of an osteoclast metastasis].
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteoblasts; Palliative Care; Radiopharmaceuticals; Ribs; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, Emission-Computed | 1998 |
Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Radiopharmaceuticals; Teratoma; Tomography, Emission-Computed | 1998 |
[Decision tree sensitivity analysis for cost-effectiveness of chest FDG-PET in patients with a pulmonary tumor (non-small cell carcinoma)].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Hospitalization; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thorax; Tomography, Emission-Computed | 1998 |
Detection of extrathoracic metastases by positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Carbon-11-thymidine and FDG to measure therapy response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Radioisotopes; Carcinoma, Small Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Thymidine; Tomography, Emission-Computed | 1998 |
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Diagnosis of spine metastases by FDG imaging using a gamma camera in the coincidence mode.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Spinal Neoplasms; Tomography, Emission-Computed | 1998 |
Dual isotope F-18 FDG and Tc-99m RBC imaging for lung cancer.
Topics: Aged; Erythrocytes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Trees; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Medicare; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 1998 |
[Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Topics: Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Lymphoma; Male; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
Topics: Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Physical Phenomena; Physics; Radiographic Image Enhancement; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG SPECT in patients with lung masses.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1999 |
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; Lung; Lung Neoplasms; Male; Monosaccharide Transport Proteins; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
Topics: Adult; Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pulmonary Atelectasis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
[Imaging of an adrenal cortex carcinoma and its metastasis with FDG-PET].
Topics: Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1999 |
Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Actinomycosis; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1999 |
[Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
Topics: Aged; Animals; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Topics: Adult; Aged; Autoantibodies; Bone Neoplasms; Carcinoma, Papillary; Data Interpretation, Statistical; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
A new look at breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Staging non-small cell lung cancer with whole-body PET.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1999 |
Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Survival Analysis; Tomography, Emission-Computed | 1999 |
Thallium and FDG uptake by atelectasis with bronchogenic carcinoma.
Topics: Biological Transport; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pulmonary Atelectasis; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
The clinical usefulness of F-18 FDG coincidence PET without attenuation correction and without whole-body scanning mode in pulmonary lesions comparison with CT, MRI, and clinical findings.
Topics: Aged; Biopsy, Needle; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Observer Variation; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Value of Pet-18FDG in lung cancer].
Topics: Carcinoma; Cost-Benefit Analysis; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
Topics: Adult; Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Imaging of secondary pulmonary changes in central bronchial carcinomas by F-18-FDG PET].
Topics: Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithm.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Neoplasm Metastasis; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed | 1999 |
FDG PET measurement of the proliferative potential of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Division; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Initial evaluation of pulmonary abnormalities: CT-guided fine-needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation.
Topics: Biopsy, Needle; Carcinoma; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2000 |
Pseudolymphoma of the lung: Benign pulmonary nodule with elevated fluorodeoxyglucose uptake.
Topics: Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Pseudolymphoma; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Japan; Life Expectancy; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Three-dimensional clinical PET in lung cancer: validation and practical strategies.
Topics: Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Tomography, Emission-Computed | 2000 |
[Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma].
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 2000 |
F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Respiratory Tract Infections; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Unsubstantiated conclusions can impede progress in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
[Picture of the month. Rest tumors and metastases].
Topics: Aged; Animals; Biomarkers, Tumor; Carcinoembryonic Antigen; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Tomography, Emission-Computed | 1999 |
Standardized uptake value as an unreliable index of renal disease on fluorodeoxyglucose PET imaging.
Topics: Aged; Blood Glucose; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Diseases, Cystic; Kidney Neoplasms; Lung; Lung Neoplasms; Male; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[How I investigate ... a broncho-pulmonary cancer by metabolic imaging (PET-18-FDG)].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Prognosis; Tomography, Emission-Computed | 2000 |
Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Silicosis callosities or bronchial carcinoma: on the problem of functional differentiation using FDG-PET].
Topics: Callosities; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Radiopharmaceuticals; Silicosis; Tomography, Emission-Computed | 2000 |
The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies.
Topics: Aged; Aged, 80 and over; ELAV Proteins; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nerve Tissue Proteins; Paraneoplastic Syndromes; RNA-Binding Proteins; Tomography, Emission-Computed | 2000 |
Metabolic staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
A combined PET/CT scanner for clinical oncology.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Data Interpretation, Statistical; Duodenal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Polyps; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG-PET detection of primary lung cancer in a patient with an isolated cerebral metastasis.
Topics: Adenocarcinoma; Biopsy; Brain Neoplasms; Bronchoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Use of PET to monitor the response of lung cancer to radiation treatment.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed | 2000 |
Utility evaluations for Markov states of lung cancer for PET-based disease management.
Topics: Aged; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Decision Making; Decision Support Techniques; Fluorodeoxyglucose F18; Health Status Indicators; Humans; Lung Neoplasms; Markov Chains; Mediastinoscopy; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Patient Participation; Quality of Life; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Problems of differential diagnosis in the diagnosis of mediastinal and pulmonary metastases with F-a8-FDG PET].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Middle Aged; Radiography; Radiopharmaceuticals; Sigmoid Neoplasms; Tomography, Emission-Computed | 2000 |
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Choline; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.
Topics: Abdomen; Adolescent; Adult; Aged; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mass Screening; Melanoma; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography; Whole-Body Irradiation | 2000 |
[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2000 |
FDG positron emission tomography in the diagnosis of peripheral pulmonary focal lesions.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Local Lymph Node Assay; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Prognosis; Tomography, Emission-Computed | 2000 |
Introduction to clinical positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Localization of a tumor of unknown origin by means of 18-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2000 |
Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Keratin-19; Keratins; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2000 |
Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung; Lung Neoplasms; Male; Radiation Pneumonitis; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Evaluation of an adrenal mass in a patient with lung cancer by FDG coincidence positron emission tomography using a dual-head gamma camera.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
Topics: Biopsy, Needle; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Germany; Humans; Insurance, Health, Reimbursement; Life Expectancy; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Survival Rate; Tomography, Emission-Computed | 2000 |
Short dynamic FDG-PET imaging protocol for patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
FDG imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Palliative Care; Probability; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Free Radical Scavengers; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Thiosemicarbazones; Tissue Distribution; Tomography, Emission-Computed | 2000 |
[Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer].
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Detection of unsuspected gastric MALT-lymphoma with F-18-FDG-PET.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Victoria | 2001 |
Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Soft Tissue Neoplasms; Thoracic Neoplasms; Tomography, Emission-Computed | 2001 |
F-18 FDG uptake in endometrial cancer.
Topics: Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed | 2001 |
Staging of non-small-cell lung cancer with positron-emission tomography.
Topics: Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Correlation of Glut-1 glucose transporter expression with.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Paraffin Embedding; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
[Diagnostic efficacy of 18F-fluorodeoxy glucose-positron emission tomography in multiple solitary pulmonary nodules].
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Lethal Midline; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
[Contribution of PET using FDG in the diagnosis of lung cancer--first results].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Phantoms, Imaging; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Technology, Radiologic; Tomography, X-Ray Computed | 2001 |
FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2001 |
[A case of radiologically negative small-cell lung carcinoma successfully detected early by whole-body FDG-PET].
Topics: Aged; Carcinoma, Small Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Differentiation of radiographically indeterminate solitary pulmonary nodules with.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2001 |
Hypermetabolism of the medial temporal lobe in limbic encephalitis on (18)FDG-PET scan: a case report.
Topics: Aged; Carcinoma, Small Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Memory Disorders; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed | 2001 |
Staging and managing lung tumors using F-18 FDG coincidence detection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
Detection of cranial metastases by F-18 FDG positron emission tomography.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pheochromocytoma; Radiopharmaceuticals; Skull Neoplasms; Tomography, Emission-Computed | 2001 |
Unilateral diaphragmatic crus uptake on FDG positron emission tomographic imaging.
Topics: Aged; Carcinoma, Squamous Cell; Diaphragm; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pleural Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Work of Breathing | 2001 |
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.
Topics: Algorithms; Brain; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Clinical skills in conducting research studies on clinical applications of oncologic PET.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography detection of metastatic penile squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Penis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
FDG-PET imaging for the staging and follow-up of small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective review.
Topics: Adult; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Early experience with PET scanning in thoracic tumours.
Topics: Adult; Aged; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Topics: Adolescent; Adult; Bone and Bones; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteosarcoma; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG PET study.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Lung Neoplasms; Male; Melanoma; Middle Aged; Phosphorylation; Prognosis; Radiopharmaceuticals; Radiosurgery; Tomography, Emission-Computed | 2001 |
Detection of choriocarcinoma in the lung by FDG positron emission tomography.
Topics: Adult; Choriocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Perfusion; Radiographic Image Enhancement; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Isolated cavitary pulmonary nodule and positron emission tomography].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Predictive Value of Tests; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2001 |
Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Constitution; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2001 |
[PET - Quo vadis?].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Accuracy of positron emission tomography with fluorine-18-fluoro-deoxyglucose].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Visual and semiquantitative analysis of 18F-fluorodeoxyglucose positron emission tomography using a partial-ring tomograph without attenuation correction to differentiate benign and malignant pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[A case of lung cancer in which FDG-PET was useful for preoperative diagnosis].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Middle Aged; Pneumonectomy; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 2001 |
F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 2001 |
Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2001 |
FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Retrospective Studies; Thorax; Tomography, Emission-Computed | 2001 |
Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Changing pattern of lung cancer and its imaging: (201)Tl SPECT versus [(18)F]FDG PET.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography.
Topics: Carcinoma; Carcinoma, Large Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
Effect of dietary intake before F-18 FDG positron emission tomographic scanning on the evaluation of a solitary pulmonary nodule.
Topics: Blood Glucose; False Negative Reactions; Fluorodeoxyglucose F18; Food-Drug Interactions; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2001 |
FDG-PET in adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET.
Topics: Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Observer Variation; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Two incorrect FDG positron emission tomographic interpretations of a pulmonary mass and mediastinal lymphadenopathy.
Topics: Adenocarcinoma; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Diseases; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
F-18 FDG uptake in pulmonary lymphangioleiomyomatosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphangioleiomyomatosis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 2001 |
Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung.
Topics: Adult; Aged; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Methionine; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2001 |
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Topics: Adenocarcinoma; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Intestinal Neoplasms; Ligands; Lung Neoplasms; Lymphoma; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tyrosine | 2001 |
PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis.
Topics: Adult; Alkaline Phosphatase; Diagnosis, Differential; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Immunohistochemistry; Isoenzymes; Lung Neoplasms; Lymphatic Diseases; Male; Mediastinum; Radiopharmaceuticals; Sarcoidosis; Testicular Neoplasms; Tomography, Emission-Computed | 2001 |
Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Radiation Pneumonitis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vinblastine; Vinorelbine | 2002 |
[Value of 18F-fluorodeoxyglucose positron emission tomography imaging in staging of non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 2002 |
Is quantitation necessary for oncological PET studies? For.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospital Costs; Hospitals, Community; Humans; Lung Neoplasms; Male; Medical Futility; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Postoperative Care; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pilot Projects; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 2002 |
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Topics: Aged; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, Emission-Computed | 2002 |
Value of positron emission tomography for lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sodium Iodide; Tomography, Emission-Computed | 2002 |
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Monitoring; Epirubicin; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Paclitaxel; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Improved image interpretation with registered thoracic CT and positron emission tomography data sets.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Radiography, Thoracic; Radiopharmaceuticals; Thoracic Neoplasms; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Tumor localization and image registration of F-18 FDG coincidence detection scans with computed tomographic scans.
Topics: Adenocarcinoma; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Metabolic imaging of a solitary pulmonary nodule.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, Emission-Computed | 2002 |
[Value of 18FDG-CDET in the evaluation of operable bronchial cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Metastasis in leptomeninges discovered with PET-FDG].
Topics: Adenocarcinoma; Bone Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Middle Aged; Radiopharmaceuticals; Radiosurgery; Rectal Neoplasms; Sigmoid Neoplasms; Spinal Neoplasms; Tomography, Emission-Computed | 2001 |
[Impact of [18F]-FDG-PET on medical decision making in oncology: evaluation by the referring physicians during the opening year].
Topics: Colorectal Neoplasms; Decision Making; Fluorodeoxyglucose F18; France; Health Care Surveys; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Otorhinolaryngologic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Surveys and Questionnaires | 2002 |
Discordant Tc-99m depreotide and F-18 FDG imaging in a patient with poorly differentiated small-cell neuroendocrine carcinoma.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Small Cell; Cell Transformation, Neoplastic; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Tomography, X-Ray Computed | 2002 |
Bilateral adrenal metastases revealed by F-18 FDG coincidence detection positron emission tomography in a patient with lung cancer.
Topics: Adrenal Gland Neoplasms; Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2002 |
Value of FDG-PET scanning in management of lung cancer.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Thoracotomy; Tomography, Emission-Computed; Unnecessary Procedures | 2002 |
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed | 2002 |
T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Registries; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Iowa; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA).
Topics: Aged; Aged, 80 and over; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Back Pain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed; Treatment Outcome; Vascular Surgical Procedures | 2002 |
FDG positron emission tomographic imaging of pseudo-pseudo tumor.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Diagnosis, Differential; Dyspnea; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Plasma Cell Granuloma, Pulmonary; Pulmonary Disease, Chronic Obstructive; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma | 2002 |
Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
Topics: Adult; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
The impact of PET on the management of lung cancer: the referring physician's perspective.
Topics: Attitude of Health Personnel; Data Collection; Disease Management; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Staging; Referral and Consultation; Surveys and Questionnaires; Tomography, Emission-Computed | 2002 |
FDG-PET imaging in small cell lung cancer: any value?
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorodeoxyglucose F18; Lung Neoplasms; Neoplasm Staging; Patient Care Planning; Patient Selection; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Lung cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Imaging of thoracic occupational and environmental malignancies.
Topics: Aged; Aged, 80 and over; Asbestos; Carcinogens, Environmental; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Mortality; Neoplasm Recurrence, Local; Neoplasm Staging; Occupational Diseases; Pulmonary Atelectasis; Radiography; Silicosis; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed | 2002 |
Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Muscles; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cord Paralysis | 2002 |
[Cavitary lung cancer and FDG-PET].
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, Emission-Computed | 2002 |
Effect of respiratory gating on quantifying PET images of lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Respiration; Tomography, Emission-Computed | 2002 |
(18)F-fluorodeoxyglucose positron emission tomography: false-positive lung scan.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Uptake of 2-fluoro-2-deoxy-D-[U-14C]-glucose during chemotherapy in murine Lewis lung tumor.
Topics: Adenosine Triphosphate; Animals; Carmustine; Deoxyglucose; Doxorubicin; Female; Flow Cytometry; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Lung Neoplasms; Mice; Mice, Inbred C57BL; Radionuclide Imaging | 1992 |
Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Topics: Animals; Carbon Radioisotopes; Deoxyglucose; Diagnosis, Differential; Disease Models, Animal; Floxuridine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fucose; Lung Neoplasms; Methionine; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Thymidine; Tomography, Emission-Computed; Tritium | 1992 |
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Topics: Abdominal Neoplasms; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Diagnostic Techniques, Surgical; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Necrosis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1992 |
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1991 |
Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1990 |
Differential diagnosis of lung tumor with positron emission tomography: a prospective study.
Topics: Adult; Aged; Carbon Radioisotopes; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Male; Methionine; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1990 |
[Positron emission tomography of lung cancer using 18F-2-fluoro-2-deoxy-D-glucose and L-[11C-methyl]-methionine].
Topics: Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Radioisotopes; Radionuclide Imaging | 1987 |